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Abstract
Examining the role of patients’ experiences as a resource for
choice and decision-making in health care: a creative,
interdisciplinary mixed-method study in digital health
Sue Ziebland,1* John Powell,1 Pamela Briggs,2 Crispin Jenkinson,3
Sally Wyke,4 Elizabeth Sillence,2 Peter Harris,5 Rafael Perera,1
Fadhila Mazanderani,6 Angela Martin,1 Louise Locock,1 Laura Kelly,3
Margaret Booth,7 Bob Gann,8 Nicola Newhouse1 and Andrew Farmer1
1Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK
2Department of Psychology, Northumbria University, Newcastle upon Tyne, UK
3Nuffield Department of Population Health, University of Oxford, Oxford, UK
4Institute of Health and Wellbeing, University of Glasgow, Glasgow, UK
5School of Psychology, University of Sussex, Brighton, UK
6School of Social and Political Science, University of Edinburgh, Edinburgh, UK
7Lay Representative, Oxford, UK
8Widening Digital Participation, NHS England, London, UK
*Corresponding author sue.ziebland@phc.ox.ac.uk
Background: Traditional health information has been based on facts and figures and not on patient
experience (PEx). Websites featuring people’s accounts of their experiences of health and illness are
popular as a source of information, support and much else. However, there are concerns that experiential
information on the internet might have adverse effects on health.
Aims: To find out whether, when and how the NHS should incorporate PEx into online health information
and elucidate the mechanisms through which PEx might influence health, develop a tool to measure the
effects of online PEx, explore how PEx is used, and investigate the feasibility and acceptability of a
randomised controlled trial of online PEx.
Methods: Mixed methods, including a conceptual literature review, qualitative secondary data analysis,
the development of a new questionnaire, online ethnography, observational and experimental studies in
an internet café environment, and finally feasibility trials to compare new websites based on PEx with
those based on facts and figures.
Results: The review concluded that online PEx could affect health outcomes through seven domains
(information, support, affecting relationships, providing ideas on how to use health services, influencing
behaviour change, learning to tell the story and visualising illness). We developed the e-Health Impact
Questionnaire, which demonstrates good psychometric properties and is suitable for use across different
health groups and various styles of online information. Online ethnographic studies found three types of
PEx on multiple sclerosis (MS) platforms: accounts of ‘living with MS’, self-expression and creativity, and
experiences of health care and treatment. Observational and laboratory-based methods included studies of
how people find and use PEx to inform health choices. We developed a three-stage model (gating, the
engagement loop and outcomes) which guided the development of six prototype multimedia websites
featuring either experiential information (intervention) or factual information (comparator) for three
exemplar health issues. We evaluated the feasibility and acceptability of a trial of the prototype PEx
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websites, comparing self-report and process measures with a comparator. In the three conditions we
randomised 87 (smoking cessation), 148 (asthma), and 42 (caring for someone with MS) participants.
At final (2-week) follow-up, retention rates were 75%, 82% and 86%, for smoking cessation, asthma and
MS carers, respectively. Usage of the allocated websites was low. The median number of logins to the
websites over the 2-week period was two, two and four; the median number of page views was 10, 15
and 27.5, respectively, with a median total duration on site of 9 minutes, 17 minutes and 31.5 minutes
respectively. There were no reported adverse events or harms. The qualitative interviews with 30 trial
participants found that the trial methods were acceptable and not burdensome and that preferences for
combinations of different types of information were both idiosyncratic and dependent on timing and need.
Limitations: This programme used a pragmatic, mixed-methods approach, in which we adapted some
standard approaches (e.g. realist review). The conceptual review provided a framework for the whole
programme but did not draw on a single overarching theoretically informed approach. Instead, we used
relevant theory and methods from the work package leads, who represented a range of disciplines.
Conclusions: Online PEx is not seen as an alternative to facts, or to care from a health professional,
but is used in addition to other sources of information, support and expression. This programme of work
indicates how the sharing of online PEx may benefit people, and how this can be measured. A randomised
controlled trial is feasible but an allocated ‘exposure’ to a ‘dose of information’ is far from from how
online experiences are shared in everyday life. Future work evaluating online health interventions which
incorporate personal experiences should aim to reflect ‘natural’ use of the internet and might include
online ethnography and offline interviews. Studies might explore how and why people use online sources
of experience-based health information, and the effects on subsequent behaviour and health and social
outcomes in different conditions. Future intervention research evaluating online health interventions should
examine and explain issues of engagement and use, and seek to identify how to increase engagement.
Trial registration: Current Controlled Trials ISRCTN29549695.
Funding: This project was funded by the Programme Grants for Applied Research programme and will be
published in full in Programme Grants for Applied Research; Vol. 4, No. 17. See the NIHR Journals Library
website for further project information.
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Plain English summary
The internet has seen an explosion of websites featuring people’s accounts of their experiences of healthand illness, through, for example, blogs, patients forums, online ratings sites and voluntary organisation
websites. These are popular, but are of uncertain benefit. We explored how we might best understand
how online patient experience influences health.
A series of studies included a review of the published literature and a new questionnaire. We observed and
talked to people about how they looked for online information about giving up smoking, having asthma
or caring for someone with multiple sclerosis. We used these studies to help us understand how best to
include video, audio and written clips about people’s experiences of these conditions on a website.
We developed three experience-based websites and three comparator websites and invited people to
participate in a randomised exploratory trial to compare their use. We recruited 148 people with asthma,
87 people who wanted to give up smoking and 42 carers of people with multiple sclerosis. The participants
had 2 weeks’ access to a website. The participants, who ranged in age from their twenties to their late
seventies, found it easy to take part, and over three-quarters completed questionnaires after 2 weeks. We
interviewed 30 trial participants, who highlighted the value of facts, figures and experience. We conclude
that it is feasible and acceptable, but probably not useful nor a good use of public money, to run a larger
trial comparing such websites. In real life, individuals seek and combine individual information sources to
suit preferences that shift over time.
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Scientific summary
Background
Health organisations remain committed to giving reliable and timely health information to the public and
patients. Traditional health information has been based on facts and figures and not on the experiences
of patients. Many different types of patient experience (PEx) are available online in health information sites,
social networking, reputation systems (an approach borrowed from e-commerce) and online support
groups. PEx may support and inform people but there have also been concerns that decisions about
health care might be adversely affected if people identify with powerful stories that are not relevant to
their circumstances.
Aim
The aim of the programme was to find out whether, when and how the NHS should incorporate PEx into
online health information.
Methods
We set out to understand the mechanisms through which PEx might influence health, develop tools to
measure the effects of these interventions, explore how PEx is used and test prototype websites on the
following exemplar groups: people who wanted to give up smoking, people with asthma and carers of
people with multiple sclerosis (MS). The programme used mixed methods and was delivered through three
work packages (WPs): WP1 comprised a conceptual literature review, a secondary analysis of existing
qualitative data and the development and testing of a new questionnaire to measure the effect of PEx;
WP2 comprised an online ethnography and observational and experimental studies on the effect of PEx in
an internet café-style environment; and WP3 comprised exploratory pilot trials to explore the feasibility of
comparing new website interventions with information-only websites.
Results
Work package 1: conceptual framework
Work package 1a: conceptual and literature review
We conducted a broad literature review to identify theories and mechanisms of action that could help to
explain the potential consequences of PEx. The review suggested that access to other people’s experiences
of a health condition could affect health outcomes both positively and negatively through the mechanisms of
information, support, affecting relationships, providing ideas on how to use health services, influencing
behaviour change, learning to tell the story and visualising illness and its effects. These seven domains
formed a conceptual framework through which PEx could affect health. This framework informed all of the
subsequent WPs, including the development of the measurement tool.
Work package 1b: secondary analysis of narrative interviews
The secondary analysis was used to gather evidence about how and why information based on real
experience is sought and used, and to select quotations from interview transcripts which illustrate
participants’ views on their use of the internet for health information. The findings were used to provide
an item pool for the e-Health Impact Questionnaire (eHIQ) measurement tool.
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Work package 1c: develop and pilot assessment tool
Trials to evaluate the impact of online PEx need to identify the most appropriate outcomes to measure.
The range of outcomes is potentially large and may be addressed, in part, by existing measures. However,
as research on online patient experiential information is in its infancy, there was no valid and reliable
assessment tool to capture the health effects of using websites which contain PEx. We developed the eHIQ
to assess health-related websites. The tool comprises two independent parts which have been rigorously
tested. Part 1 (11 items) assesses general attitudes to health-related websites. Part 2 (26 items) concerns a
specific, recently visited website. The eHIQ demonstrates good psychometric properties and is suitable for
use across a range of health groups (e.g. people with long-term conditions, carers and those viewing
websites aimed at changing health behaviour) and is also suitable for use among various styles of online
information (e.g. factual or experiential information and discussion forums).
Work package 2: observations in natural and experimental settings
Work package 2a: explore the exchange of patient experience on online
communities, using ethnographic observations and telephone interviews
Through a content analysis of online settings, ethnographic observation of online activity and telephone
interviews, we studied how people living with MS and those who care for them seek out others’
experiences, how they share their own experiences, and how this affects their understanding of MS, their
relationship with health-care practitioners, their health-care decision-making and their general well-being.
We found three main kinds of MS-related PEx across the platforms: (1) PEx focused on ‘living with MS’,
practical information support and coping, (2) PEx used for self-expression and creativity and (3) PEx linked
to health-care and biomedical research, treatments and practice. The study highlights that the distinctions
between ‘experiential’ and other types of information, especially medical, are often blurred.
Work package 2b: observational and experimental studies to find out how
people use, search for and select patient experience
Acknowledging the diverse quality of online PEx, we have conducted three studies using observational and
laboratory-based methods to discover how people find and use PEx to inform health and lifestyle choices.
The first study was expanded from that stipulated in the proposal and included, in addition to the asthma
and MS carers elements, two further elements on people who wished to stop smoking. The second study,
which focused on people with asthma and MS carers, involved the recruitment of additional patients and a
more detailed comprehensive interview. From these studies, we developed a three-stage model of patients’
peer-to-peer engagement online (gating, the engagement loop and outcomes) through which people
discover who is making the contribution and assess what is said, with different consequences. The
framework was used to generate web design guidelines which describe how best to present PEx online.
These were used to develop the prototype websites for the WP3a exploratory trials.
The third study involved a sample of smokers and sought to examine the effect of (1) message type
(i.e. PEx vs. information only), (2) perceived similarity of author and reader (based on gender) between the
reader and the author of the PEx on the participant’s readiness to accept the message and (3) palatability of
material in terms of pre-existing beliefs (attitude towards quitting by using or not using aids and support). A
longitudinal approach examined the impact of these variables on behavioural intentions and actions 2 weeks
and 3 months after exposure. We found little effect of gender matching and observed a PEx effect in men
only. Men found PEx preferable in terms of both mood and message believability, but it mattered little
whether the experience seemed to come from a man or a woman. PEx did not affect message knowledge or
website evaluation, as measured by the eHIQ, in either sex. Men showed increases in quit attempts and
decreases in nicotine dependency over the 3-month period. Women also showed decreases in nicotine
dependency over this period. There were also some significant effects of condition on nicotine dependency.
Health information expressed in a way that was preference consistent led to higher levels of engagement
with online content.
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Work package 3: evaluation of online patient experience
prototype interventions
Work package 3a: prepare prototype online patient experience interventions
We developed six prototype multimedia websites featuring either experiential information (intervention)
or factual information (comparator) for the three exemplar health issues. We used established qualitative
research methods to explore the experiences, information and support needs of people in each of the three
exemplar groups. The design and presentation of patient experiential information on the site were developed
in accordance with the WP2 guidelines. The comparator websites were based on non-experiential material
from NHS Choices, presented in a similar design to that of the intervention sites.
Work package 3b: conduct exploratory trials of online patient
experience interventions
As originally proposed, we evaluated the feasibility and acceptability of using three PEx prototype websites
intended to improve health outcomes. In addition, we compared self-report and process measures with a
comparator website. We ran three separate pilot randomised trials, one for each health condition under
the governance of a single trial protocol and analysed by condition. The trial researchers were blinded and
we maximised allocation concealment from participants by only informing them that they would receive
one of two kinds of information (complete blinding of participants was not possible given the nature of
the intervention). We found that we could easily recruit people with asthma through general practitioner
records and, to a lesser extent, identify people who wanted to give up smoking. Carers of people with MS
were harder to recruit. In the three conditions (smoking cessation, asthma and caring for someone with
MS) we randomised 87, 148 and 42 participants, respectively. At final (2-week) follow-up, retention rates
were 75%, 82% and 86%, respectively. Usage of allocated websites was low. The median numbers of
logins to the websites were 2, 2 and 4; the median numbers of page views were 10, 15 and 27.5; and the
median total duration on site was 9.5 minutes, 17 minutes, and 31.5 minutes, respectively. We captured
self-report measures of condition-specific outcomes, health status and attitudes of users towards health
websites. There were no reported adverse events or harms.
Qualitative interviews were conducted with 30 trial participants, purposively selected to represent the
different conditions and both arms. Participants who were interviewed were content with the way
that the trial was run and did not find the questionnaires, reminders or log-in requirements burdensome.
The interviews provided evidence for all seven domains identified through the conceptual review and
demonstrated the highly individual way that people integrate information for their own information
landscapes, drawing on facts, figures and experiences at different times in relation to different needs.
Conclusions
Our conceptual literature review established the theoretical underpinnings for the study and guided our
understanding of the potential positive and negative consequences of looking at other patients’
experiences online. We found that there was no validated outcome measure that could be used to
compare the effects of a ‘facts and figures’ and ‘PEx’ website, and so we set about developing and
validating a new measure, the eHIQ, for this purpose. The ethnographic studies and detailed internet café
laboratory observations helped us to understand the various ways in which PEx is used in online support
groups and how patients use and respond to a variety of different types of health information websites
that present PEx as single stories, testimonials or ‘maximum variation’ samples. These studies fed into the
development of a three-stage model of peer-to-peer engagement, which informed new guidelines.
These were used to devleop prototype PEx websites for three online feasibility trials.
In the final WP, we demonstrated the feasibility and acceptability of a patient-experience based website
intervention. We showed that this could be evaluated in a randomised trial, compared with a ‘facts and
figures’ website, although it was very hard to recruit participants who were carers of people with MS.
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Our findings raise questions over the nature of participant engagement with the websites, with low actual
usage of the interventions in this trial. A ‘phase II’ pilot trial approach of a 2-week allocated ‘exposure’ to a
‘dose of information’ is also very different from how information sources are used in everyday life. Our
findings suggest, therefore, that future work needs to understand how to embed such interventions in
people’s everyday lives. The qualitative interviews with trial participants underlined that everyone wants
and needs facts and figures and that online experiential information is not seen as an alternative to facts,
or to care from a health professional, but is used in addition to other sources of information, support and
expression. In practice, some people will prefer only facts and figures but others may like to see shared
experiences for an additional source of information that fulfils a rather different purpose. Finding measures
which accurately capture the impact of this is not straightforward.
Recommendations for research
The National Institute for Health Research (NIHR) and academic community may benefit from research in
the following areas (in order of priority).
1. Future intervention research evaluating online health interventions should reflect the way in which
people use the internet in everyday life. This is challenging within the specification of a randomised
trial. People search, browse, digest and comment on multiple information sources to varying degrees,
within a landscape of other sources of help and advice, and with varying personal preferences for types
of information. Although it is possible to package an online health information intervention in the same
way as a ‘dose’ of a medication, and to administer an exposure by allocating or denying access to the
intervention, researchers need to consider critically whether or not this reflects real information-seeking
behaviour. Further theoretical and methodological work is, therefore, needed to consider the issues of
‘exposure’ and ‘dose’ in the context of online health information interventions. This present programme
of work makes a significant contribution to this area; the Medical Research Council (MRC) new
guidance on developing and evaluating complex interventions, and the recent additional MRC guidance
on process evaluation, can help to systematically examine these issues in future work.
2. Future intervention research evaluating online health interventions should examine and explain issues of
engagement and use and seek to identify how to increase engagement. In common with many online
trials, ours showed that actual usage of the website intervention was low (in terms of numbers of
logins, numbers of page views and duration on site) for both the intervention and the comparator sites.
Further research is required to understand the nature of engagement with online interventions and the
determinants of this. The reliability of tracking data should also be assessed.
3. Future research should harness qualitative methods, including online ethnography and offline interview
research, to further explore how and why people use online sources of experience-based health
information, and what effect this may or may not have on subsequent behaviour and health and social
outcomes in different conditions. In particular, studies might consider who chooses to share experiences
online, who is influenced by these, and to what extent online sources of PEx (both solicited and
unsolicited) are representative of patients’ experiences more generally, and, indeed, what representative
means in this context. Areas of particular interest are online patient activism, especially regarding
contested illnesses and treatments, and online comments on health services (including reviews
and ratings).
4. Future studies evaluating health information websites should make use of the eHIQ, which we have
demonstrated to be an acceptable, valid and reliable measure for examining individual attitudes
towards websites presenting different types of information.
5. In designing online interventions which harness PEx, researchers should note the guidelines on
intervention design. We demonstrated that these guidelines can be successfully applied in building
three intervention and three comparator websites.
6. The seven domains (identified through our review) have been demonstrated to be a valid conceptual
basis for research on how online PEx affect health and should inform research in digital health.
SCIENTIFIC SUMMARY
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Trial registration
This trial is registered as ISRCTN29549695.
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Funding for this study was provided by the Programme Grants for Applied Research programme of the NIHR.
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Chapter 1 Overview of the programme
Health-care decisions are made at every stage of an illness from the point at which we first experiencea symptom and try to identify what it might mean. The dilemmas that people face include a lot of
‘whether, how and for how long’ questions about self-management, seeking professional help, using
treatments and minimising the disruptive effects of illness on daily life, work, and relationships. The
programme of work reported in this monograph grew from the awareness that the public and patients
need reliable health information to support these decisions and the recognition that the relatively new
ability to find other patients’ experiences online could be transforming the health information landscape
and the information that patients seek, find and use.
When the programme began in 2010, it was already becoming routine for people in the UK to seek health
information online. There was also an evident growth in online ‘patient experience’ (PEx) in many formats,
including social networking, reputation systems (an approach borrowed from e-commerce and now
widespread in health), peer-to-peer forums, chat rooms, blogs and personal experience sections on health
and voluntary sector websites. However, there were also many concerns being voiced about whether or
not the internet was too overwhelming and confusing (especially for people with low heath literacy),
whether patients would misinform or alarm themselves, and how all of this might affect their choices and
communication with NHS staff, in particular during the brief consultation in primary care.
We therefore proposed a 5-year programme to examine the phenomenon of the online experiences of
patients, to understand its potential for both benefit and harm and identify whether, when and how the
NHS might recommend incorporating people’s health and care experiences (hereafter referred to as PEx)
into online health information.
When we began this work, the role of online PEx was a new field with no agreed theoretical and
methodological basis: almost all of the research had been exploratory or descriptive. It has long been
recognised that people seek knowledge about their health from others who have been through the same
experiences.1,2 What was unknown was how the online environment might be transforming this behaviour,
perhaps opening up opportunities for support, information and new forms of connection. Our own work
had indicated that exposure to online PEx had the potential to both improve health and do harm.3 We
were aware that PEx might be of greater or lesser value depending on how it is presented, the type of
condition involved, the stage in the patient journey and individual preference.
Aim
The aim of the programme was to find out whether, when and how the NHS should incorporate PEx into
online health information.
To achieve the aim of the programme, we needed to understand the mechanisms through which PEx may
influence health, develop the tools to measure the effects, explore how PEx is used and test prototype
websites in exemplar patient groups: (1) people who wanted to stop smoking, (2) people with asthma and
(3) carers of people with multiple sclerosis (MS). The programme was delivered through three work packages
(WPs) which used mixed methods comprising a conceptual literature review, a qualitative secondary analysis,
the development and testing of a new questionnaire, an online ethnography, observational and experimental
studies in an internet café environment and, last, some exploratory feasibility trials.
Our WPs were designed and implemented by a multidisciplinary team led by a medical sociologist and
including health psychologists, a public health doctor, academic general practitioners (GPs), experts in
questionnaire design, statistics and website design, and clinical trialists, with coinvestigators from health
policy and a service user perspective.
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We summarise below the full programme and the relevance of each of the WPs.
Note: we acknowledge that there are many different ways of referring to people who are interviewed
about their health, who contribute to or seek health-related information, or who publish their own material
about their health experiences online. These terms include ‘patients’, ‘the public’, ‘people’, ‘consumers’ and
‘health service users’. For the sake of brevity and to conform with other NHS and National Institute for Health
Research (NIHR) documents, we use PEx or ‘patient experience’ to encompass the various roles of the public
and patients in this field.
Figure 1 shows the connections between the elements of the programme and the main outputs.
Work package 1
Conceptual and literature review
We used reviews and secondary analysis to clarify the theoretical mechanisms and the domains of health
that we expected to be affected by exposure to online PEx. An approach drawing on ‘realist’ literature
review methods was conducted to identify theories, mechanisms of action and the potential impact
of PEx and to establish the conceptual and theoretical framework for the whole programme. The review
identified seven domains through which access to other people’s experiences of a health condition could
affect health; these comprised finding information, feeling supported, maintaining relationships, using
health services, changing behaviours, learning to tell the story and visualising illness.
Secondary analysis of narrative interviews
Interviews from a unique Oxford archive of interviews, held by the Health Experiences Research Group
(HERG), were used for a qualitative secondary analysis. At the time of the study, the archive included over
60 health conditions, which were sampled to (1) gather evidence through thematic analysis about how
and why information based on real experience is sought and used, and (2) select quotations from interview
transcripts which illustrate participants’ views on their use of the internet for health information, to inform
the item pool for a questionnaire tool.
Development and piloting of the e-Health Impact Questionnaire
Trials to evaluate the impact of online PEx need to identify the most appropriate outcomes to be
measured. The range of outcomes is potentially large and may be addressed, in part, by existing measures.
However, as research on online patient experiential information was in its infancy at the time this WP
commenced, there was no valid and reliable assessment tool to capture the health effects of using
websites which contain PEx. We therefore developed the e-Health Impact Questionnaire (eHIQ) to assess
health-related websites which contain either experiential or factual information. The tool was developed
and tested for use across a range of health groups (e.g. people with long-term conditions, carers and
those viewing websites aimed at changing health behaviour) and can also be used for websites that
include different styles of online information (e.g. factual or experiential information and discussion
forums). This WP was written up by LK as her doctorate (awarded in 2014, supervised by CJ and SZ).
Work package 2
Online ethnographic observations
In this WP, we explored internet behaviour using in-depth observational research methods to establish how
different types and formats of online PEx are used and how online PEx material might be optimised. We
studied how and why people share experiences of health and illness on the internet in the context of MS.
Through a content analysis of online settings, ethnographic observation of online activity and telephone
interviews, we studied how people living with MS and those who care for them seek out others’
experiences, how they share their own experiences, and how this affects their understanding of MS, their
relationship with health-care practitioners, their health-care decision-making and their general well-being.
OVERVIEW OF THE PROGRAMME
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Observations and experimental studies
Acknowledging the diverse quality of online PEx, we conducted three studies using observational and
internet laboratory café methods to discover how patients find and use PEx to inform health and lifestyle
choices. The first study was expanded from that stipulated in the proposal and included, in addition
to the asthma and MS carers elements, two further elements with people who wished to stop smoking.
The second study, which focused on people with asthma and MS carers, involved the collection of
eye-tracking data, to identify where people spend time, what holds their attention and how they organise
their searches, and a comprehensive interview. From these studies, we developed a model of patients’
peer-to-peer engagement online, which was used to develop the prototype PEx websites that were used in
the feasibility trials in the final WP.
The third study involved a sample of smokers. We sought to examine the effect of (1) message type
(i.e. PEx vs. information only), (2) the palatability of material in terms of pre-existing beliefs (attitude
towards quitting by using or not using aids and support) and (3) perceived similarity (based on gender)
between the reader and the author of the PEx on a participant’s readiness to accept the message. The
study adopted a longitudinal approach to examine the potential impact of these variables on behavioural
intentions and actions 2 weeks and 3 months after exposure.
Work package 3
Development and testing of patient experience web interventions for
exploratory trials
We developed six prototype multimedia websites featuring either PEx information (intervention) or non-PEx
factual information (comparator) for each of three exemplar health issues (adults with asthma, carers of
people with MS and people considering giving up smoking cigarettes). We used established qualitative
research methods, led by experienced qualitative social scientists based in the Oxford team, to collect
unstructured, narrative interviews about the experiences, information and support needs of people in each
of the three exemplar groups. The design and presentation of PEx information on the websites were
developed in accord with the guidelines developed in WP2. The comparator websites were based on
non-PEx material from NHS Choices and were presented in a similar design to that of the intervention sites.
Exploratory trials
As originally proposed, we conducted a phase II pilot randomised single-blind trial, in which eligible
participants were randomly allocated to a condition-specific PEx-based health information website or to a
comparator website which contained no PEx information, stratified by one of three health conditions.
The original application described three separate pilot randomised trials, one for each health condition.
For operational efficiency, the three trials were run under the governance of a single trial protocol and
analysed by condition (smoking cessation, asthma or caring for someone with MS). As this was an
exploratory study, our main aim was to establish the feasibility of undertaking this research and to identify
any emergent evidence of efficacy or harm. We measured recruitment and retention rates, usage of the
intervention and comparator, and any adverse events. We measured the impact of all six websites on
health status, and we assessed attitudes towards the websites using the new instrument, the eHIQ. We
also included some condition-specific measures as secondary outcomes (such as self-efficacy measures).
We also undertook qualitative interviews with 30 purposively selected trial participants to explore why and
how they took part and used the websites (or did not).
OVERVIEW OF THE PROGRAMME
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Chapter 2 Work package 1a: how might sharing
experiences on the internet affect people’s health?
A conceptual overview
Abstract
Introduction: the role of information based on online PEx is a new field with no agreed theoretical and
methodological basis. As a first step to improving the scientific base and policy guidance, we aimed to
provide an overview, or conceptual map, of the potential health effects of online PEx in health and
health care.
Methods: we drew on realist review methods in three stages: (1) a wide-ranging review of literature in
social and health sciences distilled in a matrix that covered potential positive and negative impacts (we
continued reading until we reached data saturation); (2) further refinement of the results with reference to
a public panel; and (3) even further refinement after testing with expert colleagues.
Findings: seven domains characterise how online PEx could affect health, each with the potential for
positive and negative impacts. The domains are finding information, feeling supported, maintaining
relationships with others, affecting behaviour, experiencing health services, learning to tell the story and
visualising disease.
Conclusions: the value of first-person accounts, the appeal and memorability of stories, and the need to
make contact with peers all suggest that reading and hearing others’ accounts of their own experiences of
health and illnesss will remain a key feature of e-health.
Introduction
As we have seen, the role of information based on online PEx is a new field with no agreed theoretical
and methodological basis. As a first step to improving the scientific base and policy guidance on the
provision of information based on people’s experiences, we drew on a wide literature in the social and
health sciences to provide an overview, or conceptual map, of the potential health effects of online PEx
in health and health care. The below contains extracts from and represents an abridged version of material
first published in the Milbank Quarterly © (2012) The Milbank Memorial Fund.4
We identified seven domains of the online PEx terrain. In this section of the report, we describe the
methods we used to develop this conceptual map before going on to describe the seven domains of
the terrain in turn.
Methods
We conducted the overview in three stages: a literature review, a public panel, and a final review and
revision after we presented our initial findings at a specialists’ workshop.
Literature review
Our approach was informed by realist review, a method for synthesising research evidence regarding
complex interventions.5,6 It is based on the idea that research should pass on collective wisdom about the
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successes and failures of previous initiatives in particular policy domains ‘before the leap into policy and
practice’.5 Its main purpose is to identify explanations through which complex social programmes might
operate so that policy-makers can learn how to introduce or adapt programmes based on a good
understanding of why and how they might work.
This approach was suited to our task because the science of the role of information based on online PEx
is epistemologically complex and methodologically diverse.6 However, in our case, there was no set of
theories or even defined social or health programmes to identify and evaluate: the field is too new. We
therefore adapted the approach to allow us to identify and describe the domains of the territory rather
than to develop programme theories of how it may work. Our approach was iterative and collaborative;
SZ and SW worked intensively face to face, through e-mails and by telephone over 6 months in 2010.
Box 1 summarises the review’s five overlapping steps.
Public panel of health website users
To check our interpretation of the literature, we convened a public panel which consisted of 30
participants primarily recruited through an invitation from Oxfordshire Primary Care Trust sent to a list of
people who had previously agreed to help with research (see Chapter 11). We selected the respondents to
ensure that they were representative of a cross-section of the community (gender, age, occupation and
ethnic group) and included those who had used the internet for heath information in a variety of ways
(websites, forums, blogs) and for a variety of health conditions (either for themselves or on behalf of family
and friends).
We first showed examples of health information with and without the inclusion of ‘personal experiences of
health and illness’. The panel was divided into four groups, each with a rapporteur, and asked to think
about how people might be positively and negatively affected by experiential information. The rapporteurs
delivered the feedback to the whole group. In a final plenary session, we summarised the results of the
BOX 1 Work package 1a: summary of the steps taken to develop a ‘conceptual map’ of the operation and effects
of online patients’ experiences
Step 1: clarification of scope
(a) Settled the review question: ‘what is written in peer-reviewed journals and scholarly books about the
health effects of access to and use of online patients’ experiences?’.
(b) Refined the purpose of our review: to provide ‘a conceptual map’ of what is known about the health
effects of access to and use of online PEx about health and illness.
(c) Articulated the key ideas to be explored in a multidisciplinary project meeting in which we developed our
initial matrix.
Step 2: search for evidence
(a) Exploratory background reading gave ‘a feel’ for the literature based on our own and colleagues’
bibliographic databases (concurrent with steps 1a and 1b).
(b) Pragmatic and wide-ranging search (with assistance from a librarian at the Oxford Knowledge Centre)
sought to identify any studies that had tested the effects of exposure to online PEx or that described
theories or ideas about the potential effects of exposure to online PEx.
(c) Both authors scanned all resulting titles and abstracts and, after discussion, chose potentially promising
papers that could inform our thinking.
(d) Sought more papers and books by ‘snowballing’ from reference lists as promising ideas emerged.
(e) Our final search for additional studies came when we had nearly completed our review or when we came
across them in the course of our professional lives, for example through discussions and seminars.
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conceptual review and discussed how they compared with the results of the group discussions. A final
questionnaire asked participants what, in their view, were the most important ways in which experiences
might affect people, both positively and negatively, from the perspective of someone with a condition and
that of a caregiver of someone with a condition. A report was circulated and feedback was sought.
Final review and revision
During our final search for relevant papers we presented our findings at a specialists’ workshop at the 25th
British Computing Society conference on Human–Computer Interaction, July 2011, Northumbria University,
Newcastle upon Tyne, as part of the workshop ‘Online patient experience (PEx) and its role in e-health’,
organised by the authors. During discussion, we identified the importance of the visual presentations of
online PEx. We had not identified this topic in our reading but on realising its importance we included it in
our matrix. Finally, we agreed on the seven ‘domains’ of our conceptual map of the potential health
effects of online PEx.
Step 3: appraise studies and extract data
(a) At least one of us read full papers. Although we used no formal quality appraisal tools, we considered
papers in relation to their:
¢ relevance – does the research address the topic and enable us to add to, adapt, or amend the initial
matrix developed in step 1c?
¢ rigour – does the research support the conclusions drawn from it by the researchers or the reviewers?
(b) Both of us identified papers containing important ideas, explained them, and discussed their relevance
during a period of intensive working together.
(c) We added categories and specific instances to the initial matrix, which became our main data
extraction framework.
Step 4: synthesise evidence
(a) We developed our initial ‘map’ or overview in a tabular form, identifying potential effects of access to and
use of personal experiences of health and illness on the internet, the potential negatives and the potential
mechanisms through which it might work.
(b) A constant comparison between our reading and the working table identified the point at which no new
ideas were emerging and we were confident that we had achieved data saturation.
(c) We drew up a glossary of terms defining, recording and explaining key concepts; our understanding of
them; and their application in this overview.
Step 5: disseminate and evaluate
(a) We presented and discussed the table and glossary at a full team meeting and made some modifications
and clarifications regarding how the table should be presented.
(b) We discussed the table in a workshop with 30 members of a health service public panel, who suggested
the emphasis and importance of topics.
(c) A final search and discussions at a conference identified the importance of visual as well as written and
read presentations of experiences.
(d) We identified and described seven domains.
Adapted with permission from Milbank Quarterly © 2012 The Milbank Memorial Fund.4
BOX 1 Work package 1a: summary of the steps taken to develop a ‘conceptual map’ of the operation and effects
of online patients’ experiences (continued)
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Results
The potential health effects of seeing and sharing experiences online:
seven domains
Our approach allowed us to identify seven domains which broadly map the role of online PEx:
1. finding information
2. feeling supported
3. maintaining relationships with others
4. experiencing health services
5. learning to tell the story
6. visualising disease
7. affecting behaviour.
For each of these we considered the potential for both positive and negative effects.
Finding information
Other people’s experiences of illness can provide information that is valued in its own right. They can make
information more relevant,7,8 provide contextual information about causes and consequences, and help
people to understand what may happen.9,10 Hearing about how others have coped may change one’s
orientation to the illness11 and offer a framework for managing the uncertainties. Simple, practical tips on
how to manage problems encountered in everyday life, coping strategies that others use, and advice based
on what has worked for others are highly valued for their pragmatism12,13 and because they are easy
to understand.14
In making decisions, people draw on many sources of information. They discuss using their own and
others’ experiences as well as more traditional ‘factual’ information for decisions,15 and they often say that
they prefer not to base their health decisions solely on other people’s experiences.16 However, hearing
about other people’s decisions can help them to recognise that a decision must be made, understand
what the range of options might be and clarify the alternatives (e.g. in relation to treatment, lifestyle
and attitude).16,17
Learning through other people’s accounts of their experiences can be memorable because the accounts
are vivid,18,19 but if the experiences presented are not typical,16 are inaccurate and biased, or if the sites are
sponsored by vested interests or open to commercial exploitation,16 the information may be distorted,
which could lead to worse decisions if people are not aware of this.1,20 Our public panel emphasised that
the internet’s unregulated nature means that all sources of information might be seen as having equivalent
status, regardless of their trustworthiness. The panel also raised the issue of information overload.
Descriptions of negative or dramatic outcomes might mean that more numerous but unremarkable
experiences remain unwritten or unnoticed. The difficulty of providing ‘balanced’ information has been
previously addressed21 but no clear solutions are yet available.
Feeling supported
Having an illness, facing a health issue or being a family caregiver can challenge one’s personal identity,
and some people may feel embarrassed or even stigmatised by their condition. Knowing that others are
tackling similar problems and learning how they deal with difficult issues can reduce these feelings of
isolation, bringing a sense of belonging to a group and reassurance that one’s experiences and reactions
are ‘normal’22 so that one feels more supported.
People who have joined an online peer-to-peer group may also benefit from feeling that they are connected
by helping and supporting others.23,24 Online contacts can provide a safe environment for ‘emotional
labour’.25,26 Hearing about others’ experiences can induce feelings of compassion, so that one becomes less
self-absorbed and gains a better perspective.27 In their study of participation in online support groups,
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van Uden-Kraan et al.13 describe ‘emotional empowerment’ as the process through which information is
exchanged, emotional support is encountered, and recognition is gained through sharing experiences.
Cohen28 calls this ‘emotional support’ and suggests that it can make people simply feel better. Our public
panel considered this process important, saying that it meant that you knew you ‘were not alone’ because
hearing about other people’s experiences gave you a sense of ‘being supported’. For people who have rare
conditions, who are undergoing unusual treatments or who are geographically isolated, the internet may be
their only source of this type of support and, therefore, be especially important.29,30
In contrast, depending on their content, others’ experiences may arouse feelings of anxiety and lead to
unrealistic expectations, false hopes or even despair, fear, guilt, anger and inadequacy if others seem
to be managing better. Patients’ feelings of despair at their own condition may become worse if they find
out that peers have fared badly;31 internet-based support groups are sometimes dominated by a single
viewpoint. How one responds to other people’s experiences depends greatly on one’s mood at the time
of the encounter, and, if that goes badly, it can reinforce one’s vulnerability or feelings of inferiority.
The public panel were particularly concerned that people with mental illness might be adversely affected
by negative postings, especially from those they described as the ‘trolls and fruitcakes’.
Maintaining relationships with others
The internet raises the possibility of having a distinct set of ‘online’ and ‘offline’ relationships that can be
helpful when it is hard to maintain both an illness identity and an everyday identity. Online and offline
relationships need not, of course, be mutually exclusive; many people keep in touch with friends via the
internet and people who meet on the internet can become real-life friends.32 There are, however, big
differences in the way that people communicate and establish relationships online and offline. In an online
forum, the usual requirement for conversational give-and-take need not apply: although a person may
choose to write in extensive detail about their experiences, their audience can quickly browse through the
account, break off at any point, or go back and review a section in more detail. Needless to say, such
actions might be difficult to achieve in real-world interactions without causing offence.
Learning about how others cope may help patients become socialised into a new role in relationships
(e.g. as a patient or as the spouse or parent of a patient). Finding that other people are facing similar
problems may help one to feel more ‘normal’ and confident in managing one’s health condition in other
contexts, including family, work, relationships and travel. Thus, online support may even help to sustain
‘real-world’ relationships by providing another sounding board and emotional outlet for health concerns,
thereby ‘saving’ real-world relationships from that role.
Paradoxically, isolation in the real world could increase if people feel that only those who have been
through exactly the same thing can understand them. For example, Hinton et al.,31 writing about the use
of online infertility support groups, drew attention to the possibility that web support could increase
real-world isolation by reinforcing the notion that only those who have dealt with infertility themselves
could possibly understand what it is like. A related idea, drawing on the work of Nicholas Negroponte,33
is that by enabling people to refine and personalise all of the information they receive (characterised as
‘The Daily Me’), they will rarely be exposed to any ideas that challenge their own. In this way the internet
could reinforce entrenched interests and misunderstandings. Our public panel endorsed the idea that
over-reliance on ‘virtual support’ can lead to ‘wasted time’ browsing and posting on the web, which could
be to the detriment of face-to-face social contact in their own locality.
Experiencing health services
Finding out about other people’s experiences of care can affect the use of health services. In health
systems that encourage patients to make choices about health-care providers, feedback and commentary
about others’ experiences of providers can often be found either on ‘reputation’ sites (designed to present
public ratings) or on patients’ chat rooms, forums or social networking sites. Accessing this information can
contribute to decisions about which clinic to attend, which professionals to consult or which treatment to
request or avoid17,34 and may even help to raise and address safety issues for patients.35
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Health consultations may be more efficient and patient centered if patients pick up useful ideas about the
questions to ask, the best terms to use, and the symptoms or side effects to mention to their doctor.36
Learning through other people’s experiences of symptoms and consultations may reassure the ‘worried
well’ that they do not have the health problem they feared, thereby preventing unnecessary consultations.
Our public panel expressed concern about ‘hypochondria heaven’, in which the unnecessary use of health
services might be encouraged by seeing other people’s experiences online. People often look online to
‘follow up’ on the advice given by health professionals or to seek validation for their own interpretations
or feelings.37–39 Responses may spur them to seek a second opinion or further clarification from their
health-care team.40
At a macro level, by finding out how stigmatized conditions affect others or through restricted access to
care and support, people can become more aware of inequalities and injustices which might foster
changes in social attitudes or a more equitable provision of care.41 It may also stimulate advocacy and
campaigns. In some cases, shared experiences have been used to challenge not only the provision of
services but the very parameters of what counts as an illness, particularly for contested illnesses such as
fibromyalgia and contested treatments such as vascular surgery for MS.42 Patients who compare what
‘counts’ as an illness or a recognised treatment in different health systems find ample examples of
inconsistency, which are used to fuel campaigns for either better evidence or more treatment options.
Although there are clearly several potential benefits for the way in which people use health services and
influence the development of care services,43 clinical relationships may be strained if unrealistic expectations
are raised or if alarming stories from other patients damage people’s confidence in professionals and
adherence to treatment. Those who take the time to provide feedback on services may feel frustrated if this
does not lead to improvements. Finding out about other people’s experiences of poor care could increase
anxiety in situations in which they have little choice or control.
Learning to tell the story
From childhood onward, stories provide a powerful, palatable and memorable way of learning about the
world.44 An engaging narrative can immerse the audience in the account and thereby transfer information
in a particularly effective manner.45,46 When a story is well told and encountered at an opportune moment,
it can reassure and ground the reader or listener. It can also help her make sense of her own situation by
suggesting a practical and emotional frame for her response.12–14 We can see stories as a conduit for
memorable and meaningful information and support.
Another relatively neglected aspect of stories, which we believe is important and distinct, concerns the very
language, including the terms of reference and the figures of speech, that is used to construct an account.
Hearing how others describe what has happened to them (as well as what has happened) adds to the
richness of the vocabulary and can help to construct our own account. Although it is well understood that
we learn through stories, the effect of hearing about other people’s experiences on our ability to relate our
own narrative is less well understood. The consequences of gaining an enriched and more powerful
vocabulary, being able to tell their story well, may help people to develop an appropriate professional
interest by giving a concise and relevant account in a clinical setting, help them explain salient points to
professionals11 and elicit understanding, support and affirmation from friends, family and wider audiences
via the media and web blogs. We therefore see ‘learning to tell the story’ as distinct from other aspects of
the exchange of information and support because it focuses on the ‘how’ rather than the ‘what’ of the
accounts that we are able to relate.
Frank47 and Pennebaker and Seagal48 suggested that even the very process of constructing a coherent story
may help the healing process. Narrative construction (and reconstruction) may also help people make sense
of what has happened to them and thus support emotional recovery.49 The internet allows those who
want to share their stories with others to do so by adding a posting on a forum or chat room or perhaps
setting up a site or blog of their own. Such sharing can feel empowering, especially if it attracts many
followers or elicits approving commentary.24
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The question of verification cannot be ignored: how can we know whether or not accounts of people’s
health experiences are true? ‘Telling’ or ‘spinning’ stories is sometimes used as a synonym for telling lies,
but Bury50 recommends that we view people’s accounts of their illness as ‘factions’, a meld of facts and
fiction that weave interpretation and presentation into the account of what actually happened. As
Entwistle et al.16 observed, people rarely present themselves as naive users of any information, yet we
know relatively little about the effects (which could include incoherence and confusion) of exposure to
numerous, and sometimes conflicting, accounts of health experiences on the web. Schwartz51 proposes
that, far from helping, a plethora of options may prevent one from being able to make (and live with) a
choice. Those who post their own stories online may be harmed if their account is misappropriated,
criticised, ridiculed or even just corrected for facts. A mental health service user on our panel pointed out
that a person posting a story when he or she is in the ‘wrong’ frame of mind may later regret their action.
Internet posts can expose people to ‘flaming’ criticism from others. Yet if no-one comments on a heartfelt
posting, the writer may feel even more isolated and ignored precisely because the potential audience was
so vast. It may also be intimidating for some people to encounter a highly articulate account of an
experience similar to their own.
Visualising disease
Many health-related websites include images; even some that were originally intended to be based on text
now link to video clips on sites such as YouTube (YouTube LLC, San Bruno, CA, USA). The incorporation
of photographs and videos on health websites has been treated mainly as a design issue rather than
considered in terms of the potential consequences for the way in which people deal with their health
problems. Williams and Cameron52 argued that images – in a variety of forms – are increasingly used in
health-care communication and can be powerful ways of communicating important messages. The
internet is inherently visual and the ability to post and access images of people dealing with health issues
may be another important, albeit rarely explored, feature of health experiences and the internet.
How do people use images of PEx online? Dermatological conditions are undeniably visual; photographs
can help people to compare and evaluate the effects of different treatments ‘with their own eyes’.
Hardey (University of York, 2011, personal communication) reviewed video postings of eczema on YouTube
and found more than 1000 clips, some of which had more than 2 million viewers. Some types of behaviour
change are documented online through repeated images. Weight loss blogs, for example, often include
a visual chronicle (a series of before, during and after photographs) of a person’s changing body shape.
Sometimes these blogs feature a weekly picture of feet standing on a set of bathroom scales, adding
‘objective’ evidence to the bloggers’ claims about their progress.53 There also is evidence that adding
imagery to text-based website information about the risk of cardiovascular disease can work better than
text alone in increasing the perception of risk and motivating protective behaviour.54
Among the thousands of YouTube films of people with different health conditions, some capture a single
moment, some record progress by following treatment and some are undoubtedly positioned to promote
a particular treatment (although the presentation may or may not make this explicit). Like stories, imagery
can be powerful and memorable; like stories, this has both positive and negative consequences. Illness can
dramatically change a person’s appearance. People with serious progressive conditions, such as motor
neurone disease (MND) (also known as amyotrophic lateral sclerosis), may choose to avoid looking at
images of other people whose appearance may grimly foreshadow their own future.55
Affecting behaviour
Advertising has long recognised the persuasive power of testimonials in changing behaviour. The field of
health education and health promotion was quick to see the potential of the internet to deliver efficient,
tailored advice56 to help people lose weight, do more exercise, give up smoking, tackle depression, control
diabetes or high blood pressure and practise safe sex.57 Some behaviour change sites have evident
commercial backing, and others are funded through government or health insurance and promoted in
self-management programmes. Testimonials and stories may be used to advertise a particular product, but
they also may be intended as illustrations or for general encouragement and inspiration.
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In her study of weight loss bloggers, Oostveen53 suggests that, through public blogging, people may feel
accountable to an audience, and that by being aware that their progress is being watched, they may
feel motivated to adhere to their programme. Reflecting on what they have posted may make people feel
proud and in control, or embarrassed and regretful. For some health behaviours, such as cigarette
smoking, people acknowledge that health professionals now are unlikely ever to have been smokers
themselves, so advice from those who have ‘been there’ may have greater weight (through empathy and
resonance) with those trying to make changes. Hearing about how others deal with a problem or a
concern can also build confidence and self-efficacy.58
Narratives or stories hold people’s attention by melding imagery and feeling. De Wit et al.45 studied the effect
of statistical and narrative evidence on the perceived threat of hepatitis B infection among men who have sex
with men. They found that the intention to be vaccinated was higher among those who were presented
with a personal narrative, and they believe that this is because narratives are less susceptible to the defensive
processing through which people distance themselves from health education messages. In their study in
South Wales, Davison et al.59 noted that people use a ‘lay epidemiology’ (e.g. the popular image of an
elderly relative who lived into his nineties despite smoking and drinking) to resist acknowledging that health
education messages apply to them. This tendency to distance oneself from an unwelcome message
(e.g. about susceptibility to a smoking-related disease or a sexually transmitted infection) may be strongly
challenged by a resonant account from someone else who had held the same belief that they would not be
affected yet was shown to be mistaken in their optimism.
In some circumstances, hearing about other people’s experiences may reinforce unhealthy behaviours.
Some sites contain messages that contradict or challenge medical advice and suggest or reinforce
unhealthy behaviours. Several studies have examined the content of online pro-anorexia support groups;60
people with diabetes can learn from forums about non-prescribed ways to use (misuse) their insulin for
weight loss. Some online forums promote unsafe sexual practices and even provide advice on how to most
effectively contract human immunodeficiency virus (HIV). At the extreme end of harm, those who are
inclined toward suicide can even find forums that offer advice (and possibly encouragement) about how to
end their life.
Conclusions
The profusion of patients’ experiences online has dramatically influenced the health information field.
Health choices cannot be made without information,61 and the importance of internet health information
is not disputed. Yet our conceptual review demonstrates that the full gamut of effects (for both the
‘poster’ and the ‘consumer’) of websites that cite patients’ experiences go far beyond the provision of
‘information’or ‘support’, at least as they are conventionally conceived. Our conceptual review shows that
we are unlikely to identify the effects of exposure to online PEx simply by measuring outcomes such as
knowledge acquisition, coping or decisional quality alone.
We were careful to consider the potential for harm as well as benefit, trying to avoid the temptation to be
either pessimists and optimists.62 Online PEx may help people make better health-care choices and alert
them to health issues, improve their health literacy and understanding of susceptibility to illness, compare
their situation with that of others, improve their own illness narration, access more appropriate services
and develop better relationships. Yet we cannot assume that the effects of exposure to online PEx are
always benign. They may raise anxiety. They may be disadvantageous if they feature only a small number
of unrepresentative patients’ stories. A single story with strong emotional content can distort decisions.1,20
Overengagement with online communities can be detrimental to life ‘offline’. The powerful and
memorable delivery of a personal experience could be used for a deliberately misleading or exploitative
message. The benefits and disadvantages are unlikely to be evenly distributed across socioeconomic, age
and gender groups, yet little is known about these patterns, and, as the digital ground shifts again, new
applications may encourage new types of use and users.
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Guided by realist review methods,6 we considered the processes through which PEx may operate.
The literature suggests that the processes may differ depending on, for example, whether people are
reading about others’ experiences or writing about their own. Those who help to create health content
may be participating in a different way from those who consume rather than post their own contributions,
yet the widespread use of social media and blogs is already blurring these boundaries. Some of the
outcomes or consequences (e.g. the ability to make sense of what has happened and construct a coherent
account) may be similar, whether one has learned from other people’s stories or from constructing a
coherent account of one’s own.
The extent to which patients and members of the public have turned to other people’s experiences on the
internet has provoked both surprise and, in some quarters, concern, although with the rise of social media
and access from multiple platforms it is becoming the norm across health systems. Our review sheds some
light on the features that make first-hand accounts compelling and the processes through which they
operate. The value of first-person accounts, the appeal and memorability of stories, and the need to make
contact with peers all strongly suggest that reading and hearing others’ accounts of personal experiences
of health and illness will remain a key feature of e-health.
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Chapter 3 Work package 1b: how, why and with
what effect do people seek out and share health
information online? Secondary analysis of the Oxford
Health Experiences Group archive
Abstract
Introduction: the HERG archive contained almost 3000 interviews on over 60 health conditions.
We conducted a secondary analysis on a subset of interviews to gain insight into how, why and with
what effect people seek out and share health information online.
Methods: information relating to internet use and/or PEx was extracted from 276 interviews. First,
95 interviews were analysed in depth with a focus on seeking and sharing PEx. Second, statements
relating to the use of health-related websites were extracted, recast as questionnaire items and reviewed
by an expert panel for the eHIQ.
Findings: perceptions and experiences of online PEx differ between individuals and across conditions.
Factors influencing people’s desire for and response to PEx include personal characteristics and
preferences; condition and stage of illness; health-care environment; source and type of PEx; and the
format and medium through which PEx is communicated. Eighty-two items relevant to the impact of
health-related websites were identified for use in the eHIQ.
Conclusions: online PEx is widely available, diverse and hard to control. Reasons for, practices of and the
health effects of seeking and sharing PEx are complex and relationally contingent. A secondary analysis of
the HERG archive enabled us to explore key aspects of this complexity across multiple conditions and
develop new questionnaire items suitable for use across health conditions.
Introduction
At the time of this study, the Oxford HERG archive contained almost 3000 qualitative interviews covering
more than 60 different conditions. It is ethically approved for secondary analysis and is an invaluable
resource for health-related research. As interviewees are routinely asked about their experiences of
seeking and receiving information, internet use, professional and peer support, it was thought that the
archive would contain a great deal of information of relevance to the iPEx (Internet Patient Experiences)
programme grant. To benefit from these data, a secondary analysis, or more accurately, a series of iterative
secondary analyses, was conducted on the material.63 The aims of this process were (1) to inform the
design and implementation of subsequent WPs (especially WP1c and WP2b; see Chapters 4 and 6);
(2) to contribute to extant knowledge on how, why and in what ways seeking and sharing PEx online
affects people’s health and well-being; and (3) to identify the main reasons that people use online health
information in order to construct a set of items for an assessment tool that measures the impact of using
health-related websites to be used later in the programme (WP1c; see Chapter 4).
The analysis was conducted in two stages (Figure 2). In stage 1, two researchers (FM and LK) conducted a
high-level thematic analysis on a subset of 276 strategically selected interviews. The aim of this preliminary
stage was to familiarise ourselves with the data, develop appropriate sampling approaches and forms of
analysis for subsequent work, generate a high-level list of themes relating to people’s perceptions and
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experiences of online PEx and select key topics and questions for further analysis. To ensure that a range
of experiences, practices and perceptions of online health information was included, we aimed for breadth
rather than depth of coverage.
In stage 2, two distinct strands of work were conducted. In the first strand, FM, JP and LL investigated two
areas of interest that emerged during the first stage of analysis, and were new contributions to research in
this area. The first, focused on issues around the reception of PEx, was an exploration into how processes
of identification and visualisation mediated the ways in which people with serious neurological conditions
(MND and Parkinson’s disease) communicated and responded to PEx.55,64 The second, focused on issues
around the sharing of PEx, explored the ‘value’ that people who actively shared their experiences
attributed to doing so.65 In the second strand, drawing on the theoretical framework outlined in the
previous chapter (WP1a), LK conducted further analysis to generate an item pool for the development of
the eHIQ. This secondary analysis enabled the incorporation of internet users’ actual words as a basis for
questionnaire items and helped enhance content validity of the assessment tool.
In this chapter, we provide a high-level overview of the methods used for the secondary analyses and
present overarching findings. Much of the research discussed here has been published elsewhere.55,64–66
To avoid duplication, we do not go into the details of published work, but rather (1) provide a high-level
overview of the findings from stage 1 of the secondary analyses that have not been published elsewhere
and (2) summarise and contextualise key findings from both strands of stage 2 (which have been
published) in relation to this wider secondary analysis.55,64–66
Methods
Secondary analysis, broadly defined as the use of an existing data set to answer questions not posed in the
original research,67 has long been conducted on quantitative data. In qualitative research, where the need
for contextual sensitivity and specificity is seen as paramount, secondary analysis is less well established.
More recently, as evidenced by the creation of the Economic and Social Research Council Qualitative
Archival Research Data Centre (QUALIDATA) in the mid-1990s and its incorporation into the UK Data
Service, there has been an increased interest in the value of conducting secondary analyses on qualitative
data. In spite of this acceptance and, indeed, in some cases, active encouragement (e.g. from funding
bodies) of the secondary analysis of qualitative data, persistent concerns remain. According to Heaton,63
these can be broken down into three main areas: (1) the ‘fit’ between the data and the questions posed
in the secondary analysis; (2) the position of the researcher and their relationship with the data; and
(3) verification of the data and findings generated from it. All three of these concerns were taken into
consideration and addressed during the course of our secondary analysis.
Stage 1: preliminary secondary analysis
(276 interviews)
Strand 1: in-depth analysis of reception 
and sharing of PEx
(95 interviews)
Stage 2: further secondary analysis
Strand 2: generation of eHIQ item pool
(99 interviews)
FIGURE 2 Work package 1b: high-level overview of the secondary analysis process.
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The interviews collected by the HERG are in-depth narrative ones, conducted with a view to soliciting as
wide a range of experiences of illness as possible, which makes them particularly suitable for secondary
analysis.68 In the first half of the interview, participants are invited to tell their story for as long as they
want with as little interruption as possible. In the second half, a semistructured interviewing approach is
adopted to enquire after topics of interest that have not already been raised and to explore key topics
in more depth, including questions on information seeking, internet use and peer support. The interviews
are collected using maximum variation sampling, with variation across demographic variables and type
of experience.69 Ethics approval for secondary data sharing and analysis was received from the Eastern
Multi-Centre Research Ethics Committee (reference 03/05/016) and the interviews have been successfully
used for secondary analysis in extant studies on health-related use of the internet.10,15 Further information
about the methods used to collect and conduct the interviews is available elsewhere.70,71
Stage 1: preliminary analysis
Given the range of conditions contained in the archive, it was not possible to undertake an exhaustive
analysis of all available interviews. Key findings of HERG interview collections are published as online
resources (www.healthtalk.org). These website sections were explored to gain an insight into the topics
that the primary researchers had identified in each interview collection and to help select which interviews
to use in the secondary analysis. We decided, in the first instance, to focus our analysis on those deemed to
have closest relevance to the three exemplar conditions being investigated by the iPEx programme (smoking
cessation, asthma and carers of people with MS). To maximise the chances of finding information about
internet technologies, only interviews published from 2005 onwards were included. Based on this, seven
complete collections and a further nine ‘pilot’ interviews with people affected by MS were included in the
first round of analysis (Table 1). These were selected through discussions with key members of the project
team, including those who were very familiar with the content of the HERG archive.
With the exception of the MS-related interviews, thematic summaries and interview extracts are available
online for all of these conditions (see www.healthtalk.org). The summaries contain sections of direct
relevance to the secondary analysis (e.g. ‘information and support’, ‘support and support groups’). The
interviews were read (by FM or LK and in many cases by both) and all information relating to internet use
and/or sharing or seeking experiences (online and off) was extracted. Scoping summary reports were
compiled to identify the extent to which the collections had content relating to using the internet for
health. A list of key emergent themes and associated statements (examples of the exact wording and
TABLE 1 Work package 1b: interviews analysed in secondary analysis, stage 1
Title of collection Date Number of interviews
Carers of people with dementia 2005 31
MS N/A 9
MND 2008 47
Parkinson’s disease 2008 40
Young people with type 1 diabetes 2006 39
Young people with epilepsy 2008 41
Young people with depression and low mood 2009 39
Young people with long-term health conditions 2007 30
Total 276
N/A, not applicable.
DOI: 10.3310/pgfar04170 PROGRAMME GRANTS FOR APPLIED RESEARCH 2016 VOL. 4 NO. 17
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Ziebland et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
17
language used by interviewees) was created for each condition. This list was subjected to an additional
round of constant comparison coding, and key cross-cutting themes and areas for further investigation
were summarised. This summary was not intended to be an exhaustive assessment of all the interviews.
Instead, alongside the conceptual review (WP1a; see Chapter 2), it was used to highlight areas of interest
for more in-depth secondary analysis and to index interviews and excerpts for the development of the
assessment tool (WP1c; see Chapter 4).
The sample design and suitability of the data was further informed by consulting the original researchers
of the selected interview collections. The researchers (most of whom are still employed in the HERG)
provided input and advice based on their experiences of the collections they had created and their
expertise in terms of online PEx more generally, which was incorporated into the analysis. Following
discussions about the suitability of an interview collection for the research purpose, the original researchers
provided coding reports [generated at the time of their own research using either the NUD*IST or
NVivo (both QSR International, Warrington, UK) qualitative analysis software] that they believed would
be particularly relevant to the topic. Coding reports took the form of electronic reports of sections of
interview transcripts which related to a specific topic and were subsequently reviewed to inform the
sample selection. Examples of coding reports were entitled ‘Web forums’, ‘Information’, ‘Support groups’
and ‘Information carer’.
The steps outlined above aided familiarisation with the data sets and helped us to assess the suitability of
particular interview collections for further analysis. Sampling and selection of interview transcripts were not
finalised at the outset, but, as is usual in qualitative analysis, remained continuous throughout the process.
Stage 2: further secondary analysis
Strand 1: secondary analysis to explore the sharing and receiving of patient
experience in more depth
Numerous topics of interest emerged from the first round of analysis, and it was not possible to explore
all of them in depth. We decided to focus on areas that have been underexplored in the extant literature
and had wider implications for our understanding of online PEx. Based on this and in discussion with the
project team, two areas were chosen for further analysis. The first was an exploration into the ways in
which people articulated and responded to different types of PEx in relation to neurological conditions.
Here, we performed a secondary analysis on 87 interviews conducted between 2006 and 2008 in the UK
with people (patients and carers) affected by MND (46 interviews) and Parkinson’s disease (41 interviews).
The second was an examination of people’s self-reported reasons why they shared their experiences
through the internet and other mediums. We were interested not in psychological motivations, but in using
these data to develop a nuanced understanding of the value(s) associated with sharing PEx. Here, we
selected and analysed a strategic sample of 37 interviews conducted with people affected by 15 different
conditions who had reflected on why they chose to share their experiences (Table 2).
In both cases, a supra-analysis (analysis of existing data from a new theoretical perspective)63 was
conducted using a modified grounded theory approach.72 All of the interviews were read in their entirety,
online summaries were, once again, consulted and discussions were held with primary researchers. One of
the authors (LL) was the original researcher for the MND module and hence was able to contribute to the
analysis with contextual knowledge. Constant comparison coding was used, with discussions held among
FM, LL and JP at regular intervals to validate and further conceptualise key themes. Throughout the course
of the analysis, we presented the work in progress at programme grant meetings and conferences,
receiving useful feedback that assisted with the development of key ideas. For more detail on the methods
used please refer to Mazanderani et al.,55 Locock et al.64 and Mazanderani et al.65
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Strand 2: secondary analysis for the development of the e-Health
Impact Questionnaire
Following the preliminary analysis in stage 1, interview collections were reviewed which were likely to be
rich in data regarding the use of online health information. Of the 203 interviews reviewed, relevant
extracts from 99 transcripts were identified and analysed using a modified version of the framework
method73 (Table 3). Framework analysis allows a researcher to look at the data and conduct analysis in a
systematic and comprehensive manner.74 The framework method involves five stages: (1) familiarisation
with the data gathered; (2) identification of a thematic framework which allows emerging issues, concepts
and themes to be listed; (3) indexing the transcripts according to the thematic framework; (4) charting the
TABLE 2 Work package 1b: interviews analysed in secondary analysis, stage 2
Condition Number of interviews
Alzheimer’s disease 1
Autism spectrum disorders 2
Cervical abnormalities 6
Colorectal cancer 2
HIV 2
Leukaemia 1
Ethnic minority experiences of mental health 2
Organ donation 1
Osteoporosis 5
Pancreatic cancer 1
Experiences of psychosis 2
Rheumatoid arthritis 2
Testicular cancer 1
Parkinson’s disease 7
MND 2
Total 37
TABLE 3 Work package 1b: participant distribution by gender and condition
Condition group Male Female Total
Long term condition (younger people) 3 12 15
Diabetes (younger people) 5 14 19
Depression (younger people) 3 6 9
Parkinson’s disease (carers) 2 4 6
Motor neuron disease (carers) 3 6 9
Dementia (carers) 5 8 13
Antenatal screening 1 4 5
Fetal abnormality 5 8 13
Menopause 0 6 6
Mental health: BME (carers) 1 3 4
Total 28 71 99
Reproduced from Kelly et al.66 under the Creative Commons Attribution licence CC BY-NC-ND 3.0.
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data through extracting and synthesising it in a manner which allows within-case and between-case
comparison; and (5) mapping and interpretation of the data.75,76 Many of the themes that were expected
to be raised during analysis had been identified in the WP1a review of the literature (see Chapter 2).
This stage of the secondary analysis sought to gain a deeper understanding of existing (‘anticipated’)
themes found in the literature while being mindful of any new (‘emergent’) ones that arose.
Two further sources of data were used to corroborate the themes identified for inclusion in the item pool:
(1) focus group transcripts (n= 16) from research carried out on trust and online health information at
Northumbria University76 and (2) comment forms (n= 29) completed by members of the programme’s
public panel (WP1a; see Chapter 2) consisting of lay persons using local primary health-care services.
Using more than one data source served as a method of ‘data triangulation’, enhancing rigour in
the research.77
This process contributed to the development of an item pool relating to the impact of using health-related
websites which would be subsequently entered into psychometric testing (see Chapter 4). The assessment
tool needed to be suitable for use in the WP3b Phase II pilot randomised controlled trial (RCT). Therefore,
for each theme identified, candidate items were developed and checked for applicability to people viewing
a website containing scientific information only and a website containing scientific information plus
experiential health information. Emphasis was also placed on checking the suitability of the items among
the WP3 exemplar condition groups (i.e. smoking cessation, asthma and carers of people with MS).
Candidate items were circulated among colleagues in the project team for review and the feedback
received was incorporated into the development of the final questionnaire.
Results and discussion
Key findings from the preliminary secondary analysis (stage 1)
The conceptual review presented in Chapter 2 drew attention to how practices of seeking and sharing PEx
can have numerous and often profound (both positive and negative) consequences for people affected
by different conditions.4 Our secondary analysis of patient interviews reinforced and supported the findings
of the review.
The first five domains of how online PEx could affect health (‘information’, ‘feeling supported’,
‘relationships with others’, ‘experiencing health services’ and ‘affecting behaviour’) identified in the review
were evident across all the modules analysed. The sixth (‘learning to tell your story’) emerged in interviews
with people who had actively shared their experiences online or in other forums. As many more people
seek out others’ experiences rather than share their own, this domain was less prevalent than the first five.
Interestingly, the seventh domain (‘visualising disease’), although not common across the corpus of
interviews, was evident in certain conditions with visible and highly variable symptoms (namely MND and
Parkinson’s disease). Given their importance in both our secondary analysis and the extant literature, the
first five domains were used as a key structuring device for the development of the assessment tool for
measuring the impact of health-related websites.66 Owing to the lack of research on the sixth and seventh
domains, they were selected for further secondary analysis.55,64,65
In our secondary analysis we found both variations and similarities between how people affected by
different conditions used the internet and responded to PEx. This is significant, as a great deal of current
research on health-related use of the internet is condition specific and hence unlikely to pick up on wider
cross-condition trends and differences. Although it is not possible to provide an exhaustive list of all the
factors that influence how people respond to online PEx, we list some particularly notable ones that
emerged from our high-level analysis.
WORK PACKAGE 1B
NIHR Journals Library www.journalslibrary.nihr.ac.uk
The first is the condition in question and, linked to this, the age of the people affected by it. This was
especially striking in relation to carers of people with dementia, where, despite the fact that interviewees
spoke about benefiting from sharing PEx in face-to-face environments, there was very little evidence of
them using online PEx. This may be because interviewees tended to be older and used the internet less,
but it may also be related to the nature of the condition and the types of PEx available about dementia.
In contrast, young people are particularly active online, seeking and sharing PEx across a variety of
technologies and platforms [e.g. patient forums, Facebook (Facebook Inc., Menlo Park, CA, USA),
YouTube]. However, in the case of young people with serious chronic conditions, such as cystic fibrosis,
interviewees spoke of being upset by and in some cases actively avoiding ‘negative’ or distressing
information, including PEx.
It has long been recognised that PEx can be a highly ambivalent source of information with the potential
to bring about feelings of both hope and fear, provide support and increase isolation, and be perceived as
‘true’ knowledge or discarded as irrelevant.31,78 In our secondary analysis we found that this was most
definitely the case, with interviewees speaking of having had both ‘positive’ (e.g. feeling ‘supported’,
‘empowered’, ‘inspired’) and ‘negative’ (e.g. feeling ‘depressed’, ‘upset’, ‘devastated’) responses to online
PEx. In relation to the former, interviewees said that PEx was an extremely valuable source of information
that was simply not available elsewhere. Key areas of information provided by PEx discussed across
interviews were practical hints and tips about actually living with a condition, information about diagnosis,
prognosis, treatment, side effects, family and personal relations, finances, jokes and humour. Furthermore,
PEx affected the health and well-being of interviewees not only by virtue of its informational content
(important as this was), but from the sense of support and mutual understanding that was gained from
speaking to, sharing with and identifying with other people affected by the same condition. In terms
of ‘negative’ responses to PEx, the two most common concerns were fears about the danger of
misinformation and the emotional difficulties of dealing with PEx. Interestingly, we found that people
with serious chronic or terminal conditions tended to respond especially strongly to PEx, seeing it as an
extremely valuable source of information and support, but at the same time often finding others’
experiences very distressing.
It is important to note that what were perceived as ‘negative’ versus ‘positive’ experiences of PEx were not
static but, as with other forms of health information, changed over time, sometimes radically. For many
people diagnosis was a crucial time for seeking out PEx, while others preferred to wait and seek out PEx
once they had adjusted to their new diagnosis. The fact that for many people the internet is available at
any time and can be customised to filter and select different PEx was seen as an important feature of the
technology. Indeed, interviewees were selective about the source of the PEx they found online (who and
where was it coming from), as well as the format and medium through which it was communicated (e.g.
text written on a patient forum or a video on YouTube). Thus, the value and, crucially, evaluation of PEx as
either ‘good’ or ‘bad’ was highly relational and contingent not only across interviews, but over time, and in
relation to different modes of communication. For example, in the case of MND and Parkinson’s disease,
a number of interviewees expressed a strong preference for PEx communicated in writing rather than face
to face to avoid seeing physical symptoms of the disease that they found upsetting.
Moreover, when interviewees spoke of how online PEx had affected their health and well-being they
situated it in relation to their wider health-care environment and informational landscape (both online and
offline). In some rare cases health-care practitioners had encouraged patients to look up PEx, occasionally
suggesting websites and other sources; in others (again often in relation to more severe conditions),
the use of the internet was actively discouraged by medical practitioners. Either way, across all of the
collections we analysed, interviewees interpreted and used PEx in conjunction with information they
received from numerous different sources, including the information they received from their health-care
practitioner(s), NHS services, charitable organisations, the media, family and friends.
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Key findings from the further secondary analysis (stage 2, strand 1)
Identification, mediation and visualisation in online patient experience
In our secondary analysis of the HERG interviews, interviewees regularly stated that PEx was a valuable
source of ‘experiential knowledge’: ‘truth based on personal experience with a phenomenon’.79 However,
not all PEx was considered equally useful or relevant. Interviewees often spoke about how they were
particularly interested in and affected by PEx from people they could relate to. Although the importance of
relationships has been discussed in the sociological literature on ‘experiential knowledge’,18,80,81 little explicit
attention has been given to examining the different forms of relationality at play in whether or not PEx is
deemed as a valid source of ‘knowledge’. We explored this question in more depth through a secondary
analysis on the MND and Parkinson’s disease collections. The main findings have been published55 and are
summarised here.
A key factor that influenced whether or not interviewees considered someone else’s experience to be
relevant to them was based on the recipient’s identification with the person sharing their experience. In
the case of health-related PEx, this sense of identification was premised, in the first instance, on a shared
diagnosis. Interviewees regularly said that only someone else living with the same condition as them could
understand what they were going through and, therefore, be able to provide them with appropriate
advice and support. However, a shared medical condition was not the only factor that affected whose
experiences were considered relevant and useful. Interviewees sought out and responded most strongly to
PEx provided by people they felt were ‘the same’ or similar to them. The key factors that informed whether
or not someone was deemed similar, and hence that their experience was relevant, can be broadly
classified as medical (e.g. stage and severity of illness, medication and symptoms) or personal and/or social
(e.g. age, gender, lifestyle, family situation, education or job).
However, although the subtle processes of identification play key roles in underpinning how people
respond to PEx, identifying with a ‘disease’ and with people living with it can be a source of emotional
distress that is particularly acute in people with serious, stigmatised and/or degenerative conditions.31
This results in a tension. To learn from PEx and consider it relevant to his or her own situation, the
recipient of the PEx needs to identify with the person sharing it. At the same time, to minimise the
negative associations and emotional distress that results from this identification, the recipient seeks out
ways to distance him- or herself from the sharer. A key way people manage this tension is through
emphasising both the similarities and the differences between their experiences and those of others:
what, drawing on Ricoeur’s work on metaphor,82 we have conceptualised as ‘being differently the same’.55
The tension between making someone else’s experience relevant and, at the same time, avoiding
becoming upset by the more ‘negative’ or distressing aspects of the experience was also managed through
mediating the way in which that experience was communicated. This is expressed in the excerpt below
from an interview with a woman with MND:
You like the support you have helping one another but you’re scared that, I think, well I’m personally
scared that if I met up with someone face-to-face and we started meeting up that if they needed to
become reliant on me or to talk to me about their problems with MND that I wouldn’t be strong
enough for that. I mean it might not be the case that they would do that but you don’t know.
So I think too. I like having the e-mail contact but I don’t think I would want personal contact with
someone else with MND because I think it gets too involved then.
MND collection, interview 10
It was precisely in contexts like the one described above, seeing other people with the same condition as
them experiencing poor health or visible disability, that interviewees said the internet could be very helpful.
Indeed, the ability to control seeing people and being seen was a key reason interviewees gave for using
internet technologies for seeking out PEx and meeting people, rather than going to face-to-face support
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groups. This is illustrated in a quotation below, which was taken from an interview with a woman living
with Parkinson’s disease:
[. . .] whilst I’m happy to go onto the web forum and communicate with people who’ve, with, who
have had Parkinson’s for twenty years. I’m anxious about meeting people in the flesh, I don’t want to,
I don’t want to see my future.
Parkinson’s disease collection, interview 17
When people speak about their experiences of illness, they often use extremely vivid imagery and
metaphors that can have a powerful impact on others.64 The articulation of PEx through written and verbal
language, especially in the form of narratives and stories,14,47,50,83 has received a considerable amount of
academic attention. In contrast, the visual dimensions of PEx through images and video has been relatively
under-researched. We explored this topic further in WP2a, as discussed in Chapter 5.84
Exploring the multiple ‘values’ of patient experience in contemporary
health care
Patient experience has become an increasingly central part of contemporary health care. Patients’
experiential accounts are used for many different purposes, ranging from artistic expression through to
fundraising for biomedical research and lobbying for changes to health-care policy. Yet relatively little is
known about why people choose to share their personal experiences of illness.
Everyone who took part in the HERG interviews knew that text, audio and/or video clips of their interviews
would be made available on a publicly accessible website with the specific aim of making their experience
available to others. In addition, some interviewees had already shared their experiences in other mediums
(e.g. blogs, support groups, face to face, books, documentaries, etc.). This meant that the archive
contained a considerable number of data on this rarely discussed topic. In the first round of secondary
analysis, we noted a number of cases in which interviewees reflected on why they had chosen to share
their experiences and what they thought the effects of this had been on themselves and on others.
To explore this topic, we selected additional interviews where this had been elaborated on in more depth
and subjected them to a further round of analysis (for more detail on our sampling approach see the full
account of this research, published elsewhere65). A significant portion of what we found related to the
emotional and therapeutic benefits of peer support. As this has already been discussed in depth
elsewhere,25,84 we chose to focus on other aspects of why interviewees share their experiences, especially
in more public forums.
In summary, interviewees said that they shared their experiences because they believed that living with a
condition on a daily basis meant that they had unique insights, which could be of value to others.
They explicitly distinguished the type of knowledge and ways of knowing that came about as a result
of embodied experiences of illness from both fictional accounts of illness and medical knowledge.
This is illustrated in the quotation below taken from an interview with a man with colorectal cancer:
They’ve [hospital staff and stoma care nurses] got a bit of learning from books but it ain’t nothing like
living with it. It really is quite a different thing and all their ideas really as I say are book learning which
I don’t know who writes the books but they haven’t had one [colostomy] either if you know what I
mean. And when you live with one you learn that it can be quite capricious at times and it can do all
sorts of things, odd things that you can’t expect or you don’t expect and really and truthfully the best
thing is to find somebody who’s got one.
Colorectal cancer collection, interview 4
Moreover, interviewees said that they had decided to share their experiences because they believed that
doing so could help others in some way. In a number of cases people said this was because they had been
similarly helped by others who had done so. Thus, sharing PEx was seen as a means of contributing to the
community affected by a particular condition. The value attributed to PEx was, therefore, both epistemic
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(in that it was seen as a form of knowledge and way of knowing) and ethical (in that it was intended to
help others). In a few, rarer, cases interviewees spoke of generating tangible economic value from sharing
their experiences, for example through fundraising activities, advertising on websites or selling books.
Rather than being an end in itself, this economic value was articulated by interviewees as part of a broader
ethical project of sharing knowledge and helping others. The coconstitution of these three forms of value,
the epistemic, ethical and economic – what we have conceptualised as ‘biographical value’65 – in the
sharing of PEx is succinctly illustrated by the quotation below taken from an interview with a man
with osteoporosis:
I go out and I meet people and then win them over and tell them my story and go away feeling
happy. And, and that’s how I’d describe my NOS [National Osteoporosis Society] work. And in the
meantime it raises money and it raises awareness. So . . . it’s a win–win. So that’s the therapy, that’s
my therapy if you like.
Osteoporosis collection, interview 28
There was a general belief among interviewees who actively shared their experiences that doing so was a
‘good’ thing for the reasons articulated above. At the same time, PEx produced about or by well-known
figures were viewed as particularly powerful in terms of raising public awareness of a condition, fundraising
and research. This was reinforced by findings from stage 1 of the secondary analysis, in which famous
people with different conditions (e.g. Michael J Fox in relation to Parkinson’s disease, Stephen Hawking in
relation to MND, Jade Goody in relation to cervical cancer) were frequently mentioned. This raises questions
about the differential effects that the public articulation, be it in books, websites or any other media, of
people’s experiences can have not only on the health and well-being of particular individuals, but on public
perceptions of different conditions and the field of medicine more generally (see Mazanderani et al.65
for more details).
Findings from further secondary analysis for the development of the
e-Health Impact Questionnaire (stage 2, strand 2)
As discussed above, it was clear from the analysis that preferences for various types of online health
information varied between participants. This was viewed as an individual’s ‘baseline’ acceptance or
openness towards using the web for health information which could potentially have an influence on
using a specific website. Therefore, a pool of items assessing general attitudes towards online health
information was constructed (eHIQ part 1).
To inform the second pool of items relevant to using a specific health-related website (eHIQ part 2),
themes derived from the secondary data analysis were mapped onto five of the seven domains identified
in the review of literature in WP1a (see Chapter 2). These themes are outlined briefly here, but are
discussed further in Kelly et al.66 The first theme, ‘information’, incorporated learning about a health
condition, becoming informed of what to expect and recognising decisions that may need to be made in
the future. Health-related websites were also a valuable resource for finding practical tips and advice to
help manage health.
The second theme, ‘feeling supported’, related to finding support through others going through similar
health experiences. In some cases, accessing a particular health-related website was the first time
participants learnt that other people had similar health concerns. Increased hope and confidence was also
found through gaining and lending support.
The third theme, ‘relationships with others’, referred to a person feeling less isolated and that others
understood what they were experiencing (e.g. in an online community). Using websites also had the
potential to ease offline relationships, as these provided an area in which they could discuss their health
concerns with people going through similar experiences and learn to articulate what they were feeling.
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The fourth theme, ‘experiencing health services’, concerned the use of websites when deciding whether or
not medical advice should be sought. The use of the internet could help participants to navigate the health
system and helped to prepare people for upcoming decisions. Participants could corroborate advice, find
out more information and reflect on decisions made after accessing health services.
The final theme, ‘affecting behaviour’, incorporated the motivational effect some website content may
have on the individual. For example, learning of the consequences of ignoring best practice when
managing a long-term condition encouraged people to improve their own health-care regime.
The Northumbrian focus group transcripts and the public panel comment forms were subsequently
reviewed to ensure that each theme identified had been fully explored and that no additional themes were
evident. No new overarching themes were evident; however, the confirmatory sources did provide greater
insight into some themes identified. For example, the focus group transcripts provided further insight to
the fourth theme, ‘experiencing health services’, as participants discussed the dangers of using misleading
information found online instead of consulting a health professional. These concerns were also highlighted
in the public panel group.
Overall, the five themes were consistent with the domains identified in the WP1a literature review,
providing a strong basis for the conceptual underpinning of the eHIQ part 2 item pool. Although the two
remaining themes (‘learning to tell your story’ and ‘visualising disease’) were less pervasive across the
transcripts analysed, issues relevant to each domain were dispersed throughout the five confirmed themes.
For example, ‘learning to tell your story’ was incorporated into ‘relationships with others’ when a participant
discussed being able to communicate more succinctly with their partner after using an online forum.
‘Visualising disease’ was incorporated throughout the five themes identified when participants described
images reinforcing people’s stories or messages. It was therefore felt that the issues addressed in domains 6
and 7 were adequately represented in the item pool.
In total, 376 participant statements were extracted from the transcripts to represent all the themes present.
LK identified 149 generic statements that could be answered by people across health conditions.
Statements were recast as questionnaire items and reduced to 67 items in an iterative process involving LK,
SZ and CJ. LK, CJ and SZ added a further 15 items to ensure that all themes were adequately represented.
On review, the expert group recommended changes to two items to make them acceptable to people with
a low level of health literacy. All members agreed that the items reflected the impact of using health-related
websites. Eighty-two items were, therefore, entered into patient interviews and psychometric testing
(see Chapter 4 for a full description of the development of the eHIQ).
Conclusions
We analysed over 276 interviews about people’s experiences of 24 different health issues. This large and
diverse sample included experiences of a wide range of conditions, across different time periods and
locations in the UK. Moreover, our sample included people of different ages, gender, race and ethnicity.
In the time available it would not have been possible to access this diversity or richness of experience
without using the HERG archive. Being able to meet with and, in some cases, work closely with the original
researchers was of great value, as it helped us to select particularly salient interviews and contextualise
our findings.68 We were also fortunate in that the topics we were interested in (internet use and/or sharing
PEx) were explicitly asked about in the interviews. However, there were some limitations. First, as the
internet changes so rapidly it can be hard to get a sense of people’s experiences of the latest platforms
and technologies. Second, there was sometimes insufficient depth on specific issues. To mitigate these
limitations, additional focused interviews were carried out during the process of developing the eHIQ
(see Chapters 4 and 5 for more details).
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A huge quantity and variety of PEx is shared through internet technologies and, as society becomes ever
more connected, and more and more people share their experiences of health and illness online, this will
only grow. What counts as PEx is highly diverse in terms of the topics discussed as well as the formats and
mediums through which it is communicated. Studies on how health is affected by online PEx tend to focus
on the informational content of PEx. Our analysis and the conceptual review, outlined in Chapter 2, show
that, although PEx can indeed be a source of information, in order to understand how seeking and sharing
PEx affects people’s health and well-being it is essential to study the practices, technologies, forms of
identification and relationships that shape how people engage with PEx. PEx must, moreover, be situated
in relation to the wider health-care environment and people’s lives.
Our secondary analysis drew attention to a number of contextual factors that affect how and why people
respond to and share PEx. These included personal characteristics and preferences; condition and stage of
illness; health-care environment; source and type of PEx; and the format and medium through which it is
communicated. To ensure that this variety and contextual sensitivity was reflected in the item pool which
would inform the assessment tool relevant to the impact of health-related websites (see Chapter 4), the
secondary analysis was used alongside the conceptual review. The item pool was, therefore, based on five
core domains that were prevalent in the secondary analysis and conceptual review of relevance to both PEx
and other forms of health information: ‘information’, ‘feeling supported’, ‘relationships with others’,
‘experiencing health services’ and ‘affecting behaviour’. Eighty-two items were tested for acceptability
among experts and were considered suitable to enter cognitive testing with users and subsequent
psychometric testing.
Patient experience is a very important source of information and support for many people, but not all PEx
is considered equally important or relevant. Beyond a shared diagnosis, one of the main ways people
decide if PEx is relevant to them is based on whether or not they identify with the person sharing his or
her experience. However, identifying with a ‘disease identity’, and being exposed to others’ at times very
distressing experiences, can be a cause of emotional upset. To manage this, people use internet
technologies to control their levels and extent of communication with others, thereby enabling them to
benefit from PEx without being overwhelmed by it. A key factor in this is whether PEx is communicated in
writing, images or video, when and at what times. Based on our secondary analysis, the ways in which
experiences of illness and disease are articulated and visualised online has been highlighted as an area for
further research in WP2a (see Chapter 5).
People share their experiences because they believe that PEx is a valuable form of knowledge and,
moreover, that sharing their experiences can help others and, in some cases, influence wider public
perception, fundraising, research and policy related to particular health conditions and topics. For the
most part PEx is not considered a replacement for biomedical or clinical knowledge, but is seen as
complementary to it. The relationship between PEx and other forms of knowledge in medicine is a topic
that is developed further in Chapter 5.
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Chapter 4 Work package 1c: refining and
validation of the e-Health Impact Questionnaire
Abstract
Introduction: this chapter outlines the development of an assessment tool to capture the impact of using
health-related websites. In earlier chapters we described using a literature review (see Chapter 2) and a
secondary analysis of narrative interviews (see Chapter 3) to inform questionnaire items relating to issues
that matter to people using health-related websites. In this chapter we explain how we refined and
reduced the 82-item pool and assessed appropriateness across a range of health conditions.
Methods: the initial set of items was refined following cognitive interviews with 21 people who had
experience of a range of health conditions. Item reduction steps were then conducted using a data set
during a pilot survey (n= 167). We then conducted tests of validity and reliability on a further data
set (n= 170) to determine the psychometric properties of the questionnaire.
Findings: following cognitive interviews, 62 items were entered into psychometric testing. Two independent
questionnaire parts were identified: part 1 consisted of items relating to general views of using the internet
in relation to health and part 2 consisted of items relating to the consequences of using a health-related
website. Subscales were found to have high construct validity, internal consistency and test–retest reliability.
Conclusions: analyses confirmed good psychometric properties in the new eHIQ part 1 (11 items) and
part 2 (26 items). The questionnaire was found to be suitable for use in assessing the health-related effects
of using websites containing different types of material (scientific facts and figures, blogs, experiences,
images) across a range of health conditions.
Introduction
This WP aimed to develop a valid and reliable instrument to capture the impact of using health-related
websites. The instrument, the eHIQ, was designed for use in the WP3b feasibility trial to compare prototype
health-related websites. To be suitable for use in the trial, the questionnaire needed to be appropriate for
assessing different types of material (e.g. scientific facts and figures, and patients’ accounts of their experiences
in blogs and forums) and appropriate across a range of health groups (e.g. people with chronic conditions,
carers of people with a health condition and people viewing websites designed to influence health behaviour).
Candidate items for the questionnaire were informed by the literature review reported in Chapter 2 and
the qualitative secondary analysis of narrative interviews with patients and carers with experience of a wide
range of health conditions (reported in Chapter 3). Draft questionnaire items were subsequently reviewed
by an expert panel to assess whether or not they adequately represented the potential effects of using
health-related websites. In this chapter we describe how we tested the items with members of the public,
reduced the number of items and then assessed the psychometric properties of the questionnaire.
Methods
Following the expert review described in Chapter 3, questionnaire items were divided into two pools:
(1) items relating to general views of using the internet in relation to health (which became the eHIQ
part 1); and (2) items relating to a specific health-related website (which became the eHIQ part 2).
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Analyses of the item pools were carried out over four stages. In stage 1, items were discussed in cognitive
face-to-face interview with people who had experience of various health conditions, either as patients or
as family carers. The aim of this stage was to check that the items and questionnaire structure were
understandable, clear, acceptable and applicable to a range of different health groups. In the second
stage, a pilot version of the questionnaire was administered online to a large sample across a range of
health groups. The aim of this stage was to reduce the number of items by identifying any poorly
performing items and examining the internal structure of the questionnaire. The third stage involved
administering the reduced questionnaire to a further sample of participants. By analysing these data we
were able to finalise the subscales of the questionnaire and evaluate their validity and reliability. Further
analysis of the data was carried out in stage 4 to assess the appropriateness of creating a summary score
for each questionnaire part (eHIQ parts 1 and 2).
Participants
Participants were aged ≥ 18 years with access to the internet and living in the UK. To ensure that items
were appropriate for inclusion in a generic questionnaire, we included participants with different types of
experience (e.g. family carers, people with chronic conditions and people interested in changing a
health behaviour).
Recruitment
Stage 1: cognitive interviews
Potential participants were recruited through a list of people who had responded to the original invitation
from the Oxfordshire Primary Care Trust to attend a panel for the conceptual review (see Chapter 2) and
who had indicated that they would be interested in taking part in our research. The available demographic
information for list members was used to ensure that people with a range of conditions and ages were
contacted. Potential participants were asked to contact LK to arrange a suitable time to be interviewed.
The interviews took place in the Department of Public Health (as it was then named), University of Oxford,
or in the participant’s own home if preferred.
Stage 2: pilot questionnaire
We invited people to complete the pilot questionnaire through a variety of methods, including health
blogs, online discussion forums, social networking sites [Facebook and Twitter (Twitter, Inc., San Francisco,
CA, USA)], news pages on health websites, research volunteer pages, local news advertisements and a
research volunteer e-mail list. Potential participants were asked to click on an electronic link which led
them to the questionnaire.
Stage 3: validation questionnaire
We used a variety of methods to recruit participants for the validation questionnaire. We used some direct
recruitment (stage 3a) by sending postal research invitations [through the Oxfordshire Primary Care Trust
(n= 520) and the Birmingham branch of the MS Society (n= 235)]. We also used open recruitment
(stage 3b), including advertisements on health-related websites and social networking sites but not those
that had been used in the previous stage. Data were also obtained from a separate website evaluation
study carried out in the HERG which incorporated the candidate eHIQ items. This evaluation study ran in
parallel with stage 3 recruitment.
Ethics
Recruitment methods for stages 1, 2 and 3b were approved by the University of Oxford’s Medical Sciences
Division Research Ethics Committee (reference numbers MSD/IDREC/C1/2011/98, MSD/IDREC/C1/2011/77
and MSD/IDREC/C1/2013/063). Stage 3a was approved by the NHS Research Ethics Committee (reference
number 12/SW/0209).
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Instrument development and testing
In each stage, participants were asked to spend 10–15 minutes browsing a pre-selected health website;
these included government websites (e.g. NHS Choices), charity websites (e.g. HealthTalk) and commercial
websites (e.g. BootsWebMD). The websites were chosen to test the items with information based on facts,
figures and personal experiences and other features such as discussion boards, video clips and ratings.
Stage 1: cognitive interviews with patients
Cognitive interviewing, a qualitative method used to find out how respondents understood and answered
structured questions and the response categories, was used to improve the validity and acceptability of
items.85,86 The ‘verbal probing’ method gave the 21 respondents an opportunity to provide uninterrupted
answers to the items, followed by a focused interview85,87 in which the participant’s understanding of an
item and their interpretation of the instructions and response options were checked.75
Items were checked for consistency of interpretation between participants and across health groups.
Recurring problems with specific items or wording were highlighted. The analysis was carried out
throughout the interview process so that revisions to the wording of items could be tested. We continued
until we judged that all problems with questionnaire completion had been identified, revised and retested.
Stage 2: pilot questionnaire
Analyses of the eHIQ parts 1 and 2 were carried out separately in IBM SPSS Statistics, version 20 (2011,
IBM Corporation, Armonk, NY, USA). The items were subjected to preliminary data checks to confirm their
suitability for inclusion in further analysis. A priori decision rules for item removal included items with high
floor and ceiling effects (> 40% of respondents selecting one of the extreme response options) and items
that had large numbers of missing data (> 10% non-response). Items demonstrating poor correlations
(< 0.2) with a large number of other items were considered for removal and analysis was carried out to
identify items with low item-to-total correlations (< 0.3) and items that decreased the internal consistency
(Cronbach’s alpha value). Items were iteratively removed when displaying a high number of poor
correlations with other items or if they reduced the Cronbach’s alpha value.
An exploratory factor analysis (EFA) was carried out to identify subscales within the item pools and to
exclude items that did not group in conceptually sound subscales. We carried out standard preliminary
tests to confirm the suitability of using factor analysis on each data set [Bartlett’s test of sphericity
(p< 0.05)88 and the Kaiser–Meyer–Olkin statistic89]. Factors with eigenvalues of > 1 were extracted, and an
oblique, direct oblimin rotation of the factors was sought so that axes were not restricted to right angles.
This permitted correlation between the factors where appropriate.90,91 The output, in the form of the
structure and pattern matrices, was used to interpret the factors (or subscales) within the questionnaire,
with the structure matrix offering primary guidance for interpretation.92 Items that had been removed were
examined to ensure that no further scales were present.
At this point, a ‘translatability assessment’ was carried out in collaboration with experts in the field.
Translatability assessments consider whether or not items can be meaningfully translated into another
language while remaining conceptually equivalent to the source language and culturally and linguistically
appropriate to the target country.93 Assessing the translatability of a questionnaire during its development
should help to reduce problems in future translations. A concept elaboration document was initially
produced which aimed to clarify any ambiguities or nuances within the questionnaire. With the help of the
concept elaboration document, the questionnaire was then reviewed by the following selected language
(and country) combinations: Arabic (Tunisia), French (France), German (Germany), Japanese (Japan),
Simplified Chinese (China) and Spanish (USA). We noted that the translation exercise also helped us to
refine the English-language version.
Stage 3: validation questionnaire
Convergent validity assesses whether or not theoretically similar scales are statistically related to the newly
developed questionnaire. To assess convergent validity, participants in stage 3 were asked to complete two
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reference questionnaires in addition to the reduced eHIQ. These questionnaires were hypothesised to have
moderate correlations with the eHIQ items.
The first questionnaire which was predicted to have a moderate correlation to eHIQ part 1 scores was a
single item from the Health Information National Trends Survey (‘in general, how much would you trust
information about health or medical topics on the internet?’).94 The second questionnaire was predicted to
have moderate correlations with all subscales of the eHIQ part 2 and consisted of one subscale, ‘access
to quality information’, from the Web Trust Questionnaire.95 Two of the eight items in the ‘access to
quality information’ subscale overlapped with two items already included in the eHIQ part 2 questionnaire.
The relationship of the eHIQ subscales with an adjusted 6-item subscale was, therefore, undertaken
without the overlapping items.
We used Pearson’s correlation coefficients (r) to compare the identified subscales with their respective
reference measure.90,96 Internal consistency was tested for each unidimensional subscale using the
Cronbach’s alpha statistic (> 0.7). Participants were also asked to complete the eHIQ items on two
occasions with a 2-week interval to examine test–retest reliability. The test–retest procedure was used to
establish whether or not responses were reliable over time. The level of agreement between scores from
the two occasions was assessed using the intraclass correlation coefficient (ICC), where coefficients > 0.70
were considered satisfactory.97
Stage 4: summary scores
We explored whether or not it would be appropriate to create summary scores for each questionnaire
part. The factor correlation matrices from stage 3 were used to examine whether or not the identified
factors loaded on a single overall ‘higher order’ factor for each questionnaire part. The use of the factor
correlation matrices was preferred over the use of first-order factor raw scores, as variance which did
not contribute to the first-order factors may still have been useful in explaining the variance within a
second-order factor.98 The summary scores were calculated through summing the subscale scores and
dividing by the number of subscales to get a 0–100 metric.
Results
An overview of recruitment at each stage of the study is shown in Figure 3 and participant characteristics
are given in Table 4. The results are reported below by study stage.
Stage 1: cognitive interviews
Participants (n= 21) were six men and 15 women with a mean age of 45 years [standard deviation (SD)
16.2 years]. Five were carers and 16 had one of a number of chronic health conditions. Three rounds of
Validation
• n = 170
• 107 women
Stage 3
Initial item bank
• n = 21
• 15 women
Item reduction
• n = 167
• 125 women
Stage 1
Stage 2
FIGURE 3 Work package 1c: stages overview.
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TABLE 4 Work package 1c: participant characteristics
Characteristic n (%)
Stage 1 (n = 21)
Sex
Male 6 (28.6)
Female 15 (71.4)
Age, mean years (SD) 45 (16.2)
Stage 2 (n = 167)
Sex
Male 41 (24.7)
Female 125 (75.3)
Missing 1 (–)
Age, mean years (SD) 38.80 (14.04)
Condition
Alcohol reduction 25
Asthma 92
MND (carer) 11
MS (carer) 22
Smoking cessation 17
Stage 3 (n = 170)
Sex
Male 59 (35.5)
Female 107 (64.5)
Missing 4 (–)
Age, mean years (SD) 50.4 (13.0)a
Condition
Asthma 17
Cancer 27
Generic (carer) 2
Healthy eating 49
Menopause 7
MND 32
MS 26
MS (carer) 4
Smoking cessation 6
SD, standard deviation.
a Excludes the HERG evaluation study population who were classified by age band.
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cognitive interviewing were carried out to ensure that (1) the instructions were easy to understand and the
rubric clearly indicated how participants were supposed to answer items, (2) participants considered items
relevant to the topic and acceptable to answer, (3) the response options were appropriate to the item stem
and adequately covered the potential range of agreement, and (4) the electronic format was appropriate
for use among participants with varying levels of confidence in using computers. Twenty-nine items were
deleted and nine items were added, leaving 62 items to enter the next stage.
Two independent item pools were identified to enter psychometric testing. The first item pool contained
23 items on general attitudes towards health websites, while the second item pool contained 39 items
asking about attitudes towards a specific health website. All items were given a 5-point response scale
(strongly disagree to strongly agree).
Stage 2: pilot questionnaire
The two-part questionnaire was completed by 167 participants. The mean age of the sample was 38.8
years (SD 14.04 years); 125 participants were female and 41 were male (the sex of one participant was
unknown) (see Table 4). Checks for floor and ceiling effects confirmed that no item had > 40% of
respondents selecting one of the extreme response options and that no item had a large number of missing
data (> 10% non-response). Therefore, no items were removed owing to floor or ceiling effects or
missing responses.
Seven items (eHIQ part 1) and five items (eHIQ part 2) were iteratively removed owing to poor correlations
(< 0.2) with a large number of items in the same item pool and decreasing the overall Cronbach’s alpha
value. An EFA was carried out on the remaining eHIQ part 1 items. Five factors with eigenvalues of > 1
were initially extracted. These factors explained 63.85% of the variance. The first two factors were
believed to constitute conceptually meaningful factors. These two factors explained 61.06% of the
total variance.
In a further separate analysis, the eight items which had been removed following the EFA were examined
to investigate the presence of any further conceptually relevant scales. This analysis resulted in a scale of
six items which had Cronbach’s alpha value of 0.64. Therefore, 14 items in total for eHIQ part 1 entered
stage 3.
An EFA was carried out on the remaining eHIQ part 2 items, resulting in six factors explaining 66.26% of
the variance. All factors had a Cronbach’s alpha value of ≥ 0.76. The 34 items asking about using a specific
health-related website were, therefore, identified as suitable to enter the next stage of development.
The translatability assessment suggested several minor changes to the instructions and item wording.
Changes were suggested to improve consistency with wording, to ensure that all wording was culturally
and linguistically relevant to the selected countries and to avoid ambiguities which could jeopardise future
translations. Seven minor modifications were made to improve grammar and consistency with wording.
Two items were amended to improve their cultural or linguistic suitability and six items were amended to
avoid ambiguous wording. Three further items were identified as potentially problematic for translation.
These items were:
1. I feel I have a sense of solidarity with other people using the website.
2. I can identify with other people using the website.
3. I feel I have a lot in common with other people using the website.
Although the above items had similar, yet subtly different meanings in the English language, translators
were concerned that some languages may not have the capacity to express those differences (e.g. because
of fewer adjectives or forms of expression in the target language). Following discussions, we decided to
retain the items to capture the intended concept in English.
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Stage 3: validation questionnaire
The reduced questionnaire was completed by 170 participants (see Table 4). Stage 3a recruited
47 participants, stage 3b recruited 96 participants and the separate website evaluation study recruited
27 participants. Of the 170 respondents, 59 were men and 107 were women (four unknown). Of those
who consented to take part in either stage 3a or 3b, 71.1% (n= 143) completed the full questionnaire.
The items for each questionnaire part were entered into an EFA to examine the questionnaire structure
and find the optimal factor solutions. An EFA for items in the eHIQ part 1 confirmed four factors. An item
which did not load with other similar items and had poor distributions across response options (i.e. no
participant selected the ‘strongly disagree’ response category) was removed. A further EFA suggested three
factors; however, two items which formed the third factor were removed due to poor internal consistency
(α= 0.59). The two remaining subscales explained 56.58% of the variance with the structure and pattern
matrices (Table 5) demonstrating high loadings on their respective factors. The two remaining subscales
were entitled ‘attitudes towards online health information’ and ‘attitudes towards sharing health
experiences online’. Both subscales demonstrated good internal consistency (≥ 0.77) and were
conceptually relevant to overall attitudes towards online health information (Table 6).
An EFA for items in the eHIQ part 2 identified six subscales explaining 66.34% of the variance. One of the
six factors consisted of two items which exhibited poor internal consistency (Cronbach’s alpha= 0.50).
Inspection of the structure and pattern matrices indicated that one of the two items loaded on another,
conceptually relevant, factor, while the remaining item did not. The item which did not load on any other
factor was, therefore, removed and all remaining items were entered into a further EFA producing five
factors. Reflections on the fourth and fifth factors concluded with a consensus between the team (LK, CJ
and SZ) that, grouped together, items did not constitute theoretically sound factors and explained very
little variance. The seven items in factors four and five were, therefore, removed and a final EFA confirmed
the three remaining factors explaining 61.68% of the variance. The structure and pattern matrices
(Table 7) were used to interpret the final factor structure and confirmed high loadings of each item on
their respective factor. The three subscales were entitled: ‘Confidence and identification’, ‘Information and
presentation’ and ‘Understanding and motivation’. All scales had good internal reliability (≥ 0.80) and are
listed in Table 8.
TABLE 5 Work package 1c: eHIQ part 1 structure and pattern loadings
Item
Structure Pattern
1 2 1 2
2 0.32 0.61 –0.002 0.61
5 0.39 0.65 0.063 0.62
6 0.39 0.79 –0.03 0.81
7 0.41 0.80 –0.013 0.81
8 0.37 0.71 0.000 0.71
9 0.84 0.31 0.93 –0.18
10 0.84 0.48 0.81 0.06
11 0.67 0.38 0.65 0.04
12 0.62 0.59 0.43 0.36
13 0.84 0.45 0.83 0.02
14 0.77 0.49 0.71 0.11
Extraction method: principal component analysis.
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TABLE 6 Work package 1c: eHIQ part 1 items grouped by subscale
Scale and items
Item to total
correlation
Cronbach’s
alpha
1.1 Attitudes towards online health information 0.77
2. The internet is a reliable resource to help me understand what a doctor tells me 0.39
7. I would use the internet if I needed help to make a decision about my health (for example,
whether I should see a doctor, take medication or seek other types of treatment)
0.64
6. The internet can be useful to help people decide if their symptoms are important
enough to go to see a doctor
0.60
8. I would use the internet to check that the doctor is giving me appropriate advice 0.58
5. The internet can help the public to know what it is like to live with a health problem 0.52
1.2 Attitudes towards sharing health experiences online 0.89
13. The internet is a good way of finding other people who are facing health-related
decisions I may also face
0.72
9. The internet is a good way of finding other people who are experiencing similar health
problems
0.68
10. It can be helpful to see other people’s health-related experiences on the internet 0.72
14. Looking at health websites reassures me that I am not alone with my health concerns 0.67
11. The internet is useful if you don’t want to tell people around you (for example, your
family or people at work) how you feel
0.56
12. It can be reassuring to know that I can access health-related websites at any time of
the day or night
0.56
Adapted with permission from Kelly L, Ziebland S, Jenkinson C. Measuring the effects of online health information: scale
validation for the e-Health Impact Questionnaire. Patient Educ Couns 2015;98:1418–24.99
TABLE 7 Work package 1c: eHIQ part 2 structure and pattern matrices
Item
Structure Pattern
1 2 3 1 2 3
1 0.36 0.36 –0.80 –0.08 –0.01 –0.84
2 0.20 0.42 –0.68 –0.23 0.15 –0.72
3 0.26 0.74 –0.36 0.02 0.74 0.01
4 0.40 0.52 –0.79 –0.03 0.19 –0.71
6 0.48 0.72 –0.52 0.21 0.59 –0.13
7 0.36 0.81 –0.53 0.02 0.72 –0.18
9 0.53 0.23 –0.73 0.23 –0.18 –0.69
10 0.52 0.44 –0.69 0.21 0.12 –0.52
11 0.23 0.78 –0.35 –0.03 0.79 0.01
13 0.62 0.34 –0.57 0.44 0.04 –0.33
15 0.70 0.37 –0.49 0.59 0.11 –0.13
17 0.45 0.74 –0.60 0.11 0.57 –0.27
18 0.52 0.53 –0.66 0.22 0.25 –0.43
19 0.87 0.30 –0.42 0.89 0.03 0.06
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TABLE 7 Work package 1c: eHIQ part 2 structure and pattern matrices (continued )
Item
Structure Pattern
1 2 3 1 2 3
21 0.84 0.31 –0.36 0.88 0.08 0.14
22 0.63 0.58 –0.68 0.35 0.30 –0.36
24 0.72 0.64 –0.66 0.47 0.37 –0.24
25 0.73 0.57 –0.65 0.50 0.27 –0.26
26 0.81 0.24 –0.37 0.85 –0.01 0.08
27 0.77 0.26 –0.60 0.64 –0.10 –0.31
28 0.69 0.44 –0.74 0.41 0.06 –0.49
29 0.56 0.41 –0.76 0.22 0.04 –0.63
30 0.73 0.35 –0.67 0.52 –0.02 –0.41
31 0.56 0.70 –0.51 0.34 0.56 –0.07
32 0.04 0.67 –0.18 –0.17 0.77 0.09
34 0.40 0.81 –0.43 0.15 0.77 0.02
TABLE 8 Work package 1c: eHIQ part 2 items grouped by subscale
Items
Item to total
correlation
Cronbach’s
alpha
2.1 Confidence and identification 0.92
19. I feel I have a sense of solidarity with other people using the website 0.79
21. I can identify with other people using the website 0.72
26. I feel I have a lot in common with other people using the website 0.70
27. The website gives me the confidence to explain my health concerns to others 0.72
30. The website makes me more confident to discuss my health with the people around
me (for example, my family or people at work)
0.73
25. The website gives me confidence that I am able to manage my health 0.75
24. I value the advice given on the website 0.74
15. The people who have contributed to the website understand what is important to me 0.65
13. The website prepares me for what might happen to my health 0.61
2.2 Information and presentation 0.89
7. The language on the website made it easy to understand 0.75
11. I can easily understand the information on the website 0.66
34. The website is easy to use 0.74
3. The information on the website left me feeling confused 0.65
6. The website provides a wide range of information 0.68
17. I trust the information on the website 0.69
32. I found the images on the website distressing 0.51
continued
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Scale distributions and validation
Each scale was transformed to a 0–100 metric, where 0= low perceived value of the internet (or a specific
website) for health and 100= high perceived benefit of using the internet (or website) in relation to health.
Descriptive statistics for the final eHIQ subscales are shown in Table 9. The eHIQ subscale scores followed a
relatively normal distribution across the study sample. Scores were examined for floor and ceiling effects.
High frequencies at the limits of the scales can suggest a lack of sensitivity at the extreme points. No scales
exhibited floor or ceiling effects.
The relationships between the subscales and a range of variables were examined. No significant differences
were found for either sex (t-tests) or age (Pearson’s correlations) among all subscale scores on the eHIQ.
A significant difference [analysis of variance (ANOVA)] was observed between subscale 1.2 (‘attitudes
towards sharing health experiences online’) [F(2,166)= 4.60, p= 0.011] scales and mode of recruitment.
Post hoc comparisons using Tukey’s indicated that there were significant differences between those in
stage 3a (mean= 65.51, SD= 14.89) and the website evaluation study (mean= 76.85, SD= 15.17). This
difference may have been due to the sample size; however, it is conceivable that those in the website
evaluation study were more open to sharing experiential information as they had agreed to help evaluate a
website built around experiences of cancer.
TABLE 8 Work package 1c: eHIQ part 2 items grouped by subscale (continued )
Items
Item to total
correlation
Cronbach’s
alpha
31. Photographs and other images were used appropriately on the website 0.67
2.3 Understanding and motivation 0.90
4. The website includes useful tips on how to make life better 0.71
1. The website encourages me to take actions that could be beneficial to my health 0.67
2. The website has a positive outlook 0.55
9. I feel more inclined to look after myself after visiting the website 0.65
29. The website encourages me to play a more active role in my health care 0.70
28. The website helps me to have a better understanding of my personal health 0.74
22. On the whole, I find the website reassuring 0.69
10. I have learnt something new from the website 0.64
18. I would consult the website if I had to make a decision about my health 0.64
Adapted with permission from Kelly L, Ziebland S, Jenkinson C. Measuring the effects of online health information: scale
validation for the e-Health Impact Questionnaire. Patient Educ Couns 2015;98:1418–24.99
TABLE 9 Work package 1c: descriptive statistics for the eHIQ subscale validation survey
Subscale n Minimum Maximum Mean SD
1.1 Attitudes towards online health information 169 0.0 100.0 63.31 16.90
1.2 Attitudes towards sharing health experiences online 169 0.00 100 70.69 16.30
2.1 Confidence and identification 165 0.0 100.0 58.17 17.54
2.2 Information and presentation 167 0.0 100.0 73.18 13.93
2.3 Understanding and motivation 167 8.33 97.22 61.23 16.07
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Relationships (Pearson’s correlation coefficients) between eHIQ scores and the selected reference measures
were examined to assess convergent validity. Correlations between the eHIQ part 1 subscales and the
Health Information National Trends Survey single item were weak to moderate (r= 0.35 to 0.52; p< 0.01).
Correlations between the eHIQ part 2 subscales and the adjusted Web Trust Questionnaire subscale were
good (r= 0.75 to 0.76; p< 0.01). The results confirmed expectations that the scales are significantly
related but sufficiently divergent.
Participants were invited to complete the eHIQ on two separate occasions with a 2-week interval. Of the
170 sample, 143 were asked to complete a second questionnaire (those in the independent HERG website
evaluation study which ran in parallel to this stage were not asked to complete a second questionnaire).
Of the 143 people asked, 90 (62.94%) people responded. A computer error meant that 22 MND
responses were not valid and seven respondents did not fully complete the eHIQ part 2. The levels of
agreement (ICC= 0.76 to 0.91) indicated good test–retest reliability for all subscales.
Stage 4: summary score
The factor correlation matrix for eHIQ part 1 was entered into a factor analysis. One factor with an
eigenvalue of > 1 was extracted, explaining 76.2% of the variance. No rotation was needed, as all
subscales loaded sufficiently on the factor extracted (Table 10, eHIQ part 1). The higher order factor,
referred to here as ‘attitudes towards the use of the internet in relation to health’ was assessed for internal
consistency achieving a Cronbach’s alpha of 0.78 (n= 169). This supported summing all eHIQ part 1
subscales to create a total index score. After the summed score for the higher-order factor had been
standardised to 0–100 metric, the mean summary score was 67.0 [SD 15.04, 95% confidence interval (CI)
64.72 to 69.28; n= 169].
The factor correlation matrix for eHIQ part 2 was subsequently entered into a factor analysis. One factor
with an eigenvalue of > 1 was extracted, explaining 63.1% of the variance. No rotation was needed, as all
subscales loaded sufficiently on the factor extracted (see Table 10, eHIQ part 2). The higher-order factor,
referred to as ‘overall impact of using a specific health-related website’, was assessed for internal
consistency, achieving a Cronbach’s alpha of 0.87 (n= 163). The mean summary score was 64.22
(SD 14.20, 95% CI 62.02 to 66.41; n= 163).
TABLE 10 Work package 1c: eHIQ higher-order factor loadings
First-order factor Factor loading on higher-order factor
eHIQ part 1
Scale 1.2 0.873
Scale 1.1 0.873
eHIQ part 2
Scale 2.3 –0.854
Scale 2.1 0.779
Scale 2.2 0.747
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Discussion
This chapter outlines the stages taken to develop an instrument which is suitable for use in the WP3b
trial comparing websites based on different types of health information. We followed best practice
guidelines in health-related questionnaire development100,101 and tested the applicability of the
questionnaire items across a range of health groups and different types of health-related websites.
The items and questionnaire design were tested for suitability among (1) people with chronic conditions,
(2) people hoping to modify their health behaviour and (3) carers of people with a health condition.
The questionnaire was also tested on websites containing standard ‘scientific’ health information,
experiential health information, and forums and blogs.
Items were identified through secondary analysis and expert review and were pre-tested among patients
and carers. Cognitive interviews established that the instructions, items, response options and electronic
format of the instrument were acceptable to patients and carers. Two independent item pools were
confirmed as suitable for psychometric testing. The first item pool (eHIQ part 1) contained 23 items
concerning general attitudes towards health-related websites, while the second item pool (eHIQ part 2)
contained 39 items about attitudes towards a specific health-related website. The online questionnaire was
administered in a pilot survey and items were removed using a series of a priori item reduction decisions
and EFA.
The reduced 48-item questionnaire was subsequently administered in stage 3 to explore the validity and
reliability of the new measure. The analyses resulted in the removal of three items from the eHIQ part 1
and confirmed the presence of two subscales: 1.1 ‘attitudes towards online health information‘ and 1.2
‘attitudes towards sharing health experiences online’. The two subscales in the eHIQ part 1 explained
56.6% of the variance and higher-order factor analysis in stage 4 confirmed the appropriateness of
creating a summary index score for ‘overall attitides towards using the internet for health information’.
In relation to the eHIQ part 2, eight items were removed and three subscales were retained: 2.1
‘confidence and identification’, 2.2 ‘information and presentation’ and 2.3 ‘understanding and motivation’.
The three subscales in the eHIQ part 2 explained 61.9% of the variance. The subscales identified were
considered conceptually relevant to the impact of using health-related websites. The first eHIQ part 2
subscale, ‘confidence and identification’, measures the extent to which an individual identifies with others
using a specific website and whether or not they feel that visiting the website has affected their
confidence in discussing and managing their health. The second subscale, ‘information and presentation’,
measures ease of use, ease of understanding, the perceived trustworthiness of information and the
appropriateness of images. The final eHIQ part 2 subscale, ‘understanding and motivation’, measures the
extent to which the respondent felt reassured, better understood their condition and felt motivated to
manage their health after viewing a specific website.
Statistical analyses confirmed the hypotheses that the eHIQ subscales were moderately related to the
chosen reference measures. Correlations between the eHIQ part 1 and the Health Information National
Trends Survey trust item were weak to moderate, while correlations between the eHIQ part 2 and the
adjusted ‘access to quality information’ scale were moderate to good. This demonstrated that the eHIQ
subscales were sufficiently related to each respective reference measure to demonstrate convergent
validity, yet sufficiently dissimilar to validate the independent construct.102 The scaling properties of the
eHIQ subscales were also satisfactory, showing little or no floor and ceiling effects. All subscales had some
evidence of negative skew, indicating that the distribution was concentrated on the positive end of the
scale (i.e. positive view of the websites). This was expected, as participants were asked to view established
websites run by government organisations (e.g. NHS Choices) or major charities (e.g. the MS Society).
Despite the concentration of scores at the positive end of the construct, the distributions were
relatively normal.
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All subscales showed good internal consistency, achieving a Cronbach’s alpha of ≥ 0.77. This gave a good
indication that all items within each subscale were measuring the same latent variable. Good test–retest
reliability was found among those who completed the eHIQ again after a 2-week interval (n= 83,
ICC= 0.76 to 0.91). This indicated that, providing there had been no change in the construct being
measured, the items in each eHIQ subscale are answered consistently over time.103,104 Overall, the eHIQ
subscales are highly relevant to attitudes towards using the internet for health information (eHIQ part 1)
and using a specific health-related website (eHIQ part 2).
Conclusions
We developed an instrument (the eHIQ) to capture the impact of different types of health-related website.
The questionnaire consists of two independently administered and scored parts. The eHIQ part 1 consists
of 11 items asking about a person’s general attitudes towards health-related websites. The eHIQ part 2
consists of 26 items asking about a person’s views of a specific health-related website.
The development of a questionnaire which can be used to compare responses to different types of
websites was important both in general and in particular to be used in a subsequent intervention study
within this same programme of work (see Chapter 8). A focused internet-specific instrument may pick up
important yet subtle aspects associated with using information from the web.
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Chapter 5 Work package 2a: practices and
platforms for sharing experiences of multiple sclerosis
patient experience online – interviews, participant
observation and content analysis
Abstract
Introduction: this chapter explores the construction and exchange of MS-related PEx on the internet across
different websites, platforms and services, with a focus on online support groups and YouTube.
Methods: between June 2011 and July 2012, we studied online MS-related PEx through non-participant
observation, content analysis of forums, blogs, websites and YouTube videos, and 24 interviews [people
affected by MS (n= 17) and professionals working in relation to online PEx (n= 7)].
Findings: the MS-related PEx shared online is extremely diverse. Three categories of PEx were particularly
prominent: advice and information on ‘living with’ MS, PEx focused on medical research and treatment,
and PEx as creative and emotional expression. What and how PEx is shared online is shaped by various
factors, including the design, management and dynamics of the platforms on which it is shared. People
affected by MS not only seek out and share individual PEx, but experiment with, link up and aggregate
their experiences, creating databases of experience that can be turned into, at times highly contested,
forms of ‘experiential evidence’.
Conclusions: online PEx is an integral part of the MS health information landscape. Developing and
maintaining productive spaces for sharing PEx requires work and expertise (emotional and technical).
People affected by MS share PEx as a means of actively engaging with and sometimes challenging
mainstream medicine. This has consequences for biomedical research, health-care policy and practice.
More research is needed on how health-care professionals, patient organisations, charities and patients
produce and respond to online PEx in different conditions.
Introduction
The aim of WP2a was to explore how PEx is constructed and exchanged in online support groups, and the
ways people respond to and interpret PEx-related information in these settings. Given the time scale of
WP2a, it was not possible to conduct in-depth ethnographically informed research on all three exemplar
conditions. Through discussions with the project team, it was decided that WP2a would focus on the use of
online support groups by people, both patients and carers, affected by MS. This decision was informed by
a number of factors. As MS is the most common neurological condition to affect young adults,105 there is a
large amount of related PEx information available online (e.g. patient blogs, MS-based Facebook pages,
patient forums, YouTube videos). In addition, MS is a long-term condition with highly variable symptoms
and severity, and there is a range of treatment options, some of which conform to mainstream ‘Western’
medicine and some of which do not. People’s experiences (and discussions) of MS are, therefore, extremely
diverse.106–108 Although considerable social science research has been conducted on the experiences of
people affected by MS, the majority of this pre-dates the rise of the internet as a health information
resource. Consequently, there is a relative paucity of research on internet use in relation to MS.109,110
A focus on MS, therefore, enabled us to combine the specificity required for qualitative research with a
wide-ranging analytical scope that touched on numerous issues of relevance to the exchange of PEx.
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At the start of WP2a we were already sensitive to a number of themes and possible areas for further
exploration. However, the findings from WP1a and 1b informed our thinking but did not predetermine the
focus of WP2a. Instead, informed by grounded theory,111 we approached the field in as open a manner as
possible, using an ethnographically informed mixed-methods approach that included extended periods of
observation of online MS related patient forums, blogs and websites; interviews with people affected by
MS [carers (n= 5) and patients (n= 12)]; interviews with people working in relation to the production,
editing and moderation of online MS research, support, community and information services (n= 7);
and a content analysis of YouTube videos.
This chapter contains a high-level overview of this research with a focus on three core elements. First,
drawing on both online and interview material, we provide a high-level summary of MS-related PEx online.
Second, we discuss the (often overlooked) importance of platform-specific factors, such as forum design
and management, in the construction and exchange of PEx in different online spaces. Third, we present
findings from the research we conducted on the use of YouTube in relation to a chronic cerebrospinal
venous insufficiency (CCSVI), a controversial causal theory and associated treatment for MS proposed by
Italian physician Paolo Zamboni in 2009.112 This was a much debated topic when we were conducting our
fieldwork. In the conclusion, we bring these three areas together, focusing specifically on the relevance of
this research for the NHS and health-care practitioners.
Methods
Researching patient forums and other online PEx raises a number of ethical questions. We followed the
ethical guidelines of the British Sociological Association and the Association of Internet Researchers.
To minimise any inadvertent breaches of privacy, we limited the scope of our analysis to publicly available
content. Ethics approval was received from Warwick Medical School’s Biomedical Research Ethics
Committee. For a more detailed discussion of methodological and ethical questions in relation to analysing
PEx online, see Mazanderani and Powell.113
The research was conducted in a series of iterative stages. We started by using the publicly available
issuecrawler software (www.issuecrawler.net, Govcom.org Foundation, Amsterdam, the Netherlands) to
map out the network of MS-related websites available online and to identify websites, personal blogs and
patient forums for further analysis.114 We found that, in the UK, the NHS website (www.nhs.uk) is a key
source of information to which many other websites link. Large charities such as the MS Society and
Citizens Advice are prominent, but smaller charities, such as the MS Trust and the MS Resource Centre,
also have a strong online presence. Following this initial mapping of the MS-related web content, we
developed a three-tiered research strategy. First, we observed a range of different MS-related websites,
blogs and forums, recording key topics and themes that emerged within and across these sites. Second,
we performed a content analysis on YouTube videos about CCSVI.84 Third, we used telephone interviews
to further develop the themes emerging from our online observations. These methods were supplemented
by an advisory workshop with people affected by MS that took place in November 2011 at the University
of Oxford (see Chapter 10).
Observation and analysis of patient forums and online information sharing
Between June 2011 and July 2012, one researcher (FM) spent extended periods of time (approximately
1–3 hours per day, 3–4 days per week) reading MS-related websites, following news items and analysing
forums. She familiarised herself with different platforms and key debates, analysing current as well as
historic data within and across different websites. Although this involved moving between websites and
sources of information, three forums were chosen as key ‘sites’ to focus on: the MS Society forum
(www.mssociety.org.uk/forum); Shift.MS (http://shift.ms); and ThisIsMS (referred to as TIMS by its
members) (www.thisisms.com).
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The forums were analysed in terms of topics and themes (what people were talking about); the ways in which
PEx were articulated and responded to (discourse and imagery, the types of language used, colours, avatars
and emoticons), and patterns of communication (e.g. what types of topics received most responses, how many
people engaged in different types of conversations, and when, if ever, did moderators intervene). Notes were
taken and, where relevant, discussions were copied and stored as text files for further analysis. Rather than
limiting our analysis to the patient forums (as is often the case in the analysis of online health forums), links and
references to other sources of information, such as biomedical publications or newspaper articles, YouTube
videos or blogs, were followed up. In this way the content of the forums was contextualised in relation to
broader information practices and topics being debated in the field of MS research and care at the time.
Analysis of YouTube videos
While conducting our research we became aware of the large number of MS-related videos online, many
of which contain PEx. As there is relatively little research on YouTube as a source of PEx, and the visual
dimensions of PEx were highlighted in both the literature review (see Chapter 2) and the secondary
analysis (see Chapter 3), we decided to pursue further research on YouTube.
In January 2012, we searched for the term ‘CCSVI’ using the YouTube search facility. Four thousand videos
were returned, and we selected the top 100 most viewed videos for a quantitative and qualitative analysis.
A sample of the 15 most viewed videos were analysed by FM, Braden O’Neill and JP. Each researcher
developed their own coding scheme and after discussion a final coding scheme was agreed. Next, FM and
Braden O’Neill separately coded the full sample of 100 videos. Thirty videos were excluded because either
they were not about CCSVI107 or they were not in English (videos with English subtitles were kept).115
This left 70 videos, with number of views per video ranging from 7103 to 79,956.
The title, channel, number of views, date uploaded and country of origin were recorded for each of the
videos. We also categorised videos into two broad groups: ‘patient’ and ‘non-patient’. Videos that focused
on the experiences or thoughts of a particular person with MS were categorised as ‘patient’ videos;
videos that discussed CCSVI in ways that did not draw on the experiences of individual patients were
categorised as ‘non-patient’ videos. Where possible, the gender, type of MS and current medical treatment
were additionally recorded for each ‘patient’ video. All videos were then coded in terms of the type of
information they provided and whether they portrayed CCSVI positively, negatively, neutrally or ambiguously.
Coding was consistent across both coders, with a basic percentage agreement intercoder reliability of
90%.116 Any discrepancies were resolved through discussion.
In addition, we performed a qualitative thematic analysis on the full sample of ‘patient’ videos (n= 46).
Some ‘patient’ videos belonged to a ‘channel’ that contained more videos uploaded by the same YouTube
user, often posted over a period of time as a video diary. When this was the case, we analysed the entire
channel to contextualise specific videos. We focused on what patients said and how they said it. For each
video we noted key emergent themes, transcribed portions of the video and read the comments posted by
people who had watched the videos. For further details on the methods used and results please refer to
the article published on this work.84
Interviews
The analysis of online material provides only a partial view of the dynamics of sharing PEx online. It cannot
provide insight into people’s motivations for, or perceptions of, sharing their experiences. Moreover, only
observing what is available online misses out on the experiences of ‘lurkers’: those who read PEx, but do
not post.117 We used telephone interviews as a method for exploring aspects of PEx that could not be
studied through the analysis of online data. The telephone interviews captured the views of two groups of
informants: first, people affected by MS (people with MS, and carers) and, second, people who worked on
the production or ‘back-end’ of patient forums and online services (e.g. forum moderators, web managers,
researchers and designers).
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To recruit people affected by MS, the study was advertised on the MS Society, MS Trust and MS Resource
Centre research pages, the MS pages of NHS Choices, Shift.MS and a MS National Therapy Centre blog.
Regional MS Society groups were e-mailed and asked to circulate information about the study to their user
groups. We recruited 17 people affected by MS (five carers and 12 patients) to the study (Table 11). The
interviewees included people who had been diagnosed relatively recently and those who had had MS for
many years. Some interviewees used the internet and shared PEx prolifically, while others were more
circumspect in their use. Three interviewees had undergone venoplasty in response to a diagnosis with
CCSVI and one was the mother of a young woman who had had this treatment. In all four of these cases,
the interviewees had shared some of their experiences online.
To recruit people who worked on the production and management of patient forums and online services,
we made direct contact with representatives from major websites and organisations involved in MS-related
PEx. In all cases our informants agreed to take part in an interview (seven interviewees representing five
organisations in total; see Table 11).
Both sets of interviews were semistructured and used a common interview protocol that was based
on themes that emerged from the earlier analysis of the online material. Each interview lasted for
approximately 1 hour. Informed consent was taken and interviews were audio recorded and transcribed
verbatim. Constant comparison thematic coding was performed by FM on the interviews with the
assistance of the qualitative analysis software tool NVivo. The findings were analysed in conjunction with
the online material and observations and discussed at regular intervals with JP and other members of the
project team.
Results
Multiple sclerosis-related patient experience on the internet
The MS-related PEx circulating online is extremely large and diverse, ranging from YouTube video diaries
and brief postings on Facebook pages through to detailed biographical information provided on blogs.
Accounts of PEx are not limited to patient forums, blogs and social networking sites, but permeate the
internet, appearing regularly on the websites of pharmaceutical companies, health service providers
(including the NHS), charities and patient organisations (e.g. in the UK the MS Society, MS Trust, MS
Resource Centre and Shift.MS). Despite this, only a relatively small number of people actually share PEx on
the internet as producers of content. The majority are consumers (sometimes referred to as ‘lurkers’):
people who draw on other people’s experiences, but do not share their own. As our study focused on
online PEx, the majority of our participants had shared their experiences online at some stage, but a few
said that they preferred not to do so. The most frequently cited reasons for this were concerns about
privacy; fears of being subjected to negative or aggressive responses; the desire to maintain an emotional
distance from the condition; and, for carers, concerns about breaking trust or breaching the privacy of
their family member. Nonetheless, even participants who preferred not to share their experiences online or
expressed concern about the reliability of PEx at times searched for other people’s experiences.
TABLE 11 Work package 2a: basic interviewee information
Description of interviewee
Gender
Men Women Total
People living with MS 3 9 12
Family members and friends of people living with MS 1 4 5
People involved in the provision and management of online services 4 3 7
Total 24
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Three inter-related categories and associated practices of PEx emerged as particularly prominent in our
analysis of both online and interview material. The first, to adopt Corbin and Strauss’ terminology,118 was
PEx dealing with the everyday ‘work’ of living with MS. This includes seeking and sharing experiences
about practical concerns and the challenges of living with MS that fall beyond the remit of medicine and
health care as strictly defined (e.g. employment, financial concerns, home adaptations, mobility and
transport). This type of PEx was frequently mentioned in interviews as a relatively uncontroversial source of
very useful information that supplemented biomedical knowledge and expertise.
The second category was PEx directly linked to health-care practices and/or biomedical treatment and
research. This takes many forms. It includes the sharing of PEx-based personal experiences and decision-
making in relation to treatment and care (e.g. when someone was experiencing particularly troubling
symptoms or side effects), discussions about interactions with health-care services and practitioners, and
debates on biomedical research. As MS is a degenerative condition for which there are a number of
different treatment options, but no cure, it is unsurprising that treatments and research are frequently
discussed online. At times, these discussions include an activist component, with people advocating for
different theories and treatments, including those that are controversial (such as goat serum, stem cell
therapy or long-term antibiotic therapy).
Traditionally, a distinction has been made in social studies of medicine between ‘subjective’ experiences
of illness and ‘objective’ biomedical knowledge about disease.119 However, at least in Western Europe
and North America, the majority of people experience illness in relation to some aspect of orthodox
biomedicine (even if that relationship is an antithetical one). This is reflected in MS-related PEx on the
internet where what might be more narrowly conceived of as ‘medical’ information is combined and
supplemented with ‘experiential’ information, and vice versa, and personal accounts often include
discussions on biomedical disease models, research and treatments. Despite this blurring, in both
interviews and online comments, distinctions were frequently made between ‘facts’ and ‘opinions’, with
people frequently caveating what they said with statements such as ‘This is just my subjective opinion’;
‘I know this is not scientific, but . . .’; and ‘I’m not a medical practitioner, so please check this with
your doctor.’
Yet there was a strong sense (espoused online and in interviews) that individual, personal experiences of
living with MS were a valuable source of knowledge and constituted a distinct way of knowing and source
of knowledge that needed to be taken into consideration. In most cases this ‘experiential’79 or ‘patient
knowledge’120 was seen as (by interviewees and in online comments) as complementary to rather than as a
challenge to medical knowledge and traditional medical expertise. However, some patients did draw on
their experiences to question or even directly challenge biomedical theories, treatments and practitioners
(discussed in more depth in YouTube and the sharing of patient experience in relation to chronic
cerebrospinal venous insufficiency).
The third category and associated practices of PEx shared online (very much inter-related and inseparable
from both of the above) centred on self-expression, community building and mutual support. The focus
here was less on imparting specific information (although this was included) than on emotional and
creative expression. This included, for example, initial forums posts in which people introduced themselves
to the community, and creative writing based on experiences of MS. These types of interaction differed
between platforms and spaces, and in many cases were linked to forum cultures that encouraged
particular types of engagement.
We have separated these three categories for analytical purposes only. In practice one online post will
often combine elements of all three. Indeed, we contend that it is precisely through the interweaving
of lived experience, biomedical knowledge, creative expression and emotional support in how it is
constructed that makes PEx so valuable, and distinguishes it from other sources of health-related
information and support. However, although the blurring of categories is a key characteristic of PEx, we
found that these three categories and their various combinations were not equally distributed online.
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For example, with regard to the three forums we analysed, one slanted toward non-mainstream MS
research and treatments, whereas another was geared towards providing a platform for sharing everyday
experiences of living with MS and peer support, and the third specifically encouraged creative engagement
(e.g. through shorts films and video clips). This highlights the role that the design and management of
online spaces for sharing PEx play in how and what PEx is shared on the internet, a topic that has been
relatively understudied in e-health research and which we discuss in more depth below in the specific
context of MS.
Constructing patient experience: the role of the design and management of
online spaces
In the early days of the internet, the most common sites for sharing PEx were blogs and text-based health
forums. In a relatively short space of time, social media platforms such as Facebook and YouTube have
emerged, and e-health and tele-health services have grown and diversified. Consequently, how and what
PEx is shared online has changed radically. ‘Traditional’ text-based health forums still exist and continue to
flourish, but they operate as part of a complex ‘polymedia’ landscape in which different mediums and
platforms are situated in relation to each other.121 Users can choose between platforms and technologies,
while service providers learn from and adapt in relation to each other. In our interviews, participants
(especially those who used the internet regularly in relation to MS) often expressed a strong preference for
a specific site or service that they had become familiar with and found helpful to them. It would, however,
be inaccurate to characterise this as a free or ‘open’ market where people can simply choose the service
they prefer.
It is well recognised that search engines [predominantly GoogleTM (Mountain View, CA, USA)] and large
health-care incumbents (the NHS, pharmaceutical companies, established patient organisations) play a
significant role in how and what health information people access online.122 However, considerably less is
known about how the design and management of online forums shape online experiential information
sharing. Our data suggest that various, often subtle and pervasive, factors shape these different services,
and that this affects who ends up using these services, what PEx they share online, how they share it and
the consequences this use has for them. This was recognised and clearly articulated by interviewees
working on sites and services for sharing PEx online, for example in the quotation below:
[T]he context in which you encourage people to submit data has a massive impact on the culture
that’s developed there as well as the type of people who are attracted to your system. So if you want
Daily Strength and you make a system where people can give each other hugs and smiley faces, you
attract people who want hugs and smiley faces and put butterflies in their email. If you make a system
that tries to mimic clinical trials and does scientific studies you’re going to attract highly educated,
quantified-self type people who want to manage their illness better.
Interviewee 7, research director of health information organisation
Although the people we interviewed who worked on websites and forums were aware of and very
sensitive to the fact that the technical, aesthetic and management decisions they made had an effect on
their users and could even alienate some people, as one interviewee pointed out ‘nobody can be
everything to everyone’, and, often, difficult decisions had to be made. In some cases the individual, group
or organisation providing the platform, forum or online service (such as an organisational Facebook page)
was able to make design and management decisions that reflected and supported their aims, ambitions
and relative positioning in the field. Their ability to do so was, however, constrained by numerous factors;
four key ones which emerged from our interviews were the nature and aims of the individual or
organisation providing the service (e.g. funding, capacity, time); the condition in question and the service
provider’s position in the wider field of information and support providers (e.g. competition, target users);
technical dynamics, challenges and opportunities, often ones beyond their control (e.g. changes to
underlying infrastructure and platforms such as Google and Facebook); and user dynamics, initiative
and resistance.
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Moreover, the rise of Facebook and YouTube as popular sites for sharing PEx has resulted in a decline in
the number of people using more ‘traditional’ patient forums. However, Facebook and YouTube have not
simply replaced these forums; instead, they are used for other purposes, and in some cases are directly
linked to patient forums. For example, in the case of one charity that has both a Facebook page and a
forum, Facebook was used for shorter messages, campaigns and less private information, while forums
were perceived as more anonymous and intimate spaces:
I think that the overwhelming difference is that the forums allow people to be much more anonymous
and we even go so far as not only can you create an online identity which conceals who you are, but
you can actually ask a question completely anonymously on top of that as well. The older generation
particularly don’t trust Facebook as a way of putting personal issues out there and even, to a certain
extent, the kind of traffic we get on Facebook is quite different really.
Interviewee 1, social media officer, MS charity
However, platforms such as Facebook are not neutral or stable. They have their own commitments and
politics,123 and regularly update their services in ways that can have unexpected effects on user interaction.
For example, a change made by Facebook to their settings, something beyond the control of the MS
charity using it, had a dramatic effect on the usage patterns of the page:
[I]t [the group] hasn’t actually been this active until the last year or so because Facebook have changed
the settings or something. Once they changed their group settings so the groups were automated in
their updates so suddenly people would see that something had happened on the group. People
started looking much more at them and they became much more involved. So I would say up to about
2010 we didn’t have an awful lot of activity going on on there. There was, you know, now and again,
but now it is . . . back then we might have had to send one question a week to information where
now we have to send say five a day, so it is quite different.
Interviewee 6, web editor, MS charity
As these sites are often important sources of information and support for people affected by MS, changes,
intentional or unintentional, can have dramatic effects, in some cases leaving users feeling powerless and
bereft. This was brought forcibly to our attention in August 2011 when one of the forums we were
observing underwent an extensive upgrade. The forum had been in operation for approximately 10 years
and had a very dedicated group of users. When its layout, colour and functionality changed, many users
responded very critically. The distress and upheaval brought about by the changes were evident in the
large number of posts in which members expressed their unhappiness, in some cases stating that they
would no longer use the forum. Some of the criticism was attributed to problems with functionality
(e.g. users struggling to move their profiles over, customise their avatars and usernames, send private
messages), but many focused on aesthetics, such as the change in the colours – from pastel to brighter
shades – and the overall ‘feel’ of the forum. Numerous members stated that the forum no longer felt ‘like
home’ and complained that it was now ‘stark and clinical’ as opposed to warm and friendly: for example,
‘I just feel emptiness now when I go in this site. I hardly come here now . . .’; ‘It’s cold in here. The sense
of community and support has gone.’ The people working on the ‘back-end’ of this forum were obviously
very aware of these responses, and were surprised by them.
This case illustrates how what might seem as ‘trivial’ aesthetic decisions, such as colour or where branding
is placed, can influence what PEx is shared and how people respond to it. This was reiterated by research
participants who worked on websites and forums, who spoke of how important aesthetics, including,
colour, wording, visuals, branding, links and so on, were in not only attracting and retaining users, but in
the creation of appropriate online spaces for sharing PEx that not only provided information, but a sense
of care and support. Previous work has indicated that visual design elements unrelated to the actual health
information content can influence trust and credibility;124 in a review of design features used in effective
e-health interventions aesthetics, was raised as salient feature.121 Similarly, in our research, what can be
broadly classified as aesthetic factors played a key role in how people affected by MS perceived and used
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online spaces for sharing PEx. What counts as a ‘good’ design is not, however, easy to pin down. Some
interviewees spoke of being instantly ‘attracted’ to a specific site or service, while others felt that the same
service was unappealing or off-putting.
Familiarity with a given service also played an important role in how users perceived and used it. Different
forum cultures and networks of exchange develop over time among specific groups of people in ways that
can differ considerably from the original intentions of the service or platform provider. In all three of the
forums we studied a core group of users played a significant role in shaping the overall tone and type of
PEx shared on the forum. Sometimes they were volunteers and moderators with an official, if usually
unpaid, role, but in the many cases they were simply prolific users.
These ‘super users’ spent considerable amounts of time online: welcoming people, responding to their
queries, creating a friendly environment, and sometimes policing the forums. It is well recognised that
health forums have specific cultures and that users play a crucial role in developing this.125,126 However, the
forms of emotional labour – broadly defined as labour involved in dealing with other people’s emotions
and regulating your own – involved in the creation and maintenance of supportive and effective platforms
for sharing PEx are rarely discussed in the e-health literature.127 The importance of this form of ‘work’ was
especially evident when there were breakdowns in relations, for example when a user or group of users
‘flamed’ – engaging in hostile and disruptive behaviour – a particular service or an individual. When
this happened it not only disrupted the service (sometimes for a considerable time), but also prevented
people from using it, or indeed any online platform for sharing experiences, in the future. Forums have
different procedures for handling disruptive users and behaviours, from extremely light-touch moderation
through to actively removing posts and banning some users. In the majority of cases when conflicts or
disagreements arose on the forums we observed that they were resolved relatively swiftly with minimal
intervention. However, during the period we were conducting our research the topic of CCSVI was a
particular source of conflict and disagreement, and we observed many heated exchanges on it. It was also
a topic in relation to which a great deal of PEx had been and was being shared. We, therefore, chose to
focus on it as a specific area of interest.
YouTube and the sharing of patient experience in relation to chronic
cerebrospinal venous insufficiency
In 2009 Zamboni proposed that abnormal venous drainage, what he called CCSVI, was a possible cause
for MS. Furthermore, he suggested that venoplasty of the azygous and jugular veins – dubbed the
‘liberation procedure’ by its supporters – might improve symptoms and slow disease progression.128
Although Zamboni’s research ran counter to much orthodox biomedical thinking about MS, between
2009 and 2012 it received a great deal of media and popular attention, with thousands of people across
the world undergoing venoplasty in private clinics and/or as part of research studies.29,129
Many people affected by MS shared their thoughts about CCSVI and venoplasty on blogs, forums,
Facebook and YouTube, with some using their experiences to lobby for further research and
treatment.84,115,129,130 In particular, YouTube emerged as an important medium for sharing CCSVI-related
PEx. To study this further we analysed the top 100 most viewed YouTube videos relating to CCSVI.
The results of this analysis are published in detail elsewhere;84 therefore, we provide just a brief summary
of the key findings here.
Although many neurologists and the representatives of international MS Societies expressed skepticism
about Zamboni’s research, the YouTube videos we analysed adopted an overwhelmingly positive attitude
towards it (67/70; 96%). Many of the videos were uploaded by patients (46/70; 66%). Videos in which
people posted vivid pre- and post-treatment comparisons were particularly popular. Here, video posters
did not simply share their experiences verbally, but tried to quantify and communicate the changes
they experienced through performing various tests, such as walking up stairs, balancing on one leg or
bending. Many of these tests drew on clinical and diagnostic practices as well as medical explanations
and terminology, with patients frequently discussing MS treatments, medical professionals and the role of
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pharmaceutical companies. These videos, some of which form part of extensive video diaries that
document people’s experiences over years, were often highly personal: videoed in people’s homes,
showing their families, and embedding PEx not only in the clinical aspects of MS, but in everyday living
with the condition.
Three key themes emerged from our analysis of these videos: (1) the visual medium enabled vivid
depictions of pre- and post-treatment comparisons, often drawing on medical explanations, terminology
and tests adapted from clinical practice; (2) patients not only displayed their own medical knowledge, but
discussed current MS treatments, medical professionals and ‘big pharma’; and (3) videos were situated in
relation to specific people’s experiences, conferring a sense of authenticity and personal immediacy. Thus,
patients drew on medical knowledge to explain and reinforce their message, but, at the same time, their
status as patients rather than practitioners conferred their thoughts, experiences, and, in some cases,
advice, with a particular type of authority. The evidence generated through the YouTube videos we
analysed was, therefore, predicated both on the language and practices of contemporary biomedicine and
personal experiences of living with MS. This was most notably actualised in personal experience diaries,
through which trust and legitimacy can be particularly developed, enhancing the strength of the
‘evidence’ portrayed.
Our aim in the study was not to comment on the scientific validity of or treatment efficacy for CCSVI.
Nonetheless, an obvious question prompted by our findings is why were the YouTube videos (at least at
the time of our study) so positive? There are of course numerous possible answers to this. Many of the
most-viewed videos were uploaded by early adopters and strong advocates of CCSVI before later, more
critical studies were published.115 Thus, simply by virtue of being online for longer these videos had higher
view counts and emerged more prominently in our sample. There is, moreover, a more general bias
towards reporting positive experiences with medical treatments online.131 Additionally, a few interviewees
(including some who were supportive of CCSVI and Zamboni’s work) noted that those who might have
been more critical of CCSVI often chose to stay silent because they were afraid of being criticised by their
fellow patients or did not want to dampen other people’s hopes. This was reinforced by CCSVI advocates
who worked actively to provide positive information about CCSVI on different online spaces, including
forums and Facebook pages:
We got to the point on Facebook where there were people initiating conversations about it [CCSVI]
and then somebody was replying to it and somebody would reply to that reply and all members of the
‘pro’, if you like, camp, and basically it was a very sort of stage managed dialogue and it got a lot of
people’s backs up because they kind of felt like they were being patronised by a special interest group.
Interviewee 1, social media manager, MS charity
This resulted in a disconnect between the very positive information about CCSVI being posted online and
the far less positive response of mainstream neurologists, policy-makers and funding bodies. Consequently,
many people affected by MS who were interested in CCSVI or personally had a positive experience with
venoplasty became disillusioned with the critical mainstream biomedical response to it. At the same time,
other patients and practitioners expressed frustration that an unproven theory received so much attention
and funding, a situation they saw as a hijacking of the MS research agenda by a partisan group, with
detrimental effects on patients’ well-being.132
Although CCSVI is a specific and controversial case, the way that CCSVI activists used internet
technologies to generate new forms of knowledge is not an isolated event, but indicative of a wider
phenomenon in which online ‘communities of practice’ can generate new forms of knowledge, becoming,
albeit non-traditional, ‘epistemic communities’.133 For example, in addition to the use of YouTube described
above, users on the TIMS forum (which was and continues to be a hub for discussions on CCSVI) created a
thread to collect experiences in a more systematic manner than is typical on patient forums (this is discussed
in depth in a book on CCSVI written by one of the community members);130 and a group based in the
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Netherlands developed a tracking website (www.ccsvi-tracking.com) to aggregate and visualise outcomes
post venoplasty. This results in the collection and interlinking of PEx that might not be ‘evidence-based’ as
typically understood in medicine, but for many people serves as a form of ‘experiential evidence’, which
they turn to in order to help them make decisions and, to a lesser extent, advocate for policy changes and
particular research agendas.
Conclusions
Patient experience is now fully established as a key part of the internet health information landscape.
Even in the context of one condition, MS, there are numerous websites and sources of PEx online. What
counts as PEx is, moreover, extremely diverse in terms of content, format and associated practices. It can,
simultaneously, be a form of knowledge, a source of information, a set of practices, support and a means
of creative expression. In this chapter, we highlighted key categories and associated practices of PEx linked
to ‘everyday’ life with MS; health care and biomedicine; and emotional support and creative expression.
However, rather than belonging to only one category, what makes PEx such an importance resource for
people affected by serious health conditions is how it operates across these categories, combining
everyday experience with knowledge of health care and medicine, and emotional support.
Although individual preferences and practices clearly play a key role in what and how PEx is shared, here
we focused on the less discussed topic of how the infrastructure, technologies, design and management
of online platforms and forums shape the construction and exchange of PEx online. We found that a
relatively small group of influential people play a crucial role in shaping online spaces for sharing PEx in
MS, and highlighted the importance of the work, both technical and emotional, that goes into their
creation. As the internet is becoming increasingly integrated into health care and more services move
online, more research is needed on how often subtle design and management decisions shape these
online spaces and the nature of the services and care provided through them.
One of the key concerns expressed about the sharing of PEx online is that it can spread misinformation
that is detrimental to people’s health and well-being. Health-care practitioners cannot, however, stop
people from sharing their experiences or seeking out others’ experiences on the internet, even if these
experiences contravene the advice of medical practitioners. Regardless of how CCSVI is perceived – either
as a revolutionary theory about neurodegenerative diseases or as dangerous pseudo-science – it is an
excellent illustration of the relevance of social media and PEx for the health and well-being of individual
patients as well as the field of medicine more generally. In many cases, interested patients will seek
out information about new and controversial treatments regardless of what they are told in clinical
consultations. Thus, instead of dismissing information they do not consider ‘evidence-based’, health-care
practitioners need to enhance their understanding of the forms of evidence considered significant to
patients, even if they themselves would not consider it valid. By gaining a better understanding of the
experiences and priorities of different patients presented in social media, health-care practitioners may be
better able to focus on issues of importance to patients and avoid the polarisation that has taken place in
the case of CCSVI. It is essential for practitioners to be aware of what is circulated online and, although
they do not need to endorse it, dismissing it can have serious consequences for their relationship with the
patient (in fact, many interviewees said that they wished their doctor and/or nurse had provided them
with more links to online information). This emerged clearly from the research on CCSVI, but was also
reiterated in interviews. Participants strongly expressed the need for appropriate ‘frameworks’ or systems
that enable people to share their experiences in ‘helpful’ ways. One of the key ways interviewees felt this
could be done was through access to a wide range of different experiences that would reflect the different
perspectives and experiences of people with this variable condition.
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Chapter 6 Work package 2b: understanding the
important factors for user engagement with online
personal experiences
Abstract
Introduction: both the source and the nature of e-health content have changed rapidly over the past few
years, such that other people themselves now provide a significant source of health material online.
This chapter explores the important factors for user engagement with online PEx.
Methods: in the first half of the chapter we describe a series of qualitative user studies in which we
capture information from three groups of people (n= 36: people with asthma, carers for people with MS
and smokers wishing to quit) about the various new types of peer-led information, support and advice
online and the processes by which these individuals might select from the vast range of online stories
available. In the second half of the chapter, we employ an experimental methodology with smokers
wishing to quit (n= 113) to identify those source and message elements of personal stories that are most
able to influence health intentions and behaviour.
Findings: the analysis of the qualitative user studies has led to a new research framework that captures not
only the different kinds of personal experience available online, but also the decision process by which
people chose one source of information over another. The experimental study found some limited effects
regarding preference matching and personal experience-based health messages.
Conclusions: the qualitative and quantitative investigations have allowed us to tease out issues of
individual preference and trust and have given us a better grasp of the way in which different design
elements may influence user engagement and ultimately affect health outcomes.
Background
There is increasing evidence that the sharing of PEx forms an important part of health-related internet
use.4,134 Data from the 2013 Pew Internet Survey, which asked adults about their online health experience
over the past year, showed that one in four adults (24%) had turned to others with the same health
condition online, one in four internet users (26%) had recently read or watched someone else’s health
experience and 16% of internet users had gone online to find others who might share the same
health concerns. Furthermore, of the 8% of internet users who had posted a health-related question
online, 40% said that they had shared stories about their own experiences.135
The online sharing of experience is particularly prevalent in people who have health conditions that are
serious, sensitive in nature or involve making a decision. Examples explored in the research literature
include HIV/AIDS (acquired immunodeficiency syndrome),134 antenatal diagnostic testing,15 and infertility.31
Carers also use the internet to find and proffer information, share experiences and opinions, and provide
encouragement and support across a range of groups, including those with cancer136,137 and Alzheimer’s
disease138 and parents caring for children with special health-care needs.139 The internet is also becoming a
popular mechanism for supporting behavioural and lifestyle changes, for example weight loss and smoking
cessation, through the use of tailored interventions, reminders and online support groups.140,141
DOI: 10.3310/pgfar04170 PROGRAMME GRANTS FOR APPLIED RESEARCH 2016 VOL. 4 NO. 17
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Ziebland et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
51
Why have personal experiences become so prevalent online? The most obvious answer is that they fulfil
some critical role and recent studies have highlighted different elements of this role. For example, people
welcome opportunities for social comparison in helping them understand how well they are coping with
a particular illness.78 They can also draw on others’ accounts of their experiences of disease in order to
become more optimistic about their own condition142 or to adjust to the reality of the disease in order to
prepare them for what is to come. In either case, others’ experiences can seem to leave them feeling less
isolated in their ‘patient journey’.4 PEx can also be used to inform health decisions.15,16
The story is not unequivocally positive, as the ability to harvest health experiences with no online ‘quality
control’ can cause problems. Individuals may struggle with experiences that contain very strong emotional
content, or be left feeling that their condition will isolate them from other healthy individuals when
accounts suggest that only those who have personally dealt with the condition could know what it feels
like.31 The findings from some studies suggest that online groups can even exacerbate a process in which
an illness comes to define the individual.55,78
Furthermore, when an individual uses online experiences to aid decision-making, he or she is engaged in
a sampling or selection process, given the diverse experiences available online. This, in turn, raises the
important question of what drives the sampling process. From a theoretical standpoint we already know
something about how people come to select one health website over another: it is a staged process
that involves both a heuristic decision that is influenced by web design factors, and an analytic decision
that involves a careful exploration of the content of the online material.8,143,144 This mirrors a number of
two-stage process models in the persuasion literature (e.g. Chaiken145) in which people use cognitively
intense analytical processing when the task is an important or particularly engaging one, but use affect or
other simple heuristics to guide their decisions when they lack the motivation or capacity to think properly
about the issues involved.
We also know that the presence of personal stories or of personalised content will influence this decision;
people are drawn to material offered by and written for ‘people like me’,8,45,146,147 with some suggestion that
PEx may be more effective in reducing defensive responding to threatening health messages. However,
although we know that the inclusion of personally authored material can affect patient decision-making,
this has typically been demonstrated in experimental settings and we do not yet know how individuals sift
through these personalised stories in order to determine the sample of experiences that they will use to
influence subsequent decisions. Understanding the processes that drive engagement with online PEx is
important, given their likely impact on patient decision-making and subsequent health outcomes.148
A recent review of the potential health-related effects of access to online personal experiences4 (see
Chapter 2) has placed health-based personal accounts centre stage, and means that we are now in a
position to examine online personal experiences from users’ perspective in more detail, with a view to
understanding the process by which people come to engage, or not, with a particular individual
experience. Although we already have models detailing how users engage with and trust online health
information over time,8,95 we as yet have no similar framework for understanding engagement with online
personal experiences. Currently, understanding of how those motivated to find information and advice
(relating to their own or a close other’s health condition) navigate through the vast array of personal
experiences online is still not well developed. We can assume from the literature that factors such as
credibility or trustworthiness and relevance will play a role in the use of PEx149 but it remains unclear as to
the relative importance of these and other factors and the way in which they interact with different stages
of the engagement process. What kinds of sites do people visit, which sites do they choose to explore
further, and with what purpose in mind? These are important questions for health information providers,
web designers and the voluntary sector.
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A framework for user engagement with online patient
experience
Our introduction has documented the growth in shared personal experience online and the associated rise
in peer-to-peer health care. Increasingly, we recognise that people turn to their peers for information,
advice and support, but it is not clear how they make the decision to accept or reject the peer advice they
find online. What are the factors that underpin user engagement in this arena? In a series of qualitative
studies, we set out to explore individuals’ preferences for particular forms of PEx and to gain a sense of
how people from different health groups may seek peer support.
Qualitative studies
Consistent with the focus of the wider iPEx programme, our participants were drawn from three different
health populations: smokers wanting to quit, people with asthma and carers of people with MS.
Participants were recruited using a number of sources, including newsletters and flyers and through
various health support groups, and were compensated £20 for their participation. In total, we recruited
36 participants (20 male) aged between 20 and 65 years, with a mean age of 38.7 years. All were
experienced internet users (9.92 average number of years using the internet). Sixteen of the participants
took part in the follow-up interviews.
Breaking these down into health groups, we recruited:
l 10 smokers (nine male and one female) aged between 20 and 47 years, with a mean age of 29.5 years,
who had been smoking an average of 12 years
l 15 people with mild to severe asthma (seven male and eight female) aged between 22 and 60 years,
with a mean age of 34.07 years and an average length of asthma diagnosis of 20.58 years
l 11 MS carers (four male and seven female) aged between 39 and 65 years, with a mean age of
53 years, comprising 10 spouses and one mother of someone with MS. They had been carers for an
average of 13.61 years.
The participants visited a laboratory styled as an internet café at Northumbria University. They were asked
to search a subset of the health materials available on the internet for approximately 1 hour, seeking
information and advice on issues relevant to their personal circumstances (smoking, asthma or MS caring).
They were then asked to take part in a group discussion led by a facilitator and to complete log books
detailing their impressions of the sites they visited. These sites were also automatically logged by the
computer. Each participant was given access to seven predetermined sites during the search phase. Every
site contained user-relevant material, but only four of the seven sites contained personal experiences. This
selection was informed by content analyses of available e-health material reported in an earlier study.150
Sites were chosen to be representative of those generally available to users, with the proviso that those
requiring registration before access were excluded.
Following the initial search, when first impressions were recorded, participants were asked to choose two
sites to explore in more detail. They then shared their experiences in group discussions that addressed the
following main areas: (1) site selection and rejection; (2) site likes and dislikes; (3) aspects of personal
experience; and (4) trusted elements. Participants were then directed to personal experiences sections on
two further sites and took part in a final discussion around the content of these last two sites which
addressed: (1) recall of experiential material; (2) level of interest and usefulness of personal experiences;
(3) variety and type of experiences (i.e. individual accounts such as blogs or testimonials vs. interactive
forum-style content containing multiple experiences); and (4) trust and behaviour.
Two weeks later, participants were contacted for a 1-hour semistructured telephone interview. The
discussion covered the following main areas: (1) information searching behaviours since phase 1; (2) recall
of the websites and their content; (3) information sharing activities; and (4) decision-making and current
behavioural intentions.
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We also conducted a follow-up qualitative study with two of our groups (people with asthma and MS
carers). For this second study, we recruited 14 additional participants to the asthma group (five male and
nine female) aged between 19 and 64 years, with a mean age of 28.21 years, and we recruited nine
additional MS carers (three male and six female) with an age range of 40–73 years and a mean age of
58.9 years. These additional participants followed the same protocol as in the first study, but all were then
asked to take part in a more extensive, structured interview that also involved the use of the repertory grid
technique151 as a means of eliciting uniquely personal constructs about the ways in which they viewed the
sites they found. This work has been published.152
All focus group discussions and interviews were audio recorded and transcribed for analysis. The transcripts
were read and reread separately by two of the research team and then were subject to thematic
methods153 to identify both anticipated themes, for example design and reputation factors, and emergent
issues such as comparison processes. The themes were then subject to discussion with the rest of the team
to ensure validity in the interpretation and representation of data. For ethical reasons all participants were
given a participant number and all quotations used in the results have been stripped of any information
that could potentially identify the participant.
Resulting framework
The analysis revealed a three-phase process by which users engage with online personal experiences.
Phase 1 is a ‘gating’ process, whereby people determine the suitability of the material they encounter;
phase 2 comprises an ‘engagement loop’, whereby people look for support or advice from others with
similar or relevant experience; and phase 3 is an ‘evaluation and outcomes’ process, whereby individuals
make a judgement about the costs and benefits of engaging with the site in the longer term and in some
cases experience outcomes related to that engagement. This three-phase process is captured in the
framework (Figure 4), with the three phases described in more detail below.
Phase 1: gating
Participants reported making a swift initial judgment about whether they should engage further with the
site or move swiftly on to an alternative. We know from other studies that this ‘gating’ decision relies
heavily on the look and feel of the site, as users are known to make snap decisions on the basis of site
design elements.8,155 We found similar evidence that the first impression was influenced by the design
elements of a site, but also that people looked for assurance that the site was hosted by a credible and
impartial agency with a known reputation.
It was very easy to access what you wanted [. . .] it was easy to navigate round the website whereas
some of the other ones you got lost and it threw you into perhaps something else you didn’t want to
get into or wasn’t really appropriate.
MS, participant 9
So yeah, I probably like the NHS and the Asthma UK site. They were both obviously well established
and really really well liked from it seemed so I’d say that they’re easy to trust . . . And the British Lung
Foundation as well ‘cos they’re a charity.
Asthma, participant 5
Phase 2: engagement loop
Having made their initial selections, participants began to examine the content of the websites and the
personal experiences in more detail. For participants in all three health groups, engaging with the experiences
involved an iterative process during which they discovered who was making the contribution, assessed what
was being said, and then compared the online stories with their own experiences – in part to see how credible
the material was – while also assessing the extent to which these experiences were shared directly between
participants (in which case they could add their own) or were scripted as part of a more controlled
environment. These four processes – who, what, compare and share – were critical to meaningful engagement
with personal experiences and are discussed in more detail below with evidence from participant transcripts.
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Who?
Personal experiences reveal something about the person posting the experience, and our participants
were keen to understand who that person was. They were quick to reject experiences that came from
an individual who seemed different from them, either because that person came from a different age
group, region or demographic, or because their health profile or severity of condition was a poor match.
Sometimes these judgements were made on the basis of quite superficial information (such as the
photograph of the story-teller), whereas on other occasions the judgements reflected a more nuanced
interpretation of the underlying ‘voice’ in the story. Differences in age and severity of condition were the
main reasons for rejecting an account of an experience altogether:
The first one, the three stories, they were older people. I think they were a little bit extreme. I don’t
think they’re typical of an everyday asthma sufferer . . . So I don’t see the relevance of those particular
ones. I think it would probably be more useful to have younger people’s experiences, what triggers
them more, how people have reacted if they needed help that kind of thing.
Asthma, participant 15 (aged 46 years). Reproduced with permission from Sillence E, Hardy C,
Briggs P, Harris PR. How do people with asthma use Internet sites containing patient experiences?
Patient Educ Couns 2013;93:439–43156
Engagement process
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FIGURE 4 Schematic representation of the online health user experience (PEx) engagement framework. The stages
are shown on the left-hand side of the framework (i.e. gating, engagement loop, and then evaluation and outcomes)
and the dominating factors influencing engagement at each respective stage are shown on the right-hand side. Each
box displays the questions and factors that users address during each stage of the engagement process. Reproduced
with permission from Sillence E, Hardy C, Harris P, Briggs P.Modelling Patient Engagement in Peer-to-Peer
Healthcare. 23rd International World Wide Web Conference, Korea, April 2014.154
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So I don’t know if it’s helpful because I can’t really relate to it. I couldn’t really relate to those people.
I can’t say how. Definitely not Maria from Michigan [laughs].
Smoking, participant 7
What?
Participants appeared have very different needs when searching the online PEx. Some were seeking out
basic information, while others looked for advice on how to proceed, make changes or decisions, and
some simply acknowledged the social and emotional support on offer. Participants rejected information
offered by their peers if it did not resonate with their own understanding of a condition, or if the mixture
of information, advice and support on offer was unbalanced or a poor match with their needs. However,
even those who felt that they were quite knowledgeable about their condition were generally interested in
the different kinds of individual journey that others had experienced:
I feel quite confident in what I actually know about it in terms of just the base level of information
but I found I learned a lot more from actually listening to, and reading about the other peoples’
experiences, and how they handle different situations in comparison to how I do and also just the
different range of treatments.
Asthma, participant 6
Compare
Some participants saw clear and direct comparisons between their situation and the online experiences:
The first one about 47-aged smoking for 30 years. But she got this, she got stroke, and I was thinking,
when I read it I thought, well it’s me. I couldn’t sleep because my chest is hurting, it could be me!
That kind of that experience and you can share it, and when I read that experience I thought yes,
30 years of smoking, she is younger than me, one year younger than me, and she got stroke, it could
be me.
Smoking, participant 9
Other people, who differed in the extent to which they were coping with their varying circumstances, said
that they found it difficult to read stories that might be overly optimistic or pessimistic and that challenged
their own worldview. The MS carers were particularly vulnerable here, as they found that reading about
other people’s experiences could highlight imagined futures that they simply did not want to consider.
Share
For some participants, the presence of a forum or some means whereby people could share information
directly was important, as it provided the opportunity to interact directly with others who shared similar
health conditions and histories. The presence of a forum could also lend the site greater credibility,
as the stories were more variable and less like artificial or scripted individual testimonials:
The forums are better than the real life stories because we can interact with other people and share
their experiences with us and we can gain some knowledge.
Asthma, participant 6
However, some participants, while recognising the potential benefits of sharing, simply felt that it was not
something they were likely to engage in:
Forums are . . . definitely people would find it useful, but personally I wouldn’t because I won’t tend to
go on post about my stuff, I’m not a sharing kind of person in that way.
Smoking, participant 10
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Phase 3: evaluation and outcomes
Participants expected – and in some cases had already experienced – a range of outcomes resulting from
their interactions with online experiences. The advantages and disadvantages described by our participants
mapped well onto the domains described in the recent literature. For example, Ziebland and Wyke4 have
argued that access to patients’ stories is associated with seven domains of engagement: (1) finding
information; (2) feeling supported; (3) maintaining relationships with others; (4) experiencing health
services; (5) learning to tell the story; (6) visualising disease; and (7) affecting behaviour. We found
evidence to support each of these here (Table 12). The personal experiences provided participants with the
opportunity to learn more about their condition, to acquire knowledge about the practicalities of
managing their condition, dealing with the NHS and other services, to understand more about what they
might expect, to motivate themselves through positive stories or to remind themselves about the
seriousness of their condition or outlook, and to develop supportive relationships with others.
TABLE 12 Work package 2b: outcomes from online interactions with the experiences of others
Domain Description Example
Finding
information
The majority of smokers felt that they
were familiar with the facts about
smoking and health and so did not
rate the information content
particularly highly. However, several
appreciated the sharing of practical
tips and new ideas to help them quit.
For people with asthma, the issues
were often about acquiring hints and
tips on management
It just helps you, if someone telling you about the mistakes
they have made and help you avoid it. That’s the ideal for
what forum is for really. That’s why people are using
because they are so useful
Smoking, participant 2
I have learned something from looking at those sites that
I didn’t know
Asthma, participant 5
Feeling
supported
Smokers in particular also recognised
the supportive or motivational
function of personal experiences
For some smokers, simply knowing
that other people (like them) fail but
persist until they succeed was felt to
be valuable
For those MS carers with a recently
diagnosed partner, son or daughter,
the experiences satisfied a strong
desire for basic information about the
condition and allowed them to test
out possible symptoms with other MS
experiences in a more meaningful
manner
Even those people who managed their
asthma well recognised the possibility
that online support could be
important to others
Some MS carers also recognised that
their future selves may benefit from
online support
I don’t feel alone on the forum because there are different
people who try to quit smoking. And it’s kind
of encouraging
Smoking, participant 3
There’s a certain personality to it [the inclusion of PEx]
one you sort of connect to even at a very superficial level
of reading. It still gives you kind of sort of hope and
motivation that if other people can do it so can I
Smoking, participant 10
[The forums] are useful for both carers and sufferers . . . if
they get something that they haven’t experienced before
they can find out whether it’s a symptom or not a symptom
of the condition
MS, participant 1
Yeah I think it’s good, good support, especially for people
that sort of whose asthma’s quite bad and can’t get out as
much as they’d like to and interact with people. It’s good
for communicating and letting off steam
Asthma, participant 6
You know, it’s not changed everything about the way we
live. But as things progress then yeah I might well find
myself doing that kind of thing [using forums]
MS, participant 2
Maintaining
relationships
with others
For most of our participants, the
significant longer-term potential of the
internet was in developing new
supportive relationships
It felt like people knew each other and they were saying so
and so are you OK, I hear you’ve been in hospital and you
can see that there would be that real peer support network,
which for me, I suppose is the benefit of doing this kind of
thing online. That could never happen just normally without
the internet
Asthma, participant 7
continued
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Using the framework to improve the design of online
patient experience
Overall, the engagement framework supports findings from earlier research, reflecting the importance of
good design, visual appeal, credibility, reputation and trust in phase 1144,155 and the recognition of a range
of outcomes from engagement with people’s stories in phase 3.4 We have made the greatest contribution
in developing the engagement loop in phase 2, where we have clarified the kinds of questions different
people may ask of the PEx they encounter. This can be a useful framework, then, for comparing the needs
of different health groups against the seven domains identified in WP1,4 as we imagine, for example, that
some groups may be more concerned with seeking information, whereas others may seek greater levels of
support or an improvement in their use of health services. Some of these needs are illustrated by the three
cases studies below, which present a narrative account of the ways in which health users engaged with
online PEx.
Case study 1: re-engaging with your asthma
Asthma patients were initially drawn to websites showing good design quality. In line with previous
studies,8,155 we noted that participants preferred sites that were easy to navigate and looked professional.
Participants were then subsequently drawn to those sites containing PEx, but only if the contributions
TABLE 12 Work package 2b: outcomes from online interactions with the experiences of others (continued )
Domain Description Example
Experiencing
health services
For people with asthma the online
experiences sometimes provided
pointers as to how other people had
interacted with their doctors and this
in turn led to our participants drawing
up plans for their own use of health
services
It gave me a few places to look at myself when I get back
home and some things my doctor or nurse next time might
be able to review what’s happening, maybe sort of help me
Asthma, participant 6
Learning to
tell the story
For some people with asthma the
online personal experiences allowed
them to make sense of aspects of
their treatment that they had not
previously considered. They were able
to talk more knowledgably with
others about their condition. Others
described how they had begun to
discuss their asthma with family and
friends
Several participants had discussed the online personal
experiences with their close friends and family. These
discussions had helped the participants to construct a narrative
around asthma that highlighted the seriousness of the
condition, as well as allowing them to pass on practical
guidance as to what to do in the case of emergency
Visualising
disease
For people with asthma the issues
were often about visualising the
potential seriousness of their condition
For those people or for carers with
less recent MS diagnoses, the
perceived benefit of reading such
experiences was less clear. Other
people’s experiences were sometimes
regarded as too gloomy and few
carers wished to be reminded of what
was coming
It was interesting to read the discussions and some of the
stories of people who’ve been in hospital for a lengthy
amount of time and how they deal with things and really
how bad it can get
Asthma, participant 5
I got so far and then I started to feel really sickly because it
was talking about the future and I really don’t want to
think about things in that way. I tried, I thought I’ll have a
go, but I just couldn’t, I didn’t enjoy it, it’s not what I want
to do
MS, participant 7
Affecting
behaviour
There were some signs across the
groups that the experiences had
initiated behaviour change
At the 2-week follow-up, one of the MS carers, triggered by
the experiences online, had begun applying for power of
attorney (the authority to represent or act on another’s behalf
in legal matters), and another had started asking for more help
and support from other family members and requested a social
worker
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seemed to come from individuals judged to be similar to themselves (e.g. in terms of age and length of time
since diagnosis) and could offer ‘relevant’ stories. Before the study, participants were unsure what else they
could or should know about asthma but, as they started to engage with the online personal experiences,
many chose to explore certain stories in more detail by comparing their own experiences with those of
others online. This comparison process allowed for recognition of their experiential asthma knowledge,157
with participants able to reflect on the ways in which they had experienced and handled certain situations
with regard to their asthma. Despite many participants reporting a high level of asthma knowledge before
the study, many were still able to acquire hints and tips from others regarding the management of their
condition. For others it was a case of confirming or even fine-tuning their existing knowledge. However,
one consequence of this comparison process was that participants sometimes dismissed potentially useful
hints and tips for managing their asthma on the grounds that the online experience was written by
someone different from them. Most participants thought that the online contributions came from people
who were worse off or had more severe asthma than they did. This process of downward social comparison
has been noted in other health settings in which people under threat evaluate themselves favourably in
comparison with others.158 A consequence of this process is that, for some, the personal experiences served
as a reminder of the potentially serious nature of the condition and triggered some re-engagement with the
self-management programme through the asthma nurse.
Case study 2: multiple sclerosis carers and coping in the here and now
Shared PEx online can be used to support both the problem-focused and the emotion-focused coping
strategies of the MS carers. Problem-based coping was seen as the norm when caring for people in the
early stages of MS, as carers needed to understand both the symptoms and behaviours they might expect
of someone with MS, and may also need practical support to establish daily care routines or understand
entitlements. This is consistent with other findings showing that coping strategies for MS carers are often
focused on the current situation, the ‘here and now’ of coping. Carers felt that problem-coping strategies
would give way to emotion-focused strategies as they became reconciled to the progression of the disease
in the person with MS, accepting that knowing more about MS would not change anything. Consistent
with this shift to emotional-coping, carers valued personal stories that fuelled empathy and a greater
understanding of what the person with MS was experiencing. Participants recognised that, ultimately,
individuals would have different needs and that each would come to employ their own distinctive coping
strategies, better served by separate online resources. A sense that carers should be able to pick and
choose from the stories available was strong here. Carers recognised that although they were not always
likely to be receptive to some of the more difficult messages from other carers, they valued the fact that
the PEx offered both practical and emotional support.
Case study 3: smokers and their mistrust of the commercial testimonial
The smokers’ engagement with PEx was characterised by strong preferences for certain kinds of
experiential material. The interactive forums were seen as valuable in terms of providing support and
motivation for those wishing to quit. Smokers identified with those authors who seemed well matched in
terms of gender, age and location. Smokers noted unusual tips and hints for giving up smoking but,
overall, preferred realistic yet positive support messages. Such messages acknowledged the difficulties
associated with quitting but often included an inspirational message and a positive, successful outcome.
The testimonials were viewed with more suspicion. For smokers, at least, there was a sense that this form
of PEx might not always be genuine and in large part this reflected the strong commercial overtones
associated with PEx around this topic area. Many of the websites featured commercial advertising and
products associated with quitting. Celebrity and non-celebrity endorsements or testimonials were seen as
difficult to trust and the smokers thought it highly unlikely that they would return to this kind of website.
Overall, there was less evidence of longer-term engagement with the PEx for the smokers. The participants
commented on the difficulty of navigating to useful sections of the forums or finding relevant experiences
in the dense message threads.
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Implications of the framework for further studies
Our framework highlights both the source and the message of PEx (the ‘who’ and ‘what’ of PEx) as critical
factors in user engagement. We believe that people are quick to make judgements about the person
offering information and advice, judgements that reflect the extent to which they are seen to be ‘like me’
but also judgements that take into account their motivation in shared storytelling that in turn raise issues
around trust. Individuals are also concerned about the extent to which the content of a health message fits
with their own experience and pre-existing beliefs and reflects their particular journey. For example, the
MS carers we observed in the framework studies above tended to exhibit information-based coping
strategies if they were caring for someone in the early stages of MS, but more emotion-based strategies
when caring for someone in the later stages of MS, and their responses to available PEx varied
accordingly.159 In the two studies that follow, we explore these source and message issues in more detail
by exploring smoking cessation.
Do smokers trust the source of the patient
experience message?
People who listen and respond to others’ stories must consider whether or not the account is trustworthy.
Trust is a key construct here, as online PEx is often unregulated. Our own large-scale surveys of trust in
online health information have revealed a paradox, in that people like PEx and are drawn to sites containing
PEx, but are then less likely to trust the information and advice they find there.160 A subsequent analysis
suggested that this paradox may be related to the extent to which the contributor is seen as impartial.
Not all PEx is benign. Much of it is explicitly intended to persuade, and the prevalence of advertising as a
funding model for online support communities and health information sites only complicates this
issue further.
We know, from a range of previous studies,8,144 that the presence of advertising on a site can give a negative
first impression that can lead to disengagement or to mistrust of the messages on that site. In a recent study,
for example,124 the presence of advertising on a website showing the link between drinking alcohol and
breast cancer had no immediate effect on alcohol drinkers’ overall attitude to the site, but did subsequently
affect health behaviours: those who drank heavily reported no reduction in drinking after viewing a
‘commercial’ site but a significant reduction in drinking following exposure to a non-commercial site that
presented them with the same health message with the advertising removed. To better understand these
issues, we explored one health domain (smoking cessation) in greater depth, inviting participants to search
for relevant material and then discuss their ability to trust the different contributors they found online.
Method
We used a similar paradigm to that reported earlier in this chapter (A framework for user engagement
with online patient experience, Qualitative studies), asking 15 smokers to search for health-related
smoking material online and then discuss their findings. Participants were recruited using a number of
sources including council newsletters, leaflets and flyers. The smokers (seven male and eight female, with a
mean age of 23 years) were all experienced internet users. They had been smoking on average for 7 years
and smoked an average of 11 cigarettes per day.
Each participant was allocated to one of four focus groups and asked to attend a 2-hour session held
in an internet café-styled laboratory in Newcastle upon Tyne, UK. During the first hour of the session,
participants were invited to search the internet freely, looking for information and advice on smoking and
health. We logged the sites they visited, but also asked them to record their perceptions of each site in a
log book and to use this information during a subsequent group discussion with a facilitator. These group
discussions covered four main themes: (1) selection and rejection factors, (2) liked and disliked websites,
(3) PEx/account features and (4) trust and behaviour. Thematic analysis and coding practice followed that
of the earlier qualitative studies. Coders were primed to highlight comments in relation to trust or mistrust
and like or dislike of sites, and were also interested in the presence or absence of a ‘commercial voice’.
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Results and discussion
Participants visited 8.5 websites on average. The most commonly viewed sites (in order of number of
participants who visited the site) were the UK NHS Smokefree website (www.nhs.uk/smokefree), Netdoctor
(www.netdoctor.co.uk), Wikipedia [www.en.wikipedia.org/wiki/Smoking_cessation (accessed 1 July 2011)]
and the British Broadcasting Corporation’s smoking website [www.bbc.co.uk/health/physical_health/
conditions/smoking_health_effects.shtml (accessed 1 July 2011)]. The consistency in sites viewed suggested
that participants may have employed similar strategies and/or been influenced by similar factors when
deciding which sites to examine. From the discussions, data logs and log books, all participants attempted
to locate relevant websites using Google, although some participants also employed a more targeted
search via the NHS.
As anticipated from our earlier work, we found that people said that they very much liked having access to
other people’s experiences online and found the material engaging.
Well the patient UK one did have experiences of people who’ve smoked and who’ve quit and health
issues that they’ve had whilst smoking and once giving up and things like that and that was quite
good I think – reading about other people’s experiences.
Focus group 1, participant 3
We also found support for the claims that such experiences can help make the health issues seem more
real and engaging as people felt that they could relate more to other people who are in similar situations.
[It’s more helpful] If they’re more realistic if they’re not just literally a doctor’s sat and written it like
‘Mrs C has done this’. If it’s an actual person saying ‘look it’s really hard. I’ve shouted a lot. I’ve done
this, I’ve done that,’ then you can relate to them.
Focus group 1, participant 2
However, the presence of advertising was almost universally raised as something that was disliked about
some of the sites.
There’s lots of adverts as well which annoyed me. It’s like they get some form of gain out of telling
people to quit. There’s adverts and even some adverts weren’t even related to smoking.
Focus group 1, participant 2
As predicted, we found considerable evidence that users were suspicious about site content and that
advertising had an important role to play in this. Sites that appeared to be selling a product or that were
otherwise viewed as commercial created very negative first impressions in the sample, and participants
often felt that information contained on such a site would not be impartial or trustworthy.
More tellingly, participants became particularly suspicious if it seemed that the PEx had been used cynically
to advertise a particular product or manipulate beliefs.
There is one particular one that got like a few . . . a review of stories of how people are doing with the
product, but I think those websites try to sell their products rather than they are really trying to be help.
Focus group 3, participant 10
Participants also seemed very aware of the potential for PEx to be manipulated and were concerned about
the extent to which the experiences might be honest, questioning if they might have been scripted rather
than represent an actual experience:
That kind of story from an actual person or something would have way more impact than some typed
words on the internet that could have been put there by anyone. You don’t know who typed
the website.
Focus group 1, participant 7
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These discussion points are revealing as they show that people are drawn to PEx material, but can also
mistrust PEx when it appears to be used for commercial gain. Indeed, users may come to question the
genuineness of PEx that sits in an overly commercial context (at least in a context such as the UK, where
health care is provided free at the point of delivery). In our subsequent study with smokers, we explore
the extent to which matching the source and recipient characteristics of PEx can influence smokers’
perceptions of the acceptability of the advice presented to them and also directly influence health
outcomes in terms of reducing the number of cigarettes smoked.
Source and message elements of patient experience that can
impact on smoking cessation
Campaigns to promote healthier lifestyles face many obstacles including message resistance: a refusal to
see that the message is relevant by those individuals for whom it is most relevant.161,162 For example,
overweight individuals might ignore or denigrate a campaign designed to promote dietary improvement,
or smokers, targeted by a quit campaign, may be less likely to accept its key messages. Intriguingly,
there is evidence that presenting information as PEx may reduce such resistance and facilitate message
uptake.45,147 If so, this would clearly be a major practical advantage of presenting information using PEx
but, as yet, relatively few studies have addressed this. In this final study, we tested whether or not
PEx would reduce the tendency of a targeted audience (smokers) to resist a quit message and thereby
promote greater message acceptance.
We asked smokers to view pro-quitting information online, with the material presented to them either as
PEx (the PEx condition) or as a simple information factsheet. All of the information was based on current
evidence and suggested that attempting to quit smoking using support and aids is more likely to be
successful than attempting to quit unsupported.163 We wanted to know if information presented as PEx
would be more likely to reduce message resistance and promote message acceptance.
From our earlier studies and framework (see Figure 4) we knew that participants exhibit ‘homophily’,
that is, they seem drawn to experiences from similar others. We assessed this in two ways. First, we
manipulated the perceived gender of the PEx ‘voice’, with the prediction that people would be more
accepting of PEx from same-sex others. Consequently, we randomly allocated half of those in the PEx
condition to read PEx ostensibly written by a woman, and half to read PEx ostensibly written by a man.
Second, we assessed the effects of the palatability of the material in terms of participants’ pre-existing
beliefs (attitudes towards quitting by using or not using aids and support). To do this, we established
participants’ preferences for mode of quitting (supported vs. unsupported) and their previous quit
experiences and practices, and we used this information to classify them as having received information
that either matched their preferences (the information advocated quitting by using aids and support) or did
not match their preferences. The study thus contained an experimental manipulation involving gender
matching (random allocation to no PEx, male PEx or female PEx conditions) and a separate, measurement
component, involving preference matching (the classification post hoc of participants as having read
preference-consistent or preference-inconsistent information, irrespective of the gender of the ostensible
PEx author). The data involving these two separate elements were analysed separately.
We were primarily interested in the results of these variables on message acceptance, which we assessed
with a wide range of indicators that included participant mood, message believability and responses
to the website, as measured by the eHIQ (described in Chapter 4). We also measured message
knowledge and intentions to change at time 1 (i.e. immediately following exposure to the website)
and reported quit attempts and nicotine dependency in two follow-up phases, conducted 14 days and
3 months later.
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Method
We recruited smokers to an online study using poster advertising, e-mail and word of mouth. A total of
113 participants (mean age 24.7 years, n= 63, 55.7% female) completed all three phases of the study.
Most (n= 74; 65.5%) were students.
Measures
In a participant’s first visit to the website, we measured basic demographics, as well as smoking behaviour,
internet use, preferences for and experiences of quitting (supported vs. unsupported), nicotine dependency
and motivation to quit.164 The primary outcome measures addressed message acceptance as indicated by
measures of mood,165 message believability, message derogation and personal relevance, and evaluation of
the website, assessed using the 26 items from the eHIQ part 2.66 We also employed a range of secondary
outcome measures that included message knowledge, nicotine dependency, intentions to cut down and
intentions to quit. After 14 days and again after 3 months, participants received an e-mail inviting them to
log on to the website and complete a brief follow-up that included the measures of reported quit attempts
and nicotine dependency.
Materials
The health message was presented as a single web page and contained evidence about quitting smoking
taken from an authoritative source.163 Two different but similarly sized versions of the web page were
created, both containing exactly the same design features and layout but varying in terms of the way in
which the information was presented. In the factsheet condition, the quitting smoking facts were
presented as a bullet point list of statements. In the PEx conditions, the same facts were presented as a
personal story of quitting.
Procedure
Testing was done online. Participants logged in using a unique identification code and were randomly
assigned to one of the experimental conditions. They worked their way through the pre-manipulation
questions before being shown the condition-relevant webpage. They then completed the outcome
measures. After completing the session, participants were asked to provide an e-mail address so that
follow-up surveys could be sent to them automatically at 14 days and 3 months after the initial session.
The initial session lasted approximately 20 minutes and each follow-up lasted approximately 5 minutes.
Those who completed all three parts were compensated £20 for their time. Ethics approval was granted
for the study by Northumbria University’s Psychology Department Ethics Committee.
Results
For the gender-match analyses, participants were matched on the basis of the correspondence between
their gender and that of the ostensible author of the PEx. For the preference-match analyses, participants
were matched on the basis of the correspondence between the information and their preferences for
quitting supported (match) or unsupported (no match). Alpha was set at p≤ 0.05 for all analyses.
Baseline measures
The sample comprised regular internet users who smoked, on average, eight cigarettes per day. Men
(mean 9.58, SD 7.59) reported smoking significantly more than women (mean 7.00, SD 6.27, η2p = 0.59).
The men (mean 1.92, SD 1.71) also had significantly higher nicotine dependency scores than the women
(mean 1.21, SD 1.56, η2p = 0.48). Motivation to quit was high; participants reported moderate to high
urges to smoke and 75 people said that they had made a quit attempt in the previous 2 weeks.
Time 1 results
The time 1 gender-match effects were analysed using one-way between-subjects ANOVA with three levels
(no PEx, gender-matched PEx or gender-unmatched PEx) followed by Helmert contrasts. Contrast 1 tests
the question ‘Does PEx make a difference?’. Contrast 2 tests the question ‘Are there differences between the
types of PEx?’. Analyses were conducted separately within gender. Men who viewed PEx found it more
believable than no PEx information (mean 5.4 vs. 4.4, η2p = 0.14) and were also in a better mood after
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viewing (mean 5.4 vs. 3.9, η2p = 0.25). It made little difference whether the PEx was gender matched or
unmatched. No other time 1 effects were significant.
The time 1 preference-match effects were analysed using a two (information type: information only,
PEx) × two (preference match: preference consistent, preference inconsistent) between-subjects ANOVA.
Missing data on dependent variables resulted in the following cell sizes for most analyses: information
only, n= 21 (preference consistent), n= 16 (preference inconsistent); PEx, n= 50 (preference consistent),
n= 20 (preference inconsistent).
There were significant main effects of preference match on several of the dependent measures: when the
message was preference-consistent, participants spent more time viewing the material (consistent mean
95.2 seconds, inconsistent mean 67.8 seconds, η2p = 0.06), were more motivated to quit smoking
(consistent mean 4.7, inconsistent mean 4.0, η2p = 0.04), reported thinking more deeply about the
information (consistent mean 3.7, inconsistent mean 2.7, η2p = 0.08), reported being more worried by it
(consistent mean 4.2, inconsistent mean 3.4, η2p = 0.04), and worrying more about the health risks of their
smoking (consistent mean 4.0, inconsistent mean 2.9, η2p = 0.09). In terms of responses to the site, they
had higher scores on eHIQ confidence (consistent mean 30.4, inconsistent mean 26.7, η2p = 0.06) and eHIQ
understanding (consistent mean 31.3, inconsistent mean 27.6, η2p = 0.06), but not on eHIQ information
(consistent mean 26.9, inconsistent mean 25.9, η2p = 0.01).
There was only one significant main effect of information type: the PEx promoted more positive mood
(mean 4.6) than did the information only (mean 4.2, η2p = 0.04). The key preference match × information
type interaction was significant for only one dependent measure (η2p = 0.05): preference consistency
affected intentions to cut down in the information-only condition (consistent mean 5.5, inconsistent mean
4.2) but not in the PEx condition (consistent mean 5.0, inconsistent mean 5.2).
Follow-ups
There were no effects of preference match at follow-up and so the subsequent analyses deal with only the
gender-match effects. The follow-up measures taken at time 2 (14 days) and time 3 (3 months) were
therefore analysed using two-way ANOVA for mixed designs with gender-match condition (no PEx,
gender-matched PEx, gender-unmatched PEx) as the between-subjects independent variable and time as a
three-level (times 1, 2 and 3) repeated measures independent variable.
Men reported a significant increase in quit attempts over time (η2p = 0.08). Both men (η
2
p = 0.20) and
women (η2p = 0.17) showed a significant decrease in nicotine dependency over time. For both sexes there
were also significant effects of condition on nicotine dependency; however, the pattern varied. Men had
significantly higher nicotine dependency in the matched PEx than the unmatched PEx condition (95% CI
0.29 to 2.27; p= 0.013), but women had significantly higher dependency in the no PEx than PEx condition
(95% CI 0.15 to 1.42; p= 0.017). However, these findings may reflect the lingering impact of differences
observed at baseline. There were no other significant findings.
Discussion
We explored the effect of PEx in conjunction with an exploration of the effect of matching PEx to the
gender of the participant. We found little effect of gender matching and only observed a PEx effect in
the men. Men found PEx preferable in terms of both mood and message believability, but it mattered little
whether the experience seemed to come from a man or woman. PEx did not affect message knowledge or
website evaluation as measured by the eHIQ in either sex.
Over time, other effects emerged. Men showed increases in quit attempts and decreases in nicotine
dependency over the 3-month period. Women also showed decreases in nicotine dependency over this
period. There were also some significant effects of condition on nicotine dependency. However, these
effects may reflect the lingering impact of gender differences in dependency at baseline.
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We also found some initial effects (at baseline) of matching for preference in terms of the way people
might choose to give up smoking (supported or unsupported). Health information expressed in a way that
is preference consistent led to higher levels of engagement with online content, which supports the
general health literature on the role of homophily as a component of effective health behaviour change.
Conclusion
In this chapter we have proposed a framework that captures the ways in which people engage with
the experiences of others online. This framework was drawn from qualitative studies with three groups
(people with asthma, MS carers and smokers wishing to quit). The framework is useful in that it helps us
to understand the decision process by which users chose one source of information over another and gives
us a structured means to interpret the different components of the users ‘voice’. In subsequent studies, we
have explored some of the elements of this framework further with one of our participant groups: smokers
seeking advice about quitting. We have seen that some of the commercial elements of website design can
be counterproductive; smokers were suspicious of websites that contained advertising and other more
commercial elements and were drawn, instead, to those sites that appeared to offer impartial information
and advice. We have also seen that many people like to be given information in the form of PEx. Our MS
carers, for example, were able to turn to PEx for both practical and emotional support in ways that echoed
the seven domains of PEx engagement proposed by Ziebland and Wyke4 and presented in Chapter 2.
However, we must exercise a note of caution about the health outcomes associated with PEx. We found
only a limited advantage (and primarily for men) in presenting material as PEx in our final study, where
men viewing PEx reported being in a better mood and finding the material more believable, and we found
no real advantage in gender matching stories to individuals. These are early days for such explorations
and there are a number of PEx variables that may be more critical in supporting health and well-being.
We have found our engagement framework to be a useful tool in helping to identify some of the design
questions we should be asking, but there is some way to go in terms of collecting a solid evidence base for
the usefulness of PEx as a persuasive tool.
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Chapter 7 Work package 3a: development and
user testing of prototype websites based on
(1) patients’ experiences and (2) ‘facts and figures’
Abstract
Introduction: the sharing of online PEx could bring health and social benefits in a number of ways.
One of our interests was to explore whether or not the value of these experiences could be harnessed as
an intervention and ultimately compared with ‘facts and figures’ sites as part of a feasibility trial.
Methods: narrative interviews were conducted to explore the experiences and information and support
needs of people in each of the three exemplar groups (smokers, people with asthma and family or friend
carers of people with MS). Using guidelines on how best to present experiential information online, three
prototype multimedia web resources were developed.
Findings: three prototype multimedia experience-based web resources were developed, together with
three comparator websites which presented health information in a ‘facts and figures’ format without
experiential information from patients, although they did include video clips from health professionals.
All sites used the same ‘look and feel’. We recruited 47 members of the public to pilot the entire
participant journey, from the initial invitation to the completion of the follow-up measures.
Conclusions: the sites were successfully developed in line with the guidelines and provided new,
password-protected access for the WP3 trial.
Introduction
As we have discussed, the sharing of online PEx could bring health and social benefits in a number of ways.
One of our interests was in exploring whether or not the value of these experiences could be harnessed as
an intervention. In the next two chapters we describe the design of a novel PEx-based internet intervention,
and the subsequent randomised controlled exploratory trial undertaken to assess feasibility and measure the
impact of the intervention on a range of outcome measures. As with the rest of the programme of work,
we examined three exemplar groups: people with asthma, people wishing to quit smoking and people
caring for someone with MS.
In this chapter we describe the conduct of three qualitative interview studies of our three exemplar
conditions and describe how guidelines on how best to present health information online (see Chapter 6)
were used to design three multimedia online resources based on contextualised information derived from
PEx. We also describe the development of three comparator websites which contain facts and figures
without experiential information from patients.
Interview methods
The exemplar health conditions were chosen to allow an exploration of different aspects of the effects of
exposure to online health experiences: behaviour change, management of a chronic condition and
preparedness for a caring role.
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Three separate qualitative interview studies were conducted by experienced qualitative social scientists
working within the Oxford HERG. Each study aimed to collect 30–50 narrative interviews with respondents
from the target groups. These groups were (1) smokers or ex-smokers, describing their experiences of
quitting or attempting to quit; (2) people with asthma describing in particular how they live with and
manage their illness; and (3) family and friend carers of people with MS, talking about their caregiving
role. Each study sought to explore the experiences, and information and support needs, of these
populations. Each project was informed by a literature and field review and by the appointment of a
specialist advisory panel comprising researchers, clinicians, lay persons, representatives from the voluntary
sector and other stakeholders. The panel advised on all aspects of the studies, including the scope,
selection of participants, sampling and content of the interviews, the analysis and the preparation of
thematic summaries for the websites.
In each of these studies, interviews started with an appropriate variation on an open-ended question
intended to invite a narrative response from the participant. This was followed by a guided series of
questions and prompts about any issues of interest that may not have been fully discussed in the narrative.
These typically included questions about signs and symptoms, treatment decisions, emotions, information
and support needs, self-management, and communication with health professionals. All participants were
asked if they had messages for others starting out on the same journey and if there was anything they
would like health professionals to learn from their experiences.
As diverse a sample as possible was generated through national, purposive sampling so as to gather
experiences which might be considered ‘typical’ as well as experiences which were more unusual.166
Participants in each of the three conditions had had a wide variety of different experiences and were from a
broad range of sociodemographic backgrounds. Participants were recruited through primary care staff, hospital
consultants and specialist nurses, advisory panel members, local and national support groups, advertising online
and in local newspapers and snowballing through participants’ and personal contacts. Using established
qualitative research methods, analysis and data collection proceeded simultaneously and continued until ‘data
saturation’ was reached to ensure that the widest practical range of experiences had been included.
The interviews, which usually took place in people’s homes or other place of their choosing, were digitally
audio or video recorded (depending on the participant’s preference), transcribed, checked by the interview
participant and copyrighted to the University of Oxford. The methods were approved by the Berkshire
Research Ethics Committee, reference 12/SC/0495.
Specialist software (NVivo) was used to support the analysis which explored different aspects of people’s
accounts and to group similar themes across all of the interviews. The method of constant comparison was
used to ensure that all perspectives on the issues that are important to participants were included, not just
the anticipated themes that health professionals and researchers consider important.70 For each of the
three studies, topic summaries were produced, written in lay language, accompanied by video, audio or
text-only extracts from the interviews (in total approximately 250 clips per study), chosen to illustrate each
topic. The titles of these topics summaries are shown in Table 13.
For rigour, the thematic analyses were checked by another experienced qualitative researcher from the
Oxford HERG team and the summaries were checked by this person and by at least one medically qualified
member of the advisory panel. Brief biographies of the study participants were included to add context to
the individual clips from each interview.
We also video recorded health professionals (a professor of behavioural medicine and a GP on the smoking
site; a respiratory nurse, a professor of environmental and respiratory medicine and a GP for the asthma
site; and a MS nurse consultant, a MS specialist nurse and a GP for the MS carers site) talking about aspects
of each health area, including an explanation of the condition or health topic, and treatments. These
professional accounts were used to create multimedia ‘health professionals corners’ which included text
and video excerpts from the interviews. They were included on both the intervention and comparator sites.
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TABLE 13 Work package 3a: topic summaries for the PEx websites for each condition
Asthma intervention site Giving up smoking intervention site MS carers intervention site
What is asthma?
Early signs and symptoms
Childhood onset
Adult onset
Triggers
What asthma feels like
Changing symptoms over time
Being diagnosed with asthma
Medications treatment: inhalers
Medication and treatment: other
treatments
Alternative and complementary
therapies
Managing asthma: reviews and
action plans
Managing asthma: adjusting
medication and other self-care
strategies
Asthma attack and emergencies
Dealing with health professionals
Remembering to take medication
Finding information about asthma
Emotions and coping
Asthma and the workplace
Finances and benefits
Exercise, diet, weight and other
lifestyle issues
Support and support groups
Relationships, family and friends
Advice to others
Messages to health professionals
Parents, friends and first cigarettes
Smoking: memories and experiences
Nicotine, dependence and cravings
Cannabis, alcohol and coffee
The image of smoking and smoking in
secret
First thinking about quitting
Life events and their effect on people’s
motivation to stop smoking
Appearance and physical health
Smoking-related diseases
The role of others in the decision to quit
Changing culture, public health
campaigns and the smoking ban
Money and smoking
Help from pharmacists, GPs and nicotine
replacement therapies
Complementary approaches to quitting
Going it alone
Giving up with others and online support
‘Cutting down’, unsuccessful attempts
and trying again
Being a non-smoker
Effects of not smoking
Messages to others
Unsolicited advice from health
professionals, family and friends
Reflecting on relapses
What is MS?
First symptoms
Getting a diagnosis
Reactions to diagnosis
Deciding whether to tell others
Looking for information
Decisions about treatment
Work
Financial impact
Family life
Being a ‘carer’
Maintaining a social life
Normality and optimism
Love and relationships
Changing symptoms over time
Adaptations, aids and equipment
Dealing with emotions
Getting help with care needs
Feelings of loss, grief and bereavement
Support from family, friends and
neighbours
Contacts with health, social services and
voluntary organisations
Advocacy and activism
Thoughts about the future
Talking about end of life
Messages to health and social care
services
Messages to carers, relatives and friends
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Design of intervention websites
Three separate websites were designed using guidelines which were developed in WP2b (see Chapter 6).
As far as possible, all guideline points were incorporated into the prototype sites. Examples of how this
was applied are shown in tabular form in Table 14. For example, one important point arising from the
guidelines was to provide a means to help people locate the experience material most relevant to them.
To address this we allowed people to search for ‘experiences by group’. These groups varied by health
‘condition’ and included, for example, age at diagnosis (asthma), time since giving up (smoking) and
relationship to person with MS (MS carers). As the material was based on sampling to data saturation on
themes, participants should have found a perspective akin to their own in most of the lay summaries,
although this might not be reported by a person of the same age, family situation or social class as them.
There were a few exceptions to the adherence with the guidelines as we decided to exclude features
that would be incompatible with the subsequent intervention study (randomised trial). For example,
the facility to leave public comments and to rate web pages are standard features of modern websites,
TABLE 14 Work package 3a: examples of how the websites were developed to address the three-stage
engagement model (developed in Chapter 6 by PB, ES and PH)
Design element Adherence to design element
Gating Logos used: Oxford University and the Thames Valley Primary Care Research Partnership NHS logo
Two ways of accessing the same information are provided: topic headings are presented down the
side and across the top of the page. User can return to the home page from any point, can access
material via topic or through ‘experiences by group’ (groupings as appropriate)
The videos of health professionals are separate and clearly labelled
No advertising
Engagement: who Experiences are grouped (e.g. for smoking cessation, by gender, age of participant at interview,
relapses, time since giving up, time since diagnosis). The participants’ location was not included to
protect anonymity, although it was clear that all were based in England or Wales. Brief individual
biographies were included
Wide sample of experiences which are grouped into analytic themes. This should provide resonant
PEx
Engagement: what The strapline provides an overview of each interview clip – biography gives more detail
Video and transcript are provided. Video clips have a time bar at the bottom; the total length of
the clip is indicated
The collections aimed to include the widest practicable range of experiences, which are then
organised into topic summaries to reflect different perspectives on each issue. Analysis was
checked by a second researcher to ensure balance and final material reviewed by an advisory panel
to make sure that material presented was not misleading
A maximum variation sample of interviewees was sought
The research team strove for an appropriate balance when writing the topic summaries
Engagement:
compare
All of the experiences are grouped according to topic – to present full range of perspectives – and
also by subsection of participants (e.g. age group, caring status and time since quitting smoking)
Points are broken down into lay summaries. Internal links at the bottom of the summaries guide
reader to related issues and there is the easy option of getting back to the home page with one
click
Engagement: share Ratings box included. However, ratings not displayed to avoid changing the site for subsequent
participants
Comments box included so that people can interact with the site. However, comments not
displayed to avoid changing the site for subsequent participants
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but it was decided that these may present problems for the randomised trial design, as the presence of
comments could alter the intervention for other users. To address this issue, the websites were designed
to allow comments to be posted and pages rated but these were not visible to other trial participants.
In other words users could submit comments and feedback to the ‘site owners’, but these would not
be published. We did not include external links to other sites as we did not want to encourage trial
participants to use other resources instead of their allocated website. Screenshots of the final websites
are shown in Figures 5–7.
FIGURE 5 Work package 3a: the home pages of the intervention sites.
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FIGURE 5 Work package 3a: the home pages of the intervention sites. (continued )
FIGURE 6 Work package 3a: example of an illustrated lay summary from the asthma intervention.
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Design of comparator websites
For the randomised trial, we also required three comparator websites, one for each of the three conditions,
containing ‘facts and figures’ about each condition, but no PEx. We decided that, as far as possible, these
websites should have exactly the same ‘look and feel’ and navigation characteristics as the intervention
websites, so that the only difference was in their content. To test the value of the PEx-based sites against
the ‘gold standard’, these multimedia websites were populated with information from NHS Choices, the
NHS health information website. Where necessary, minor changes were required, for example to remove
experiential information that had been included in NHS Choices or to add in sections that were present on
the intervention sites but not on NHS Choices. In this case, material was identified from other reputable
sources (the MS Society, Asthma UK and NHS Smokefree). The material was then presented in a similar
way to that of the intervention websites, with similar numbers of topic headings, pictures and other
features. Screenshots of the final websites are shown in Figure 8.
The list of topic areas included on each of the three comparator websites is given in Table 15.
Participant activity tracking and data portal development
In addition to the six information websites, we developed a ‘portal’ website through which the randomised
trial could be administered. This contained all sensitive trial data (including all personal information and the
questionnaire responses pre and post website exposure). It was linked to the content server hosting the
information websites by means of a ‘wrapper’. The participant-facing interface comprised:
l a welcome page where the participant entered their assigned participant code
l a home page with an introduction explaining the trial
l a participant-facing system for capturing baseline questionnaire data
l a system for the user to fill in the post-exposure questionnaire data
l a password recovery system
l a forgotten login details link.
FIGURE 7 Work package 3a: presentation of a video clip and transcript from the asthma intervention.
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FIGURE 8 Work package 3a: the home pages of the comparator sites.
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TABLE 15 Work package 3a: topic areas covered by the comparator websites
Asthma comparator site Giving up smoking comparator site MS carers comparator site
l What is asthma?
l Health professionals talk
about asthma
l Causes of asthma
l Symptoms of asthma
l When asthma gets worse
l Diagnosing asthma
l What is good asthma care?
l Personal asthma action plan
l Taking asthma medicines
l Other treatments and add
on therapy
l Side-effects of treatments
l Complementary therapies
l Living with asthma
l Complications of asthma
l Occupational asthma
l Asthma and pregnancy
l Traveling with asthma
l Financial support
l Get in touch with others
l Health professionals talk about giving
up smoking
l Help and support to stop smoking
l Self-help tips to help you stop smoking
l Quit making excuses
l Stop smoking – coping with cravings
l Under 18s guide to quitting
l Paan, bidi and shisha
l 10 health benefits of stopping smoking
l 7 key times to quit smoking
l Smoking in pregnancy
l NHS Stop Smoking Advisers help
you quit
l How your GP can help you quit
l Ask the GP: smoking Q&A
l Treatment and support to quit smoking
l 10 myths about stop
smoking treatments
l Stop smoking without putting on weight
l What to do if you relapse after quitting
smoking
l What is MS?
l Health professionals talk
about MS
l Symptoms of MS
l Causes of MS
l Diagnosing MS
l Treating MS
l Treatment for MS relapses
l Treatment for specific
MS symptoms
l Treatment to slow the progression
of MS
l Clinical trials
l Complementary and alternative
therapies for MS
l Diet to modify MS
l Living with MS
l Relationships and support
l Having a baby
l Money and financial support
l Driving
l A guide to carers’ rights
l Carers’ assessments
l Help for carers
l Caring and working
l Talking about the future and
dealing with emotions
FIGURE 8 Work package 3a: the home pages of the comparator sites. (continued )
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The interface for the research team comprised:
l A participant registration system which, in conjunction with the randomisation system, put the
participant into the correct branch of the trial.
l A participant randomisation system.
l A registration handover system to hand over user baseline and registration sessions to the content server.
l A system for sending a welcome e-mail to a participant on completion of registration. Participants were
e-mailed the URL to the login page of the information sites, their username and their password.
l A system to pull usage tracking data from the content server on a daily basis via public–private key pair
encryption, as an automated scheduled task. This was fed into a system to hold a decrypted copy of
user tracking data linked to correct users.
l A facility to send participant reminders to view the intervention sites at defined time periods.
l A trial completion system that performed the following tasks 2 weeks after participant registration:
¢ The portal e-mailed the participant to explain that the trial was over and that they no longer
had access to the information sites, and directed them to return to the portal to fill in the
post-exposure questionnaires.
¢ The portal interacted with the content sites to block the users from being able to log in to the system.
¢ If questionnaires were not returned within 24 hours then e-mail reminders were sent at defined
time intervals.
¢ Once post-exposure questionnaires were completed, the portal interacted with the content sites to
reinstate the user login and e-mailed the participant to advise that they were able to view their
allocated website again if they wished. After this point the participants’ usage of the website was
no longer tracked.
l An online issue tracker.
Assessment of use of the websites
Participants’ usage of their allocated website was tracked and logged by means of a ‘wrapper’ which
facilitated communication between the content server (which hosted the six information websites) and the
data ‘portal’. User activity was tracked by both page views (number and type) and interaction with web
pages (e.g. if a participant viewed videos or listened to audio clips). We also tracked if participants used
the search facility and what search words they used. The recorded data were linked to baseline and
follow-up questionnaire data by a unique participant identification number.
Tracking data was collected in the following ways by individual user:
l total visits to site (including times and date stamps)
l total time spent on site
l total number of page views
l breakdown of session times (start and finish)
l breakdown of page type visited and time spent on each
l breakdown of clips viewed and length of time they were viewed for, split by the three formats: video,
audio and text only
l JavaScript (www.javascript.com) enabled/disabled in participants’ browser.
User testing
Before commencement of the randomised trial, we recruited 47 members of the public to pilot the entire
participant journey, from the initial invitation to the completion of the follow-up measures. A primary goal
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of this pilot testing was to determine the functionality of the information websites and data portal and the
credibility of the comparator sites. Twenty participants were recruited from the programme public panel
and 27 participants were recruited externally. As part of the full pilot, participants were invited to
undertake an informal heuristic evaluation of the websites, with particular focus on the design and appeal
of the websites, the tone of the material, ease of navigation, perceived trustworthiness and participants’
overall level of engagement.
Participants were registered on the trial’s online data portal and their usage of the websites was tracked.
They also provided additional information regarding platform and browser use, which was useful to the
team when troubleshooting some access problems that turned out to be related to the user’s browser.
A total of 41 participants completed the evaluation (i.e. submitted follow-up measures) and 31 provided
feedback by e-mail and/or telephone interview. Feedback on individual website pages was also provided
using the comments and ratings options on the websites themselves.
All feedback was examined and discussed by the research team. On the whole, feedback from participants
across all sites was positive, for example:
It was a logically laid out website which made it easy to use. The use of colour and graphics was
good, it made it easier and more enjoyable to use and helped to bring the information alive.
Smoking comparator site, user tester 5
I liked watching the videos though and feeling like they were real people’s experiences was good. I did
find the website trustworthy and the design was professional.
Smoking intervention site, user tester 2
Seemed liked a good website, trustworthy and professional. It contained a lot of information which
was very clearly laid out and easy to access.
Asthma comparator site, user tester 3
Other feedback was very useful in suggesting minor modifications which were incorporated into the
design. For example, a ‘no smoking’ sign on the home page of the giving up smoking websites was seen
as punitive by smokers and was replaced. The image chosen for the ‘health professionals’ section on the
websites was also altered in response to consistently negative feedback.
Some people were unhappy with the aesthetics of the websites. This illustrated the challenge in designing
online information sites to appeal to all. Example comments were:
Seems authoritative and boring, not particularly engaging on the homepage, but once you delve
further in the testimonies are very good.
Smoking intervention site, user tester 3
Design of website is offering lot of text, can improve with more visual links (perhaps colour coding
topics/groups) which will invite for easy navigation though steps.
Smoking intervention site, user tester 4
Looks a bit academic and pages are a bit ‘too busy’.
Asthma comparator site, user tester 5
Participants’ comments both agreed with and sometimes challenged the guidelines used to develop the
prototype websites, with the duplicate menu being the most controversial:
The NHS logo really helped, as did the Oxford Uni one.
MS carer intervention site, user tester 5
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Anything with an Oxford badge appears trustworthy.
Smoking comparator site, user tester 3
Irritated by having menu on the left and across the top.
Asthma intervention site, user tester 3
I do not think it is necessary to have ‘Information by topic’ at the top when it is on the side.
Asthma comparator site, user tester 6
Importantly, participant feedback and the tracked user data on the online portal also revealed that the
material had not been optimised for viewing across multiple platforms with multiple browsers, especially
using iOS devices [such as iPhone (Apple Inc., Cupertino, CA, USA)]. In addition, some participants were
unable to stream videos while others were able to watch the videos but this was not registered as ‘usage’
by the online portal. This had direct implications for the quality and quantity of the usage data we would
be able to collect during the main trial. As a result the software expert producing the online portal further
optimised the site for multiple platforms, and tested and retested the tracking capability across platforms
and devices. In addition, full trial participants were subsequently advised of the optimal platform and
browser combinations in the study information sheet.
Conclusions
We successfully developed three multimedia prototype websites based entirely on experiential data from a
maximum variation sample of narrative interviews on three health topics. The summaries which formed
the basis of the sites were grounded in what was important to the study participants as detailed in their
personal accounts. Three multimedia comparator websites, with the same look and feel as the intervention
websites, were also constructed based on ‘facts and figures’ style information from a ‘gold-standard’
source, the NHS Choices website. The intervention websites were developed to adhere to guidelines on
how best to present online PEx based on work conducted earlier in this programme. We also developed a
data portal website which collected two distinct sets of data: clinical data (participants’ screening and
demographic data and all baseline and outcome questionnaire data) and the user activity tracking data.
User testing led to minor amendments of the information websites and the data collection portal prior to
their use in the randomised trial, which is described in the next chapter.
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Chapter 8 Work package 3b: the EXPERT study –
randomised trial of patient experience-based websites
Abstract
Introduction: the aim was to assess the feasibility and measure the impact of a PEx-based website using a
randomised trial. We did this for three conditions: smoking cessation, asthma and caring for someone
with MS.
Methods: in this phase II pilot randomised single-blind trial, eligible participants were allocated randomly to
a PEx website or a non-PEx comparator website, stratified by health topic. Participants completed baseline
measures, were given access to their allocated website for 2 weeks, and completed follow-up measures.
Website usage was tracked. Semistructured interviews were conducted with purposively selected
participants and analysed using an interpretative thematic analysis.
Findings: in the three conditions (smoking cessation, asthma and caring for someone with MS) we
randomised 87, 148 and 42 participants, respectively. At 2-week follow-up, retention rates were 75%,
82% and 86%, respectively. The median numbers of logins to the websites were 2, 2 and 4; the median
numbers of page views were 10, 15 and 27.5; and the median total duration on site was 9 minutes,
17 minutes and 31.5 minutes, respectively. We found no evidence of differences on self-report measures
which included condition-specific outcomes, health status and attitudes of users towards health websites.
There were no adverse events.
Conclusions: the trials demonstrated ‘technical feasibility’ and had good internal validity, although usage of
allocated websites was low. Carers were difficult to recruit. Future, more pragmatic work needs to consider
how to evaluate PEx tools in the context of ‘real-world’ internet use and information-seeking behaviour.
Introduction
In this chapter we describe the design, conduct and findings of a phase II pilot randomised single-blind trial,
in which eligible participants were randomly allocated to a condition-specific PEx-based health information
website or to a comparator website which contained facts and figures information, stratified by one of three
health conditions. The original application described three separate pilot randomised trials, one for each
health condition. For operational efficiency, the three trials were run under the governance of a single trial
protocol and analysed by condition. In this programme of work we followed the Medical Research Council
(MRC) guidance for complex interventions.167 The conceptual and literature review work described in
Chapter 2 established what was already known on this topic and identified the theoretical ways in which
the online sharing of personal experiences of health and illness may yield benefits. This theoretical
understanding was developed by the work described in Chapter 3, where we further explored the ways in
which experiences are reported as helpful, using data from interviews with patients. Chapter 6 explained
how we established the factors which maximise engagement with online information and which we then
used to inform the optimum design of our intervention (as described in Chapter 7). The next step for us in
developing and evaluating this complex intervention was to undertake this exploratory study, with our main
aim being to establish the feasibility of undertaking this research and to identify any emergent evidence
of efficacy or harm. This work will inform further, more pragmatic effectiveness research. As discussed
previously, the three exemplar conditions were chosen to assess the impact of experiential information on
(1) confidence to self-manage a chronic disease (asthma); (2) motivation to change an unhealthy behaviour
(smoking); and (3) preparedness to undertake a caring role (carers of people with MS): our initial theoretical
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work suggested that these are three of the several ways in which experiential information may be beneficial.
We also measured the impact of all six websites on health status, and we assessed attitudes towards the
websites using the new instrument, the eHIQ (see Chapter 4). Our objectives are as follows.
Primary objective
l To evaluate the feasibility issues in an online randomised study providing health information websites
containing PEx information compared with matched health information websites that do not contain
experiential information.
Secondary objectives
l To assess the efficacy of two types of online health information (PEx accounts compared with
matched health information websites that do not contain experiential information) on a range of
self-reported outcomes.
l To explore whether or not the interventions have differential effects on pre-specified subgroups
of participants.
l To measure the impact of the intervention and comparator websites using the eHIQ.
Methods
Design
A phase II pilot randomised single-blind trial, in which eligible participants were randomly allocate to a PEx
website or a comparator ‘facts and figures’ website stratified by health topic.
Interventions
As described in the previous chapter, for each condition (asthma, smoking cessation, MS carer) two
websites were developed: one containing PEx information and the other containing information solely
based on facts and figures with no experience-based content. Each were password protected, multimedia
internet sites based on guidelines which were developed by the team working on WP2b. The comparator
sites shared the design and multimedia features (such as video) of the intervention sites but the content
excluded any accounts of personal experience. They used source material from the national health
information portal NHS Choices with all experiential information removed.
Participants
Trial participants had asthma, were smokers with a willingness to quit or were carers of a person with MS.
To be eligible for the asthma condition, participants were required to have clinically diagnosed asthma as
coded in their primary care electronic record, and have been prescribed inhaled corticosteroids for at least
3 months in the previous year. To be eligible for the smoking cessation condition, participants were required
to be current smokers, who had been smokers for at least 1 year, and who indicated some willingness to
quit, including those referred to smoking cessation services. To be eligible as carers of people with MS,
participants were required to identify themselves as an unpaid caregiver (i.e. not a professional carer) for
another person who had a diagnosis of MS. Participants who matched more than one condition could be
included only once, and only one participant per household could be included.
We included participants who were male or female, over the age of 18 years, resident in the UK, with
access to the internet and able to use websites. We excluded people who could not understand English
(owing to the nature of the intervention), who were terminally ill or who had a significant disease or
disorder that may have put that person at risk because of participation in the research, or may have
influenced the result of the research, or which affected that person’s ability to participate.
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Recruitment
The recruitment of participants eligible for the asthma and smoking cessation conditions was
predominantly through primary care practices in two regions of England, facilitated by the local primary
care research networks. GPs who agreed to take part were asked to identify eligible individuals from their
practices and to send them full information on the research study. In addition, for the smoking cessation
recruitment, posters advertising the study were placed in public places, such as GP waiting rooms and
libraries, and online adverts were placed on Facebook. The recruitment invitations and posters gave
contact details for the study team so that potential participants could make initial contact to indicate their
willingness to take part.
The recruitment of participants eligible as carers of people with MS took a different approach. Being a
carer for someone with MS is not routinely recorded in primary care records. We took a broad and iterative
approach to the recruitment of carers, helped by our patient and public advisory panel. Recruitment was
not easy, and over time we used many routes. We placed posters and leaflets in GP practices, neurology
clinics, MS therapy centres, local enablement and well-being services, and local leisure centres. We enlisted
the support of several third-sector organisations that distributed recruitment adverts on their websites and
social media feeds, including the MS Society, Shift.MS, Carers UK and the Carers Trust. We met with the
local carers group, advertised in their newsletter and staffed a stand at a local carers’ conference. We
placed paid-for adverts in Enable magazine, in local newspapers, in the London Metro paper and on
Facebook. We had our own study recruitment webpage and promoted this through various channels,
including the Oxford Daily Info website and tweets sent to key organisations and public figures. We were
supported by members of the programme public panel and the MS patient and carer panel who helped us
to identify recruitment avenues as well as potential participants. Further participants were recruited
through word of mouth and personal contact.
Study procedures
For each condition, potential participants who indicated a willingness to take part completed screening
questionnaires to assess their eligibility against our inclusion/exclusion criteria (see above). All eligible
participants were sent a patient information sheet and consent form by post to be signed and returned to
the research office in a reply-paid envelope. Once consent had been received participants’ details were
entered into a secure trial management portal and they were sent a unique ‘welcome code’ with a link to
the trial registration webpage. If after 1 week the participant had not used their welcome code, a reminder
was sent by automatic e-mail inviting them to visit the trial registration page. If the participant no longer
wished to take part, they could simply ignore this reminder. If the participant did wish to take part they
could use the link in the e-mail to access the trial registration page where they were asked to complete
baseline questionnaires on the online portal. Once these measures had been completed they were invited
to create a unique user identification and password and then they were randomised to have access to
either the intervention or the comparator website, for a period of 2 weeks. Randomisation used a
computer-generated random number sequence in a 1 : 1 ratio. The sequence was generated by a trial
statistician independent of the study. Participants did not know whether they were receiving the
comparator or the intervention website, only that we were evaluating two approaches to giving health
information. Nevertheless, the nature of the intervention meant that they could not be blind to whether
they were looking at personal experiences or facts and figures information. The study investigators
undertaking the analyses were blind to allocation, which was an automated process. Participants were able
to log on and access the website interventions as much or as little as they wanted. At the end of the
2-week period, participants were invited by e-mail to complete final follow-up measures, using the same
portal. Up to two e-mails and one telephone call were used to remind those who did not initially respond.
Participants’ usage of their allocated website was also tracked.
Measures
The outcome measures for each condition are shown in Table 16. As a feasibility trial, our primary measures
concerned the number of participants consented and recruited, the usage of the websites (in terms of
numbers of logins, page views and time on site) and the numbers with completed outcome measures or lost
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to follow-up. For secondary outcomes, we used condition-specific self-report measures as well as the widely
used and well-validated Short Form questionnaire-36 items (SF-36) health status measure (including both
physical and mental dimensions and all subscales), and the eHIQ, a new self-completion measure designed
earlier in this programme of work to measure the effects of accessing online health information. The eHIQ
part 1 contains 11 items covering general attitudes towards using the internet to access health information.
The eHIQ part 2, which contains 26 items, is administered at follow-up, as it captures the attitudes of the
respondents towards the website they have recently viewed. Both parts of the questionnaire use five-point
response categories, from ‘strongly agree’ to ‘strongly disagree’, for all items.66,99 The eHIQ part 2 scores are
combined to make three subscales: confidence and identification (reflecting confidence to discuss health
with others and a person’s ability to identify with the website); information and presentation (reflecting
trust and suitability of website content); and understanding and motivation (reflecting understanding and
learning about relevant information and motivation to take action (see Chapter 4). Each subscale is scored
between 0 and 100, with higher scores indicating a more positive rating.
The choice of condition-specific outcome measures was informed by our theoretical understanding of what
the benefit of shared personal experiences might be. So, for the asthma condition, we were specifically
interested in whether or not other people’s experiences could have effects on aspects of self-management
including self-efficacy and asthma control. For asthma we therefore used the Chronic Disease Self-Efficacy
Scale (CDSES), which is a six-item questionnaire assessing confidence in self-managing a chronic condition.168
(The score is the mean of the six items. If more than two items were missing, the scale was not scored.)
We also used the 12-item Partners in Health (PIH) scale, which assesses knowledge and behaviour in relation
to self-management for a chronic condition.169 The 12 items cover four domains of competency in relation
TABLE 16 Work package 3b: outcome measures for each condition in the EXPERT study
Outcome measure Asthma Smoking MS carers
Feasibility measures
Numbers of participants recruited ✓ ✓ ✓
Numbers of participants retained ✓ ✓ ✓
Completeness of outcome measures ✓ ✓ ✓
Intervention usage ✓ ✓ ✓
Secondary outcomes
eHIQ ✓ ✓ ✓
SF-36 health status ✓ ✓ ✓
PIH questionnaire ✓
CDSES ✓
Single-item asthma control question ✓
MTSS ✓
Abstinence rates ✓
Number of quit attempts ✓
SASEQ ✓
PFCS ✓
CDSES, Chronic Disease Self-Efficacy Scale; MTSS, Motivation To Stop Scale; PFCS, Preparedness For Caregiving Scale;
PIH, Partners in Health; SASEQ, Smoking Abstinence Self-Efficacy Questionnaire.
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to self-management (knowledge, coping, management of condition and adherence to treatment), and the
total sum score is used (the higher score indicating greater competency). We also used a single-item asthma
control question taken from the 5-item Asthma Control Test (which was used as a baseline descriptive
measure), whereby participants rated their asthma control on a five-point scale from ‘not controlled’ to
‘completely controlled’.170
For smoking cessation, we were interested in whether or not other people’s experiences could be
harnessed to achieve health behaviour change, namely to quit smoking or to change the motivation to
quit. We therefore used the following self-report measures: abstinence rates (single self-report question),
quit attempts (single self-report question), the single-item Motivation To Stop Scale (MTSS) to measure
whether motivation had changed, on a 7-point scale (where a rating of 1 reflected the absence of any
belief, desire or intention to stop smoking, and a rating of 7 reflected a strong desire and short-term
intention to stop),164 and the Smoking Abstinence Self-Efficacy Questionnaire (SASEQ), a six-item
questionnaire on which smokers are required to indicate, using a five-point Likert scale, how confident
they are in abstaining from smoking in six example situations.171
For carers of someone with MS, we wanted to assess whether or not other people’s experiences of caring
could help carers feel more confident and supported in their own caring roles. Most of the validated
instruments in this area are specific to dementia care and this restricted our choice of questionnaires.
We did not find any instruments specific to the caring role in MS. We used the 8-item Preparedness For
Caregiving Scale (PFCS), which assesses how well prepared participants think they are.172 Each question is
scored 0–4, with 4 representing ‘very well prepared’, and the higher the score the more prepared the
caregiver feels for caregiving. The score for the PFCS is calculated as the mean of the eight items.
Sample size and statistical analyses
We planned to recruit a total of 300 participants, 100 for each of the three conditions. The focus of the
study was to assess feasibility, which could usually be addressed using a smaller sample but we anticipated
that this sample size would provide enough power to estimate acceptability judged by engagement with
the PEx components of the site with a precision of ± 14% in each condition/arm (50 participants) and 8%
for the whole trial/per arm (150 participants). This was based on a worst-case scenario of acceptability
being 50%. We assumed the acceptability rate to be in the region of 80%. We also wanted sufficient
participants to be able to adequately assess issues of recruitment and retention, as attrition rates are often
high in fully internet-based trials.
Feasibility outcome measures were summarised using descriptive statistics such as rates reported as
percentages. We undertook descriptive statistics to characterise participants at baseline; constructed a
Consolidated Standards of Reporting Trials (CONSORT) diagram to show the flow of participants through
the trial, including the proportion who completed each stage to trial entry; and measured usage of the
interventions in terms of total visits to site, total time on site and total number of website pages visited.
Formal hypothesis testing of the self-report outcome measures was not performed, as this was a feasibility
trial and was not intended (or powered) to assess evidence of significant treatment effect. However, the
estimated difference in outcome measures of efficacy and corresponding 95% CIs were calculated using
analysis of covariance (ANCOVA) adjusting for baseline values. In terms of effect sizes, based on a
balanced randomisation of intervention–comparator groups in a ratio of 1 : 1 (i.e. 50 intervention and
50 comparator for each condition), the trial would detect potential large effects of the intervention for
each condition; for dichotomous outcomes these were equivalent to relative risks of ≥ 2.1 for a baseline
rate of ≤ 30% given an alpha of 0.05 and 90% power, and for continuous outcomes these detectable
differences would be of the order of 0.4 SD based on the same power and significance.
Qualitative study
Following completion of final follow-up measures, a subset of study participants was purposively selected
and invited to be interviewed by one of three qualitative researchers from the HERG at the University of
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Oxford. The participants were selected for maximum variation of their demographic characteristics and
use of the intervention (determined by usage data), to give us a diverse sample. Information sheets and
consent forms were sent out by e-mail following an expression of interest by participants (who were asked
to indicate their willingness to take part when filling in their online measures). The consent forms were
completed in person. The interviews focused on reasons for participating in the trial, engagement with the
online resources, and attitudes towards online interventions and generic health resources and support.
Participants from both intervention and comparator arms in each of the three conditions were included to
explore differences which may have been attributable to the allocated website. The interviews used two
semistructured interview guides: one for participants allocated to the intervention websites and one for
those allocated to the comparator websites. These were based on reviews of existing literature and earlier,
exploratory work. The guides differed to ensure that the participant remained blind to trial allocation and
purpose. For example, those participants in the intervention arm of the trial were asked specifically about
how they chose which PEx clips to view. The guides covered the following topics: motivation for
participation, acceptability of trial procedure, experience of taking part in the online intervention and trial,
use of the internet for health-related purposes and attitudes towards different types of health information.
We used a set of laminated ‘home pages’ from six different types of websites to facilitate this discussion.
Open-ended questions and prompts were used to further explore participants’ experiences of taking part
in this online study and their attitudes towards the website content. The researchers did not ‘unblind’ the
participants by telling them more about the study until the end of the interview.
The interviews were transcribed and analysed by thematic analysis using the method of constant
comparison. A specialist software package (NVivo 10) was used to organise the data. Recurrent themes
and subthemes were identified, as they emerged from the data, by the three interviewers, who initially
coded their own interviews. This was followed by extensive discussion and comparison of the emergent
themes between the researchers.
Changes from the original proposal
The original protocol stated that follow-up measurements would be collected at 1 month and 3 months,
and that participants would be randomised in a 2 : 1 active–comparator ratio. After discussion with our
trial statistician and the rest of the trial team, we reduced the follow-up to one measurement immediately
post exposure to the website, and changed the randomisation ratio to 1 : 1. The change to a shorter
follow-up (immediately post exposure to the website intervention) was for a number of reasons: that this
would maximise blinding and minimise contamination; that our primary aim was to establish feasibility;
that our main measures related to the immediate effect of the website exposure; and that we wanted to
minimise attrition. This decision was discussed and agreed with the funder.
Ethics and governance
Ethics approval for this study was provided by the NHS Health Research Authority Research Ethics
Committee, reference 13/NW/0162. The trials were overseen by a Trial Steering Committee chaired by
Professor Elizabeth Murray of University College London. The trial registration number is ISRCTN29549695
and it was registered on 17 May 2013.
Results
The results for each of the three conditions in the trial are presented separately. There were no adverse
events for any participant.
Smoking cessation
Recruitment through primary care was relatively slow, and we engaged more primary care practices (23 in
total) than anticipated. The first participant was recruited in June 2013, and the last participant completed
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follow-up in August 2014. The trial ended as we had recruited > 80% of target sample size and the
funding was ending. A total of 129 invitations were sent in response to expressions of interest in the
study, and 89 individuals (69%) completed registration (i.e. they consented and completed baseline
questionnaires). Two participants withdrew before randomisation, leaving 87 randomised participants
(recruitment rate of 87/89= 98%). Of these, 44 (51%) were allocated to the PEx website. Of the
randomised participants, 22 out of 87 (25%) were lost to follow-up (please see the CONSORT flow
diagram in Figure 9).
The baseline demographic, internet use and smoking characteristics of randomised participants are
presented in Table 17. These were balanced between groups. Most were regular users of the internet with
good to excellent self-reported internet abilities. Of the 87 participants, 45 (52%) were women. The
majority of participants reported smoking < 20 cigarettes per day, with most smoking between 11 and 20
cigarettes per day (53% of the sample). Most had intentions to quit smoking, with only three participants
reporting either not wanting to quit (3%) or knowing that they should quit but not ‘really’ wanting to
(18%, n= 16). Twenty-seven participants reported having made an attempt to quit during the 2 weeks
before they started the study (31%).
Invitations sent to eligible participants
(n = 129)
Registration completed
(n = 89)
Excluded
(n = 40)
• Did not complete
   registration, n = 40
PEx website
(n = 44)
Completed follow-up
(n = 34)
Included in the primary analysis
(n = 44)
Exclude
(n = 10)
• Withdrawn, n = 0
• Lost to follow-up, n = 10
Facts and figures website
(n = 43)
Completed follow-up
(n = 31)
Included in the primary analysis
(n = 43)
Exclude
(n = 12)
• Withdrawn, n = 0
• Lost to follow-up, n = 12
Randomised
(n = 87)
Withdrawn
(n = 2)
FIGURE 9 Work package 3b: CONSORT flow diagram – smoking cessation.
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TABLE 17 Work package 3b: baseline demographic and characteristics of the smoking cessation participants
Baseline variable Comparator (N= 43), n (%) Intervention (N= 44), n (%)
Age
Mean (SD); minimum–maximum 53.6 (15.1); 17–80 55.1 (12.9); 24–92
Gender
Female 23 (53.5) 22 (50.0)
Male 20 (46.5) 22 (50.0)
Self-rated ability to use the internet
Excellent 9 (20.9) 10 (22.7)
Good 15 (34.9) 21 (47.7)
Fair 16 (37.2) 11 (25.0)
Poor 3 (7.0) 2 (4.5)
Bad 0 (0) 0 (0)
Internet use
At least once per day 26 (60.5) 28 (63.6)
Several times per week 17 (39.5) 10 (22.7)
Once per week 0 (0) 3 (6.8)
Less than once per week 0 (0) 3 (6.8)
Ethnicity
White: English/Welsh/Scottish/Northern Irish/British 39 (90.7) 41 (93.2)
White: any other white background 2 (4.7) 2 (4.5)
Mixed 1 (2.3) 0 (0)
Asian: Pakistani 0 (0) 1 (2.3)
Black: Caribbean 1 (2.3) 0 (0)
Number of cigarettes smoked per day
≤ 10 12 (27.9) 15 (34.1)
11–20 25 (58.1) 21 (47.7)
21–30 4 (9.3) 7 (15.9)
≥ 31 2 (4.7) 0 (0)
Did not answer 0 (0) 1 (2.3)
Time from waking up to smoking first cigarette
After 60 minutes 8 (18.6) 13 (29.5)
31–60 minutes 9 (20.9) 11 (25.0)
6–30 minutes 17 (39.5) 15 (34.1)
Within 5 minutes 8 (18.6) 4 (9.1)
Did not answer 1 (2.3) 1 (2.3)
Serious attempt to stop smoking in past 2 weeks?
No 32 (74.4) 27 (61.4)
Yes 11 (25.6) 16 (36.4)
Did not answer 0 (0) 1 (2.3)
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The usage of the websites is shown in Table 18. This shows that the median number of logins during the
2-week period for both smoking cessation sites was 2, with a median number of page views of 11.5 for
the intervention site and 7 for the comparator site. The median duration of use was 15 minutes for the
intervention site and 5 minutes for the comparator site. One user never logged in to their allocated site,
and two other users logged in but did not record a page view or spend any time on the site. Table 18 also
presents the results of post hoc significance tests for differences in usage between groups. This was a post
hoc analysis suggested by the chairperson of our Trial Steering Committee. The differences between
groups for number of logins and number of page views were not statistically significant. The total duration
on site was significantly longer (p= 0.013) for the PEx website.
Figures 10 and 11 are dot plots of the total number of logins and total number of pages, respectively,
visited by the randomised group. The solid blue line indicates the median, and the lower and upper
quartiles are shown by the dotted lines.
Figure 12 shows dot plots of the total duration on the website in minutes by randomised group.
The solid blue line indicates the median, and the lower and upper quartiles are shown by the dotted lines.
The mean SASEQ scores were similar between the randomised groups. The baseline mean score (SD) for the
intervention group was 1.94 (1.02) and for the comparator group was 1.84 (0.89); at 2-week follow-up
these scores were 1.89 (0.99) and 1.71 (0.95), respectively. Both groups had low mean SASEQ scores,
indicating low self-confidence in abstaining from smoking in a variety of situations. An ANCOVA found an
adjusted mean difference for the change in SASEQ scores between the two randomised groups of 0.155
(95% CI –0.262 to 0.573), adjusted for baseline SASEQ scores.
The findings from the other exploratory comparisons of the smoking-specific outcome measures are shown
in Table 19. This table shows that the baseline and follow-up scores and the change scores for the MTSS,
abstinence rates and quit attempts were similar between groups for baseline and follow-up measures and
for change scores.
TABLE 17 Work package 3b: baseline demographic and characteristics of the smoking cessation participants
(continued )
Baseline variable Comparator (N= 43), n (%) Intervention (N= 44), n (%)
Which of the following describes you?
I don’t want to stop smoking 1 (2.3) 2 (4.5)
I think I should stop smoking but don’t really want to 9 (20.9) 7 (15.9)
I want to stop smoking but haven’t thought about
when
5 (11.6) 2 (4.5)
I REALLY want to stop smoking but I don’t know
when I will
15 (34.9) 16 (36.4)
I want to stop smoking and hope to soon 6 (14.0) 6 (13.6)
I REALLY want to stop smoking and intend to in the
next 3 months
2 (4.7) 4 (9.1)
I REALLY want to stop smoking and intend to in the
next month
3 (7.0) 5 (11.4)
Don’t know 2 (4.6) 2 (4.6)
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TABLE 18 Work package 3b: usage data for the smoking cessation comparator and intervention websites
Usage measure All participants (n= 87) Comparator (n= 43) PEx (n= 44)
Total number of logins to website
n 86 42 44
Median (minimum–maximum) 2 (1–20) 2 (1–8) 2 (1–20)
IQR 1–3 1–3 1.5–3
p-value 0.419a
Total number of pages visited
n 84 42 42
Median (minimum–maximum) 10 (1–237) 7 (1–225) 11.5 (1–237)
IQR 4–24.5 3–20 5–30
Adjusted difference in medians (95% CI) 3 (–9.142 to 15.142)b
p-value 0.624
Total duration on site (minutes)c
n 86 42 44
Median (minimum–maximum) 9 (0.5–213) 5 (0.5–69) 15 (0.5–213)
IQR 1–26 1–16 3–35
Adjusted difference in medians (95% CI) 12 (2.608 to 21.392)b
p-value 0.013
IQR, interquarile range.
a Mann–Whitney U-test for medians.
b Quantile regression model adjusted for frequency of internet use (categorised as ‘at least once a day’ and ‘at least once
a week’) at baseline.
c Units of total duration was recorded in minutes; for participants with 0 minutes recorded we approximated this to 0.5 minutes.
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FIGURE 10 Work package 3b: dot plot graphs of total number of logins by the randomised group for smoking
cessation. IQR, interquartile range.
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FIGURE 11 Work package 3b: dot plot graph of total number of pages visited by the randomised group for
smoking cessation. IQR, interquartile range.
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FIGURE 12 Work package 3b: dot plot graphs of total duration (minutes) on website by the randomised group for
smoking cessation. IQR, interquartile range.
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The results for the SF-36 were also similar between groups and are shown in Table 20. Participants in both
arms showed non-significant improvement in health state from baseline in the mental component and a
very small, non-significant worsening in the physical component. There was no visible pattern between the
two groups. The adjusted mean differences between the two groups (ANCOVA, n= 64 participants with
full data) for the absolute change in physical component summary (PCS) score of the SF-36 was 1.393
(95% CI –0.702 to 3.489) and for the absolute change in mental component summary (MCS) score of the
SF-36 was 0.785 (95% CI –3.09 to 4.648).
Asthma
Recruitment was rapid through nine primary care practices. The first participant was recruited in June 2013,
and the last participant completed follow-up in November 2013. The trial ended as we had recruited in
excess of the target sample size. Two hundred invitations were sent in response to expressions of interest in
the study, and 150 individuals (75%) completed registration (i.e. they consented and completed baseline
questionnaires). Two participants withdrew before randomisation, leaving 148 randomised participants (a
recruitment rate of 148/150= 99%). Seventy-three of these (49%) were allocated to the PEx website. Of
the randomised participants, 27 (18%) were lost to follow-up (please see the CONSORT flow diagram in
Figure 13).
The baseline demographic and internet use characteristics of randomised participants are presented in
Table 21 and were balanced between groups. Most were regular users of the internet with good to
excellent self-reported internet abilities. Of the 148 participants, 87 (58.8%) were women.
TABLE 19 Work package 3b: exploratory comparisons between the smoking cessation randomised groups on
smoking-specific measures
Measure All participants (N= 87), n (%) Comparator (N= 43), n (%) Intervention (N= 44), n (%)
MTSS
Change in MTSS from baseline
Decreased motivation 14 (16) 6 (14) 8 (18)
Improved motivation 19 (22) 9 (20) 10 (23)
No change 28 (32) 14 (33) 14 (32)
Unknown 26 (30) 14 (33) 12 (27)
Abstinence at follow-up
Cigarettes or other tobacco used in the last 7 days at 2 weeks
Yes 57 (65) 28 (65) 29 (66)
No 8 (9) 3 (7) 5 (11)
Unknown 22 (25) 12 (28) 10 (23)
Quit attempts
Quit attempts in the last 2 weeks at baseline
Yes 27 (31) 11 (26) 16 (36)
No 59 (68) 32 (74) 27 (62)
Unknown 1 (1) 0 (0) 1 (2)
Quit attempts in the last 2 weeks at 2 weeks
Yes 25 (29) 11 (26) 14 (32)
No 39 (45) 20 (46) 19 (43)
Unknown 23 (26) 12 (28) 11 (25)
WORK PACKAGE 3B
NIHR Journals Library www.journalslibrary.nihr.ac.uk
90
TABLE 20 Work package 3b: summary statistics for the SF-36 health status PCS and MCS scores by the randomised
group for smoking cessation participants
Measure
Comparator (N= 43) Intervention (N= 44)
n Mean (SD)
Minimum to
maximum n Mean (SD)
Minimum to
maximum
Baseline PCS 43 44.08 (11.02) 19.63 to 64.91 44 48.59 (8.41) 24.91 to 61.07
2-week PCS 31 43.21 (11.10) 19.85 to 61.88 33 48.43 (8.76) 21.29 to 63.73
Change in PCS from baseline 31 –0.92 (4.12) –11.74 to 5.92 33 –0.14 (4.49) –7.77 to 14.20
Baseline MCS 43 43.00 (13.57) 10.56 to 65.69 44 46.68 (11.19) 17.94 to 67.15
2-week MCS 31 43.42 (15.18) 10.45 to 69.15 33 47.99 (10.25) 25.38 to 62.54
Change in MCS from baseline 31 2.20 (8.79) –19.14 to 26.82 33 1.89 (7.44) –10.78 to 21.02
Invitations sent to eligible participants
(n = 200)
Registration completed
(n = 150)
Excluded
(n = 50)
• Did not complete
   registration, n = 50
PEx website
(n = 73)
Completed follow-up
(n = 62)
Included in the primary analysis
(n = 73)
Exclude
(n = 11)
• Withdrawn, n = 2
• Lost to follow-up, n = 9
Facts and figures website
(n = 75)
Completed follow-up
(n = 59)
Included in the primary analysis
(n = 75)
Exclude
(n = 16)
• Withdrawn, n = 0
• Lost to follow-up, n = 16
Randomised
(n = 148)
Withdrawn
(n = 2)
FIGURE 13 Work package 3b: CONSORT flow diagram – asthma.
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In general, the participants’ asthma symptoms were well controlled and did not interfere with daily living
to a great extent (Table 22).
The usage of the websites is shown in Table 23. This shows that the median number of logins in the 2-week
period for both sites was 2, with a median number of page views of 14 for the intervention site and 15 for
the comparator site. The median duration of use of the intervention site was 15 minutes and for the
comparator site was 19 minutes. Three users never logged in to their allocated site. Table 23 also presents
the results of post hoc significance tests for differences in usage between groups. This was a post hoc
analysis suggested by the chairperson of our Trial Steering Committee. The differences between groups for
number of logins and number of page views and total duration on the sites were not statistically significant.
Figures 14 and 15 show dot plots of the total number of logins by randomised group with and without
the extreme observations, respectively. The solid blue line indicates the median, and the lower and upper
quartiles are shown by the dotted lines.
Figure 16 shows dot plots of the total number of pages visited by randomised group. The solid blue line
indicates the median, and the lower and upper quartiles are shown by the dotted lines.
TABLE 21 Work package 3b: baseline demographic and internet use characteristics of the asthma participants
Baseline variable Comparator (N= 75), n (%) Intervention (N= 73), n (%)
Age
Mean (SD); minimum–maximum 55.7(13.9); 19–84 58.2 (11.7); 27–77
Gender
Female 41 (54.7) 46 (63.0)
Male 34 (45.3) 27 (37.0)
Self-rated ability to use the internet
Excellent 26 (34.7) 18 (24.7)
Good 35 (46.7) 34 (46.6)
Fair 12 (16.0) 17 (23.3)
Poor 2 (2.7) 3 (4.1)
Bad 0 (0) 1 (1.4)
Internet use
At least once per day 49 (65.3) 37 (50.7)
Several times per week 19 (25.3) 21 (28.8)
Once per week 6 (8.0) 6 (8.2)
Less than once per week 1 (1.3) 9 (12.3)
Ethnicity
White: English/Welsh/Scottish/Northern Irish/British 66 (88.0) 66 (90.4)
White: any other white background 4 (5.3) 1 (1.4)
Mixed 0 (0) 1 (1.4)
Asian: Indian 1 (1.3) 2 (2.7)
Black: Caribbean 0 (0) 1 (1.4)
Black: African 1 (1.3) 0 (0)
Not reported 3 (4.0) 2 (2.7)
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TABLE 22 Work package 3b: counts and percentages of baseline responses from the Asthma Control Test
questionnaire by randomised groups (asthma participants)
Item
All participants (N= 148),
n (%)
Comparator (N= 75),
n (%)
PEx (N= 73),
n (%)
How often did your asthma keep you from getting as much done at work, school or home?
All of the time 1 (0.7) 1 (1.3) 0 (0)
Most of the time 5 (3.4) 3 (4.0) 2 (2.7)
Some of the time 11 (7.4) 3 (4.0) 8 (11.0)
A little of the time 33 (22.3) 16 (21.3) 17 (23.3)
None of the time 98 (66.2) 52 (69.3) 46 (63.0)
How often have you had shortness of breath?
More than once per day 11 (7.4) 6 (8.0) 5 (6.8)
Once per day 6 (4.1) 1 (1.3) 5 (6.8)
Three to six times per week 12 (8.1) 7 (9.3) 5 (6.8)
Once or twice per week 63 (42.6) 36 (48.0) 27 (37.0)
Not at all 56 (37.8) 25 (33.3) 31 (42.5)
How often did your asthma symptoms (wheezing, coughing, chest tightness, shortness of breath) wake you up at night or
earlier than usual in the morning?
Four or more times per day 9 (6.1) 4 (5.3) 5 (6.8)
Two to three nights per week 8 (5.4) 5 (6.7) 3 (4.1)
Once per week 4 (2.7) 2 (2.7) 2 (2.7)
Once or twice per week 37 (25.0) 17 (22.7) 20 (27.4)
Not at all 90 (60.8) 47 (62.7) 43 (58.9)
How often have you used your reliever inhaler (usually blue)?
Three or more times per day 12 (8.1) 5 (6.7) 7 (9.6)
Once or twice per day 26 (17.6) 13 (17.3) 13 (17.8)
Two or three times per week 21 (14.2) 11 (14.7) 10 (13.7)
Once per week or less 42 (28.4) 27 (36.0) 15 (20.5)
Not at all 47 (31.8) 19 (25.3) 28 (38.4)
How would you rate your asthma control?
Not controlled 2 (1.4) 1 (1.3) 1 (1.4)
Poorly controlled 2 (1.4) 1 (1.3) 1 (1.4)
Somewhat controlled 22 (14.9) 9 (12.0) 13 (17.8)
Well controlled 72 (48.6) 41 (54.7) 31 (42.5)
Completely controlled 50 (33.8) 23 (30.7) 27 (37.0)
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TABLE 23 Work package 3b: usage data for asthma comparator and intervention websites
Usage measure All participants (n= 148)a Comparator (n= 75) PEx (n= 73)a
Total number of logins to website
Median (minimum–maximum); IQR 2 (1–48); 2–3 2 (1–32); 2–3 2 (1–48); 2–4
p-value 0.716b
Total number of pages visited
Median (minimum–maximum); IQR 15 (1–65); 5–27 15 (1–65); 5–27 14 (1–62); 5–27
Adjusted difference in medians (95% CI) –1 (–7.830 to 5.830)c
p-value 0.773
Total duration on site (minutes)d
Median (minimum–maximum); IQR 17 (0.5–471); 5–42 19 (0.5–471); 5–41 15 (0.5–119); 4–43
Adjusted difference in medians (95% CI) –3 (–14.946 to 8.946)c
p-value 0.620
IQR, interquarile range.
a Three participants did not visit the allocated websites (all in the PEx group).
b Mann–Whitney U-test for medians.
c Quantile regression model adjusted for frequency of internet use at baseline.
d Units of total duration was recorded in minutes; for participants with 0 minutes recorded, we approximated this to
0.5 minutes.
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FIGURE 14 Work package 3b: dot plot graphs of total number of logins by the randomised group for asthma
(with extreme values). IQR, interquartile range.
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FIGURE 15 Work package 3b: dot plot graphs of total number of logins by the randomised group for asthma
(without the extreme values). IQR, interquartile range.
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FIGURE 16 Dot plot graph of total number of pages visited by the randomised group for asthma.
IQR, interquartile range.
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Figures 17 and 18 show dot plots of the total duration (minutes) on website by randomised group with
and without the extreme observations, respectively. The solid blue line indicates the median, and the lower
and upper quartiles are shown by the dotted lines.
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FIGURE 17 Work package 3b: dot plot graphs of total duration (minutes) on website by the randomised group for
asthma (with extreme values). IQR, interquartile range.
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FIGURE 18 Work package 3b: dot plot graphs of total duration (minutes) on website by the randomised group for
asthma (without extreme values). IQR, interquartile range.
WORK PACKAGE 3B
NIHR Journals Library www.journalslibrary.nihr.ac.uk
96
Table 24 shows summary statistics for baseline, 2-week follow-up and mean PIH scores. The mean (SD)
change from baseline in the PEx (intervention) group was an increase of 0.068 (0.61), compared with an
increase of 0.073 (0.64) in the comparator group. Treatment effect (mean differences with CI) was
estimated using ANCOVA adjusting for baseline mean PIH scores, and showed that there were no
significant differences between groups.
For the CDSES, two participants completed five of the six items at baseline (the mean of the five items
was calculated) and four participants completed five items at follow-up (the mean of the five items was
calculated). Higher scores indicate higher self-efficacy. The mean change from baseline to 2-week follow-up
in the comparator group was an increase of 0.093, compared with a decrease of –0.068 in the PEx group.
Treatment effect (mean differences with CI) was estimated using ANCOVA adjusting for baseline mean
CDSES scores, which showed no significant difference between groups (Table 25).
The results for self-rated asthma control at the follow-up measurement are shown in Table 26.
TABLE 24 Work package 3b: summary statistics for the PIH summary scores by the randomised group and ANCOVA
for asthma
Measure
Comparator (N= 75) PEx (N= 73)
n Mean (SD)
Minimum to
maximum n Mean (SD)
Minimum to
maximum
Mean baseline PIH scores 71 6.816 (0.864) 4.250 to 8.0 72 6.690 (0.888) 4.083 to 8.0
Mean 2-week PIH scores 55 6.974 (0.995) 3.750 to 8.0 61 6.847 (0.863) 4.333 to 8.0
Change from baseline 54 0.073 (0.639) –1.583 to 1.5 61 0.068 (0.606) –1.833 to 1.25
ANCOVA
PEx 115 aAdjusted mean difference –0.0186 95% CI –0.2475 to 0.2103
a Adjusted for mean baseline PIH scores.
TABLE 25 Work package 3b: summary statistics and ANCOVA for the CDSES summary scores by asthma
randomised group
Measure
Comparator (N= 75) PEx (N= 73)
n Mean (SD)
Minimum to
maximum n Mean (SD)
Minimum to
maximum
Baseline CDSES scoresa 74 8.207 (1.530) 2.33 to 10.0 73 8.231 (1.611) 1.83 to 10.0
2-week CDSES scoresb 59 8.401 (1.501) 4.00 to 10.0 62 8.238 (1.389) 4.40 to 10.0
Change in mean CDSES
scores
58 0.093 (0.951) –3.00 to 2.33 62 –0.068 (0.910) –1.33 to 3.67
ANCOVA
PEx 120 Adjusted mean differencec –0.1574 95% CI –0.4661 to 0.1512
a One participant completed only two items, not included.
b Includes n= 117 participants who completed all six items and n= 4 participants who completed five items.
c Adjusted for mean baseline CDSES scores.
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The results for the SF-36 were also similar between groups and are shown in Table 27. Participants in both
arms showed a small, non-significant improvement in health state from baseline in both the mental and
physical components. The adjusted mean differences between the two groups (ANCOVA, n= 119
participants with full data) for the absolute change in PCS score of the SF-36 was 0.196 (95% CI –1.454
to 1.846) and for the absolute change in MCS score of the SF-36 was 0.843 (95% CI –1.066 to 2.750).
Multiple sclerosis carers
The recruitment of carers of people with MS proved challenging and was reviewed by the project team
and the Trial Steering Committee on several occasions. As detailed in Methods, multiple routes to
recruitment were used. Recruitment was slow, with usually between one and four carers recruited per
month over the course of the study. Targeted advertising proved relatively unsuccessful and snowballing
through personal contacts was more helpful. The first participant was recruited in June 2013 and the last
participant completed follow-up in August 2014. The trial ended as the funding was ending and we had
exhausted approaches to recruitment. Eventually, 47 invitations were sent in response to expressions of
interest in the study, and 42 individuals (89%) completed registration (i.e. they consented and completed
baseline questionnaires). No participants withdrew before randomisation and there were, therefore,
42 randomised participants (a recruitment rate of 100%). Twenty-two of these (52%) were allocated to
the PEx website. Of the randomised participants, 6 out of 42 (14%) were lost to follow-up (please see the
CONSORT flow diagram in Figure 19).
TABLE 26 Work package 3b: counts and percentages of responses for self-rated asthma control by randomised
group (asthma participants)
Self-rated asthma control during the past
2 weeks
All participants (N= 148),
n (%)
Comparator (N= 75),
n (%)
PEx (N= 73),
n (%)
Not reporteda 27 (18.2) 16 (21.3) 11 (15.1)
Poorly controlled 2 (1.4) 1 (1.3) 1 (1.4)
Somewhat controlled 11 (7.4) 8 (10.7) 3 (4.1)
Well controlled 61 (41.2) 26 (34.7) 35 (47.9)
Completely controlled 47 (31.8) 24 (32.0) 23 (31.5)
a Lost to follow-up.
TABLE 27 Work package 3b: summary statistics for the SF-36 health status PCS and MCS scores by
randomised group
Measure
Comparator (N= 75) Intervention (N= 73)
n Mean (SD) Minimum to maximum n Mean (SD)
Minimum to
maximum
Baseline PCS 74 48.30 (10.34) 18.38 to 60.88 72 48.40 (8.88) 25.77 to 61.76
2-week PCS 59 49.48 (9.12) 20.02 to 60.43 61 49.56 (9.33) 18.00 to 64.45
Change in PCS from baseline 58 0.67 (4.76) –11.68 to 15.10 61 0.91 (4.80) –11.11 to 17.15
Baseline MCS 74 49.62 (11.09) 10.43 to 62.13 72 49.74 (9.16) 24.01 to 63.05
2-week MCS 59 50.59 (10.82) 15.53 to 62.5 61 51.74 (8.01) 28.67 to 63.16
Change in MCS from baseline 58 0.48 (5.63) –17.56 to 18.08 61 1.25 (5.43) –10.10 to 25.62
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The baseline demographic and internet use characteristics of randomised participants are presented in
Table 28 and were balanced between groups. Most were regular users of the internet with good to
excellent self-reported internet abilities. Of the 42 participants, 18 (42.3%) were women.
The usage of the websites is shown in Table 29. This shows that the median number of logins in the
2-week period for both sites was 4, with a median number of page views of 27.5 for both the intervention
and comparator sites. The median duration of use was 31 minutes for the intervention site and 31.5 minutes
for the comparator site. Table 29 also presents the results of post-hoc significance tests for differences in
usage between groups. This was a post hoc analysis suggested by the chairperson of our Trial Steering
Committee. The differences between groups for number of logins and number of page views and total
duration on site were not statistically significant.
Figure 20 shows a dot plot of the total number of logins by the randomised group. The solid blue line
indicates the median, and the lower and upper quartiles are shown by the dotted lines.
Figure 21 shows dot plots of the total number of pages visited by the randomised group. The solid blue
line indicates the median, and the lower and upper quartiles are shown by the dotted lines.
Invitations sent to eligible participants
(n = 47)
Registration completed
(n = 42)
Excluded
(n = 5)
• Did not complete
   registration, n = 5
PEx website
(n = 22)
Completed follow-up
(n = 19)
Included in the primary analysis
(n = 22)
Exclude
(n = 3)
• Withdrawn, n = 0
• Lost to follow-up, n = 3
Facts and figures website
(n = 20)
Completed follow-up
(n = 17)
Included in the primary analysis
(n = 20)
Exclude
(n = 3)
• Withdrawn, n = 0
• Lost to follow-up, n = 3
Randomised
(n = 42)
Withdrawn
(n = 0)
FIGURE 19 Work package 3b: CONSORT flow diagram – carers of people with MS.
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TABLE 28 Work package 3b: baseline demographic and internet use characteristics of the carers of people with
MS participants
Baseline variable Comparator (N= 20), n (%) Intervention (N= 22), n (%)
Age
Mean (SD); minimum–maximum 61.5 (11.6); 28.0–78.8 60.3 (13.2); 21.0–77.0
Gender
Female 8 (40.0) 10 (45.5)
Male 12 (60.0) 12 (54.5)
Self-rated ability to use the internet
Excellent 8 (40.0) 8 (36.4)
Good 8 (40.0) 9 (40.9)
Fair 4 (20.0) 3 (13.6)
Poor 0 (0) 2 (9.1)
Bad 0 (0) 0 (0)
Internet use
At least once per day 16 (80.0) 19 (86.4)
Several times per week 4 (20.0) 2 (9.1)
Once per week 0 (0) 0 (0)
Less than once per week 0 (0) 1 (4.5)
Ethnicity
White: English/Welsh/Scottish/Northern Irish/British 19 (95.0) 22 (100.0)
White: any other white background 1 (5.0) 0 (0)
TABLE 29 Work package 3b: usage data for carers of people with MS – comparator and intervention websites
Usage measure All participants (N= 42) Comparator (N= 20) PEx (N= 22)
Total number of logins to website
n 42 20 22
Median (minimum–maximum); IQR 4 (1–12); 2–5 4 (1–9); 2–5 4.5 (1–12); 2–5
p-value 0.692a
Total number of pages visited
n 42 20 22
Median (minimum–maximum); IQR 27.5 (1–438); 13–61 27.5 (1–291); 12–46 27.5 (1–438); 14–67
Adjusted difference in medians (95% CI) 19 (–11.40 to 49.40)
p-value 0.214b
Total duration on site (minutes)c
Median (minimum–maximum); IQR 31.5 (0.5–143); 10–61 31.5 (1–143); 13–50 31 (0.5–139); 8–84
Adjusted difference in medians (95% CI) 1 (–34.34 to 36.34)
p-value 0.955b
IQR, interquarile range.
a Mann–Whitney U-test for medians.
b Quantile regression model adjusted for frequency of internet use (categorised as ‘at least once a day’ and ‘at least once
a week’) at baseline.
c Units of total duration was recorded in minutes; for participants with 0 minutes recorded we approximated this to
0.5 minutes.
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FIGURE 20 Work package 3b: dot plot graphs of total number of logins by randomised group for carers of people
with MS. IQR, interquartile range.
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FIGURE 21 Work package 3b: dot plot graph of total number of pages visited by randomised group for carers of
people with MS. IQR, interquartile range.
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Figure 22 shows a dot plot of the total duration (minutes) on website by the randomised group. The solid
blue line indicates the median, and the lower and upper quartiles are shown by the dotted lines.
The mean PFCS scores were similar between the randomised groups. The summary of PFCS scores are
shown in Table 30. The change in PFCS score from baseline was very similar in both groups (intervention
–0.16, comparator –0.15), with both groups showing a small decrease in PFCS score at the 2-week
follow-up.
The results for the SF-36 were also similar between groups and are shown in Table 31. Participants in both
arms showed non-significant worsening in health state from baseline in the physical component scores.
The adjusted mean differences between the two groups (ANCOVA, n= 36 participants with full data) for
the absolute change in PCS score of the SF-36 was 0.365 (95% CI –2.756 to 3.486) and for the absolute
change in MCS score of the SF-36 was 2.655 (95% CI –1.788 to 7.099).
e-Health Impact Questionnaire findings
The eHIQ part 2 is administered at follow-up only, as it captures the attitudes of the respondents towards the
website they have recently viewed. Tables 32 and 33 show the eHIQ part 2 results comparing the responses
from participants who viewed the PEx website with those of participants who viewed the comparator
websites, for all three conditions combined. Table 32 shows that there were only small, non-significant
differences between the PEx and the non-PEx groups, both overall and on the three subscales (confidence
and identification; information and presentation; and understanding and motivation).
Qualitative interviews
The qualitative interviews are discussed in detail in Chapter 9. Here we present only brief findings in
relation to the trial design and process. The demographic characteristics of the interview participants are
discussed in Chapter 9. In brief, the 30 interview participants were slightly older, and more likely to be
retired, than those in the feasibility trials. The interviews demonstrated that the interventions and the
online trial process were acceptable and usable. We did not identify major barriers to participation in the
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FIGURE 22 Work package 3b: dot plot graphs of total duration (minutes) on website by randomised group for
carers of people with MS. IQR, interquartile range.
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TABLE 31 Work package 3b: summary statistics for the SF-36 health status PCS and MCS scores by randomised
group for carers of people with MS
Measure
Comparator (N= 20) Intervention (N= 22)
n Mean (SD)
Minimum to
maximum n Mean (SD)
Minimum to
maximum
Baseline PCS 20 51.01 (11.70) 18.23 to 63.01 22 50.00 (9.08) 31.51 to 67.26
2-week PCS 17 50.72 (10.63) 18.79 to 63.26 19 48.80 (7.47) 30.21 to 61.27
Change in PCS from baseline 17 –1.73 (2.84) –6.33 to 5.12 19 –0.72 (6.33) –15.32 to 15.19
Baseline MCS 20 48.64 (8.75) 28.26 to 58.55 22 45.68 (14.55) 15.08 to 64.06
2-week MCS 17 46.22 (9.02) 26.86 to 57.55 19 44.19 (14.70) 17.59 to 60.57
Change in MCS from baseline 17 –3.11 (5.80) –18.06 to 6.03 19 0.21 (7.00) –15.89 to 14.21
TABLE 32 Work package 3b: follow-up summary statistics for the eHIQ part 2 questionnaire by randomised groups
for all participants (all three conditions combined)
Measure Comparator PEx
eHIQ-part 2 overall scores
n 103 110
Mean (SD) 67.15 (11.99) 65.07 (10.12)
Minimum–maximum 23.38–98.03 36.11–96.99
Subscales
Confidence and identification
n 105 112
Mean (SD) 60.08 (15.22) 58.85 (12.62)
Minimum–maximum 2.78–97.22 16.67–97.22
Information and presentation
n 106 114
Mean (SD) 75.32 (10.84) 73.25 (10.73)
Minimum–maximum 43.75–100 46.88–100
Understanding and motivation
n 106 112
Mean (SD) 64.62 (15.30) 68.87 (12.85)
Minimum–maximum 11.11–100 19.44–100
TABLE 30 Work package 3b: summary of the PFCS scores at baseline and follow-up by randomised group for carers
of people with MS
Measure
Comparator (N= 20) PEx (N= 22)
n Mean (SD)
Minimum to
maximum n Mean(SD)
Minimum to
maximum
Baseline PFCS 20 2.42 (1.03) 0.63 to 4.00 22 2.28 (0.75) 0.88 to 3.88
2-week PFCS 17 2.19 (1.01) 0.50 to 4.00 19 1.97 (0.77) 0.13 to 3.25
Change in PFCS score from baseline 17 –0.15 (0.78) –2.38 to 0.88 19 –0.16 (0.59) –1.38 to 0.75
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trial nor to use of the interventions: the interviews confirmed the pilot study findings that the technical
aspects of the online trial had worked well, that the reminders were considered appropriate and that the
questionnaires were not too burdensome.
People were motivated to take part in the trial for a fairly narrow range of reasons, including because the
condition was relevant to them, the study sounded interesting, they were asked by their general practice
and they liked to help with research.
There were few problems reported with accessing the websites (underlining the value of the pilot work
and troubleshooting), although a couple of the participants had had difficulty on at least one occasion
with opening the video clips. During the pilot study this had been associated with particular browsers. In
the interviews people sometimes appeared unsure which ‘browser’ they had been using. The amount of
time needed to complete the questionnaires at baseline and follow-up and the frequency of reminders
were generally acceptable. Several of the participants said that they would have preferred longer access to
the website as the limited period of 2 weeks meant that they had not had time to visit it as much as they
would have liked. One man commented that, despite the e-mail reminders, he had been taken aback to
discover that he no longer had access.
Participants were generally positive towards the website content, navigation and layout (comparator and
intervention). Participants confirmed that certain aspects of the guidelines which had been used to develop
the sites, such as the importance of reputable branding and the lack of commercial advertising, supported
their impression of the trustworthiness of the website.
The interviews also shed light on the nature of usage and engagement with the websites, and how this
differed from a pragmatic ‘real-world’ use of online resources. Some participants (including those allocated
to the intervention and to the comparator) reported methodically working through their allocated websites
in the order that the material appeared, as they felt that this was the task required of them, rather than
selecting the information that interested them. Similarly, some reported logging on to the site only in
response to automated reminder e-mails.
Discussion
The primary objective of this trial was to assess the feasibility and measure the impact of a PEx-based
website in comparison with a ‘facts and figures’ website using a randomised trial. Our findings show that
it was possible to recruit people with asthma and people who smoke to the studies. People with asthma
were, in particular, relatively easily recruited through primary care. In contrast, carers of people with
MS were very hard to recruit, despite our trying multiple routes and making serial amendments to our
approved strategies with the ethics committee. This may indicate that carers, by the nature of their role,
have other priorities or are simply too busy to take part in research studies. It may also reflect the fact that
TABLE 33 Work package 3b: mean differences and 95% CI between randomised groups for the subscales of the
eHIQ part 2 at follow-up (ANCOVA) for all participants (all three conditions combined)
Measure n Unadjusted mean difference 95% CI
Overall score 213 –2.085 –5.076 to 0.906
Subscales
Confidence and identification 217 –1.225 –4.957 to 2.506
Information and presentation 220 –2.079 –4.946 to 0.789
Understanding and motivation 218 –1.751 –5.516 to 2.014
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many people with MS do not have someone who has this role, or, if they do, that person may not define
themselves as a ‘carer’ or may resist this terminology.173 The qualitative interviews suggest that the
eligibility criteria were not always applied correctly: some smokers had already given up, while others
had no desire to quit. Similarly, participants in the asthma trial did not take part with a motive to
improve self-management. There are clearly lessons here for recruitment and eligibility assessment in
subsequent work.
As might be expected, recruited participants had a relatively high self-rated ability to use the internet. The
interventions were delivered successfully and there were no adverse events. Retention rates were moderate
(75% for smoking cessation, 82% for asthma and 86% for carers), considering the short period of follow-up.
We sent up to two reminder e-mails and one telephone contact to participants to complete their self-report
follow-up measures. Other work has shown the high levels of attrition in online trials of fully automated
internet interventions, and the value of more intensive contact in reducing this.174 The absence of face-to-face
contact (between participants and researchers) in a study such as this is one attraction of internet trials,
as it lowers the cost and allows the trial to be more geographically dispersed. However, there is a trade-off
between this lack of personal contact and rates of loss to follow-up.
Our comparisons between randomised groups showed no differences on the self-report measures, which
included condition-specific outcomes, health status and a questionnaire specifically designed to capture the
attitudes of users towards a health website. In this study, the comparator group received access to factual
information from the leading health information site in the UK (NHS Choices), so it would be surprising if
our novel interventions containing personal accounts were to show major comparative benefits, and, in
any case, as ours was a feasibility study we did not have the statistical power to examine these differences.
The findings from our secondary outcome measures may be useful to derive effect sizes to inform power
calculations for future studies which are designed to look for these differences. It is encouraging that
the experience-based intervention groups showed no harms compared with the fact-based website
comparators. Our choice of a best-practice comparator was appropriate to determine whether or not the
novel interventions may be ‘harmful’, but future work should consider evaluating experience-based
information as additional rather than as alternative, especially given the comments in the qualitative
interviews about the place of experience-based information as a complement rather than a contrast to
more factual information.
With the caveats of the difficulty in recruiting carers of people with MS, and the eligibility issues, we
believe that the trial demonstrated adequate ‘technical feasibility’ and had good internal validity. However,
we believe that there are significant questions to address regarding external validity and generalisability to
‘real-world’ internet use and information-seeking behaviour. On average, actual use of the websites (both
intervention and comparator) was infrequent. The median numbers of logins in the smoking cessation,
asthma and carers trials were (respectively) 2, 2 and 4; the median numbers of page views were 10, 15
and 27.5; and the median total duration on site was 9 minutes, 17 minutes and 31.5 minutes. This
suggests that the MS carers sites were used more frequently than the asthma site, which in turn was used
more frequently than the smoking sites. It is important to note that there was wide variation between
the minimum and maximum users. This low actual use of an internet intervention is common in many
e-health trials, and the plausibility of this level of exposure having an effect should be considered, as well
as some determination of what level of engagement with the intervention would be sufficient. The low
usage of both intervention and comparator also suggests that participants were ‘assessing’ the websites
(as instructed), rather than using them in a more natural way. The qualitative interview findings also raised
questions over the nature of engagement and whether the participants were using the sites to help
themselves or because they were undertaking a task to help researchers.
In designing further work and addressing engagement and use, it will be important to address the issue
of what constitutes ‘exposure’ and ‘dose’ in relation to online information, and whether or not these are
appropriate conceptualisations for information behaviour. We used a period of 2 weeks during which we
invited participants to access their allocated website. In practice, people do not use a single source of
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information for a short defined period of time (unless, as with a patient decision aid, it is designed to
influence a single decision at one point in an illness trajectory which may more easily fit a trial design).
In packaging up experience-based interventions designed to influence outcomes such as self-efficacy or
health behaviour change, rather than a single decision, we used a randomised trial design, in line with
conventional approaches to generating evidence for an intervention. In a real-world setting, experiential
information is rarely isolated from other resources, and internet users do not all use websites in the same
way or ‘consume’ them in a 2-week period. Internet users search and browse, and do not generally visit
sites ‘on prescription’. They can also produce and share experiences as well as consume them, thus
contributing to the experiences made available to others, and websites which gather people’s experiences
tend to evolve over time. Any future larger efficacy study of these or similar web-based resources needs
to address these issues and understand how to embed such interventions in people’s everyday lives. This
could draw on the MRC’s new guidance on developing and evaluating complex interventions, including
the recent additional guidance on process evaluation.167,175
Such future work should incorporate an understanding of real-world online information behaviour,
including the use of social media. Future work could assess the potential value in being able to tell your
story, in addition to hearing about others’, as well as the opportunity for an experience-based intervention
to be changed by its users. There is also a need to establish the place of other people’s accounts: should
they be ‘stand-alone’, or incorporated into other internet-based interventions, or used as an adjunct
alongside them? It will also be important to identify which user groups, and at what points within a
trajectory of illness (or health behaviour), this type of intervention may be most useful for, as our qualitative
interviews demonstrated that people, not surprisingly, have their own personal preferences for types of
information, at different times. Future work should consider how information, including experiential
information, can best be tailored for an individual. Finally, future health economic work could examine the
cost benefit of PEx-based web resources, especially given the absence of harm demonstrated in this study,
and the low marginal cost of a highly scalable public website intervention.
This study adds to a nascent literature looking at the value of digital interventions which attempt to
harness narrative information from peers to influence health attitudes and behaviour.176,177 Emerging work
by others is testing the value that narrative accounts could have in modifying attitudes to breast screening
among African American women,178,179 in helping people with hypertension achieve control of their blood
pressure180 and in achieving lifestyle change for people with coronary heart disease and low-back pain.181
Conclusion
The internet is playing a significant role in health and health care and offers one opportunity for innovative,
low-cost, highly scalable approaches to health challenges. The online sharing of personal experiences of
health and illness is a relatively new phenomenon and we have tested the feasibility of assessing its impact
in a randomised trial. Our original intention for this programme of work was to identify whether or not,
when and how to incorporate PEx into online health information. We showed that PEx-based interventions
could be developed and used and that a trial was technically feasible, with some recruitment issues. We
showed no harm from the interventions. In common with many internet interventions, actual use of the
websites was relatively low and there was attrition from the trials. In beginning to address the ‘whether or
not, when and how’ questions (also addressed by our other workstreams, from different perspectives), one
contribution of this feasibility trial was to establish the limitations of a RCT approach. In the next chapter we
discuss how personal preference for style of information is an important factor that does not fit easily with
a standard RCT design, and future work also needs to understand how to maximise engagement with
information-based websites and how to assess the value of such interventions in more pragmatic, everyday
use, rather than (as with a drug intervention) an isolated ‘dose of information’ with a 2-week exposure.
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Chapter 9 Qualitative interviews with a subset of
the feasibility trial participants
Abstract
Introduction: qualitative interviews were conducted to explore the process of taking part in the trial, to
gain an understanding of participants’ perspectives on their allocated website and to encourage reflections
on the pros and cons of different types of online health information.
Methods: thirty of the trial participants took part in an interview within a few weeks of completing their
follow up measures. The interviews were conducted in people’s homes, or at their workplace if they
preferred, and were audio recorded and transcribed for thematic analysis.
Findings: the interviews included perspectives on the process of the trial, which was acceptable and not
burdensome to the participants (data are discussed in Chapter 8), and a discussion of a variety of different
types of websites, prompted by laminated cards. The results were analysed in relation to the seven
domains identified in the conceptual review. The relevance of the seven domains were supported by the
interviews and there was evidence (as anticipated) that different domains were applicable to different
conditions; for example, the negative impact of visualisation was raised only in MS and smoking, not in
asthma. Facts and figures were seen as important, particularly soon after diagnosis (asthma and MS).
Conclusions: the interviews underlined the highly individual manner in which patients assemble their own
online information landscape, the requirements of which change at different stages. Personal experiences
are valued and approached, with some caution, as a supplement, but not a substitute, for facts and figures
from a trustworthy source.
Background and methods
Trial participants were asked to indicate if they would be willing to take part in a face-to-face interview in
the weeks after they completed their follow-up measures. We selected participants purposively to cover
the three different groups (asthma, MS carers and smoking cessation) and to include those from the
intervention and comparator arms of the trial. We interviewed men and women and also aimed for a
range of different types of engagement with the websites (some who had visited the site often and some
who had only looked at it a couple of times). More details about the qualitative interview sample can be
seen in Table 34.
The interviews were conducted by SZ (12 interviews), coinvestigator LL (nine interviews) and research
assistant NN (nine interviews). A researcher arranged to visit people’s homes to conduct the interview at
TABLE 34 Work package 3b: summary of the qualitative interview sample
Characteristic Smoking cessation Asthma MS carers
Mean participant age 62 years (range 47–72 years) 54 years (range 21–72 years) 61 years (range 23–79 years)
Allocated to intervention (n) 7 (3 male, 4 female) 3 (2 male, 1 female) 6 (2 male, 4 female)
Allocated to comparator (n) 5 (4 male, 1 female) 4 (1 male, 3 female) 5 (4 male, 1 female)
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a time that suited the respondent. Interviews lasted between 45 and 90 minutes and were digital audio
recorded for transcription and analysis. The interview schedule was developed with assistance from the
wider programme team and covered:
1. Taking part in the trial: motivation to participate, views of the trial procedures, the questionnaire
measures and reminders. These data are discussed in Chapter 8.
2. Specific questions (different for each arm of the study) about the website: what they looked at, how
they decided what to look at, thoughts about the straplines, visual design and different ways of
presenting material. To prompt discussion and help remind people about the site layout, we took
laminated cards showing different pages. These questions drew on the engagement framework aspects
of gating, engagement and outcomes (see Chapter 6). These data are discussed in Chapter 8.
3. Content comparisons: participants were asked to discuss the pros and cons of six different types of
health website. Participants were shown laminated cards with (1) a health blog, (2) a patients’ forum,
(3) a national charity home page with facts and figures, (4) a national charity page with a personal
experience, (5) a hospital trust ‘rating’ page and (6) the Patients’ Opinion home page. Participants were
also asked which of these they might use or contribute to and discuss the reasons for their answers.
This content comparison helped us to explore the seven domains from the conceptual review, which is
the focus of this chapter.
4. Finally, participants were asked about their views of ‘sharing experiences’ online and whether or not
(and why) this was something they could imagine doing themselves. They were asked if there were any
other issues they wanted to raise in relation to the study and if they would like to be sent results of the
study in due course (all said that they would).
Approach to analysis
The three researchers who had conducted the interviews and coinvestigator SW read the same few
interviews and agreed a coding frame based on the elements of the engagement framework (gating,
engagement and outcomes) and the seven domains from the conceptual review (finding information,
feeling supported, maintaining relationships with others, affecting behaviour, experiencing health
services, learning to tell the story and visualising disease). We also coded ‘trust’ and the emerging issue
of ‘timing/need’, which reflected an important set of comments around the point(s) in any given health
trajectory at which experiential information might be regarded as more relevant or helpful. Each of the
researchers coded her own interviews using the coding frame and NVivo. We used constant comparison
to develop our coding, and considered the reasons for any differences between the three conditions in
preparing the thematic analysis for this chapter.
The qualitative analysis presented in this chapter is based on all of the interviews because people in both
arms of the study were asked to discuss and compare the six different types of websites. People in the
comparator arm as well as the intervention arm had some very interesting things to say about the pros
and cons of PEx and facts and figures, sometimes prompted by the laminated cards that we used in the
interviews and sometimes due to their reflections on the value, and limitations, of the website they had
access to in the study. Quotations from the interviews are presented along with brief sociodemographic
information about the participant and whether they had been in the comparator or intervention arm.
Findings
Findings about the trial process (sections 1 and 2 of the interview, described above) contributed to the
interpretation of the feasibility trial results and are discussed in Chapter 8. In this chapter we discuss the
findings from the interviews (mainly, but not exclusively, drawn from section 3 of the interview) in relation
to the seven domains from the conceptual review. Finally, we discuss comparisons between different types
of sites and the importance of timing of access.
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Finding information
The research interviewers were careful not to assume that people were approaching the websites primarily
as a source of ‘health information’ (we were, after all, aware that there were at least six other domains
that might be relevant). All of the participants made it clear that the need for ‘information’ was what often
motivated them to look at health websites, and that they would all want to be able to find reliable factual
information about their condition or health issue (see also Timing and need). There were people in both
the comparator and intervention groups who said this kind of factual information was either the only or
the main type of information they wanted. For example, one person in the asthma comparator arm
volunteered the following comment in relation to not wanting to look at videos, before any interview
prompts had been raised about the sharing of personal experiences:
I prefer reading information and I would view a site like this, not for chatty, touchy-feely stuff,
but for information because I’m not particularly interested in other people’s experiences of asthma,
because I’ve had it so long that I feel that, you know, they’re not going to be particularly interesting
or helpful.
Asthma comparator, 58-year-old woman
This is also an indication of the importance of timing and need, to which we return below.
An asthma intervention participant commented on the relative priority they would attach to
experiential information:
Well I would think that the most important part of it is the symptoms and the available choices
and medication.
Interviewer: So the medical kind of factual?
Yeah. The other thing about people’s experiences and what have you, although interesting, are not as
important. I mean what everybody wants is to alleviate their symptoms and if the money’s there to
break it up a bit with some personal experiences so much the better because it does make it easier to
read if you get my meaning?
Asthma intervention, 66-year-old man
As anticipated, for the MS carers learning through other people’s experiences included getting practical
advice about equipment and adaptations to the home. The value of hearing from other people who have
‘been there’ was frequently raised among those who had access to the intervention site.
So, and what was useful was, it’s all very well going to a site that tells you what’s available but it
doesn’t tell you how people have coped with it, and that’s why the carers’ thing is so much more
valuable. You know the physio will tell me but, it’s not quite the same as somebody who’s
been in that situation and said, ‘This has worked for us,’ and you think, ‘Ah yeah, that might work
for me’.
MS intervention, 59-year-old woman
Hearing other people’s experiences also helped some MS carers to make sense of what they had been told
by various health professionals.
Because it highlighted . . . you go to, you go to see various people, you know take my partner and you
go to see a consultant and people say different things and that was really useful because then you
could see exactly what it was that they were, you know, meaning – for example benign MS.
MS intervention, 50-year-old woman
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One person with asthma thought that people’s ‘detailed descriptions’ on the website were useful for those
who had not talked about their illness to others.
To hear other people’s detailed descriptions of what they went through if you can put it that way, you
know, because I’ve never talked to anybody about it. You know I know quite a few people who have
asthma in various degrees but it’s not that we sort of talk about it, but it was interesting to hear other
people’s views.
Asthma intervention, 78-year-old man
Concerns about the potential for harm included that information drawn from other people’s experiences
could be either irrelevant or misleading. People with asthma and those caring for someone with MS
pointed out that these conditions affect people very differently and therefore other people’s advice may
not be relevant. One MS carer said that when it comes to adaptations to the home, even information from
health professionals can be misleading ‘particularly in terms of finances and things’ as they might not
understand that people struggling with limited funds may be encouraged to make expensive mistakes if
they do not know what is going to work.
People who had many years’ experience of living with asthma or caring for someone with MS thought that
it was unlikely that they would find anything new on a website; however, some who had looked at the
PEx material in detail had been pleased and surprised to discover something new.
It was really interesting to see how other carers were coping with the idea of getting people in and
things like that and how much problems there can be.
. . . We’ve had that a while so it’s not a major problem but you have to then buy new beds and things.
And also you need two people. Well, really he prefers, and I do, that we can cope on our own as best
we can. So there was a gentleman who mentioned the ceiling hoists which a friend of mine with MS
also has, and that confirmed that that’s the only way to go you know.
So that was a really useful piece of information otherwise we’d have perhaps got hoists in and . . . I’ve been
and tried them; I had a nice afternoon trying them out but, I did realise that they have limited potential.
MS intervention, 59-year-old woman
The ‘smoking cessation’ group felt, somewhat wearily, that they already knew everything there was to
know about why it would be beneficial to give up. Some were evidently resistant to any more ‘information’
about the harms of smoking being thrust at them.
Feeling supported
Much of the literature about the role of health websites has focused on the potential for ‘peer-to-peer
support’, which is arguably one of the most transformational aspects of the internet, especially for people
who might be socially or geographically isolated, or who find it difficult to talk to others about their
emotional responses. In our data this was particularly evident in the MS carers interviews; the following
extract is from a woman who felt that she had benefited from access to the trial PEx website.
As someone who’s on my own, basically because relatives are far away, it’s quite useful; reassuring;
encapsulates the most helpful comments of other carers; helps me realise aspects of [my husband’s]
symptoms and behaviour which are to be expected, because it’s very difficult for him to know if it’s
the MS if he has a tummy problem, or if it’s something else and then it’s easier for both of us to
accept quite regularly. Reinforces the path we’re on – like I mentioned with carers – and you can see
any alternatives might have bigger problems than they’d solve. And it helped about equipment; it
helped more about emotions and every carer seemed to be unique and was finding the best way
through which helped me think about the best way through.
MS intervention, 59-year-old woman
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One of the participants with asthma commented that, among the benefits of seeing what other people
have written about and dealt with, it is:
. . . also helpful to know (a) that you’re not alone and (b) how other people cope in
those circumstances.
Asthma comparator, 45-year-old woman
The MS carer interviews included several examples of when hearing from another carer had helped (or
could help) people to feel less alone and better able to cope. The MS carer quoted above had attended a
face-to-face support group but felt that the PEx site was ‘a more useful thing’ for her:
I’ve been to carers’ meetings and they’re very helpful about what might be out there but it doesn’t get
you into the emotion of being a carer in the same way. And I found out things, I can’t specify, but
information about [husband’s] emotions which helps me to deal with them, and they don’t crop up at,
you know other venues. So, it’s really useful when people talk about how they’re . . . I don’t know
what you call them . . . the person you’re caring for feels and how their emotions are affected and it
helps you to deal with it as well.
MS intervention, 59-year-old woman
Hearing about what other people are going through can sometimes help people to feel that they are
comparatively well off. A woman in her sixties who was in her first few weeks of giving up smoking had
not seen the PEx website, but volunteered early in the interview that she would have liked to see some
other people’s experiences of trying to give up. She wanted to see not only the positive accounts but also
what it was like for those who were struggling to give up, partly for ‘downward comparisons’, but also
because she would ‘mistrust’ a site that was only positive. A person with asthma commented on the value
of these ‘downward comparisons’ with people on the PEx website:
You also are thankful that you’re not as bad as some people you know because for some people it is
really debilitating [. . .] I mean it doesn’t stop me doing what I want to do.
Asthma intervention, 78-year-old man
Carers of people with MS were aware that looking at other people’s experiences could be either uplifting
or depressing. Online peer-to-peer contact could be a ‘mixed blessing’ or a ‘double-edged sword’, and it
would not always be easy to predict how someone might respond to hearing someone else’s account:
It’s a balance the stories isn’t it . . . I mean the personal dimension where people have struggled and
have, you know, made some progress or have come through well is very positive and inspiring but then
equally without being, you know, depressing is also useful to know about the sort of difficulties where
people have where, you know, the challenges that emerge as people become doubly incontinent and
what you have to do about caring for that and all the rest of it because it’s something’s real and you
don’t want people feeling, ‘Oh god I . . .’ you know either the person who’s suffering or the person . . .
sounds awful when the person’s dealing with this, or the carer, ‘Oh god I’m inadequate, I can’t cope
with this’.
MS comparator, 65-year-old man
Apologetic that he might be sounding unsympathetic, one person with asthma pointed out that people
can tend to ‘witter on’ in forums and on blogs. Of course, a benefit of an online group is that one can
remove oneself without causing the offence that might ensue in a face-to-face meeting.4 Others wondered
why it seemed to be that some people wanted to live their lives, and rehearse their health problems,
in public and online. Those in the smoking cessation group differed from the asthma and MS carer
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participants in that several said that they really did not like the idea of being advised what to do – and
they were doubtful that other people would want to hear about their experiences either:
. . . because, to me, it’s self-evident – if you want to give up smoking, you give up smoking.
Smoking intervention, 59-year-old man
Another smoker said that they would not want to ‘shove my opinions down other people’s throats’.
I don’t know . . . if I had breast cancer I wouldn’t want to read people’s last diaries maybe necessarily
while I was undergoing my chemotherapy.
Interviewer: Yeah.
But if we’re talking about something like this I think it’s really helpful to have people who’ve had bad
experiences or who have failed at various things because then it makes you just feel a lot better about,
you know, the fact that you’re not coping well or you know you’ve given up smoking seven times in
the last eight months you know and each time you’ve lapsed and you think, ‘Oh I’m hopeless,’ and
you think, ‘Well so and so that happened to them and they persisted or they tried this other thing and
it really worked,’ so I think that’s really good. I would always . . . I would mistrust a site I think that
only had positive things.
Smoking intervention, 78-year-old woman
This perspective was echoed by some of the people with asthma or MS carers who, although a little
concerned about unmoderated content on online forums, reasoned that it also would not be helpful to
exclude negative stories:
Well there is a danger there isn’t there that if you’re feeling vulnerable and in need of support anyway
and you don’t have any other support network and you know if there are forums they’re usually . . .
I wouldn’t say uncensored but they do tell [. . .] they shouldn’t exclude people who tell a negative story
otherwise there’s not much point in having a forum, it just becomes a controlled network, so there is
that danger. Now as an individual you might come away from there feeling, ‘Well at least I’m not as bad
as that,’ which isn’t necessarily a good idea but it might give some people some support to say look
there’s people who are worse off, you could do better or you might identify them as a bit, you know,
you’re being just as good, as bad as they are. So I don’t know about that one, could be a double edged
sword. Overall I’d think it would come down as perhaps helping people who are seeking support overall.
Asthma intervention, 60-year-old man
The same participant drew attention to the value of the curated collection of clips on the intervention PEx
site, which avoided being repetitive or presenting only one perspective.
Those were interesting as well and I thought that would also give support to people who perhaps are
a little bit anxious particularly if they’ve been recently diagnosed or it’s grown over, you know, in
recent times, so yeah, so that’s where I first went yeah.
Interviewer: OK. And did you look at any of the clips, the video clips?
Yes yes. I suppose also those are well put together. I think the . . . sometimes if they’re too repetitive
or the people aren’t explaining themselves very well that might put you off, but if they’re put together
in a supportive way I think they would provide people with encouragement yeah [. . .] I thought overall
they were well put together; people . . . it’s always a danger if you’re using non-professionals I
suppose or people . . . they just look at it from their own angle but then I suppose that’s the point and
as long as they put it over clearly then yeah I think they were . . . they added to the website yeah.
Asthma intervention, 60-year-old man
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The PEx site was designed to cover many different perspectives on each topic so that people using the site
could find material that resonated with their own views and experiences. This had not been successful
for one of the MS carers, who felt that her perspective was not included because she cared for a partner
with MS but they did not live together:
In some ways it was quite disappointing to use partly because the examples . . . I think I was looking
for something that wasn’t there, possibly because our situation is so different from most people in
that situation. Because we don’t live in the same place; because we’re not man and wife; so I’m much
more like a friend and I appreciate that this is designed for friends as well. But obviously a lot of the
things that were said were, where somebody was in a very intimate relationship 24/7. So there were
times when I thought, ‘Ah now that might give me a clue,’ and it didn’t quite hit the spot.
MS intervention, 59-year-old woman
Maintaining relationships with others
Carers of people with MS talked about the unmet need for support for people who are caring for a
spouse with MS. One participant (in the non-PEx arm) explained how much he had gained from meeting
someone else who was caring for a wife with MS. He reflected that he had not found anything similar on
a website, although the need, evidenced by the high divorce rate (especially in cases when the woman has
MS), seemed clear to him:
And we’d talked about things and we had exactly the same experiences of, when you go through that
diagnosis it’s a big shock and then you worry a lot for a long time, and then things become normal.
But, you redefine yourself as the partner of someone who has MS, and I found myself telling people
that all the time. If they asked who I was, it was almost the first thing that came out all the time.
And, it’s like you’ve . . . someone’s flicked a switch and you’re not who you were before and your
partner isn’t who they were before. And, it’s really, really weird. I had never spoken to anyone else
before who’d had that. And, it was just really incredibly helpful.
Interviewer: Yeah.
And that’s not . . . I haven’t found that on any website anywhere or anything like that. All you do
see is that, you know statistics like; I think this is roughly right but, men who are partners, 75% of
men who are partners of women with MS, divorce them. And, it’s about 25% of women whose
male partners got MS, divorce them. And there’s a very big difference there but, I think there’s
probably . . . and there is probably a need for some sort of support there that isn’t, that just isn’t there
at the moment. Because, I think, MS is like one of those things . . . you know people try and hide
Alzheimer’s because we’ve been through this with parents and god knows what, and partners
of people with Alzheimer’s try and cover it up and everything. MS is one of those completely
hidden things . . .
MS comparator, 59-year-old man
Sometimes the online environment can offer welcome anonymity. One of the smoking participants
commented that it might be easier to share personal issues with strangers rather than with friends, family
or health professionals:
. . . with a professional it’s a bit more like more like going to confession, do you know what I mean?
There’s a sort of barrier . . . sometimes it’s easier to share personal things with someone you
don’t know.
Smoking intervention, 78-year-old woman
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One of the asthma participants recognised the potential value of the online forum because of his
daughter’s experience of online communities for people with fibromyalgia:
What she does find is that it’s easier to cope with now there is a fair bit of it on the web and things
like Facebook where they discuss how their days have been and that sort of thing and she’s not alone
. . . this is . . . she’s found very much a great help, you know, that there’s people she can talk to over
the web whereas she doesn’t physically know anybody in her local friendly circle that’s got it but there
are people out there that she can contact and talk to and sort of say, ‘Oh I’ve had a rotten day,’ or,
‘I’ve felt better today,’ or whatever you know.
Asthma intervention, 78-year-old man
Affecting behaviour
Stories can inspire people to cope with their health problems. One man who had been diagnosed with
asthma as a child was inspired and reassured to discover that a famous cricketer also had asthma:
I do remember there was an interview with I can’t remember who it was – it was a famous cricketer –
who had asthma or who has asthma, and I do remember thinking, ‘Gosh well you know if this person
can be a, you know, a test cricketer and he’s got asthma, you know, that’s a good thing I can run,’
because as a child, although Ventolin had been invented my GP had obviously never heard of it so I
didn’t have any treatment; you know the only treatment for an asthma attack was to lie down and
gasp on the floor and, you know, try and get fresh air. And so I was always scared of running and
that sort of thing and so then in the second phase when I was older and then got the drugs I suppose
at that point seeing success stories and thinking, ‘I can run if these other people can do things’.
Asthma comparator, 58-year-old woman
Interestingly, this was the same person quoted above in Finding Information who said, ‘I’m not particularly
interested in other people’s experiences of asthma, because I’ve had it so long that I feel that, you know,
they’re not going to be particularly interesting or helpful.’ Again, this illustrates how shared experience at
the right time – success stories ‘at that point’, as she puts it – may be valuable.
One participant (in the non-PEx arm of the smoking study) felt that other people’s experiences of quitting
(or trying to quit), if they were ‘smokers like me’, might be a ‘worthwhile addition’ to a website for
smokers trying to give up:
But a worthwhile addition to it would be, people who have been smokers like me, for 47-odd years,
and you know what’s your experience been actually finally quitting?
Interviewer: Right.
And how have you stuck with it? How have you done it? And there are lots of little things that help;
there’s one thing in my view except my own inner decision.
Interviewer: Yes.
My decision.
Interviewer: So what other, you know what other types of experiences would you like to see? People
who’ve . . . just people who have been successful or people who’ve tried and . . .?
People who’ve been . . . people who tried and failed even and are willing to try again.
Interviewer: Yeah.
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And even people who say, you know, ‘Look this is the hardest thing you’ll probably ever do in your
life’. It is very hard.
Smoking comparator, 59-year-old woman
Experiencing health services
There were a few accounts from people who had been encouraged to seek health care, although not
necessarily because of the 2-week exposure to the trial websites. An asthma study participant said that
taking part had reminded them that they were overdue to see their asthma nurse, which was probably
simply a beneficial side effect of taking part in the research rather than a consequence of exposure to
the intervention.
It has been suggested that health websites (in general) might support self-care by increasing people’s
confidence in their ability to look after themselves. One of the participants from the asthma study
described being reassured by the PEx website that their current approach to their health care was
satisfactory, and a MS carer said that they felt a ‘bit more confident to go to the GP’ to ask for help:
Asthma intervention, 60-year-old man: Perhaps if anything it reassured me that I was doing just about
most of what I could do to control the asthma and keep it in check, and it perhaps confirmed that
there was nothing contradictory to what I’d been told or any course of action that, you know, any
medication that I’m taking at the moment. There was nothing contradicting what I’d been told –
different terminology but mounting to the same thing so I suppose if anything I came away feeling
that this is . . . I had more confidence, it was reinforcing. If there was something glaringly different to
what I’d been following then I might have gone back to my doctors and said, ‘Oi’. [laughs]
Interviewer: Yeah OK. Has anything that you looked at prompted you to go and talk to anyone else;
go back to your GP; talk to support groups?
Asthma intervention, 60-year-old man: I think it’s made me a little bit more confident to go to the GP
with problems.
[. . .] Yeah and I suppose websites could go either way couldn’t they, you know that online stuff might
put you into downward spiral or, it might prompt you to think, ‘Actually there’s other people out
there who’ve gone and got help, maybe I should do that’.
MS intervention, 59-year-old woman
It has made me think more and more that that’s what I should be doing. [Interviewer: Hm mm.] And
it’s my mind-set and also habit as well and I think these e-cigarettes is to look . . . well say a lot of
friends are doing those now and that seems . . . they seem quite happy with that. [Interviewer: Yeah.]
And I think that might be sort of one of the aids to . . . and also I need to go and see the doctor and
say, ‘Right, can I have some patches as well,’ and work out the best way for me to stop smoking.
Smoking comparator, 47-year-old man
Learning to tell the story
Our conceptual review indicated that one of the consequences of accessing online PEx might be that
people would learn new ways to talk about their health, which might help them to describe their condition
more accurately (or more persuasively). Any such change would probably be gradual, diffuse and difficult
to assign to any one influence. However, one man who was caring for his partner with MS explained how
hearing men talk about their emotions might help others to express themselves. This is, of course, related
to ‘support’ but provides a particular stimulus to action:
I think there’s a gender issue here too because women have traditionally, for historical reasons, had a
greater caring role and they still do because we still have a patriarchal society [. . .] but many women
find it more easy to talk about their emotions and their feelings and to exchange. Men tend to not do
that so easily and tend to internalise and block down, and I think the opportunity for, you know, a
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male person, for everyone, but maybe to actually see other male carers talking [. . .], ‘Oh so you know,
actually I’m not alone; actually those are issues and actually I have these feelings of, you know anger
and upset and whatever and it’s actually OK to feel those things because that’s an understandable
human reaction, but then I’ve got to sort of deal with those and channel onto . . .,’ you know so all of
that’s . . . and I guess this must be true . . . lots of support and therapy across all sorts of issues and
conditions, not just MS but yes, I’ll take the view that the ability to share that is quite important.
MS comparator, 65-year-old man
Another man caring for his wife with MS expressed a similar idea about how hearing about other people’s
problems might encourage a person to ‘talk to someone else about how they feel’:
I think, actually getting things off your chest or talking about things is always helpful. And, if it’s
something that you find difficult to talk about with other people then it’s probably even more helpful
to you to get it off your chest. And, if someone experiences someone else doing that it can possibly
help them. Either just to read about it or, hear about it or, to encourage them to go and talk to
somebody about how they’re feeling I think. For their own sort of mental health really.
MS comparator, 59-year-old man
In contrast, several of the participants in the asthma and smoking cessation groups were sceptical about
the value of telling other people about health problems. Some expressed amazement that anyone would
want to write, or read, a health blog. A person with asthma commented:
People are all different. It might be a generational thing as well in that it was the way I was brought
up – basically, you know, you sort yourself out, you don’t go lumbering other people with your
problems; or nod and say yes but by and large they’re not interested, they have their problems and so
why should they want to hear yours?
Interviewer: [laughs]
I don’t know yeah.
Interviewer: If you thought they were going to help someone.
I mean the worst person to meet in an office environment is when you ask them how are you and you
get the whole nine yards and you think oh . . . that’s unkind to some extent but because there are
people who definitely need help and support and you would do – give them support – but I mean as
a general rule, you know I’ve done it myself – you know you’re feeling like death but yeah you’re fine.
Asthma intervention, 60-year-old man
Visualising disease
The conceptual review drew attention to the inherently visual nature of health websites. Many sites include
pictures of people with a health condition, and other illustrations. These images, intentionally or otherwise,
position the condition in particular ways.
In the interviews we asked people if there were any images they would prefer not to see on a health
website. Responses were clearly divided by condition. While a few of the people with asthma discussed
design issues and talked in general about the benefits of breaking up text with images, they did raise
concerns about negative or distressing images. In comparison, MS carers were aware that images of
people with advanced disability might be distressing, particularly for the person with MS, although one
remarked that ‘with MS there aren’t so many gory pictures because it’s not that sort of disease’:
They don’t want it in their face; they’ve got it, they want access to things to help them but they don’t
want to really be reminded of it in a sad sort of way and that’s . . . websites can do that too seeing
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people severely disabled in a wheelchair, for my husband for example, probably wouldn’t do him any
favours and it doesn’t actually interest me that much other than from the practical point of view that
that particular piece of kit being suitable for my husband, then I would want to see it.
MS comparator, 64-year-old woman
The smoking cessation group expressed some quite strong feelings about the images that have been used
in anti-smoking campaigns, which some suggested could be counterproductive:
That I do not want to see? Pictures of diseased lungs. [Interviewer: Hm mm.] I know that and I don’t
want to see it because it makes me instantly want to go and smoke a packet of cigarettes.
[Interviewer: Hm mm.] Because it makes me so nervous.
Interviewer: Are there any things that you’d really rather not see on a site that’s supposed to be
helping and supporting people to give up smoking?
Well yes. I mean we’ve all seen the photographs, the medical photographs of lungs of someone with
cancer. [Interviewer: Yeah.] And I don’t think we need to see them any more. [Interviewer: No.] You
know I mean that kind of shock tactic it didn’t make me want to stop. [Interviewer: No.]
I just didn’t bother to look at the picture; I would open the packet in such a way that I didn’t look at
the picture. And so I think most people see through that.
Interviewer: Yeah. You know you can’t . . . ultimately there is only one way and that is really through
understanding and loving support.
Smoking intervention, 59-year-old woman
In contrast, the next quotation was from the one participant who suggested that images should be more
graphic to shock people – on the grounds that everyone now knows that smoking is ‘not a good thing’
and people may need an extra push to stop:
I think people use the pictures which have a more hard-hitting effect.
Interviewer: OK so by graphic you mean sort of like . . .?
Images of lungs and that sort of thing yeah.
Interviewer: Lungs yeah. OK yeah.
And also the effect it has on others. I think that’s more of a positive for people to say, ‘Right . . .’
because I do think it’s . . . it’s not so much educational because I think most people have got a general,
you know, they know it’s not a good thing. But I think if you can actually show it through and through
and show that, you know, from start to finish, this is what will happen, not could happen, will happen.
Smoking comparator, 47-year-old man
One participant in her mid-sixties, who had just given up smoking, also commented on the image of a
professor and expert on smoking cessation research, who was filmed for the website, talking in his office.
She reacted to the way that he was positioned ‘against his files and his study papers and all the rest of it;
his research documentation’. As someone who admitted that she had rather enjoyed her self-image as a
bit of a rebel, she was not persuaded by the image of ‘authority figures’ telling her what to do:
But the photograph is totally, it’s just totally inappropriate you know [. . .] You see it interests me why
I’m an addictive personality but the photo . . . he’s a great guy, no problem with that, but why put
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that, why? What is the reason for showing the professor’s photograph against his files and his study
papers and all the rest of it; his research documentation – why, why do that? What purpose does it
serve me who’s trying to stop smoking?
Interviewer: Authority? [laughs]
It’s an authority figure. Well you know [makes a ‘V sign’ with fingers and laughs], they’re closed,
they’re closed. I used to put a cigarette between those [laughs].
Smoking comparator, 66-year-old woman
Facts, figures, experiences and blogs
People were asked to compare and comment on the different types of health websites, using a series of
laminated cards with screengrabs from different types of sites accompanied by an explanation from their
interviewer. Among all three groups and both arms of the feasibility trial, there was general agreement
that everyone needs the facts and figures from reliable, non-commercial sources such as the NHS,
well-known universities and voluntary organisations. People were very alert to the dangers of advertising
and commercial influence on the site content:
I quite like the idea of factual information; again it’s just telling it straight and being able to work your
way through something logically and forming your own thought process over it and that way you’ve got
something to take away and discuss with your health professional or friends and family, whatever, to try
and ascertain the meaning. I suppose that’s the way I tend to work so I’d say that was quite useful.
Asthma comparator, 45-year-old woman
When it came to patients’ experiences, there was considerably more variation in response. As we have
indicated previously, some of the people we interviewed were at a loss to understand why anyone would
ever want to talk about, or hear, anyone’s experiences of their health issues. People who had experience
of caring for someone with MS had often realised the value of hearing about other people’s experiences,
but they and the people with asthma emphasised that the conditions affect people very differently, making
it hard to learn from a single blog, or an individual posting on a forum. There were also concerns about
unmoderated content which might attract highly damaging comment and activity from ‘trolls’ on forums.
Those who had visited the PEx repeatedly commented on the benefit of being able to see many different
people’s experiences gathered together under topics so that they did not become too repetitive (see
Feeling supported).
It was also clear from the interviews that although there are some functions that can be very well
performed by a website, the material is seen as a supplement, not an alternative, to care from a
professional. Similarly, those who valued the PEx material also wanted to see facts and figures:
And that’s where a website is very handy because you can back-up what you’ve been listening to and
also give you that little bit . . . well no GP’s going to know exactly how much you can take in or how
much you want to as some people don’t want to know do they?
Interviewer: Mm yes or don’t want to know right now but they might want to know later.
No they might want to know later yes quite. If you’d just had a really serious diagnosis you might not
want to know immediately anything more but you might . . .
MS intervention, 59-year-old woman
I think things like this, well the factual ones should encourage people to use the services less but when
they do go it’s for more important issue which can’t be resolved you know outside the health service.
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Interviewer: OK and is that something that would make you think, ‘Ooh quite like to know more
about that, I might ask the GP,’ or . . . or look it up further on Google or something or other?
I would probably try and read more about it I suppose yeah. I suppose if I wanted more information
after I’d tried to do that then I’d probably would talk to the GP or the nurse who deals with it.
Asthma comparator, 57-year-old man
Yeah. I’d want the facts first, only then would I perhaps want to look at individual stories and that’s
only if I could search them to follow somebody who’d perhaps got as near enough the same condition
as myself and I’d then follow them through but if I had a condition that was concerning me I’d want
facts and information about it and then I’d go to my doctor and take a conventional approach to it.
Asthma intervention, 60-year-old man
Timing and need
Timing and need was a strongly emergent theme from the interviews. We have already touched on this in
the example of the 58-year-old woman in the asthma comparator group who said that she was now ‘not
particularly interested in other people’s experiences of asthma, because I’ve had it so long that I feel that,
you know, they’re not going to be particularly interesting or helpful’. The same participant also told us
that at one stage in her illness she had found the example of a famous cricketer with asthma helpful in
encouraging her to think she could still go running.
Many of the people recruited for the asthma feasibility trial had had the condition for some time; they
generally felt well informed and their condition was well controlled. It is not surprising, therefore, that they
often felt that they had little to gain from either the facts and figures or the personal experiences sites.
However, they could see that they or others might have benefited from information at a different point in
their illness, such as when they were newly diagnosed or experiencing changing symptoms. The same
woman in the asthma comparator group as mentioned above explained further:
But of course somebody who’s newly diagnosed . . . or particularly if they had a child who was newly
diagnosed, would be looking for totally different things . . . and probably with the other conditions
you’ve been looking at as well, somebody who is newly diagnosed is going to be in a sort of, you
know, shock/horror ‘What do I actually do? What does it mean? Am I the only one?’ sort of thing. It’s
almost a completely different thing . . . I suppose it almost feels like making a bit too much of a fuss
about it – talking to other people about it. But then you see my asthma’s pretty well controlled most
of the time . . . I mean going back to a parent of a child who’d been newly diagnosed, that’s such a
completely different sort of experience. I think if you’re afraid of the condition then I think having
discussions with other people is going to be perhaps more effective. So I think again it comes back to
this difference between, you know, if you’ve had asthma for, you know, over half a century as I have,
versus if it’s all completely new and you don’t know anything about it – you’re going to want
completely different sorts of support and information.
Asthma comparator, 58-year-old woman
This example is typical of how people talked about personal variation in the time at which they might need
different sorts of information.
One woman in the intervention arm, who was caring for her husband with MS, explained that the trial
had come at a particularly helpful point for some pieces of information and emotional support, as she had
been experiencing some depression because of her sense of isolation and sadness at her husband’s disease
progression. The following extracts show how she selected material for her own current needs. In addition,
searching the site online was, for her, a more efficient way of gleaning others’ experiences than a support
group would have been:
I find it difficult to find the time to talk to people a lot and go to MS meetings and things like that,
and very often you’re talking about people’s relatives and things, whereas I find that the website
condensed the sort of information that I needed. So I did find out things which could have taken quite
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a long time to find out otherwise . . . I had to by-pass a lot of things because my husband is now chair
bound. So, I didn’t need to look at anything about mobility cars, scooters, you know anything like that
because we’ve already been through that. So, it was particularly things for the future. He’s not too
worried but I like to be prepared.
Interviewer: OK so quite selective, quite targeted?
Very targeted, yes, probably missed half of it because it’s no longer appropriate, which doesn’t mean
it wasn’t of real value to people who are in a different position . . .
Interviewer: What kinds of things were useful?
Well I did look at some of the things that we’re sort of currently in, like [paid] carers and things, and it
was really interesting to see how other carers were coping with the idea of getting people in and
things like that, and how much problems there can be . . . I was particularly interested in hoists
because he doesn’t need one yet, but we need to know what sort of hoists might be available [. . .]
I think initially when you’re diagnosed you want to look at a whole lot of information. [partner] and
I were very different; he didn’t want to know, he just wanted to get on. I wanted to be prepared . . .
so I wanted to get hold of literature and find out as much as I could. So it’s very useful in those early
stages I think . . . And what was useful was, it’s all very well going to a site that tells you what’s
available but it doesn’t tell you how people have coped with it, and that’s why the carers’ thing is so
much more valuable. You know, the physio will tell me but, it’s not quite the same as somebody
who’s been in that situation and said, ‘This has worked for us,’ and you think, ‘Ah yeah, that might
work for me’.
MS intervention, 59-year-old woman
At the same time, she was selective about experiences that she knew she did not want to see, perhaps
because they were upsetting:
When people were in a similar situation to myself then I would, you know watch the whole clip. And I
think I tried to look at every clip where it might be relevant. As opposed to clips where people were in
the very early stages and talking about holidays – dream on [laughs] – you know, they were irrelevant
and probably painful.
Conclusions
The above extracts touch on many of the seven domains. What the domains can tell us is what the
benefits (and possible adverse consequences) from shared experience can be. The theme of ‘timing and
need’ helps to explain why and when these benefits and harms may be realised. This discussion further
underlines the importance of the person’s point along a trajectory, as well as their specific needs at that
point and their personal information preferences for facts, figures and experience. We discuss the
implications of these findings further in Chapter 10.
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Chapter 10 Discussion
During the 5 years since we started the programme, we have seen considerable changes in how peopleaccess the internet, for example the rapid growth in mobile access through tablets and smartphones
and the rise of Twitter and other social media. Although this period has also seen substantial changes in
health and care policy and responsibilities, the Department of Health remains committed to giving reliable
and timely health information to the public and patients. The primacy of the internet as a conduit for
essential information is rarely disputed; the UK government has committed that everyone who has the
capacity to be online will be by 2020. In 2015, those without internet access tended to be older and more
disadvantaged with greater health and social care needs; for example, the Office for National Statistics
reported in May 2015 that 27% of adults with disabilities had never used the internet, compared with 11%
of non-disabled adults. Recognising the risk that the shift to online information and service provision in the
NHS might exacerbate current inequalities in access to health information, NHS England is working to widen
digital participation through a programme with the Tinder Foundation (www.tinderfoundation.org).
When we began this programme there was no agreed conceptual and theoretical basis for research on the
effects of accessing other patients’ experiences online. We started the programme with a conceptual
literature review (based on a realist approach), conducted by the principal investigator and coinvestigator
Professor Sally Wyke, to identify the mechanisms through which PEx might influence health. The review
included numerous different types of studies, as well as editorials and opinion pieces, to understand what
might be the positive and negative consequences of looking at other patients’ experiences online. We
concluded that there were seven ways that health might be affected: through finding information, feeling
supported, maintaining relationships, experiencing health services, learning to tell the story, visualising
disease and affecting behaviour. Our review successfully established the theoretical underpinnings for the
study and guided all subsequent WPs. Published in Milbank Quarterly in 2012,4 the review has been widely
cited in the field (38 citations by July 2015 and an Altmetric score of 54, putting the paper in the top 5%
of all publications).
We established that there was no validated outcome measure that could be used to compare the effects
of a ‘facts and figures’ with the effects of a PEx website, and we therefore set about developing and
validating a new measure, the eHIQ, for this purpose. The item pool for the questionnaire was based on a
secondary analysis of qualitative interviews in the HERG archive from a range of conditions, and included
young, middle-aged and older people’s experiences of chronic conditions, cancers, learning disability,
neurodegenerative conditions and mental illness. This proved a highly efficient method of identifying an
item pool.
We conducted online ethnographic studies to observe what happened in online support groups and
interviewed people who participated and managed the sites. The ethnographic study focused on online
MS support groups and examined how people affected by MS (patients, family members and friends)
responded to and interpreted PEx in these settings. Methods included online observations and content
analysis of forums and YouTube videos, particularly in relation to controversial theories and treatments.
This work was important in helping us understand what people actually do in online environments, which
is sometimes in contrast to what they report they do.
We conducted detailed internet café-style laboratory observations to help us to understand the various
ways in which PEx is used in online support groups and how patients use and respond to a variety of
different types of health information websites that present PEx as single stories, testimonials or ‘maximum
variation’ samples. These studies fed into the development of new ‘engagement guidelines’ for
incorporating PEx in websites.
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We conducted three national qualitative interview studies of the experiences of people with asthma, carers
of people with MS and smokers’ experiences of trying to give up. Interviews were collected by experienced
qualitative social scientists based in the principal investigator’s team in Oxford. The interview collections
were analysed and edited so that written, audio and video extracts from the interviews could be published
on three new prototype PEx websites, based on the engagement guidelines. This material has now been
published on three website sections on www.healthtalk.org, where it is available to the public as part of a
voluntary sector website covering over 90 different health conditions. A matched set of three very similar
websites was developed to be used in the feasibility trials; the comparator websites featured information
from NHS Choices without PEx.
The prototype websites and methods for an online trial were piloted. We then conducted a feasibility trial
to see if we could use RCT methods to understand and compare the effects of PEx using prototype
websites on the three exemplar conditions. Finally, we interviewed a subset of 30 of the people who had
participated in the three arms of the feasibility trial.
We demonstrated that it is feasible and acceptable to compare a PEx website with a ‘facts and figures’
website in a randomised trial. However, our findings suggest that, although this may be feasible, the
requirements of our phase II trial design may mean that the websites are used in a way that is divorced
from how people use the internet and other sources of information in real life. Although methods to
evaluate complex interventions can help to address this issue, we believe that challenges remain for
researchers in conceptualising online sources of information and support as interventions with doses
and exposures.
The qualitative interviews with trial participants underlined that everyone wants and needs facts and
figures and that online experiential information is not seen as an alternative to facts, or to care from a
health professional, but is used in addition to other sources of information, support and expression. Future
work needs to ensure that personal stories are not isolated from the rest of the information landscape, in
addition to allowing for the iterative nature of information behaviour.
We have had strong patient and public involvement (PPI) support throughout the programme, led by
coinvestigator Margaret Booth. The project was both consultative and collaborative in user involvement.
We consulted users in preparing the proposal; Margaret Booth attended regular meetings throughout the
programme and ensured that we gave appropriate consideration to when and how to involve members
of the public in advising our design and reflecting on our findings. We have also benefited from a good
link to English health policy through coinvestigator Bob Gann, who has kept us informed about policy
developments and helped to organise presentations of our findings to NHS England colleagues.
In summary, we achieved all that we set out to do and were also able to include some associated studies
(e.g. we were pleased to attract an additional doctoral student to the programme to explore the feasibility
data on health literacy; a doctorate was awarded to Braden O’Neill in 2014).
Limitations
This programme used a mixed-methods and interdisciplinary approach. We made some pragmatic
adaptations to established methods, for example in our wide-ranging conceptual review which deviated
somewhat from a conventional realist review.
The conceptual review provided a framework for the whole programme but we did not draw on a single
overarching theoretically informed approach. Instead, we used relevant theory and methods from the WP
leads, who represented a range of disciplines.
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The leads for the different WPs drew on their own disciplinary backgrounds in medical sociology, public
health, health psychology, health policy, primary care trials and sociology of technology and science.
We believed that the overall aim of the programme was best served through a series of connected, and
regularly communicated, WPs which drew on relevant theory and method from the disciplinary lead of the
package. This seemed preferable, and more mutually respectful, than an approach which attempted to
drive an entire programme of work from one of the contributing disciplines. We were able to do this
because the topic was of central scholarly interest to all of the authors and we were genuinely committed
to learning through an interdisciplinary approach which has enriched our knowledge of the field. Hence
the programme was multiply theoretically informed but not driven by a single theoretical perspective.
Patient experience in policy
During the last 5 years there has been a noticeable shift in the perceived value of PEx in health policy.
The Mid Staffordshire NHS Foundation Trust Public Inquiry and the Francis Report drew attention to the
importance of listening to patients’ experiences and the accounts of their family carers. Analyses of online
feedback and ‘hard’ statistics on hospital trust infection rates suggest that patients and their visitors may
become aware of problems before they are evident to managers. PEx is now viewed as an essential
indicator, indeed the ‘final arbiter’, of heath care, and all attenders at NHS facilities are encouraged to
complete a brief questionnaire (the Friends and Family Test). It is an indication of the importance of PEx in
health policy that there is now a NHS England Director for Patients’ Experience.
Accompanying this focus on collecting PEx, there is increasing emphasis on the need to use what we find
to improve services; indeed, some of us have argued that it is unethical to do otherwise.182 Whereas
policy-makers seem keen that hospital staff should learn from PEx, there is evidence of reluctance, or
uncertainty, from health and care professionals. In January 2015 the National Quality Board published
Improving Experiences of Care: Our Shared Understanding and Ambition, which suggests that there is a
problem in how staff view and value PEx:
If we are to make sure experience is thought of in the same way as other aspects of high-quality care
and that people’s experiences continually improve, there will need to be a fundamental shift in how
people’s experiences are viewed and valued.
National Quality Board.183 Contains public sector information licensed under the
Open Government Licence v3.0
Traditionally, health information has been based on facts and figures, not experiences. There are now
many popular websites containing PEx; for example, healthtalk.org alone received 2 million unique visits in
the first quarter of 2015. Against the backdrop of increased policy interest in learning from PEx to guide
clinical practice and priorities, our programme has shed some light on the role that online PEx has for
people coping with a long-term health condition, caring for someone with MS or contemplating giving
up smoking.
The findings from our observations, internet café studies, exploratory trials and qualitative work all suggest
that, at least in the context of a health issue that affects them or a close friend or family member, people
are cautious and reflective consumers of PEx information. This contrasts with earlier concerns in the
literature that people might be swayed towards inappropriate choices through the power of the patient
‘testimonial’.1,20 Indeed, in the internet café observations and the qualitative studies with trial participants,
people consistently reported, not surprisingly, being more cautious about PEx than about ‘facts and
figures’. There was consensus among the qualitative study participants that everyone wants and needs
facts and figures from a reliable source. When narratives from other patients were valued, it was as a
supplement, not a replacement, for facts and figures from trusted non-commercial sources and advice and
hands-on care from health-care professionals. In practice, some people, at some stages of any particular
illness trajectory, will prefer to see only facts and figures, while others will want to access other people’s
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experiences as an additional source of information, fulfilling a rather different purpose. Admittedly the
distinctions are not always clear-cut, as narratives may incorporate facts (e.g. some narrators mention
evidence about the effects of a treatment). Indeed, we contend that it is precisely the interweaving of lived
experience, biomedical knowledge, creative expression and emotional support that makes PEx so valuable,
and distinguishes it from other sources of health-related information and support.
It would be considered very poor practice to develop a health information leaflet without checking its
readability level and thinking carefully about how facts and figures (e.g. risk information) are conveyed.
The internet, however, is different: material can be presented in numerous different ways and competent
users can choose their own ‘playlist’, selecting the images, videos, text, graphs and interactions that they
want. They can, in effect, fashion their own information landscape.
What we have observed repeatedly in this programme, using different methods and approaches, is that
people personalise the range of resources they may use according to the timing, stage of illness and their
own preferences. There may be times when people prefer to avoid certain facts or particular images,
which is why clear design and signposting are needed. A person may choose to use the web, share
experiences or look at survival data at one stage of their illness and choose not to at another.
We could see a parallel with the growth of personalised medicine and the choice of the right ‘drug’,
before we consider how much and how often it should be given. In the world of personalised medicine,
drug treatments will increasingly be customised for individuals based on their personal genetic and disease
profile. Similarly, our findings on personal preference, timing and need suggest that we need a more
tailored offering, whereby people can select information styles that suit them at a particular moment,
rather than a standard intervention package. The evidence for segmenting and customising in personalised
medicine relies on new forms of ‘big data’, from large cohort studies, biobanks, genome sequencing and
record linkage. In the provision of online information, big data studies – tracking real-life use of high
volume sites and surveying users – may help us to understand better how and why some people benefit
from some information sources and not from others, and who these people are likely to be.
There may be some broad observable patterns in what people ‘on average’ want at different times, but
one of the transformational changes that the internet has brought is that it is no longer relevant to think
of designing a resource that everyone will access in the same manner. The challenge now is to find ways
to conduct robust research in an environment characterised by this highly individual, personalised use.
Recommendations for research
The NIHR and academic community may benefit from research in the following areas (in order of priority).
1. Future intervention research evaluating online health interventions should reflect the way that people
use the internet in everyday life. This is challenging within the specification of a randomised trial,
which is generally designed for repeatable, consistent, controllable exposure. In practice, people search,
browse, digest and comment on multiple information sources to varying degrees, within a landscape
of other sources of help and advice, and with varying personal preferences for types of information.
Although it is possible to package up an online health information intervention in the same way
as a ‘dose’ of a medication, and to administer an exposure by allocating or denying access to the
intervention, researchers need to consider critically if this reflects real information-seeking behaviour.
Further theoretical and methodological work is, therefore, needed to consider the issues of ‘exposure’
and ‘dose’ in the context of online health information interventions. This present programme of work
makes a significant contribution to this area, and the 2008 MRC guidance on developing and evaluating
complex interventions167,175 and the recent additional MRC guidance on process evaluation167,175 can help
to systematically examine these issues in future work.
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2. Future intervention research evaluating online health interventions should examine and explain issues of
engagement and use, and seek to identify how to increase engagement. In common with many online
trials, we showed that actual usage of the website intervention was low (in terms of numbers of logins,
page views and duration on site) for both the intervention and comparator sites. Further research is
required to understand the nature of engagement with online interventions and the determinants of
this. The reliability of tracking data should also be assessed.
3. Future research should harness qualitative methods, including online ethnography and offline interview
research, to further explore how and why people use online sources of experience-based health
information, and what effect this may or may not have on subsequent behaviour and health and social
outcomes in different conditions. In particular, studies might consider who chooses to share experiences
online, who is influenced by these and to what extent online sources of PEx (both solicited and
unsolicited) are representative of patients’ experiences more generally, and, indeed, what representative
means in this context. Areas of particular interest are online patient activism, especially around
contested illnesses and treatments, and online comments on health services (including reviews
and ratings).
4. Future studies evaluating health information websites should make use of the eHIQ, which we have
demonstrated to be an acceptable, valid and reliable measure for examining individual attitudes
towards websites presenting different types of information.
5. In designing online interventions which harness PEx, researchers should note the guidelines on
intervention design. We demonstrated that these guidelines can be successfully applied in building
three intervention and three comparator websites.
6. The seven domains (identified through our review) have been demonstrated to be a valid conceptual
basis for research on how online PEx affects health and should inform research in digital health.
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Chapter 11 Patient and public involvement
I t was planned from the start that there would be an important public role in the research programme.Margaret Booth, who had extensive experience in serving as a lay member and patient representative on
health-related bodies, led this and attended all of the programme steering group meetings.
It was agreed at the first programme steering group meeting in February 2010 that ‘patients and the
public’ for this work should be anyone who used the internet for health information. It would be too
restrictive to confine user involvement to those who used the internet to access PEx. Different public panels
would be convened to inform different WPs as appropriate.
The initial public panel was recruited through an invitation sent via the Oxfordshire Primary Care Trust to lay
people who had previously expressed interest in helping with research of this nature. From 89 respondents,
panellists were selected to maximise representation from a cross-section of the community (gender, age,
occupation and ethnic group). The panel included those who had used the internet for health information in
a variety of ways (websites, forums, blogs) and for a variety of health conditions (either for themselves or on
behalf of family and friends). People who were or had been health professionals were excluded. It was
apparent that non-manual workers were over-represented in the group and so additional user advisors were
invited through personal contacts and snowballing to generate a final panel of 30 individuals.
This panel was maintained throughout the programme. Its members were invited to participate in
subsequent WPs as appropriate. They were sent updates and briefing reports to maintain their interest
and engagement during periods when there was no need for active involvement. A separate panel was
selected to inform the MS work of WP2a. Additional arrangements for public participation were used for
WP3a to correspond to an existing framework.
An initial meeting of the core panel was held in Oxford in November 2010 to introduce the research and
to discuss the preliminary results from WP1a, the literature review. To facilitate attendance, the meeting
took place in the early evening. Travel expenses were reimbursed and an honorarium and refreshments
were offered. A brief presentation by the researchers was followed by discussion in groups facilitated by
members of the research team, who took notes on the discussion. There was then a final overall feedback
and discussion session. Participants were also able to add comments in writing. A note summarising the
conclusions was then sent to the participants. A similar approach was adopted for the two subsequent
public panel sessions (on WP2a and overall dissemination of the results).
Details of the involvement of users in the various WPs and their contribution are set out below.
Work package 1a: the literature review
The public panel was asked to comment on the initial findings of the WP1a conceptual literature review
and, in particular, the advantages and disadvantages of accessing PEx via the internet from the
perspectives of patients and family carers. The panel proved to have a clear appreciation of the pros and
cons of online PEx and provided many comments which largely reflected the findings of the conceptual
review. However, we became aware that the distinction between different types of online information was
not always straightforward to describe or discern in the discussions. This alerted us to the need to provide
clear examples of the different types of website (e.g. in the WP3 qualitative interviews). It was also evident
that not all of the panel had used online PEx. It was not always possible to distinguish comments which
related to PEx from those relating to other types of health information on the internet. In general the
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public panel members tended to concentrate on practical benefits (e.g. the value of the internet for
providing information about a health condition vs. potential drawbacks such as information overload and
the difficulty of identifying inaccurate information). However, some members raised the possible positive
and negative emotional impacts of internet PEx (memorably described by one participant as the dangers of
‘fruitcakes and trolls’). A panel member drew attention to the potential negative consequences for people
with mental illness who might subsequently regret having shared their experience or participated in
forums. This was a new perspective, one not raised in any of the literature we had read, and was included
in the publication based on this WP.4 A report was circulated to the group and feedback was sought. This
WP was drawn on during all subsequent WPs.
Work package 2a: the construction and exchange of multiple
sclerosis-related patient experience on the internet
A specialised public panel was convened. This comprised MS patients and their carers (10 attended on the
day and a further two expressed interest and contributed to later activities). Panellists responded to an
invitation sent through local branches of the MS Society. In November 2011, a meeting was held at which
participants were split into two discussion groups, one for patients and another for carers. In practice, the
carers were not substantial users of the internet for health information of any kind. Some mentioned that
they already used face-to-face support groups (they had, after all, been recruited through a local MS
Society group) and so did not report having much need to seek out or share experiences online. The MS
patients, in contrast, were regular users of the internet both for information about MS and for looking at
others’ experiences and sharing their own (one had a blog). In some cases this was a supplement to
face-to-face groups. Patients and carers valued sharing personal experiences, whatever the medium,
as a source of practical information and personal support. Both groups voiced major concerns about the
quality of information on the internet and the potential for damage through hearing about other people’s
experiences (e.g. if the observer was shocked to hear what might be in store for them). Depression is a
symptom of MS and can affect both the way in which experiences are reported and the way in which
they are received. The patients were well informed about the controversies regarding alternative
treatments for MS and some had participated in internet exchanges about these. However, others
expressed concerns that these controversies had led to some MS forums having an aggressive culture and
that they preferred to use general social networking sites such as Facebook to access other people with MS.
Other valuable points made by patients were that use of the internet is likely to vary over the course of
the condition, with heavier use likely around the time of initial diagnosis. At times, severe MS symptoms
could prevent use of the internet; MS symptoms are very variable and sites for other conditions with similar
symptoms could be valuable to MS patients. A message felt to be important by users was that that
generalisations should be avoided; it is necessary to contextualise internet use and the sharing
of experiences.
Work package 3a: the development of prototype online
interventions based on patient experience
Website interventions were developed based on qualitative analyses of interviews about a wide range
of people’s experiences of quitting smoking, having asthma or caring for friends and family with MS.
In accordance with the HERG’s normal practice, advisory panels were set up for each of these studies.
These comprised representatives from national and local volunteer groups and service users, in addition
to the usual professional stakeholders. They met at an early stage in the work to inform the sampling
strategy and content of the interviews, and again mid-project. The panels also critically reviewed the
thematic summaries that formed the basis of each website.
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Work package 3b: the EXPERT feasibility trial
In preparation for the trial, members of the WP1a and WP2a public panels, together with new recruits chosen
to represent younger age groups and men, were invited to help pilot the methods and advise on various
aspects of the online trial. In total, 47 people participated. They were asked to log in to the trial portal,
complete the baseline measures, view one of the (allocated) six information websites and complete the
follow-up measures. Users were asked to provide feedback on their journey through the process and on the
acceptability of the measures. Feedback was received from 41 users by e-mail and was followed up with a
telephone call. The researchers were particularly interested to learn if the length of the questionnaires and the
time it took to complete them all (both at baseline and at follow-up) were reasonable. The research group
was also interested in the users’ general impression of their allocated website (design and attractiveness,
whether or not it appeared trustworthy, if the tone was appropriate, if it was easy to navigate) and users
were asked to suggest improvements. Where possible, users were given an arm of the trial that was relevant
to them, but the main purpose was to get their views on the process and general impressions, and so no
particular knowledge of the health conditions was needed.
This exercise identified technical problems, a few of which were significant and were resolved. Most
participants navigated the process without substantial problems, although some felt that it was too lengthy.
There were both positive and negative comments about all the websites. Suggested improvements to the
websites were discussed and implemented when feasible; for example, both smoking cessation sites
originally had the ‘no smoking’ sign on their home pages, but this sign was described as too negative by
users who were smokers and it was replaced with another image.
During the recruitment phase for the WP3b trial, it proved difficult to locate and recruit the planned number of
MS carers. An attempt was made to arrange a meeting with members of the MS carers’ panel, carers from the
core panel and people from relevant voluntary organisations to discuss ways to boost recruitment. This proved
to be impractical (it was difficult to find any date and time that was suitable for more than a few people) and
instead members of the MS carers’ panel were asked by e-mail if they could suggest improvements to the
recruitment advertisement and alternative ways to find and recruit carers. Responses were obtained by
telephone and e-mail. As a result, changes were made to recruitment documents and other recruitment routes
pursued, but, despite all efforts, we agreed to close recruitment for the trial with 42 participants.
The lay coinvestigator was also a member of the Trial Steering Committee.
Dissemination of results
A final public panel meeting was held in Oxford on 8 May 2014 to discuss the best way of disseminating
the results of the research project. The members of both the original panel and the MS panel were invited;
nine of the former and two of the latter attended. In addition, there were seven representatives of
voluntary organisations in relevant fields, where possible from the communications departments. Following
an introduction from the research team, the participants were divided into two groups for a discussion.
The representatives of organisations formed one group and public panel members formed a second group.
The meeting concentrated on the results from the conceptual review, health literacy and the web design
guideline work and the proposed dissemination strategy.
There were good discussions in both groups but few additional ideas about dissemination routes for the
study findings. Both groups expressed the view that the term ‘people’ should be used in referring to PEx
and not ‘patient’. They said that people do not generally think of themselves as patients and are interested
in the impact of health conditions on all aspects of their lives, not just on their interactions with health
services. It was felt that websites featuring PEx could be particularly suited to young people and ethnic
minority groups, who are hard to reach with health messages. Ways to disseminate the PEx sites to these
groups include doing so via schools or ‘champions’.
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The groups discussed the role of recommendations from professionals; few of the public panel had been
directed to internet sites by health professionals, and some members said that they were reluctant to
discuss their use of the internet for health information with professionals, especially doctors. This was
partly because of shortage of time during consultations, but some thought that health professionals were
uncomfortable if patients were well informed about their condition and questioned the professionals’
views. This suggests that health professionals may need to find ways to assure patients that their use of
the internet to self-manage their conditions is welcome and appropriate, and that the doctor is happy to
recommend reliable websites.
A member of the original public panel attended and actively participated in the June 2014 meeting on
dissemination held by the research team with representatives of the Department of Health and
NHS England.
Discussion
In a 5-year programme there are challenges in finding the best and most convenient method of involving
users in the research. A number of issues with public participation in the research were identified and
discussed at an early stage of the work. These were as follows.
1. There might be difficulty in selecting an appropriate group of users whose knowledge and experience
were such that they would find participation in a public panel interesting and worthwhile and also
provide a helpful input to the work.
2. When the research involved individuals, these would generally be as members of the public rather
than as patients and the research would relate to their experiences in using the internet for health
information rather than to experiences of obtaining treatment or health care. We anticipated that
care would have to be taken to avoid the public panel merely going over the same ground as study
participants but less rigorously.
3. The research teams responsible for the different WPs were in different parts of the country and the
overall programme covered separate WPs spanning several years. This raised issues of whether there
should be a single public panel or several, and where meetings should be held.
In practice, there was no difficulty in obtaining a good number of volunteers for the original public panel,
although older age groups and professional workers were over-represented. Small numbers of additional
members were invited to join the panels to balance this. The panel members proved to be knowledgeable
about health information on the internet and issues arising from its use. They were interested in the work
and had lively discussions, providing useful material for the researchers. The only problem was that it was
sometimes difficult for those leading the sessions to keep the discussion focused on the topic of online PEx
rather than health information on the internet more generally. Sometimes it was not clear whether a
comment or concern was intended to apply to all types of online health information, or to PEx only.
We decided that we would not try to find some way of involving users in every WP. Participation would be
concentrated in those packages where there was a clear role for the users, distinct from the input of
study participants.
The largest group of research staff was based in Oxford and this, together with the nature of the research
in different locations, made it sensible to base all of the user involvement in Oxford, with appropriate
panels for different WPs. The research project and user involvement continued for some 5 years. It was
difficult to maintain contact with all of the original public panel throughout this period, in spite of the
effort put into doing so. A little under half of the original panel remained actively involved throughout the
period of the research, though most of the MS panel did so.
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Discussions in small groups sparked ideas and brought a range of views to the fore, which was useful to the
research team. We endeavoured to ensure that meetings were interesting and enjoyable for participants.
However, it could be difficult to arrange meetings at a time convenient for all members of the panels. The
larger meetings required the involvement of a considerable number of the research team as it was desirable
to have separate members of the team facilitating and recording all the discussions. Other approaches,
such as contacting individual members of the panels by e-mail and/or telephone, had both advantages and
disadvantages. The nature of the research meant that all members of the public panels were experienced
users of the internet and happy to communicate and comment by e-mail. It was essential for them to
comment on the trial process for WP3b after following it through on the internet. When it was possible to
discuss views over the telephone, these could be explored fully, and people who were not confident about
speaking in a group may have been more forthcoming in one-to-one conversations. However, conducting
and recording telephone calls was time-consuming. Comments made only in e-mails tended to be briefer
and lacked the opportunity for development and discussion that was afforded by the face-to-face
group meetings.
Lessons learned
Organising PPI uses time and resources. It is important to use the public only in ways which give the
participants a genuinely useful and worthwhile role in the research and justify both their input and that of
the research team.
Members of the public are likely to have a wide range of views largely reflecting their personal experience.
Those volunteering to be members of PPI groups may hold particularly strong views which may not lead to
clear consensus.
It might have resulted in better and more focussed discussions, especially on dissemination, if material on
the topics to be discussed had been sent to participants in advance. However, to do so would have
required an even greater time commitment from the participants, as well as the preparation of new
material by the research team.
It was a challenge to maintain the involvement of the same members of the original public panel
throughout the long period of the research. We tried to mitigate this with e-mail updates. We also needed
to supplement the original panel of PPI volunteers with under-represented sociodemographic groups at
later stages of the programme.
It can be difficult to arrange face-to-face meetings of a PPI group, especially if the health conditions of
members restrict their mobility or a relatively uncommon condition means that they are drawn from a wide
geographical area. In this programme there were particular challenges in convening the MS and MS carers
group, but the point is generalisable to other health conditions.
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Sally Wyke (Coinvestigator, Deputy Director, Institute of Health and Wellbeing, University of Glasgow)
contributed to the overall study design, worked closely with Sue Ziebland on the conceptual review (WP1a)
and provided expert guidance throughout, especially on the development of the WP1c assessment tool.
She coauthored the WP1a chapter, sat on the programme steering group, contributed to the final report
and gave final approval of the manuscript.
Elizabeth Sillence (Coinvestigator, Senior Lecturer in Psychology, Northumbria University) contributed to
the overall study design, contributed to WP2b on the development of the guidelines on how best to
present experiential information online and coauthored the WP2b chapter. She sat on the programme
steering group, contributed to the final report and gave final approval of the manuscript.
Peter Harris (Coinvestigator, Professor of Psychology, University of Sussex) contributed to the overall study
design, contributed to WP2b on the development of the guidelines on how best to present experiential
information online and coauthored the WP2b chapter. He was also a member of the EXPERT Trial Steering
Committee and sat on the programme steering group. He contributed to the final report and gave final
approval of the manuscript.
Rafael Perera (Coinvestigator, Professor of Medical Statistics, University of Oxford) contributed to the
overall study design, was heavily involved in the development of the protocol and the statistical analysis
plan for the EXPERT trial (WP3b), sat on the programme steering group, contributed to the final report and
gave final approval of the manuscript.
Fadhila Mazanderani (Chancellors’ Fellow, University of Edinburgh) contributed to the design of and was
the main researcher on WP1b (secondary analyses of narrative interviews) and WP2a (exploration of the
exchange of PEx in online communities). She also worked closely with Braden O’Neill, who conducted the
health literacy work with the asthma data from the EXPERT trial. She sat on the programme steering
group, coauthored the WP1b and WP2a chapters, contributed to the final report and gave final approval
of the manuscript.
Angela Martin (Programme Co-ordinator, University of Oxford) managed and contributed to all WPs bar
WP2b, coauthored the chapter describing WP3a, sat on the steering group, contributed to the final report
and gave final approval of the manuscript.
Louise Locock (Director of Applied Research, HERG, University of Oxford) contributed to the overall study
design and to the conduct of WP1b and WP2a. She contributed to the qualitative study on experiences of
asthma (WP3a), and conducted a large proportion of the qualitative interviews with trial participants
(WP3b). She coauthored the chapter describing WP3b and the discussion. She sat on the programme
steering group, contributed to the final report and gave final approval of the manuscript.
Laura Kelly (Researcher, University of Oxford) contributed to the design of and was the main researcher
on WP1c, development of the eHIQ. She sat on the programme steering group, coauthored the chapter
describing WP1c, contributed to the final report and gave final approval of the manuscript.
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Margaret Booth (Coinvestigator and Lay Representative) contributed to the design of the PPI activities that
informed WP1a (the conceptual review), WP2a (the exploration of the exchange of PEx in online communities)
and the piloting of the participant journey through the EXPERT trial. She was a member of the EXPERT Trial
Steering Committee, sat on the programme steering group, wrote the PPI chapter of the final report and gave
final approval of the manuscript.
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to the overall study design and was involved throughout by providing insight into the relevance of the
programme for NHS information policy. He sat on the programme steering group, contributed to the final
report and gave final approval of the manuscript.
Nicola Newhouse (Researcher, University of Oxford) contributed to the design and development of the
EXPERT trial websites (WP3a), was the main researcher responsible for the EXPERT piloting work and was
part of the EXPERT trial team (WP3b). She sat on the programme steering group, contributed to the report
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overall study design, was involved in the initial development of the protocol for the EXPERT trial (WP3b),
sat on the programme steering group, contributed to the final report, in particular the chapter describing
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Publications
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affected by motor neurone disease. Chronic Illn 2012;8:201–13.
Mazanderani F, Locock L, Powell J. Being differently the same: an exploration of the mediation of identity
tensions in the sharing of illness experiences. Soc Sci Med 2012;74:546–53.
O’Neill B, Mazanderani F, Powell J. ‘People power’ or ‘pester power’? YouTube, multiple sclerosis, and the
liberation procedure. Lancet 2012;380:S20.
Ziebland S, Wyke S. Health and illness in a connected world: how might sharing experiences on the
internet affect people’s health? Milbank Q 2012;90:219–49.
Hughes N, Locock L, Ziebland S. Personal identity and the role of ‘carer’ among relatives and friends of
people with multiple sclerosis. Soc Sci Med 2013;96:78–85.
Kelly L, Jenkinson C, Ziebland S. Measuring the effects of online health information for patients: item
generation for an e-health impact questionnaire. Patient Educ Couns 2013;93:433–8.
Mazanderani F, Locock L, Powell J. Biographical value: towards a conceptualisaton of the commodification
of illness narratives in contemporary healthcare. Sociol Health Ill 2013;35:891–905.
Mazanderani F, O’Neill B, Powell J. ‘People power’ or ‘pester power’? YouTube as a forum for the
generation of evidence and patient advocacy. Patient Educ Couns 2013;93:420–5.
Mazanderani F, Powell J. Using the Internet as a Source of Information about Patients’ Experiences.
In Ziebland S, Coulter A, Calabrese JD, Locock L, editors. Understanding and Using Health Experiences:
Improving Patient Care. Oxford: Oxford University Press; 2013. pp. 94–103.
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experiences? Patient Educ Couns 2013;93:439–43.
Sillence E, Hardy C, Briggs P, Harris PR. Online health information and patient adherence. J Patient
Compliance 2013;2:24–6.
O’Neill B, Gonçalves D, Ricci-Cabello I, Ziebland S, Valderas J. An overview of self-administered health
literacy instruments. PLOS ONE 2014;9:e109110.
Kelly L, Ziebland S, Jenkinson C. Measuring the effects of online health information: scale validation for the
e-Health Impact Questionnaire. Patient Educ Couns 2015;98:1418–24.
Sillence E, Briggs P. A Timeline to Approach the Study of Trust and Engagement in Online Health and
Wellness. In Sundar SS, editor. The Handbook of Psychology and Communication Technology.
West Sussex: Wiley-Blackwell; 2015. pp. 469–87.
Sillence E, Hardy C, Briggs P, Harris PR. How do carers of people with multiple sclerosis engage with
websites containing the personal experiences of other carers and patients? [Published online ahead of print
11 October 2015.] Health Inform J 2015.
Newhouse N, Martin A, Jawad S, Yu L-M, Davoudianfar M, Locock L, et al. Randomised feasibility study
of a novel experience-based Internet intervention to support self-management in chronic asthma.
BMJ Open 2016; in press.
Powell J, Newhouse N, Martin A, Jawad S, Yu L-M, Davoudianfar M, Locock L, Ziebland S. A novel
experience-based internet intervention for smoking cessation: feasibility randomised controlled trial.
BMC Public Health 2016; in press.
Conference presentations
Work package 1a and overview
Ziebland S, Wyke S. Health and Illness in a Wired World: How Might Access to Patients Experiences on the
Internet Affect People’s Health? Oral presentation given at the 25th British Computing Society conference
on Human-Computer Interaction as part of an iPEx organised workshop, ‘Online patient experience (PEx)
and its role in e-health’, Northumbria University, Newcastle upon Tyne, UK, July 2011.
Wyke S, Ziebland S. Health in (Y)our Hands. Oral presentation, Radboud University, Nijmegen, the Netherlands,
October 2012.
Wyke S, Ziebland S. Health and Illness in a Connected World: How Might Patients’ Experiences on the
Internet Affect People’s Health? Oral presentation, University of British Colombia, Vancouver, BC, Canada,
November 2011.
Ziebland S. Health and Illness in a Connected World. Keynote. Qualitative Inquiry Conference, Ben Gurion
University, Negev, Israel, February 2012.
Ziebland S. Health and Illness in a Connected World. Invited seminar, DIPEx International and Social Change,
University of Monash, Melbourne, VIC, Australia, February 2012.
Ziebland S. The Rise of ‘Patients’ Experiences’: Evidence, Distraction or Final Arbiter. Cochrane Lecture,
London School of Hygiene and Tropical Medicine, Society for Social Medicine, 2012.
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Ziebland S, Wyke S. Health and Illness in a Connected World: How Might Sharing Experiences on the
Internet Affect People’s Health? Abstract and oral presentation, Science and Technology Studies Unit
Conference, University of York, York, UK, July 2012.
Ziebland S, Wyke S. Health and Illness in a Connected World: How Might Sharing Experiences on the
Internet Affect People’s Health? Oral presentation, British Sociological Association Medical Sociology
Annual Conference, University of Leicester, Leicester, UK, September 2012.
Ziebland S, Powell J, Wyke S, Locock L, Farmer A, Perera R, et al. Examining the Role of Patients’
Experiences as a Resource for Choice and Decision-Making in Health Care: An NIHR Programme for
Applied Research. South West Society for Academic Primary Care, January 2013.
Work package 1b
Mazanderani F, Powell J, Locock L. Being Differently the Same in the Sharing of Experiences in Healthcare.
Oral presentation given at the 25th British Computing Society conference on Human-Computer Interaction
as part of an iPEx organised workshop, ‘Online patient experience (PEx) and its role in ehealth’,
Northumbria University, Newcastle upon Tyne, UK, July 2011.
Mazanderani F, Powell J, Locock L. Biographical Value: Exploring the Economics, Epistemics and Ethics of
Patients’ Experiential Narratives. Oral presentation given at the British Sociological Association, Medical
Sociology Annual Conference, University of Chester, Chester, UK, September 2011.
Work package 1c
Hardy C, Hinton L. Mazanderani F, Kelly L. Communicating with Other Patients Online: Exploring the
Effects of Sharing Health Experiences on the Internet. Oral presentation given at the European Association
of Communication in Healthcare Annual Conference, as part of an iPEx organised symposium,
‘Communicating with other patients online: exploring the effects of sharing health experiences on the
internet,’ University of St Andrews, St Andrews, UK, September 2012.
Kelly L, Jenkinson C, Ziebland S. Measuring the Effects of Exposure to Health Websites. Oral presentation
given at the European Association of Communication in Healthcare Annual Conference as part of an iPEx
organised symposium, ‘Communicating with other patients online: exploring the effects of sharing health
experiences on the internet,’ University of St Andrews, St Andrews, UK, September 2012.
Kelly L, Ziebland S, Jenkinson C. Developing and Pre-Testing an Item Pool Relating to the Effects of
Exposure to Health Websites. Abstract and poster presentation at International Society for Quality of Life
Research, Budapest, Hungary, October 2012.
Kelly L, Simpson H, Verjee-Lorenz A, Clayson D, Churchman D, Jenkinson C, Ziebland S. Translatability
Assessment of the e-Health Impact Questionnaire (eHIQ). Poster presentation at the 18th International
Society of Pharmacoeconomics and Outcomes Research, New Orleans, LA, May 2013.
Kelly L, Simpson H, Two R, Ziebland S, Jenkinson C. Measuring the Effects of Using Health-Related
Websites: Translatability Assessment of Questionnaire Items in the E-Health Impact Questionnaire (eHIQ).
Poster presentation at Med 2.0, London, UK, September 2013.
Kelly L, Jenkinson C, Ziebland S. Developing a Tool to Measure the Effects of using Health-Related
Websites (the e-Health Impact Questionnaire). Oral presentation, International Society for Quality of Life
Research, Miami, FL, October 2013.
Kelly L, Ziebland S, Jenkinson C. The e-Health Impact Questionnaire: Developing a Tool to Measure the
Effects of using Health-Related Websites. Value Health 2013;16:A605. Poster presented at International
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Society of Pharmacoeconomics and Outcomes Research 16th Annual European Congress, Dublin, Ireland,
November 2013.
Work package 2a
Mazanderani F, Powell J. Bodies of Knowledge: Reconfiguring Multiple Sclerosis as a Vascular Disease.
Making (In)Appropriate Bodies Conference, hosted by the Science Studies Department, University of
Vienna, Vienna, Austria, December 2011.
Mazanderani F, Powell J. Anecdote and Evidence: Social Media and the Enactment of ‘Proof’ in a
Controversial Theory about Multiple Sclerosis. Oral presentation, The Co-Production of Knowledge: Social
Media, STS and . . ., hosted by the University of York, York, UK, July 2012.
Mazanderani F, Powell J. Platforms, Patients and the Production of Experience. Oral presentation given at
the European Association of Communication in Healthcare Annual Conference as part of an iPEx organised
symposium, ‘Communicating with other patients online: exploring the effects of sharing health experiences
on the internet’, University of St Andrews, St Andrews, UK, September 2012.
Mazanderani F, Powell J. An Aesthetics of Care? Attraction, Attachment and Alignment in Online Multiple
Sclerosis Communities. Abstract and oral presentation, Society for Social Studies of Science and European
Association for the Study of Science and Technology Joint Conference, Copenhagen, Denmark,
October 2012.
O’Neill BG, Mazanderani F, Powell J. ‘People Power’ or ‘Pester Power’? YouTube as a Forum for the
Generation of Evidence and Patient Advocacy. Oral presentation, Royal Society of Medicine, London, UK,
November 2012.
Mazanderani F. Illness Narratives, Experiential Knowledge and Contemporary Regimes of ‘Living With’
Disease. Oral presentation, Medical Sociology Annual Conference, University of York, York, UK,
September 2013.
Mazanderani F, O’Neill B, Powell, J. YouTube and Patient Activism: Online Video and the Generation of
‘Experiential’ Evidence. Oral presentation, Med 2.0, London, UK, September 2013.
Mazanderani F and Powell J. When Bodies Fall Apart. Internet Use, Patient Activism and the Mediation of
Medical Knowledge. Oral presentation, Medical Sociology Annual Conference, University of York, York,
UK, September 2013.
O’Neill B, Ziebland S, Powell J. Health Literacy and the Internet: EXperiences Evaluated in a Randomised
Trial (EXPERT). Oral presentation, Connected Life, Oxford, UK, 2014.
Work package 2b
Mo P, Sillence E, Briggs P, Harris P. What Kind of Information on Smoking Cessation is Available Online?
A Content Analysis of Common Websites. Oral presentation, 25th British Computing Society conference on
Human–Computer Interaction as part of an iPEx organised workshop ‘Online patient experience (PEx) and
its role in ehealth’, Northumbria University, Newcastle upon Tyne, UK, July 2011.
Hardy C, Sillence E, Briggs P, Harris PR. A Toolkit Approach for eHealth research: Using Focus Groups,
Interviews, Data Logging, and Eye Tracking to Examine Individuals across a Range of Health Conditions.
Oral presentation, European Association of Communication in Healthcare Annual Conference as part of an
iPEx organised symposium ‘Communicating with other patients online: exploring the effects of sharing
health experiences on the internet’, University of St Andrews, St Andrews, UK, September 2012.
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Hardy C, Sillence E, Briggs P, Harris P. Engaging With Online Patient Experiences: Exploring Differences
Between Health Groups. Abstract and oral presentation, Global Health Conference, Venice, Austria,
October 2012.
Briggs P, Hardy C, Sillence E, Harris P. An Engagement Framework for Understanding the Communication
Needs of Different Health Groups. Poster and extended abstract, CHI Conference on Human Factors in
Computing Systems, Paris, France, 27 April–2 May 2013.
Sillence E, Hardy C, Briggs P. Why Don’t We Trust Health Websites that Help Us Help Each Other?
ACM Web Science 2013, Paris, May 2013.
Hardy C, Sillence E, Briggs P, Harris P. Online Peer-to-Peer Healthcare: Exploring Push-Pull Factors of
Engagement. Oral presentation, Med 2.0, London, UK, September 2013.
Briggs P, Hardy C, Harris PR, Sillence E. Patient-led Perspectives on eHealth: How Might Hyperpersonal
Data inform Design? Proceedings of HCIK, ACM Press, Korea, 2014.
Sillence E, Hardy C, Harris P, Briggs P. Modelling Patient Engagement in Peer-to-Peer Healthcare.
23rd International World Wide Web Conference, Korea, April 2014.
Sillence E, Harris P, Briggs P. Assessing Patient Experience and Patient Preference when Designing Web
Support for Smoking Cessation. Extended abstract and oral presentation, Association for Computing
Machinery conference on Digital Health, Florence, Italy, May 2015.
Work package 3a
Hughes N. Personal Identity and Caring: Stories Told by Relatives and Friends of People with Multiple
Sclerosis. Oral presentation, Contemporary Narratives of Care, Birkbeck, London, October 2013.
Kirkpatrick S, Locock L, Salisbury H, Ziebland S. ‘I’d Always Seen Myself as Invincible but Suddenly I’d Got
this Condition that Wasn’t Going to Go Away’: The Emotional Impact of a Diagnosis of Asthma in
Adulthood. British Sociological Association Medical Sociology Annual Conference, Aston University,
Birmingham, UK, September 2014.
Hughes N. Personal identity and role of ‘carer’ among relatives and friends of people with MS. Oral
presentation, 6th National Conference for Psychologists Working in MS, Genoa, Italy, October 2014.
Work package 3b
Newhouse N, Ziebland S, Locock L, Perera R, Farmer A, Powell J. Sharing Experiences Online: Design of a
Randomised Trial to Determine the Feasibility and Efficacy of Three Novel Internet-Based Interventions
Based on Patient Experience. Oral presentation, Med 2.0, London, UK, September 2013.
Newhouse N. The EXPERT study: Patient Experience as Information Resource: What Does the Right ‘Dose’
Look Like? Oral presentation, UK Society for Behavioural Medicine, Oxford, UK, December 2013.
Powell J, Ziebland S, Newhouse N. The EXPERT Study: Randomised Controlled Trial of an Internet-Based
Intervention Harnessing Patient Experiences to Support Self-Management of Asthma. Oral presentation,
Med 2.0, Malaga, Spain, October 2014.
Newhouse N. The EXPERT Study. Patient Experience as Information Resource: What Does the Right ‘Dose’
Look Like? Oral presentation, Centre for Behaviour Change Conference, London, UK, February 2015.
Powell P, Newhouse N, Martin A, Jawad S, Yu L-M, Davoudianfar M, et al. Randomised Feasibility Study of
a Novel Experience-based Internet Intervention for Smoking Cessation. Poster presentation, Association for
Computing Machinery Conference on Digital Health, Florence, Italy, May 2015.
ACKNOWLEDGEMENTS
NIHR Journals Library www.journalslibrary.nihr.ac.uk
140
Powell P, Newhouse N, Martin A, Jawad S, Yu L-M, Davoudianfar M, et al. The EXPERT Study: Feasibility
Randomised Controlled Trial of an Internet-Based Intervention using Patient Experience to Support
Self-Management of Asthma. Oral presentation, Society for Academic Primary Care Conference, Oxford,
UK, July 2015.
Overarching programme
Ziebland S. Health and Illness in a Connected World: Understanding the Role and Value of ‘Patients’
Experiences’ Online. British Sociological Association Medical Sociology South Coast Conference, Brighton,
UK, July 2015.
Other outputs
Series of presentations for undergraduate students from Radboud University, Nijmegen, the Netherlands,
October 2013:
l O’Neill B. ‘People Power’ or ‘Pester Power’? YouTube as a Forum for the Generation of Evidence and
Patient Advocacy.
l Newhouse N. EXPERT Trial.
l O’Neill B. Technology of Stories: Health Literacy and EXPERT.
A secondary analysis of the asthma qualitative interviews in WP3a contributed to the evidence considered
by the National Institute for Health and Care Excellence Quality Standard on asthma.
A new website on experiences of asthma: www.healthtalk.org/asthma.
A new website on experiences of giving up smoking: www.healthtalk.org/giving-up-smoking.
A new resource for the family and friends of people with MS: www.healthtalk.org/ms-friends-family.
Examining the Role of Patients’ Experiences as a Resource for Choice and Decision-Making in Health Care.
iPEx programme dissemination event for senior policy-makers, London, June 2014.
Examining the Role of Patients’ Experiences as a Resource for Choice and Decision-Making in Health Care.
iPEx programme final dissemination event, London, June 2015.
Data sharing statement
Data can be obtained on application to the corresponding author, Professor Sue Ziebland:
e-mail sue.ziebland@phc.ox.ac.uk.
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1 SYNOPSIS 
Study Title Experience of a Health Website Evaluated in a Research Study 
(EXPERT): An exploratory study to assess feasibility and 
measure the impact of online health information, (experiential and 
fact-based) for self-management of asthma, motivation to stop 
smoking, and preparedness for caring for someone with multiple 
sclerosis. 
Internal ref. no. JP/EXPERT/0005 
Study Participants Males and Females over 18 living in the UK with internet access 
and one of three conditions: someone self-managing their 
asthma; someone who smokes but has a willingness to quit; or 
someone who is a carer of a person with multiple sclerosis. 
Planned Sample 
Size 
Approximately 300 participants 
Follow-up duration Two weeks from recruitment to final follow-up measure 
(questionnaire). 
Planned Study 
Period 
Seventeen months (January 2013 to May 2014) 
Primary Objective To estimate the feasibility issues in an online randomised study 
providing an active and comparator information based website 
intervention. 
Secondary 
Objectives 
1. To assess the efficacy of two types of online health 
information (patient experience accounts compared with 
non-experience based information) on a range of self-
reported outcomes. 
2. To measure the impact of the intervention and comparator 
websites using the eHealth Impact Questionnaire (eHIQ) 
3. To explore whether the interventions have differential 
effects on pre-specified subgroups of participants. 
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Primary Endpoint The feasibility endpoints are as follows: 
 Number of participants providing consent  
 Total recruitment (number of participants randomised to a 
website allocation)  
 Number of participants with complete 
records/measurements (completed all baseline and follow 
up measures and at least one website log in recorded) 
 Number of participants with partial 
records/measurements (completed at least one baseline 
or follow up measure and/or at least one website log in 
recorded) 
 Usage of intervention and comparator sites (total number 
of log ins, total number of pages visited, total usage 
duration). 
 Number of participants lost to follow up or withdrawn  
Secondary 
Endpoints 
 
 
 
 
Our outcome measures for efficacy (comparing change from 
baseline to 2-week follow-up between intervention and 
comparator groups) are as follows: 
1. Asthma: Partners in Health (PIH, 12-item) 
2. Smoking: Motivation To Stop Scale (MTSS, single item, 8 
point scale) 
3. Caring: Preparedness for Caregiving Scale (PFCS, 8-item) 
Our secondary outcome measures are: 
1. For all participants: eHealth Impact Questionnaire (eHIQ); 
SF36 physical dimension and mental dimension 
summary scores; and the following SF36 subscales: 
mental health (also known as the MHI-5), physical 
functioning, role physical, bodily pain, general health 
perceptions, vitality, social functioning, and role 
emotional.  
2. Additionally for Asthma: Chronic Disease Self-efficacy 
Scale (6-item); Single-item control question. 
3. Additionally for Smoking: Abstinence rates (single 
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question); quit attempts (single question); Smoking 
Abstinence Self-efficacy Questionnaire (SASEQ, 6-item) 
2 ABBREVIATIONS 
AE Adverse event 
AR  Adverse reaction 
CRF Case Report Form 
DMC Data Monitoring Committee 
eHIQ Electronic Health Impact Questionnaire 
GCP Good Clinical Practice 
GP General Practitioner 
IB Investigators Brochure 
ICF Informed Consent Form 
ICH International Conference of Harmonisation 
NIHR National Institute for Health Research 
NRES National Research Ethics Service  
PC-CTU Primary Care – Clinical Trials Unit 
PEx Patient Experience 
PI Principal Investigator 
PIS Participant/ Patient Information Sheet 
R&D NHS Trust Research and Development Department 
REC Research Ethics Committee 
SAE Serious Adverse Event 
SAP Statistical Analysis Plan 
SOP Standard Operating Procedure 
TMC Trial Management Committee 
TMF Trial Master File 
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TSC Trial Steering Committee 
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3 BACKGROUND AND RATIONALE 
The provision of reliable, relevant and timely health information for the public and patients is 
fundamental to the delivery of the National Health Service. “High Quality Care for All” (2008) 
stresses the importance of an NHS that gives patients and the public more information and choice‚ 
and has quality of care at its heart‚’ (1). The Department of Health’s strategy “The Power Of 
Information: Putting all of us in control of the health and care information we need” (2012) (2) 
recognises the change in the way people access information and sets out a ten year framework to 
ensure information and new technologies are harnessed to achieve high quality care and improve 
outcomes for patients and service users.   The NHS has already recognised the potential of internet 
patient experiences (PEx). The NHS Choices website includes videos of individual experiences as 
well as explanations of treatments and conditions.  
 
Traditionally, authoritative health information has been based on facts and figures, not on the 
experiences of patients. However, people facing a new diagnosis or health related decision, or 
living with a long term condition, often feel that they need to know how others have experienced 
what they are going through (3).  People seek knowledge about their health from others who have 
been through the same experiences (4-6). They now routinely do this via the internet (7). Sharing 
experiences is part of a wider shift in the relationship between lay and medical expertise (8, 9) but 
not all groups engage with online patient experiences in the same way (10).   
 
Hearing other patients’ experiences has the potential to affect decision-making, one’s sense of 
isolation or support, and adjustment to the illness or health condition (11). At the same time there 
are concerns that testimonials, or unmoderated comments, may combine a powerful and 
memorable delivery with a misleading message (12). Experiential information is not an alternative to 
existing medical evidence and may influence different, complementary health related domains, such 
as support, decision-making, knowledge, self-care, coping and anxiety. Our current work indicates a 
range of domains that could be affected by exposure to online PEx. These include: finding 
information, feeling supported, maintaining relationships with others, affecting behaviour and 
experiencing health services, a further two (learning to tell the story and visualising disease) are 
less acknowledged but important features of online resources (13). However, we know relatively 
little about how people use and evaluate online PEx; there are no generic assessment tools 
sensitive to measure the impact of PEx, and thus we remain unsure whether, when and how the 
NHS should provide information based on other patients’ experiences. The provision of PEx for 
NHS users needs as firm an evidence base to support its collation and provision as all other health 
information (14). This evidence needs to be embedded in clinical practice, where feasibility and 
acceptability are crucial and evaluated in a randomised controlled study. 
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In this study we are therefore proposing to evaluate the impact of online health information websites 
containing information derived from patients’ experiences (their narrative accounts of health and 
illness) in three exemplar conditions, and compare this impact with that of three comparator 
websites which contain facts and figures (and information from health professionals) but no 
experiential information from patients. Our three exemplar conditions have been chosen to assess 
the impact of experiential information on (1) confidence to self-manage a chronic disease (asthma); 
(2) motivation to change an unhealthy behaviour (smoking); (3) preparedness to undertake a caring 
role (carers of people with multiple sclerosis). Our theoretical work suggests that these are three of 
the several ways in which experiential information may be beneficial. We are also measuring the 
impact of all six websites using a new bespoke tool, the eHealth Impact Questionnaire, and 
examining any changes on mental health scores and quality of life scores. This research proposes 
an exploratory study; that is, our main aim is to establish the feasibility of undertaking this research 
and to identify any emergent evidence of efficacy or harm. Our intention is to use the knowledge 
from this study to inform further, more pragmatic, effectiveness research in future. 
4 OBJECTIVES 
4.1 Primary Objective 
To evaluate the feasibility issues in an online randomised study providing health information 
websites containing patient experience information compared with matched health information 
websites that do not contain experiential information. 
4.2 Secondary Objectives 
1. To assess the efficacy of two types of online health information (patient experience 
accounts compared with matched health information websites that do not contain experiential 
information) on a range of self-reported outcomes. 
2. To measure the impact of the intervention and comparator websites using the eHealth 
Impact Questionnaire (eHIQ) 
3. To explore whether the interventions have differential effects on pre-specified subgroups 
of participants. 
5 STUDY DESIGN 
5.1 Summary of Study Design 
This is a randomised, controlled single-blind study.  We have chosen three exemplar conditions – 
asthma, smoking cessation and carers of individuals with multiple sclerosis.  For each condition we 
have created two websites, one containing patient experience information (active intervention) and 
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the other containing information based solely on facts and figures and no experienced based 
information (comparator).  Recruitment of participants eligible for the asthma and smoking cessation 
arms of the study will be through primary care.  In addition we would like to recruit smokers willing 
to quit by placing adverts in newspapers, online and in public places where smokers are likely to 
see them.  Participants eligible for the carers of people with multiple sclerosis arm will be recruited 
through various routes including neurology clinics, newspaper adverts, website adverts, voluntary 
groups, online forums and social networking sites.  All eligible participants will be sent a patient 
information sheet and consent form by post to be signed and returned to the research office.  
Participants will be asked to provide baseline measures prior to the allocation of the intervention or 
comparator website.  They will then be given the opportunity to create a unique user ID and 
password which will allow them unlimited access to their allocated website for two weeks.  
Participants’ website use will be tracked so we will be able to tell how many times a participant 
accessed the site, the number and type of pages viewed, the amount of time spent using the 
website, as well as any search terms used to find information on the site.  After two weeks, 
participants will be asked to provide follow up measures and they will no longer have access to their 
website.  A selection of participants will be invited for interview after completion of the study. 
Interviews will be conducted by an experienced qualitative researcher in the participant’s home or at 
another suitable location acceptable to the participant. Most communication with participants will be 
via email but we may also telephone participants to request they complete follow up questionnaires.  
Those participants invited for interview will be contacted by telephone or email and the interview 
itself will be conducted in person. 
5.2 Primary Endpoints/Outcome Measures 
The primary outcome measures in this exploratory study concern feasibility, and will be assessed 
regularly during the recruitment period and at the end of the study as totals and split by the three 
conditions asthma, smoking cessation, and carers, to include: 
 Number of participants providing consent  
 Total Recruitment (number of participants randomised to a website allocation)  
 Number of participants with complete records/measurements (completed all baseline and follow 
up measures and at least one website log in recorded) 
 Number of participants with partially completed records/measurements (completed at least one 
baseline or follow up measure and/or at least one website log in recorded) 
 Usage of intervention and control sites 
 Number of participants lost to follow up or withdrawn (lost to follow up defined as randomised 
participants who can no longer be contacted or do not respond to requests from the research 
team and withdrawn defined as participants who have asked not to be contacted). 
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5.2.1 Secondary Endpoints/Outcome Measures 
 Our secondary endpoints comprise outcome measures for efficacy (comparing change from 
baseline to 2-week follow-up between intervention and comparator groups). The primary 
measures for efficacy are as follows: 
1. Asthma: Partners in Health (PIH, 12-item) 
2. Smoking: Motivation To Stop Scale (MTSS, single item, 8 point scale) 
3. Caring: Preparedness for Caregiving Scale (PFCS, 8-item) 
 
Our secondary measures for efficacy are: 
1. For all participants: 
a. eHealth Impact Questionnaire (eHIQ); 
b. SF36 physical dimension and mental dimension; 
c. SF36 subscales (mental health, physical functioning, role physical, bodily pain, 
 general health perceptions, vitality, social functioning and role emotional. 
2. Additionally for Asthma: 
a. Chronic Disease Self-efficacy Scale (6-item); 
b. Single-item control question. 
3. Additionally for Smoking: 
a. Abstinence rates (single question); 
b. Quit attempts (single question); 
c. Smoking Abstinence Self-efficacy Questionnaire (SASEQ, 6-item) 
5.3 Study Participants 
5.3.1 Overall Description of Study Participants 
Study participants will be male or female, over the age of 18, resident in the UK and with access to 
the internet.  They will either have asthma, be smokers with a willingness to quit, or be carers of a 
person with multiple sclerosis. Participants who match more than one condition can only be 
included once.  Only one participant per household can be included. 
5.3.2 Inclusion Criteria 
1. Smokers 
a. People who are current smokers, who have been smokers for at least a year, and who 
indicate some willingness to quit, including those referred to smoking cessation 
services. 
b. Male or female aged 18 or over. 
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c. Willing and able to give informed consent for participation in the study. 
d. Live in England. 
e. Have access to the internet and able to use websites. 
 
2. People with asthma 
a. People who have been clinically diagnosed asthma as coded in their primary care 
electronic record, and who have been prescribed inhaled corticosteroids for at least 3 
months in the previous year.  
b. Male or female aged 18 or over. 
c. Willing and able to give informed consent for participation in the study. 
d. Live in England. 
e. Have access to the internet and able to use websites. 
 
3. Carers of people with multiple sclerosis 
a. People who identify themselves as a caregiver for another person who has a diagnosis 
of multiple sclerosis. 
b. Male or female aged 18 or over.   
c. Willing and able to give informed consent for participation in the study. 
d. Live in England. 
e. Have access to the internet and able to use websites. 
5.3.3 Exclusion Criteria 
1. Smokers 
a. People who are terminally ill. 
b. People who cannot understand English. 
c. People who have previously entered the study. 
d. People who have another significant disease or disorder which, in the opinion of the 
GP, may either put that person at risk because of participation in the study, or may 
influence the result of the study, or affect that person’s ability to participate in the study. 
 
2. People with asthma 
a. People who are terminally ill. 
b. People who cannot understand English. 
c. People who have previously entered the study. 
d. People who have another significant disease or disorder which, in the opinion of the 
GP, may either put that person at risk because of participation in the study, or may 
influence the result of the study, or affect that person’s ability to participate in the study. 
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3. Carers of people with multiple sclerosis 
a. People who are terminally ill. 
b. People who cannot understand English. 
c. People who have previously entered the study. 
d. People who have a significant disease or disorder which, in the opinion of the Principal 
Investigator, may either put that person at risk because of participation in the study, or 
may influence the result of the study, or affect that person’s ability to participate in the 
study. 
e. People whose only caring role is in a professional (paid) capacity. 
5.4 Expenses and Benefits 
There are no financial costs to participants in taking part in the study and we will therefore not be 
reimbursing expenses or providing other financial benefits. It is hoped that participants will benefit from the 
health information provided in their allocated website.  For participants who take part in the interviews, we 
will reimburse travel expenses for an interview not conducted in their own home. Interview participants will 
not receive any other payments. 
5.5 Study Procedures 
5.5.1 Recruitment 
For the asthma and smoking cessation study arms, we will work with the Primary Care Research 
Network to identify GPs at practices who would be interested in taking part.  We will then contact 
practice GPs with information about the study and ask them to identify eligible participants based on 
the inclusion and exclusion criteria specified in this protocol.  We will request that they screen for 
eligible patients via database searches and knowledge of their patient population. We will provide 
the GP with study documents to send to eligible participants to include: a covering letter, patient 
information sheet, consent form, contact details form and reply-paid envelope. In addition we would 
like to recruit smokers willing to quit by placing adverts in newspapers, online and in public places 
where smokers are likely to see them. These advertisements will invite interested potential 
participants to contact the research office for further information and provide their contact details. 
The Trial Manager will then send them the study documents as described above. 
 
For carers of people with multiple sclerosis, we will have an open recruitment process with 
advertisements for study participants placed in secondary care clinics, venues for community and 
carers groups, newspapers, and in charity and NHS newsletters, websites and in online social 
media aimed at carers. These advertisements will invite interested potential participants to contact 
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the research office for further information and provide their contact details. The Trial Manager will 
then send them study documents as outlined above. 
 
We will also recruit carers of people with Multiple Sclerosis through Primary Care in GP practices 
who are willing and able to participate.  We will provide the GP with study documents to send to 
eligible participants to include: a covering letter, patient information sheet, consent form, contact 
details form and reply-paid envelope.  We will ask that the GP does not contact anyone that meets 
the exclusion criteria for MS Carers. 
 
In addition we would like to be able to recruit carers of someone with Multiple Sclerosis by providing 
them with a Participant Information Sheet & Consent form directly.  Information sheets & consent 
forms could be distributed at conferences for carers or at carers’ group meetings, or other suitable 
venues and events.  Potential participants would be able to read through the information booklet 
and discuss the study before agreeing to take part, or could take the information away with them 
and, if they decided to take part, could return the completed consent form by post.  Potential 
participants wishing to take the form away would be provided with a FREEPOST envelope to return 
it in. 
 
5.5.2 Informed Consent 
For all recruitment methods, potential participants will be invited to read the patient information 
sheet and discuss the study with others before deciding whether to take part and to contact the 
research team with any questions (contact details will be provided in the information sheet).  If the 
participant agrees to take part, they will be asked to complete the consent and contact details form 
and return this to the research office in a reply-paid envelope. The information sheet outlines the 
purpose of the study and details what will happen to the participant if they consent to take part. It 
also states that the participant is free to withdraw from the study at any time for any reason and with 
no obligation to give the reason for withdrawal and that this will not affect their future care.  There is 
no time limit between participants receiving the Patient Information Sheet and providing consent 
within the recruitment period. A copy of the signed Informed Consent will be retained by the 
participant and a copy sent to the participant’s GP if they were recruited through primary care. 
 
Once a completed consent and contact details form is received by the research office, the Trial 
Manager (or other appropriate member of the research team), will enter the participant’s details into 
a secure, password-protected online Trial Management Portal (see screen-shot below), to include 
condition (asthma, smoking cessation or carer), first name, last name, email address, consent form 
received. 
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5.5.3 Collection of baseline measures 
A unique ‘Welcome Code’ will be generated and automatically sent by email to the participant with a 
link to the study registration webpage.  The Trial Manager will be emailed confirmation that the 
participant has been sent their Welcome Code.  If after one week the participant has not used their 
Welcome Code, a reminder will be sent by automatic email inviting them to visit the study 
registration page.   If the participant no longer wishes to take part they can simply ignore this 
reminder.  If the participant does wish to take part they can use the link in the email to access the 
study registration page where they will be asked to complete some online questionnaires.  Whilst 
completing these questionnaires participants can navigate back and forth through the sections to 
make any amendments as required.  They will also be prompted if questions are left blank but they 
are not required to answer all the questions before proceeding. 
APPENDIX 1
NIHR Journals Library www.journalslibrary.nihr.ac.uk
170
31st October 2013 Version 4.0  
 
EXPERT: Experience of a Health Website Evaluated in a Research Study 
JP/EXPERT/005. Protocol. Version 4.0 31/10/2013 
 
CONFIDENTIAL Page 17 of 31 
5.5.4 Allocation to intervention or comparator, and blinding 
Once the participant submits their questionnaire answers (baseline data) by clicking ‘finish’ they are 
randomised into the study and allocated a website. Participants will be randomised in a 1:1 ratio 
between the intervention and comparator websites in each of the three study arms.  
They will be invited to create a unique User ID and Password and will be provided with an on-
screen link to their allocated website as well as being sent email confirmation. Access to the 
website will be available for two weeks for each participant. 
 
Because of the nature of the intervention and comparator (information-based websites) it is not 
possible to completely blind participants. However in the information for participants we will only 
explain that our intention is to find out whether or not people find health information websites useful 
and if so, how best to provide health information online. In this way we hope that participants will 
not be aware of our primary hypothesis regarding the differential effect of experiential information. 
The investigators looking at questionnaire data will be blind to the allocation of intervention or 
comparator during study recruitment, administration of interventions, and analysis.  The website 
usage data and qualitative interviews will be reviewed and analysed separately by researchers 
based in the Health Experiences Research Group who will not be blind to allocation due to the 
nature of the data. 
5.5.5 Reminders, usage data, and follow-up outcome measures 
At 2, 6 and 10 days after completing baseline data all participants will be sent automated email 
reminders to visit their allocated website.  Any visits to the website will be recorded and tracked. At 
the end of the two week period the participant will be emailed to request that they complete the 
follow up questionnaires and will be given a link to the questionnaires website.  At this point access 
to the allocated information website is withdrawn.  Participants who do not complete follow up 
questionnaires will be sent reminders by email every day for up to two days after the due date (a 
maximum of two reminders).  After completion of follow up questionnaires participants will be 
emailed to thank them for taking part and reminded that we may contact them again to invite them 
for interview.  The Trial Manager will be sent details of participants who have not completed follow 
up questionnaires after receiving two reminders.  The Trial Manager or other designated member of 
the research team will contact these participants by telephone to request they complete follow up 
questionnaires.  Any participants withdrawn or lost to follow up will be flagged appropriately. 
5.6 Follow-up interviews 
A subset of study participants will be invited to be interviewed by an experienced qualitative 
researcher from the Health Experiences Research Group, Department of Primary Health Care 
Sciences, University of Oxford.  These interviews will be undertaken to explore with participants 
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their attitudes and behaviour in relation to their allocated websites and other sites they may use, as 
well as their views on participating in the research. Participants selected will be contacted by 
telephone or email; those who agree to be interviewed will be sent a separate Patient Information 
Sheet and consent form and arrangements will be made for when and where the interview will take 
place.  The participants will be selected for maximum variation to give us as diverse a sample as 
possible. For each of the six websites, we will include people of both genders and of different age 
brackets, people who demonstrate a high and low usage of their allocated website and 
questionnaire responders and non-responders. The sampling method seeks to achieve 
representation of the diversity of experiences, rather than numerical representation. Analysis and 
data collection will proceed simultaneously during the recruitment period and continue until ‘data 
saturation’ is reached to ensure that the widest practical range of experiences has been included. 
Participants will be contacted as soon as possible after the deadline for submission of follow up 
questionnaires.  We hope to interview 20 to 30 people. 
5.7 Definition of End of the Study 
The end of the study is the date when the last participant submits their follow up questionnaires or 
the last participant is interviewed, whichever is later. 
5.8 Discontinuation/ Withdrawal of Participants from the Study  
A participant may withdraw from the study at any time without providing a reason.  Participants can 
notify the research team of their wish to withdraw by contacting the research office.  If a participant 
does withdraw from the study they may also request that any data already provided by them is 
deleted. This is explained in the Patient Information Sheet.  If a participant does not complete follow 
up measures and does not respond to reminders or requests to complete follow up measures they 
will be considered lost to follow up.  Any data from participants lost to follow up will continue to be 
used in the study. The Principal Investigator may withdraw a participant from the study at any time if 
necessary in accordance with Good Clinical Practice. 
5.9 Source Data 
Source data will include baseline and follow up questionnaires (electronic format) as well as 
consent and contact forms.  It will also include website usage data. 
6 DETAILS OF STUDY INTERVENTION 
6.1 Description of study intervention 
The intervention is a password protected, multi-media internet site based on guidelines developed 
as part of the NIHR funded programme grant RP-PG-0608-10147. For each condition (asthma, 
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smoking cessation, carer) two websites have been developed one containing patient experience 
information and the other containing information solely based on facts and figures with no 
experience-based content.  Participants will be randomised to have access to one or other of these 
websites within the relevant condition.  The comparator sites share the design and multimedia (such 
as video) features of the intervention sites but the content excludes any accounts of personal 
experience. They use source material from the national health information portal NHS Choices with 
all experiential information removed.  
6.2 Assessment of use of the website 
User activity will be tracked by both page views (number and type) and interaction with web pages 
e.g. if a participant views videos or listens to audio clips.  We will also track whether participants use 
the search facility and what search words they use. The recorded data will be linked to baseline and 
follow-up questionnaire data by a unique participant ID number. IP addresses will not be stored.     
 
Tracking data will be collected in the following ways by individual user: 
● Total visits to site (including times and date stamps) 
● Total time spent on site 
● Total number of page views  
● Breakdown of session times (start and finish) 
● Breakdown of page type visited and time spent on each. There will be eight page types: home 
page; topic summary page; categories page; interviewee page; video clip page; audio clip page; 
text only clip page; text only glossary page 
● Breakdown of clips viewed and length of time they were viewed for, split by the three formats: 
video, audio, and text only 
● If a user has JavaScript disabled in their browser this will be recorded 
 
6.3 Measures to guard against contamination 
There is a theoretical risk of contamination (i.e. patients allocated to one of the websites viewing the 
other website). In this study the websites have been developed specifically for the study and are 
only available to study participants, accessible only with username and password. Nevertheless it is 
possible that people with access to one of the websites might share their login details with others, 
or might otherwise copy the content and share it outside the study setting. We will ask participants 
not to divulge their individual username and password, or otherwise allow other people access to 
the website or its content.  We will not recruit people who share a household.  We will explain that 
we are monitoring participants’ use of the site, and that giving access to other people will make it 
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difficult to interpret the data.  We will ask about possible contamination in our qualitative interviews 
with a subset of participants and in a single question to all participants at follow-up. 
7 SAFETY REPORTING 
The intervention and comparator websites delivered in this study are low-risk information-only 
interventions and do not require any change in standard clinical management of the patients 
recruited to this study. Participants who have concerns about their health after viewing information 
provided on their allocated website will be advised to contact their GP or NHS Direct.  Participants 
will be able to comment on the website content that they are asked to view and these comments will 
be reviewed regularly by a member of the research office.  Any concerns expressed about website 
content will be reported to the Trial Steering Committee for review. 
8 STATISTICS 
 Analysis and reporting of results will conform to CONSORT guidelines, as follows: 
 Study flow will be reported using a CONSORT diagram. 
 Any deviations from the protocol will be reported, with reasons. 
 We will report dates of recruitment and follow-up. 
 We will report baseline characteristics of both groups (intervention and comparator). 
 Analyses will be on an intention to treat basis, and the number of included participants will be 
clearly stated. 
 For each primary and secondary outcome measure, a summary of results for each group will be 
reported, together with the estimated effect size and its precision. 
 We will report any other analyses performed, including subgroup analyses and adjusted 
analyses.  These will be highlighted as hypothesis generating instead of hypothesis testing 
analyses in the final report 
 We will report any concerns expressed by participants as detailed in section 7 Safety Reporting 
above. 
A detailed statistical analysis plan is to be produced separately by the Primary Care Clinical Trials 
Unit statistician. Our primary objective is to establish the feasibility issues in this study. For this 
analysis the focus will be on determining overall feasibility parameters for the whole study and not 
on comparisons between intervention arms (secondary endpoints/outcomes of effectiveness). 
These parameters are: 
 Number of participants providing consent  
 Recruitment rates (number of participants randomised to a website allocation)  
 Number of participants with complete records/measurements (completed all baseline and follow 
up measures and at least one website log in recorded) 
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 Number of participants with partially completed records/measurements (completed at least one 
baseline or follow up measure and/or at least one website log in recorded) 
 Usage of intervention and control sites 
 Number of participants lost to follow up or withdrawn (lost to follow up defined as randomised 
participants who can no longer be contacted or do not respond to requests from the research 
team and withdrawn defined as participants who have asked not to be contacted). 
 
Except for usage of intervention and control sites, all these will be summarized using rates reported 
as a percentage with 95% confidence intervals.  Usage will be summarized using means and 
standard deviations or if deemed highly skewed median and interquartile ranges. Use of the search 
facility and search terms will be reported using multiple descriptive statistics (frequency of terms 
used).  We will carry out exploratory comparisons between groups which will be based on 
percentages, means of continuous normally distributed variables or medians for skewed data, to 
evaluate unexpected differences between the arms which could impact on feasibility. Appropriate 
measures of dispersion will be reported.  
 
Our secondary objective is to compare change from baseline to 2-week follow-up between 
intervention and comparator groups on a range of self-reported measures, as follows: 
1. Asthma: 
a. Primary outcome 
i. Partners in Health (PIH, 12-item) 
b. Secondary outcomes 
i. Chronic Disease Self-efficacy Scale (6-item); 
ii. Single-item control question. 
iii. eHealth Impact Questionnaire (eHIQ); 
iv. SF36 physical dimension and mental dimension; 
v. SF36 subscales (mental health, physical functioning, role physical, bodily pain, 
general health perceptions, vitality, social functioning and role emotional). 
2. Smoking: 
a. Primary outcome 
i. Motivation To Stop Scale (MTSS, single item, 8 point scale) 
b. Secondary outcomes 
i. Abstinence rates (single question); 
ii. Quit attempts (single question); 
iii. Smoking Abstinence Self-efficacy Questionnaire (SASEQ, 6-item) 
iv. eHealth Impact Questionnaire (eHIQ); 
DOI: 10.3310/pgfar04170 PROGRAMME GRANTS FOR APPLIED RESEARCH 2016 VOL. 4 NO. 17
© Copyright: The University of Oxford 2010
175
31st October 2013 Version 4.0  
 
EXPERT: Experience of a Health Website Evaluated in a Research Study 
JP/EXPERT/005. Protocol. Version 4.0 31/10/2013 
 
CONFIDENTIAL Page 22 of 31 
v. SF36 physical dimension and mental dimension; 
vi. SF 36 subscales (mental health, physical functioning, role physical, bodily pain, 
general health perceptions, vitality, social functioning and role emotional) 
 
3. Caring: 
a. Primary outcome 
i. Preparedness for Caregiving Scale (PFCS, 8-item) 
b. Secondary outcomes 
i. eHealth Impact Questionnaire (eHIQ); 
ii. SF36 physical dimension and mental dimension 
iii. SF36 subscales (mental health, physical functioning, role physical, bodily pain, 
general health perceptions, vitality, social functioning and role emotional). 
 
We will also, in a cross-sectional analysis, compare the scores on the eHealth Impact Questionnaire 
(eHIQ) at the 2 week follow-up point between the two groups. 
 
Outcomes will be compared using chi-square tests of significance for categorical data (including 
binary data) and t-tests for continuous data. For binary data logistic regression will be used to explore 
potential confounding and to investigate explanatory variables. Categorical outcomes will be 
dichotomized and logistic regression will be used as well. For continuous outcomes, these analyses 
will be based on linear regression models (if necessary after transformation of data to comply with 
normality and homoscedasticity assumptions).  ANCOVA based on adjustment for non-evenly 
distributed characteristics between the groups at baseline will be used to test for differences in 
outcomes between intervention and control groups. 
 
For all outcomes we will investigate interactions with age, sex, ethnicity, educational attainment, 
internet use and ability, measures of disease severity, general health status, level of social support, 
level of health literacy, life orientation score (LOT-R), baseline mental health score, and usage of the 
intervention. 
 
We will include descriptive statistics to characterise participants in terms of baseline characteristics; 
CONSORT diagram of the flow of participants through the study, and proportion who completed each 
stage to study entry; and usage of intervention in terms of total visits to site, total time on site, and 
total number of website pages visited. 
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We will undertake pre-specified subgroup analyses on the following subgroups: 
 High self rated internet ability versus low self-rated 
 High level of self reported social support versus low 
 High self-rated health literacy versus low 
 High educational attainment versus low educational attainment groups 
 Optimism versus pessimism trait according to LOT-R instrument 
The baseline data of those who entered the study but did not complete follow up according to the 
study protocol, and those who did, will be compared to determine how representative the study 
results are and to investigate any potential threats to validity from differential losses to follow up in 
each arm. 
The investigators undertaking analysis will be blind to the allocation of intervention or comparator. 
Qualitative Component 
Interview transcripts will be analysed by the qualitative researcher responsible for the data  
collection.  The transcripts will be coded and entered into a specialist software package such as  
NVivo10 which will be used to organise and analyse anticipated and emergent themes using the  
method of constant comparison.  
8.1 The Number of Participants 
We are aiming to recruit a total of 300 participants – 100 in each of the three groups (smoking 
cessation, asthma and MS carers).  The focus of the study is to assess feasibility which could usually 
be addressed using a smaller sample (30-40 per condition ref).  However, this sample size would 
provide enough power to estimate acceptability judged by engagement with the PEx components of 
the site with a precision of plus or minus 14% within each condition/arm (50 participants) and 8% for 
the whole study /per arm (150 participants).   This is based on a worst case scenario of acceptability 
being of 50%.  Assuming acceptability to be in the region of 80%, we estimate that with 150 patients 
in the PEx group for each of the three conditions a 95% confidence interval would have a lower limit 
of 73% and a higher limit of 87%. 
 
Based on a balanced randomisation to active:control groups in a ratio of 1:1 (i.e. 50 intervention, 50 
comparator) we should be able to detect potential large effects of the PEx component.  For 
dichotomous outcomes these are equivalent to relative risks of 2.1 or above for a baseline rate of 
30% or less given an alpha of 0.05 and 90% power; while for continuous outcomes these detectable 
differences would be of the order of .4SDs based on the same power and significance.  We anticipate 
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that these differences in questionnaire measures between the groups would translate into small to 
moderate effect size differences on a clinical outcome in a larger pragmatic trial. 
8.2 The Level of Statistical Significance 
The primary analysis will be contingent on achieving P=0.05. Pre-specified secondary analyses will 
also be powered at P=0.05.  
8.3 Criteria for the Termination of the Study. 
It is not thought that the study will need to be terminated early due to safety concerns.   Any 
concerns about website content and the safety of participants that arise during the course of the 
study will be reviewed by the Trial Steering Committee and we will act on their advice as 
appropriate. 
8.4 Procedure for Accounting for Missing, Unused, and Spurious Data. 
We have not defined any procedures a priori to account for missing, unused or spurious data.  As 
part of the primary objective of assessing feasibility, the rate of missing values is highly relevant and 
will be an important outcome included in the final report. We will therefore report data on attrition 
rates, compliance (website visit) and completion of outcome measures, which should help to define 
these procedures for the full study.  A detailed description will be included in the Statistical Analysis 
plan (SAP) as specified in the PC-CTU’s SOP “Statistical Analysis Plan”. 
8.5 Procedures for Reporting any Deviation(s) from the Original Statistical Plan 
We do not anticipate any deviation from the statistical plan outlined above. However, provision for 
alternative methods and changes to analyses will be included in the SAP.   
8.6 Inclusion in Analysis 
We will analyse our data using an intention to treat analysis.  All eligible, randomised and evaluable 
participants will be included in the analysis. Details of this primary analysis and secondary analyses 
(per-protocol population) will be included in the SAP.  
9 DIRECT ACCESS TO SOURCE DATA/DOCUMENTS  
Direct access will be granted to authorised representatives from the sponsor and host institution to 
permit study -related monitoring, audits and inspections. 
10 QUALITY CONTROL AND QUALITY ASSURANCE PROCEDURES  
The study will be conducted in accordance with the current approved protocol, ICH GCP, and PC-
CTU SOP “Quality Management”. A risk assessment has been conducted in conjunction with PC-
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CTU Quality Assurance Manager and a monitoring plan agreed.  Monitoring will be carried out by 
the PC-CTU Quality Assurance Manager, Trial Manager or other appointed person.  PC-CTU data 
will be evaluated for compliance with the protocol and accuracy in relation to source documents 
where possible. Following PC-CTU SOP “Monitoring of Clinical Trials”, the monitor(s) will verify that 
the study is conducted in compliance with GCP and the study protocol.  
 
The Trial Management Committee (TMC) will be responsible for the monitoring of all aspects of the 
study’s conduct and progress and will ensure that the protocol is adhered to and that appropriate 
action is taken to safeguard participants and the quality of the study itself. The TMC will be 
comprised of individuals responsible for the study’s day to day management and will meet regularly 
throughout the course of the study.  
 
A Trial Steering Committee (TSC) will be convened to provide independent oversight of the study 
and ensure its conduct is in accordance with the protocol. As this study involves a low-risk 
intervention, it is not considered necessary to convene a separate DMC so members of the TSC will 
perform this role and review the data. 
11 ETHICS 
Due to the type of intervention used in this study we do not believe that there are any significant 
ethical issues. 
11.1 Declaration of Helsinki 
The Principal Investigator will ensure that this study is conducted in accordance with the principles 
of the Declaration of Helsinki. 
11.2 ICH Guidelines for Good Clinical Practice 
The Principal Investigator will ensure that this study is conducted in accordance with the principles 
of the ICH Guidelines for Good Clinical Practice (July 1996). 
11.3 Approvals 
All study material will be submitted to an appropriate Research Ethics Committee (REC), relevant 
R&D departments and host institution(s) for written approval.   
The Principal Investigator will submit and, where necessary, obtain approval from the above parties 
for all substantial amendments to the original approved documents.     
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11.4 Participant Confidentiality 
The study staff will ensure that participants’ anonymity is maintained.  Patient contact details will be 
collected and stored separately from baseline and follow up data and according to PC-CTU 
guidelines.  Participant’s personal data will be stored electronically in an encrypted and password 
protected file and only accessible by authorised study personnel.  All paper documents will be 
stored securely in locked filing cabinets in the Department of Primary Health Care Sciences, 
University of Oxford.  Participants will be allocated a unique study reference number which will be 
used in the study database and linked to the data provided via the online questionnaires so this can 
be analysed anonymously.  This database will be stored on a secure University of Oxford server 
and will be password protected.    
12 DATA HANDLING AND RECORD KEEPING 
Consent and contact details will be collected on paper forms and sent to the research office by the 
participant using reply-paid envelopes.  Paper forms will be stored according to PC-CTU SOP 
“Document Control”.  MS Carers who respond to advertisements may provide their name and contact 
details via email in which case the data will be entered and stored in a secure, password protected 
electronic file and the original email will be deleted.  Baseline and follow up data will be collected 
electronically via secure forms on a password protected website portal and then be transferred to a 
clinical database management system (CDMS), OpenClinica.  This database will be held on a secure 
University of Oxford server and be password protected.   The collection, transfer and storage of 
personal data will comply with the Data Protection Act, clinical trial guidelines and PC-CTU Standard 
Operating Procedures relating to Data Management.  Data completeness will be monitored regularly 
by the PC-CTU Data Manager. At the conclusion of the study all essential documents will be archived 
in accordance with the PC-CTU SOP “Archiving” and stored for at least five years from the end of the 
study.  The Principal Investigator is responsible for authorising retrieval and disposal of archived 
material. 
13 FINANCE AND INSURANCE 
The study is funded until the end of January 2015 and forms part of a larger programme grant 
awarded by the NIHR (reference number RP-PG-0608-10147).  
13.1 Compensation for harm 
Negligent Harm: Indemnity and/or compensation for negligent harm arising specifically from an 
accidental injury for which the University is legally liable as the Research Sponsor will be covered 
by the University of Oxford. The NHS will owe a duty of care to those undergoing clinical treatment, 
with Trust Indemnity available through the NHS Litigation Authority Scheme. 
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14 PUBLICATION POLICY 
The Investigators will be involved in reviewing drafts of the manuscripts, abstracts, press releases 
and any other publications arising from the study. Authors will acknowledge that the study was 
funded by the NIHR Programme Grant (RP-PG-0608-10147). Authorship will be determined in 
accordance with the ICMJE guidelines and other contributors will be acknowledged. 
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16  APPENDIX 1 
Asthma Eligibility Flow Chart 
 
 
  
 Is the participant over 18? 
Does the participant live in England? 
 
Does the participant have access to 
the internet and able to use websites? 
Is the participant able to give informed 
consent? 
 
Is the participant terminally ill or have 
another significant disease or disorder 
which will affect their ability to 
participate? 
Can the participant read English? 
Has the participant been clinically 
diagnosed with asthma as coded in 
their primary care electronic record, 
and been prescribed inhaled 
corticosteroids for at least 3 months in 
the previous year? 
YES 
YES 
YES 
YES 
YES 
 
Ineligible 
NO 
NO 
NO 
NO 
YES 
NO 
YES NO 
Eligible for 
EXPERT 
Study 
NO 
Asthma 
Eligibility 
Flow  
Chart
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17 APPENDIX 2 
Smoking Eligibility Flow Chart 
 
  
 Is the participant over 18? 
Does the participant live in England? 
 
Does the participant have access to 
the internet and able to use websites? 
Is the participant able to give informed 
consent? 
 
Is the participant terminally ill or have 
another significant disease or disorder 
which will affect their ability to 
participate? 
Can the participant read English? 
Is the participant a current smoker and 
been smoking for at least a year and 
now indicated a willingness to quit? 
 
YES 
YES 
YES 
YES 
YES 
 
Ineligible 
NO 
NO 
NO 
NO 
YES 
NO 
YES NO 
Eligible for  
EXPERT 
Study 
NO 
Smoking 
Eligibility 
Flow  
Chart 
APPENDIX 1
NIHR Journals Library www.journalslibrary.nihr.ac.uk
184
31st October 2013 Version 4.0  
 
EXPERT: Experience of a Health Website Evaluated in a Research Study 
JP/EXPERT/005. Protocol. Version 4.0 31/10/2013 
 
CONFIDENTIAL Page 31 of 31 
18 APPENDIX 3 
MS Carers Eligibility Flow Chart 
 
 
 Is the participant over 18? 
Does the participant live in England? 
 
Does the participant have access to 
the internet and able to use websites? 
Is the participant  able to give informed 
consent? 
 
Is the participant  terminally ill or have 
a significant disease or disorder which 
will affect their ability to participate? 
Can the participant read  English? 
Does the participant care for a friend 
or family member who has multiple 
sclerosis (not in a professional, paid 
capacity). 
YES 
YES 
YES 
YES 
YES 
 
Ineligible 
NO 
NO 
NO 
NO 
YES 
NO 
YES NO 
Eligible for 
EXPERT 
Study 
NO 
MS Carer 
Eligibility 
Flow  
Chart 
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Appendix 2 Topic guides for the EXPERT
qualitative interviews
EXPERT qualitative interviews with trial participants: patient
experience version
DO NOT UNBLIND.
Preamble
You have been taking part in a trial of different types of health website. We’d like to hear your views
about taking part in the study, and understand more about how people may use such sites and why.
Reassure that this is not a test.
l Could you start by telling me why you agreed to take part?
l What were you expecting would be involved?
l Did it meet your expectations?
l What browser did you use?
Part A: ‘process questions’
General usage
Turning now to how you used the site:
l How often do you think you visited the site?
l How much time did you spend on it?
l How did you decide what to look at?
Feelings about it
l What do you think about the design of the site?
l Tell me what you thought about it . . . (Pick up burden, pleasure, etc.)
l What did you get from it? Did you find it useful? Interesting?
l Likes or dislikes?
l Was there anything you did not know before?
l Did you come across anything that worried you?
l Anything you think was missing from the site?
l Has looking at the site made you feel differently about giving up smoking/having asthma/looking after
a relative with MS? In what way?
Specific questions about the design of the patient experience site
l Was it user friendly?
l Were all the links working?
l Did you notice that you could comment?
l IF YES: what did you feel about the opportunity to comment – did you? If not, any reason why not?
Would you like to see other people’s comments too on a site like this one? (May need to explain that
we did not show any comments so we made sure everyone in the trial saw the same thing.)
l Explore specific comments.
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l Also, whether participants are reluctant to be the first to leave a comment; is a comment needed first.
[Also analyse qualitative comments.] Consequences of comments on others’ experiences.
Clip use and selection
l Did you look at any of the interview clips (video, audio, written)?
l Did you have a preference for video or written text (i.e. did they listen to the clip or read the transcript)?
l How did you choose which clips to look at?
l How much do you want to know about the people whose clips you looked at (did you want to know
anything that wasn’t available on the site?)
l Was there enough information in strapline (show examples)? Would shorter/longer straplines have
been more inviting?
Trustworthiness
l Anything misleading? Why?
l What it was about it that led to you feeling that way (e.g. how it was presented, or who was
providing it)?
Further action/health service use
l Did it encourage you to talk to other people about what you found? Or go to the doctor’s?
Using other sites
l If you hadn’t been looking at this site would you have been looking elsewhere? (This is to learn about
the landscape of use.)
l Did looking at it encourage you to look at other materials (on other websites, books, etc.)?
l Do you use other health websites occasionally or regularly? Which? Why?
NOTE: encourage comparisons with other named sites – we will avoid surfing during the interview but are
very happy to look at sites afterwards if people want to show them to us.
l One of our aims in running this study is to see how practical it is to run a trial comparing different
health websites. This means we’ve been testing a lot of things for the first time, such as the
questionnaire measures, the log-in process, setting up the websites . . .
l Can you tell us what the process of taking part was like and whether there are any practical or
technical aspects you think we could improve in future?
Part B: principles of PEx and other content – a key area
We’d like to talk a bit now about the different types of health-related content that people may visit online.
Broadly, we might distinguish between web site content that is:
l content provided by professionals or medical charities – facts and figures about conditions
l collections of people’s experiences of particular health issues or conditions
l individual people’s blogs about their health
l patients’ forums/chat rooms
l feedback and reputation sites about people’s experience of particular services.
Show laminated cards
l What do you think of all these different types of site?
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l Do you use any similar sites yourself?
l Would you be interested in doing so?
l Which sort/why?
Encourage people to speak freely and mention any other sites they are
familiar with
l We wonder why it is people in general may use various websites like these – what do you think?
l We are interested in what it may do for them, what might be positive?
l And what about the downsides?
l How do you think looking at any of these different kinds of content may affect how much people use
health services? (More? Less?)
l What difference does it make seeing pictures on websites, those people upload themselves, anything
you’d prefer not to see? (Visualisation domain.)
l Where people are looking at other people’s health experiences do you think they look for positive
experiences of ‘success stories’, for example stories showing how other people have coped?
l Or is it also useful to see accounts from people who are finding it all too much?
PART C: sharing your own experiences
We are interested to know what you think about sharing your own experiences with other people (apart
from health professionals).
l Have you ever told people who you do not know, or do not know well, about your experiences of
asthma/being a carer/trying to give up smoking? This might be in a face to face support group,
an interview, an article, in an online forum or blog, or in a book.
l Do you feel you ever would?
l Are there some types of experiences you think people might be more or less likely to tell others about
(expand if possible).
l Do you feel any more likely to tell YOUR story since seeing these other people’s experiences – if so,
why do you think this might be? If not, why not – has it put you off in any way? Do you feel that your
experiences are already covered and there is no need to add?
l Other reasons – would be good to explore this quite thoroughly since not much known about why
people do and don’t.
Final questions
‘Trade off‘ questions.
l If voluntary organisations and the NHS are going to fund websites what type of content do you think it
is most important for them to provide (could ask respondents to rank the laminated cards and tell
us why)?
l Would you like a summary of the findings in due course?
EXPERT qualitative interviews with trial participants:
non-patient experience version
DO NOT UNBLIND.
Preamble
You have been taking part in a trial of different types of health website. We’d like to hear your views
about taking part in the study, and understand more about how people may use such sites and why.
Reassure that this is not a test.
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l Could you start by telling me why you agreed to take part?
l What were you expecting would be involved?
l Did it meet your expectations?
l What browser did you use?
Part A: ‘process questions’
General usage
Turning now to how you used the site:
l How often do you think you visited the site?
l How much time did you spend on it?
l How did you decide what to look at?
Feelings about it
l What do you think about the design of the site?
l Tell me what you thought about it . . . (Pick up burden, pleasure, etc.)
l What did you get from it? Did you find it useful? Interesting?
l Likes or dislikes?
l Was there anything you did not know before?
l Did you come across anything that worried you?
l Anything you think was missing from the site?
l Has looking at the site made you feel differently about giving up smoking/having asthma/looking after
a relative with MS? In what way?
Specific questions about the design of the non-patient experience site
l Was it user friendly?
l Were all the links working?
l Did you notice that you could comment?
l IF YES: what did you feel about the opportunity to comment – did you? If not, any reason why not?
Would you like to see other people’s comments too on a site like this one? (May need to explain that
we did not show any comments so we made sure everyone in the trial saw the same thing.)
l Explore specific comments.
l Also, whether participants are reluctant to be the first to leave a comment; is a comment needed first.
[Also analyse qualitative comments.] Consequences of comments on others’ experiences.
Clip use and selection
l Did you look at any of the HP interview clips?
l Did you have a preference for video or written text (i.e. did they listen to the clip or read the transcript)?
l How did you choose which clips to look at?
l Did you want to know anything that wasn’t available on the site?
l Was there enough information in the strapline (show examples). Would shorter/longer straplines have
been more inviting?
Trustworthiness
l Anything misleading? Why?
l What was it about it that led to you feeling that way? (e.g. how it was presented, or who was
providing it. NB – all health professionals).
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Further action/health service use
l Did it encourage you to talk to other people about what you found? Or go to the doctor’s?
Using other sites
l If you hadn’t been looking at this site would you have been looking elsewhere? (This is to learn about
the landscape of use.)
l Did looking at it encourage you to look at other materials (on other websites, books, etc.)?
l Do you use other health websites occasionally or regularly? Which? Why?
NOTE: encourage comparisons with other named sites – we will avoid surfing during the interview but are
very happy to look at sites afterwards if people want to show them to us.
l One of our aims in running this study is to see how practical it is to run a trial comparing different
health websites. This means we’ve been testing a lot of things for the first time, such as the
questionnaire measures, the log-in process, setting up the websites.
l Can you tell us what the process of taking part was like and whether there are any practical or
technical aspects you think we could improve in future?
Part B: principles of patient experience and other content – a key area
We’d like to talk a bit now about the different types of health-related content that people may visit online.
Broadly, we might distinguish between website content that is:
l content provided by professionals or medical charities – facts and figures about conditions
l collections of people’s experiences of particular health issues or conditions
l individual people’s blogs about their health
l patients’ forums/chat rooms
l feedback and reputation sites about people’s experience of particular services.
Show laminated cards
l What do you think of all these different types of site?
l Do you use any similar sites yourself?
l Would you be interested in doing so?
l Which sort/why?
Encourage people to speak freely and mention any other sites they are
familiar with
l We wonder why it is people in general may use various websites like these – what do you think?
l We are interested in what it may do for them, what might be positive?
l And what about the downsides?
l How do you think looking at any of these different kinds of content may affect how much people use
health services? (More? Less?)
l What difference does it make seeing pictures on websites, those people upload themselves, anything
you’d prefer not to see? (Visualisation domain.)
l Where people are looking at other people’s health experiences do you think they look for positive
experiences of ‘success stories’, for example stories showing how other people have coped?
l Or is it also useful to see accounts from people who are finding it all too much?
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PART C: sharing your own experiences
l We are interested to know what you think about sharing your own experiences with other people
(apart from health professionals).
l Have you ever told people who you do not know, or do not know well, about your experiences
of asthma/being a carer/trying to give up smoking? This might be in a face to face support group,
an interview, an article, in an online forum or blog, or in a book. Do you feel you ever would?
l Are there some types of experiences you think people might be more or less likely to tell others about
(expand if possible).
l Are you likely to tell YOUR story on a website? If not, why not?
l Other reasons – would be good to explore this quite thoroughly since not much known about why
people do and don’t.
Final questions
‘Trade-off‘ questions:
l If voluntary organisations and the NHS are going to fund websites what type of content do you think it
is most important for them to provide (could ask respondents to rank the laminated cards and tell
us why)?
l Would you like a summary of the findings in due course?
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Appendix 3 Screenshots shown to the work
package 3b trial interviewees to illustrate types of
health websites available online
Reproduced from Patient Opinion
184 under the terms of the Creative Commons Attribution Licence
(CC BY-NC-SA 4.0).
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Reproduced with permission from the author of the blog post.
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Reproduced with permission from Diabetes Support.185
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Reproduced with permission from NHS Choices.186
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Reproduced with permission from Diabetes UK.187
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Reproduced with permission from Diabetes UK.188
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Appendix 4 Series of eight briefing sheets
produced for dissemination activities
 
 
 
             
 
 
Examining the role of patients’ 
experiences as a resource for choice 
and decision-making in health care. 
 
iPEx Briefing Paper 1
Introduction and background to the iPEx project  
 
 
What is the programme about? 
 
UK health policy values and promotes 
patient choice, self-care, and patient and 
public involvement. These aims cannot be 
achieved unless people can access high 
quality information. Until now this 
information has focussed on facts and 
figures about an illness, the risks of 
treatment options, and the likely outcomes. 
But people seek more than scientific facts. 
They want to know about the experience of 
illness – the reflections, insights and 
practical advice from people who have 
been there – and to be able to share their 
own experiences with others.  
 
The team has internationally recognised 
expertise in making patients’ ‘experiential’ 
information accessible to the public; but the 
scientific base underpinning this activity 
needs strengthening. We remain unsure 
whether, when and how the NHS should 
provide information based on other 
patients’ experiences. How do people find 
and interpret online patient experiences 
and relate it to their own lives? What are 
the positive and negative consequences? 
How might this affect their health and well- 
being? How do we measure these effects? 
This research programme was designed to 
answer these questions. 
 
Work packages 
 
Work package 1 developed the concepts 
and methods to quantify the effects of 
exposure to on-line patient experiences. 
 
Work package 2 identified how and why 
people seek, use and interpret patient 
experiences and establish guidelines for 
presenting patient experiences on-line. 
 
The outputs of work packages 1 and 2 
were integrated to generate a new 
theoretical framework for the online 
exchange of patient experiences. 
 
Work package 3 developed on-line patient 
experience prototype interventions and 
used exploratory trials to investigate their 
effects. 
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The team 
Our team comprises researchers and NHS personnel with unrivalled expertise in innovation and research in 
patients’ experiences, internet use, development of health outcome measures, primary care trials of complex 
interventions, and dissemination of health information. 
 
Principal Investigator 
Sue Ziebland  
Professor of Medical Sociology, 
NIHR Senior Investigator, 
Director, Health Experiences Research Group,  
University of Oxford 
 
Co-investigators 
Robert Gann 
Programme Director, Widening Digital Participation,  
Department of Health  
Sula Wiltshire 
Director of Quality and Innovation, Oxfordshire CCG 
John Powell 
Associate Professor, 
University of Oxford 
Sally Wyke 
Interdisciplinary Chair of Health and Wellbeing,  
University of Glasgow 
Pamela Briggs 
Professor of Applied Psychology, 
Northumbria University 
Rafael Perera 
Professor of Medical Statistics, University of Oxford 
Louise Locock 
Associate Professor, Director of Applied Research,  
Health Experiences Research Group, 
University of Oxford 
Margaret Booth 
A lay representative 
Crispin Jenkinson 
Professor of Health Services Research,  
University of Oxford  
Peter Harris 
Professor of Psychology, University of Sussex 
Andrew Farmer
Professor of General Practice, University of Oxford  
Elizabeth Sillence 
Senior Lecturer in Psychology, Northumbria University 
 
 
 
Researchers 
Fadhila Mazanderani 
Chancellors’ Fellow, University of Edinburgh 
Claire Hardy 
Postdoctoral Researcher, King’s College London 
Laura Griffith 
Lecturer in the Anthropology of Health Care, 
University of Birmingham 
Susan Kirkpatrick 
Senior Qualitative Researcher, University of Oxford 
Nicolas Hughes 
Nursing Lecturer, University of Leeds 
Laura Kelly 
Research Officer, University of Oxford 
Braden O’Neill 
Family Medicine Resident, North York General Hospital, 
University of Toronto 
Nikki Newhouse 
Research Assistant, University of Oxford 
Ly-Mee Yu 
Senior Medical Statistician, CTU, University of Oxford 
Sena Jawad 
Medical Statistician, CTU, University of Oxford 
Mina Davoudianfar 
Clinical Trial Manager, CTU, University of Oxford 
 
Programme co-ordinators 
Ruth Sanders 
Research Delivery Manager, Health Experiences Research 
Group, University of Oxford 
Angela Martin 
Programme co-ordinator,  
Health Experiences Research Group,
University of Oxford 
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Design 
Contact 
Health Experiences Research Group, 
Nuffield Department of Primary Care Health Sciences, 
University of Oxford. 
Tel: 01865 289373 
email: angela.martin@phc.ox.ac.uk 
www.ipexonline.org 
The iPEx programme presents independent 
research funded by the National Institute for Health 
Research (NIHR) under its Programme Grants for 
Applied Research funding scheme (RP-PG-0608-
10147). The views expressed in this briefing sheet 
are those of the authors, representing iPEx, and 
not necessarily those of the NHS, the NIHR or the 
Department of Health.  
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Examining the role of patients’ 
experiences as a resource for choice 
and decision-making in health care. 
 
iPEx Briefing Paper 2  
Work package 1a - Conceptual work  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Objective and approach 
 
 
Our objective was to review the literature in 
order to identify theories, mechanisms of 
action and the potential impact of PEx and 
to establish the conceptual and theoretical 
framework for the broader study. 
 
The PI and another senior member of the 
team reviewed the literature and tabulated 
the findings. 
 
The output of the review was discussed 
with experts in the field and at a user panel 
meeting attended by 30 interested users 
(mostly recruited via the Oxfordshire PCT) 
who were selected to be representative of 
the community as a whole. Input from the 
user panel enabled further modification of 
the table. 
How might exposure to online 
patients’ experiences influence 
health?  
 
The Department of Health is committed to 
giving reliable and timely health information 
to the public and patients. Traditional health 
information has been based on facts and 
figures, not the experiences of patients. 
Many different types of patient experience 
(PEx) are available on-line in health 
information sites, social networking sites 
and on-line support groups. PEx may 
support and inform people but there are 
also concerns, for example people may 
make poor decisions if they identify with 
powerful stories that are not relevant to 
their circumstances. 
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Sue Ziebland and Sally Wyke 
 
Key Messages 
 
The review identified seven domains through 
which online patients’ experiences could affect 
health. Each has the potential for positive and 
negative impacts. 
 
• Finding information 
• Feeling supported 
• Maintaining relationships with others 
• Affecting behaviour 
• Experiencing health services  
• Learning to tell the story 
• Visualising disease 
The literature studied included disciplines such 
as sociology, social and cognitive psychology, 
information sciences, e-health, and health 
services research.   
 
The review: 
 
• underpinned all later stages of the 
programme; 
• clarified which aspects of health are likely 
to be affected by exposure to online PEx; 
• identified different types of PEx and 
theories relevant to the underlying 
mechanisms of action through which PEx 
might operate; 
• identified the different types of outcomes 
that might be relevant to online PEx; 
• contributed to the development of the e-
Health Impact Questionnaire assessment 
tool to be used later in the programme. 
Ziebland S, & Wyke S. (2012). Health and Illness in a 
Connected World: How Might Sharing Experiences on the 
Internet Affect People's Health? Milbank Quarterly, 2012 
Jun; 90(2): 219–249. 
 
Contact 
Health Experiences Research Group, 
Nuffield Department of Primary Care Health Sciences, 
University of Oxford. 
Tel: 01865 289373 
email: angela.martin@phc.ox.ac.uk 
www.ipexonline.org 
The iPEx programme presents independent 
research funded by the National Institute for Health 
Research (NIHR) under its Programme Grants for 
Applied Research funding scheme (RP-PG-0608-
10147). The views expressed in this briefing sheet 
are those of the authors, representing iPEx, and 
not necessarily those of the NHS, the NIHR or the 
Department of Health.  
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Examining the role of patients’ 
experiences as a resource for choice 
and decision-making in health care. 
 
iPEx Briefing Paper 3 
Work package 1b – Secondary analysis of narrative interviews 
 
 
 
 
 
 
 
 
 
 
 
 
  
Background 
 
This programme had access to a 
unique archive of over 2,000 narrative 
interviews which at the time of the 
study covered more than 60 health 
conditions collected by the Health 
Experiences Research Group in the 
Nuffield Department of Primary Care 
Health Sciences at the University of 
Oxford. Through analyses of these 
existing narratives, we have identified 
aspects of health that may be affected 
by exposure to online patient 
experiences (PEx). These can be 
grouped into the broad domains of 
support, knowledge, decision-making, 
self-management, health behaviour, 
and health status. 
Objectives and approach 
 
We analysed 10% of the HERG 
interview archive with the following 
aims: 
 
• To gather evidence about how and 
why online information based on 
other patients’ experience is sought 
and used.  
 
• To select quotes from interview 
transcripts for an ‘item pool’ to 
illustrate participants’ views on their 
use of the internet for health 
information, for a questionnaire 
(the e-health impact questionnaire). 
 
• The qualitative secondary analysis   
using a modified grounded theory 
approach. 
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Health conditions  
 
Interview transcripts on the following health 
conditions were analysed:  
• Neurodegenerative conditions (patients and 
their family carers): motor neurone disease 
(MND), Parkinson’s disease, dementia, 
multiple sclerosis; 
• Young people’s experiences of chronic 
conditions: epilepsy, diabetes (type 1), 
depression, asthma, eczema, chronic pain, 
congenital heart problems, cystic fibrosis, 
epilepsy, kidney disease, chronic fatigue 
syndrome, muscular dystrophy, morphea, 
sickle cell disease and scoliosis; 
• Cancers: leukaemia, pancreatic cancer, 
testicular cancer, cervical intraepithelial 
neoplasia 3 (CIN3);  
• Mental health: ethnic minority experiences, 
psychosis; 
• Learning disability: autism; 
• Conditions of the skeletal system: rheumatoid 
arthritis and osteoporosis. 
Publications 
Mazanderani, F., Locock, L. & Powell, J., (2012). 
Being differently the same: The mediation of identity 
tensions in the sharing of illness experiences. Social 
Science and Medicine, 74 (4): 546-553. 
Locock, L., Mazanderani, F. & Powell, J.,(2012). 
Metaphoric language and the articulation of emotions 
by people affected by motor neurone disease. Chronic 
Illness, 8 (3): 201-213. 
 
Mazanderani, F., Locock, L. & Powell, J., (2013). 
Biographical Value: Towards the conceptualisation of 
the ‘commodification’ of illness narratives in 
contemporary health care. Sociology of Health and 
Illness, 35 (6): 891-905. 
Themes for further analysis 
Potential themes or areas of interest were 
identified for further analysis. These themes 
included: tensions and ambiguities generated 
through accessing other people's experiences, 
questioning the role that the medium used for 
articulating experience plays in negotiating these 
tensions (for example, written stories, 
photographs, film and face to face meetings) and 
issues relating to identification and normalisation 
– the sharing of PEx to make one either feel 
'similar to' or 'different from' someone else.
Fadhila Mazanderani and Laura Kelly 
The iPEx programme presents independent 
research funded by the National Institute for Health 
Research (NIHR) under its Programme Grants for 
Applied Research funding scheme (RP-PG-0608-
10147). The views expressed in this briefing sheet 
are those of the authors, representing iPEx, and 
not necessarily those of the NHS, the NIHR or the 
Contact 
Health Experiences Research Group, 
Nuffield Department of Primary Care Health Sciences, 
University of Oxford. 
Tel: 01865 289373 
email: angela.martin@phc.ox.ac.uk
www.ipexonline.org 
Key dimensions of internet PEx from the 
secondary analysis 
 
• Major charity groups, the NHS and 
pharmaceutical companies remain key 
players in the provision of online 
information, including internet PEx. 
• How people use the internet and the 
information sharing activities they engage in 
are highly specific. 
• When dealing with experiential information 
it is extremely difficult to separate ‘practical’ 
from ‘emotional’ information.  
• The same information may be interpreted 
differently at different times and by different 
people.  
• Questions of identity formation play a key 
role: the tension between developing a 
sense of solidarity and community versus 
illness becoming an all-consuming identity.   
• Sharing experiences of illness has a strong 
ethical dimension as people try to reach out 
and help others. 
Department of Health 
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Examining the role of patients’ 
experiences as a resource for choice 
and decision-making in health care. 
 
iPEx Briefing Paper 4 
Work package 1c – Develop and pilot an assessment tool to capture the health 
effects of exposure to online patient experience 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Background 
 
Trials to evaluate the impact of online 
patient experience need to identify the 
most appropriate outcomes to be 
measured. The range of outcomes is 
potentially large and may be addressed, in 
part, by some existing measures – e.g. 
health status and health-related quality of 
life, emotional adjustment, coping and 
decisional conflict. However, as research 
on online patient experiential information 
is in its infancy, no valid and reliable 
assessment tool existed that is 
appropriate to capture the effects of using 
websites which contain patient 
experiences as well as ‘facts and figures’ 
information.   
Objective and approach 
To develop a tool to measure the impact of 
using health-related websites which contain 
experiential and factual information.         
Our approach was: 
• To inform and construct 
questionnaire items using a 
conceptual literature review and 
secondary qualitative analysis of 
interviews relating to patient and 
carer experiences of using health 
information on the internet.  
• To refine and reduce the number of 
questionnaire items using expert 
and user opinion followed by 
statistical analysis.  
The tool needed to be suitable for use 
across a range of health groups (for 
example, people with long term conditions, 
carers and those viewing websites aimed at 
changing health behaviour. The 
questionnaire also needed to be suitable for 
use with various styles of online information 
(for example, 'facts and figures' information, 
patient experiences information and 
discussion forums). 
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Development of the e-Health Impact Questionnaire 
                             (e-HIQ)
Laura Kelly, Sue Ziebland and Crispin Jenkinson 
Stage 1 
Literature review and qualitative secondary data 
analysis  
Stage 2 
Items developed and assessed using expert opinion 
and cognitive debrief interviews  
Stage 3 
Online questionnaire completion and item reduction 
Stage 4 
Online questionnaire completion. Validity and reliability 
testing of final questionnaire 
 
The e-HIQ-Part 1 consists of 11 items asking 
about a person’s general attitudes towards 
health-related websites.  
 
The e-HIQ-Part 2 consists of 26 items asking 
about a person’s views regarding a specific 
health-related website.  
 
Both parts of the questionnaire have a five 
point response category for all items ranging 
from ‘strongly disagree’ to ‘strongly agree’. A 
person’s score for identified domains (or sub-
scales) within the questionnaire can be 
calculated.  
 
A summary score for each questionnaire part 
can also be calculated. 
 
A translatability assessment of the e-HIQ was 
performed on questionnaire items to confirm 
cultural and linguistic suitability for translation 
in the future.  
Use of the eHIQ 
 
The e-HIQ demonstrates good psychometric 
properties and enables the measurement of 
the impact of using health-related websites 
across a range conditions. This tool has been 
used in the final work package, the randomised 
controlled trial which compared websites using 
‘facts and figures’ to websites containing ‘facts 
and figures’ plus experiential information. It has 
been translated into other languages by 
members of DIPEx International.  Since spring 
2015 the questionnaire has been introduced as 
part of routine feedback on HealthTalk.org   
The assessment tool, referred to as the ‘e-Health 
Impact Questionnaire’ (e-HIQ), was designed to assess 
the impact of using health-related websites. This online 
self-report questionnaire consists of two independent 
parts which have undergone numerous stages of 
development. The use of existing literature, qualitative 
analysis, expert/patient opinion and psychometric 
analyses provide evidence of the validity and reliability 
of the measure. 
 
Kelly L, Jenkinson C and Ziebland S. (2013). Measuring the 
effects of online health information for patients: Item 
generation for an ehealth impact questionnaire. Patient 
Education and Counseling. 2013 Dec; 93(3):433-8.
 
Kelly L, Ziebland S, & Jenkinson C. (in press). Measuring the 
effects of online health information: scale validation for the e-
Health Impact Questionnaire. Patient Education and 
Counseling. 
Contact 
Health Experiences Research Group, 
Nuffield Department of Primary Care Health Sciences, 
University of Oxford. 
Tel: 01865 289373 
email: angela.martin@phc.ox.ac.uk 
www.ipexonline.org 
The iPEx programme presents independent 
research funded by the National Institute for Health 
Research (NIHR) under its Programme Grants for 
Applied Research funding scheme (RP-PG-0608-
10147). The views expressed in this briefing sheet 
are those of the authors, representing iPEx, and 
not necessarily those of the NHS, the NIHR or the 
Department of Health.  
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Examining the role of patients’  
experiences as a resource for choice 
and decision-making in health care. 
 
iPEx Briefing Paper 5 
Work package 2a – Ethnographic observations  
 
 
  
Objective and approach 
 
Building on the conceptual literature review 
(briefing paper 2) and secondary analysis 
(briefing paper 3), the aim of this work 
package was to explore how PEx is 
constructed and exchanged in online MS-
related support groups; and the ways 
people affected by MS (patients, family 
members and friends) respond to and 
interpret PEx-related information in these 
settings. 
 
We used a combination of different 
methods, including: online ethnographic 
observations; targeted content analyses of 
forums and YouTube videos; telephone and 
face-to-face interviews with users and 
people working in relation to the provision 
of experiential information on the internet, 
such as web developers and forum 
moderators (n=24). During the course of the 
research we developed a specific interest in 
how PEx is sought and shared in relation to 
controversial theories and treatments. 
Background  
 
The quality of online health material varies 
greatly. User-generated social networking 
sites, patient forums and reputation systems 
are proliferating. Patient experiential 
information is now offered in many forms – 
ratings, comments, blogs, discussion forums, 
interactive message boards, scripted 
vignettes, stereotypes and short films. 
 
We know that the services available for 
people differs between conditions and that 
people respond to and use online PEx in 
very different ways. We also know that there 
is often a mismatch between what people 
do, and what they say they do, making this a 
very challenging area for academic study.  
 
Given the diverse range of PEx online and 
the variety of experiential information sharing 
practices, in this work package we decided 
to focus specifically on the sharing of PEx in 
relation to Multiple Sclerosis (MS).  
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Contact 
Health Experiences Research Group, 
Nuffield Department of Primary Care Health Sciences, 
University of Oxford. 
Tel: 01865 289373 
email: angela.martin@phc.ox.ac.uk 
www.ipexonline.org 
Fadhila Mazanderani and John Powell 
 
MS-related PEx on the internet 
 
We found three main kinds of MS-related 
PEx and associated practices across the 
platforms we analysed: 
• PEx focused on ‘living with MS’, practical 
information and support (e.g. coping with 
the illness, making life-style adaptations, 
managing benefits etc.). 
• PEx used for creative and other forms of 
self-expression (e.g. poetry, 
autobiographic accounts, humour, 
artistic videos). 
• PEx directly linked to healthcare and 
biomedical research, treatments, policy 
and practices. 
 
This highlights the huge variety of 
information that counts as PEx, but also 
shows how in practice distinctions between 
‘experiential’ and other types of information, 
especially medical, are often blurred. 
 
YouTube and the visualisation of PEx 
 
YouTube has become a popular site for 
sharing patient videos. We conducted a 
quantitative and qualitative analysis of 
videos shared in relation to a controversial 
theory about treatment for MS. These 
videos combined people’s everyday 
embodied experiences of living with MS, 
evidence of medical knowledge and tests, 
with highly visual representations of 
experience pre and post treatment. These 
videos are a powerful but often overlooked 
source of online PEx. 
From ‘experiential knowledge’ to 
‘experiential evidence’? 
 
People affected by MS not only share individual 
PEx, they ‘experiment’ (e.g. with dietary regimes, 
medication and interventions), monitor and 
broadcast their responses online. In some cases 
these experiences are aggregated on different 
forums and sites and used to generate alternative 
forms of 'evidence' built on a hybrid of personal 
experience and medical knowledge (that may or 
may not be recognised as valid). These activities 
have consequences for healthcare practice and 
biomedical research as they can result in patients 
seeking treatments that have not been tested and 
approved, and even cause a break-down in trust 
between healthcare practitioners and patients.  
   
Digital labour and the creation of online 
‘spaces of care’   
 
Very little research has been conducted on the 
understanding of MS development and 
management of platforms and sites for sharing 
PEx. Rather than being neutral conduits, different 
sites and forums shape how and what PEx gets 
shared online. Ensuring these sites are ‘safe’ 
spaces often requires considerable work - often 
invisible and unpaid - from patients as well as 
from people formally employed as website 
managers, editors and moderators. As online 
services and platforms become an increasingly 
central part of contemporary healthcare it is 
essential that more attention is paid to the work 
that goes into the creation of online spaces of 
care. We suggest that this includes an awareness 
of what we have termed the aesthetics of online 
care. This signifies an ethically-sensitive balance 
between the degree to which an internet user 
feels attracted to, attached to and aligned with the 
purpose and values of an online space. 
 
 
Mazanderani F., Powell J. 2013. Using the internet as 
a source of information about patients’ experiences. In: 
Ziebland S, Coulter A, Calabrese JD, Locock L, 
editors. Understanding and Using Health Experiences: 
Improving Patient Care. Oxford: Oxford University 
Press, pp.94-103. 
 
Mazanderani, F., O’Neill, B. & Powell J. 2013. “People 
power” or “pester power”? YouTube as a forum for the 
generation of evidence and patient advocacy. Patient 
Education and Counseling, 93 (3): 420-425. 
The iPEx programme presents independent 
research funded by the National Institute for Health 
Research (NIHR) under its Programme Grants for 
Applied Research funding scheme (RP-PG-0608-
10147). The views expressed in this briefing sheet 
are those of the authors, representing iPEx, and 
not necessarily those of the NHS, the NIHR or the 
Department of Health.  
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Examining the role of patients’  
experiences as a resource for choice 
and decision-making in health care. 
 
iPEx Briefing Paper 6 
Work package 2b – Observational and experimental studies  
 
 
  
Objectives and approach 
 
Acknowledging the diverse quality of online 
patient experience, our aim was to use 
observational and experimental studies to 
find out how people select from the various 
patient experiences available online.   We 
wanted to understand how they used 
patient experience to support or inform their 
own health and life-style choices and also 
to assess how exposure to patient 
experiences might influence recall of health 
material and patient decision-making. 
Key research questions 
 
We addressed the following four research 
questions:  
•  What factors influence patient sampling 
of online patient experience and how do 
patients determine which sites and/or 
experiences merit further attention? 
•  Do patients’ own sampling strategies 
bias their exposure to health information 
and advice? 
•  How does exposure to online patient 
experience influence decision-making 
and other health related outcomes? 
• Does PEx offered in unstructured, 
unregulated settings lead to different 
sampling and outcomes compared to 
more structured sites? 
 
Methods: 
Participatory and exploratory workshops 
and focus groups designed to elicit patient 
opinion of existing sites. 
 
Experimental studies that controlled for the 
design and content of PEx sites in order to 
assess health related impact. 
 
Background  
 
We wanted to find out how people view 
internet patients’ experiences (PEx), 
including what makes an individual trust and 
engage with another patient’s shared 
experience. We produced a set of guidelines 
and design principles for ‘best practice’ 
presentation of PEx on health information 
websites.  
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The iPEx programme presents independent research 
funded by the National Institute for Health Research 
(NIHR) under its Programme Grants for Applied 
Research funding scheme (RP-PG-0608-10147). The 
views expressed in this briefing sheet are those of 
the authors, representing iPEx, and not necessarily 
those of the NHS, the NIHR or the Department of 
Health.  
Pamela Briggs, Elizabeth Sillence, Peter Harris
 
 
Key outputs and papers 
 
Outputs include guidelines for the inclusion of 
experiential information in health information sites. 
These guidelines have been used to develop 
evidence based prototypes for the feasibility trials 
of websites based on patient experience.  
 
 
Briggs, P., Hardy, C., Harris, P.R. and Sillence, E. 
(2014).  Patient-led perspectives on ehealth:  How might 
hyperpersonal data inform design?  Proceedings of 
HCIK, Korea, ACM Press.  
Sillence, E.,  Hardy, C., Harris, P. and Briggs, P. (2014).  
Modelling Patient Engagement in Peer-to-Peer 
Healthcare.  23
rd
 International World Wide Web 
Conference, April 7-11, Korea.
Sillence, E., Hardy, C., Briggs, P. & Harris, P.R. (2013). 
How do people with asthma use Internet sites containing 
patient experiences?  Patient Education and 
Counselling, 93(3): 439-43. 
Sillence, E., Hardy, C., Briggs, P. & Harris, P.R. (2013). 
Online Health Information and Patient Adherence. 
Journal for Patient Compliance, 2 (3), 24-26. 
 
 
Key messages 
 
We developed a PEx engagement 
framework involving a three stage process: 
a gating stage, an engagement loop, and 
finally an outcome stage. A user can exit the 
PEx or website at any point in the 
engagement process. 
1. The first stage – gating – is largely 
concerned with whether the user trusts 
the parent website. If the user is aware of 
the site or organisation (reputation), 
believes the site is impartial, and likes the 
look and feel of the site, they will be more 
inclined to engage with the PEx. 
2.  The second stage of the engagement 
process – the engagement loop – 
addresses four questions the patient asks 
of the material:  
• Who is sharing the experience?  Is the 
PEX from someone like me or someone I 
know? 
• What is shared?  Does the PEX offer the 
right mix and amount of information, 
support and advice?  
• How does it compare with my own 
situation?  Does it reflect my own 
knowledge and experience? 
• Can I share my own experiences – telling 
my own story and adding my voice to the 
others?   
3.  In the third stage, patients assessed the 
outcomes of PEX engagement as: 
learning about their condition, 
understanding the practicalities of 
managing their condition; helping them 
deal with health services, managing 
expectations, motivating themselves 
using positive stories, comprehending the 
seriousness of their condition or outlook, 
and developing supportive relationships 
with others.   
Engagement with patient experiences  
 
People prefer credible, well designed websites 
from which they can examine the PEx in more 
detail. This involves an iterative process during 
which people discover who is making the 
contribution, and assess what is being said in a 
three stage process (detailed opposite).  Patient 
coping strategies may change over time and this 
will be reflected in the nature of their engagement 
with online patient experience. 
Contact 
Health Experiences Research Group, 
Nuffield Department of Primary Care Health Sciences, 
University of Oxford. 
Tel: 01865 289373 
email: angela.martin@phc.ox.ac.uk 
www.ipexonline.org 
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Work package 3a – Development and testing of patient experience web interventions for 
exploratory trials 
 
 
  
Objective and approach 
 
Our objective was to develop 6 websites on 
three conditions which could be password 
protected for the duration of the randomised 
controlled trial.  
 
We used established qualitative research 
methods to explore the experiences, 
information and support needs of people in 
each of the three exemplar groups.  
The research methods were based on those 
used in projects already conducted by the 
Oxford Health Experiences Research Group. 
The comparator (facts and figures) sites 
incorporated NHS Choices information.  
 
We developed multimedia websites featuring 
experiential information (intervention) or facts 
and figures information (comparator) for 
three exemplar health issues, using   
guidelines, developed in this programme, for 
how best to present experiential information 
online.  
 
Background  
 
The feasibility trials required the development 
of six new websites.  As with the rest of the 
iPEx programme, we examined three 
exemplar conditions: asthma, smoking and 
caring for someone with multiple sclerosis 
(MS). 
 
Each project was informed by a literature and 
field review and by the appointment of a 
specialist advisory panel comprising 
researchers, clinicians, lay persons, 
representatives from the voluntary sector and 
other stakeholders.
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Contact 
Health Experiences Research Group, 
Nuffield Department of Primary Care Health Sciences, 
University of Oxford. 
Tel: 01865 289373 
email: angela.martin@phc.ox.ac.uk 
www.ipexonline.org 
The iPEx programme presents independent 
research funded by the National Institute for Health 
Research (NIHR) under its Programme Grants for 
Applied Research funding scheme (RP-PG-0608-
10147). The views expressed in this briefing sheet 
are those of the authors, representing iPEx, and 
not necessarily those of the NHS, the NIHR or the 
Department of Health.  
Laura Griffith, Susan Kirkpatrick, Nicolas Hughes and Ruth Sanders 
Selection of health conditions 
 
We selected the three health conditions to allow us to 
compare different aspects of exposure to facts and 
figures and patient experiences. Our aim was to 
provide transferable lessons for the use of patient 
experiences across other care settings and conditions.  
The topic summaries from the experiential sites did not 
map precisely across to the comparator sites. 
Information derived from patient experiences has a 
different emphasis. The summaries which formed the 
basis of the intervention websites were entirely 
informed by what was important to the study 
participants. websites 
The topic summaries from the experiential sites did not 
map precisely across to the comparator sites. 
 
Key messages 
 
The six websites (three intervention sites 
and three comparator sites) and the 
associated data collection portal were 
constructed with the assistance of an 
external specialist web development team.  
The look and feel of the websites was 
identical. 
 
All websites included topic-specific video 
material from health professionals. 
 
The patient experience sites contained a 
series of topic summaries for each health 
condition, each of which contained video, 
audio, and text excerpts from interviews 
with people with experience of the 
conditions, talking about their personal 
stories. The intervention websites harness 
the full range of personal experience of a 
condition from diverse individuals, and 
provide this in discrete, searchable topic 
areas which can be consumed as videos, 
audio recordings, or written transcripts. 
 
The facts and figures sites were based on 
material from the NHS Choices website. 
 
Versions of the 3 experiential sites were 
published on www.healthtalk.org in early 
2015, after completion of the feasibility 
trials. 
 
 
Publications 
Hughes, N., Locock, L. & Ziebland, S., 2013. 
Personal identity and the role of ‘carer’ among 
relatives and friends of people with multiple 
sclerosis. Social Science and Medicine 96: 78-85. 
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Work package 3b – Feasibility randomised controlled trials 
 
 
 
Objective and approach 
 
A series of exploratory trials in three health 
conditions were undertaken to assess the 
acceptability, feasibility and effect on self-
report and process measures of patient-
experience based websites, in comparison with 
matched health information websites that did 
not contain experiential information. 
 
We recruited people with asthma, smokers 
who wanted to quit, and people who were 
family or friends of someone with MS. We 
wanted to see whether hearing about other 
people’s experiences of managing their chronic 
illness (asthma) might increase confidence to 
self-manage; whether hearing about other 
people’s stories of giving up smoking might 
change people’s motivation to quit; and 
whether hearing carers’ stories, might make 
other carers feel more supported. For each of 
these studies we asked half the participants 
(chosen at random) to look at the intervention 
(experiences) site, and the other half of 
participants to look at the comparison (facts 
and figures) site. Both groups were given two 
weeks to look at the sites, and we asked them 
to fill in questionnaires before and afterwards
 
Background  
 
The sharing of online patient experiences 
could bring health and social benefits in a 
number of ways. One of our interests was to 
explore whether the value of these 
experiences can be harnessed as an 
intervention. We developed prototype 
websites which were either based on patient 
experiences (the interventions) or which only 
contained ‘facts and figures’ (comparators). 
All the websites had the same ‘look and feel’ 
and were designed in accord with the 
guidelines developed during this programme 
(see Briefing Paper 6).  
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